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Abstract  
 
Faithful chromosome segregation cannot be achieved without correctly aligning each 
chromosome pair, a process referred to as chromosome biorientation. Disabling the 
key mitotic kinase Polo like kinase 1 (PLK1) is known to impair multiple aspects of 
mitosis, particularly chromosome alignment. This is believed primarily due to 
unstable bipolar spindle-kinetochore attachments. However, contrary to this belief, 
PLK1 inactivation does not necessarily abolish metaphase establishment. Instead, it 
is shown to interfere with its long-term maintenance. This study has demonstrated 
that the failure of chromosome biorientation maintenance is driven by a previously 
undescribed mechanism that relies on PLK1 activity. Without active PLK1 during 
mitosis, BLM helicase is illegitimately recruited to and unwinds a specific centromere 
domain underneath the kinetochores. This recruitment is dependent on PICH 
translocase and leads to the impairment of centromere configuration and rigidity. 
Concurrently, bipolar spindle pulling forces enhance this centromere destructive 
pathway. During an absence of PLK1 activity, but under active spindle pulling forces, 
the distorted centromeric chromatin is promptly converted into an ultra-fine DNA 
structure. This has been referred to as ‘pre-anaphase DNA threads’, in order to 
distinguish them from the previously identified ultra-fine DNA bridges (UFBs) that 
form during anaphase. These new fragile DNA thread structures subsequently fail to 
withstand spindle tension. This results in centromere deformation that displays as 
whole-chromosome arm splitting, which has been termed as ‘centromere 
dislocation’. This severely damages centromere integrity, whilst also destroying 
normal metaphase maintenance. Therefore, PLK1 serves as a centromere guardian 
in order to protect centromeres against deformation, which is driven by a PICH/BLM-
mediated chromatin unwinding activity. 
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Chapter 1: Introduction  
 
1.1 Overview of Introduction  
 
Faithful transmission of the genome during cellular division relies on various processes 
for its attainment. Cells must accomplish accurate genome duplication during DNA 
replication, whilst also ensuring that the newly synthesised DNA molecules remain 
connected until mitosis. In addition, the duplicated DNA molecules must undergo 
distinct organisation and arrangement. An interference in the action of any one of these 
processes can lead to errors in chromosome transmission and drive the progression of 
numerical chromosome instability (CIN). This is often displayed as an inheritable loss or 
gain of chromosome number, otherwise referred to as aneuploidy. The unequal 
inheritance of chromosome number is typically observed in a number of different 
cancers and can be attributed to errors in chromosome segregation (Vargas-Rondón et 
al. 2018). Better understanding of how such erroneous segregation arises remains 
critical to the understanding of certain disease progression, including the development 
of cancer. 
 
Error-free chromosome segregation relies on fully duplicated condensed chromosomes 
being closely aligned during metaphase. This follows a process known as chromosome 
biorientation, which is achieved through bipolar attachment of the mitotic spindle to 
each chromosome. The mitotic spindle emanates from opposite poles of the cell, 
capturing sister chromatids at distinct genomic regions known as centromeres 
(McKinley and Cheeseman 2016). This specialist attachment by the mitotic spindle 
requires the pre-assembly of a macromolecular protein complex termed as the 
kinetochore (KT). Each KT is arranged at opposite sides of every centromere, which 
results in the formation of sister KT structures. Subsequently, sister KTs are then able to 
provide a foundation for the bipolar connection between the centromere and mitotic 
microtubules (MT) (Hinshaw and Harrison 2018). Once each chromosome has 
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established bipolar orientation and attachment, sister-chromatid separation can ensue 
during anaphase. This results in the equal distribution of duplicated genetic material 
into two identical daughter cells (Fig. 1.1).  
 
This multifaceted process of protein assembly and chromosome capture is tightly 
regulated, whilst also being monitored by a sophisticated surveillance mechanism. This 
surveillance system is referred to as the spindle assembly checkpoint (SAC) and 
functions to survey the status of spindle attachment. The detection of MT-attachment 
errors results in prolonged SAC activation and subsequently, anaphase progression is 
inhibited (Foley and Kapoor 2013; Heald and Khodjakov 2015). This inhibition is achieved 
by suppression of the anaphase promoting complex/cyclosome (APC/CCDC20) (Musacchio 
and Salmon 2007). Hence, cells with incorrectly aligned chromosomes can be prevented 
from progressing into anaphase. Only when stable bipolar attachment is achieved 
(chromosome biorientation) can the SAC become satisfied. Consequently, the 
APC/CCDC20 becomes active and processes involved in achieving faithful chromosome 
segregation can ensue (Peters and Nishiyama 2012).  
 
However, maintaining faithful chromosome segregation is not attained by simply 
upholding stable MT-KT attachment and SAC regulation. As previously eluded to, the 
correct assembly and organisation of chromosome architecture is also critical. Cohesion 
of sister chromatids must be maintained throughout DNA replication and requires its 
timely release during mitosis. Cohesion of sister chromatids is achieved through the 
action of SMC-containing complexes known as cohesin, which function to grasp the 
duplicated DNA molecules in order to hold them together (Nasmyth 2011). In addition, 
mitotic chromosome compaction is facilitated by the action of a structurally related SMC 
complex, known as condensin (Hirano 2005). Therefore, both cohesin and condensin 
function to ensure the correct assembly and organisation of chromosome architecture 
and hence provide crucial support to achieve faithful chromosome segregation.  
 
Figure 1.1. Typical progression of the cell cycle.
a) Representative image of a single chromosome, depicting the centromere, kinetochore
and sister-chromatid cohesion by cohesin complexes. b) Diagram to depict each stage of
the cell cycle. During DNA replication (S phase), sister chromatid cohesion is established. On
entry into mitosis, the duplicated DNA is condensed by the action of condensin. This leads
to the formation of distinct mitotic chromosomes during prophase. During prometaphase,
microtubules begin to attach to sister kinetochores. At metaphase, chromosomes align at
the centre of the cell due to bipolar spindle attachment (chromosome biorientation). This
promotes sister-chromatid disjunction and supports equal chromosome transmission
during anaphase.
Prophase
Prometaphase
Metaphase
Anaphase
Telophase
G1
S-phase
G2
Sister chromatids
Cohesin complexes
Centromere
Kinetochore
Microtubules
a b
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In addition to the aforementioned features that ensure faithful chromosome 
segregation, cellular mechanisms functioning as late as anaphase have also been 
attributed to securing accurate transmission of the genome. It has been shown that 
separating sister chromatids are able to remain intertwined by DNA linkages, despite 
commitment to anaphase. These DNA linkages can take the form of bulky anaphase 
bridges, which are detectable through the use of conventional DNA staining methods 
such as DAPI; or alternatively, ultra-fine DNA bridges (UFBs). Unlike bulky anaphase 
bridges, UFBs are detectable by protein association rather than by conventional DNA 
staining methods (Baumann et al. 2007; Chan et al. 2007; Chan and Hickson 2009). UFBs 
can originate at various distinct chromosomal locations. These include centromeres, 
telomeres, ribosomal DNA (rDNA) regions and common fragile sites (CFS) (Fernández-
Casañas and Chan 2018). UFBs are generally considered to be unresolved double-
stranded DNA (dsDNA) catenanes, but it remains unclear whether dsDNA catenanes 
best describes the origin of all UFB formation(s). UFBs become observable through the 
detection of a distinct set of proteins, collectively referred to as the UFB-binding 
complex. The core of this complex consists of PICH (PLK-interacting checkpoint helicase), 
BLM (Bloom’s syndrome helicase) and one of BLMs interacting partner proteins, 
Topoisomerase III (TOP3) (Baumann et al. 2007; Chan et al. 2007). It is generally 
believed that the UFB-binding complex functions to resolve unprocessed DNA 
intertwinements, thereby functioning to promote faithful chromosome segregation 
(Fernández-Casañas and Chan 2018). However, the regulation and precise molecular 
mechanism of UFB resolution continues to be explored.   
 
Many of the mechanistic processes involved in maintaining faithful chromosome 
segregation requires regulatory control by protein kinases. The activity of the mitotic 
kinase Polo-like kinase 1 (PLK1) has been attributed to several key events during mitosis 
(Barr et al. 2004; Zitouni et al. 2014). This includes a requirement for PLK1 activity during 
stable MT-KT attachment, an essential feature of chromosome biorientation (Barr et al. 
2004; Lénárt et al. 2007; Sunkel and Glover 1988). Cells lacking PLK1 activity have been 
shown to display gross chromosomal mis-alignment patterns and this has been 
accredited to a failure of cells to correctly maintain stable MT-KT attachment (Lénárt et 
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al. 2007; Steegmaier et al. 2007). However, a precise molecular mechanism to fully 
explain this remains undescribed. Therefore, further investigation into the loss of 
function of PLK1 during mitosis may help to explain how PLK1 facilitates chromosome 
biorientation and promotes faithful chromosome segregation. In addition, PLK1 
inactivation experiments may also help to reveal how UFB-binding proteins could be 
regulated.  
 
PICH, one of the core UFB-binding proteins was originally identified through its 
interaction with PLK1 and both proteins display matching localisation patterns at 
kinetochores during mitosis (Baumann et al. 2007). Therefore, PLK1 may provide a 
regulatory role for PICH activity. However, a definitive explanation of PICH function and 
regulation remains uncertain. PICH has been shown to display evidence of DNA 
manipulation during in vitro studies and also displays a preference for recruiting to DNA 
molecules that are subject to increasing tension (Baumann et al. 2007; Biebricher et al. 
2013). Consistent with this, PICH localises to centromeres, the principal site of tension 
during chromosome alignment. During chromosome biorientation, centromeric DNA 
encounters extensive pulling forces by the mitotic spindle and likely requires constant 
condensation activity to counteract this pulling. Therefore, the spatiotemporal 
localisation of PICH at kinetochores may support a functional role in maintaining 
centromeric DNA architecture, during chromosome biorientation. Thus, it is tempting to 
speculate that PLK1 may provide regulatory control for PICH activity and/or other UFB-
binding proteins. Therefore, investigating the effects of PLK1 inactivation during 
chromosome biorientation will help to explore this hypothesis.    
 
The following chapter will discuss and highlight some of the essential processes involved 
in ensuring faithful chromosome segregation. This will begin by discussing the 
importance of the structural organisation of chromosomes, which is generally achieved 
by the action of both condensin and cohesin complexes. In addition, it will highlight how 
cohesin maintenance is linked to the regulation of the mitotic checkpoint. An overview 
of centromere establishment and kinetochore assembly will also be discussed. This will 
include how errors in MT-KT attachment are believed to be corrected and thereby 
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safeguarding chromosome biorientation. Furthermore, the last steps of segregation will 
be considered, concentrating on the formation of UFB structures during anaphase, 
whilst also detailing the key proteins believed to be involved in their resolution. This will 
include PICH, BLM and the mitotic kinase PLK1. Finally, the results sections will discuss 
the experiments undertaken and provide data to support the findings that identify PLK1 
as a critical component for the protection of centromeres during mitosis (Addis Jones et 
al. 2019). 
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1.2 Chromosome organisation by the action of condensin complexes  
 
Chromosomes must be correctly assembled into three-dimensional chromatin 
structures in order for accurate sister chromatid separation to occur. Distinct 
chromosome assembly is largely accomplished by the action of condensin complexes 
(Hirano 2005). This is achieved during the initial stages of mitosis, although early 
chromosome assembly may also begin during interphase (Hirano 2016). The depletion 
of condensin complexes has been shown to lead to segregation defects, in particular 
chromatin bridges and cytokinesis failure (Hudson et al. 2003; Ono et al. 2003). 
Therefore, the establishment of condensed chromosomes during mitosis, via the action 
of condensin complexes, remains critical for ensuring faithful chromosome segregation. 
 
1.2.1 Condensin structure and how it dictates mitotic chromosome assembly 
 
Most eukaryotes contain two multi-subunit condensin complexes, condensin I and II. 
Structurally, each condensin complex shares the same core structural maintenance of 
chromosome (SMC) heterodimer. This consists of SMC2 and SMC4, which interact at the 
hinge domain such that together the coiled-coil arms (SMC2 and SMC4) adopt a V-like 
shape. A non-SMC subunit (Kleisin) forms a bridge between the SMC arms, completing 
the formation of a ring-like structure (Hirano 2016). This configuration is believed to 
enable SMC containing proteins to participate in DNA entrapment (Hirano and Hirano 
2006; Nasmyth 2011). Condensin I and II can each be distinguished by structural 
differences in their non-SMC regulatory subunits. This includes a Kleisin subunit (CAP-H 
and H2) and a pair of HEAT subunits (CAP-D2/G and CAP-D3/G2) (Hirano 2016) (Fig. 
1.2a). However, despite a detailed understanding of condensin structure, it remains 
unclear how the ring-like condensin complex is able to organise chromatin correctly.  
 
It is largely agreed that condensin activity directly contributes to achieving the rod-
shaped chromosomes observed during mitosis (Hirano 2005, 2012, 2016). However, a 
precise molecular mechanism to explain how the mitotic chromosome is assembled 
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continues to be uncertain (Sakai et al. 2018). Despite this ambiguity, condensin 
promotes the formation of chromatin loops and the consecutive arrangement of such 
chromatin loops is the likely basis for chromosome assembly during mitosis (Gibcus et 
al. 2018; Sakai et al. 2018). However, explaining how such chromatin loops are organised 
remains a topic for debate in the field.  
 
It is clear that mitotic chromosomes rely on condensin activity for their correct 
assembly. This has been demonstrated by depletion experiments. Following the 
depletion of condensin I, mitotic chromosomes become disorganised, being described 
as ‘swollen’ in appearance. In contrast, depletion of condensin II leads to a different 
chromosome disorganisation, described as ‘curly’ in shape (Ono et al. 2003). These 
observable architectural alterations highlight the importance of both condensin 
complexes to achieve the correct cylindrical shape of mitotic chromosomes. It has also 
been demonstrated with the use of Xenopus extracts that condensin I contributes to the 
lateral compaction (i.e. inward compaction) of chromosome architecture, along with 
another SMC containing complex cohesin (discussed in next section).  In contrast, 
condensin II can provide axial shortening (i.e. top to bottom compaction) aiding in 
correct chromosome assembly (Shintomi and Hirano 2011) (Fig. 1.2b). These findings 
provide a logical explanation of how condensin functions to achieve the rod-like shape 
of mitotic chromosomes.  
 
1.2.2 Activation and spatiotemporal regulation of condensin  
 
Condensin activity is regulated by different phosphorylation events (Bazile et al. 2010). 
Early in vitro studies inferred that cyclin dependent kinase 1 (CDK1) phosphorylation of 
condensin was able to promote its activity (Kimura et al. 1998). Recent reports have 
confirmed that CDK1-dependent phosphorylation was sufficient for condensin I activity 
(Shintomi et al. 2015). In addition, PLK1 has been reported to phosphorylate condensin 
II at a site on one of its non-SMC subunits, CAP-H2 (Kagami et al. 2017). This PLK1 
dependent phosphorylation occurs after the initial CDK1 ‘priming’ phosphorylation (St-
Figure 1.2. Mitotic chromosome assembly by condensin complexes.
a) Diagram to illustrate the structural features and components of Condensin I and
Condensin II. b) Condensin plays vital roles in chromosome compaction and organisation,
generating the distinctive mitotic chromosome architecture. DNA is organised around
nucleosomes, which forms chromatin structures. Condensin supports the arrangement of
chromatin loops, and influences how mitotic chromosomes are arranged. Condensin I is
required for lateral compaction of chromatin loops (red lines), whilst condensin II may
function to promote axial shortening (grey arrows) (diagrams adapted from Robellet, et al.
2017; Antonin & Heumann 2016; Hirano & Tatsuya 2012).
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CAP-H CAP-H2
CAP-G CAP-D3 CAP-G2
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Pierre et al. 2009). Therefore, it has been suggested that CDK1-dependent 
phosphorylation promotes the initial stages of condensin activity, whilst PLK1 
phosphorylation may ensure continual condensation as CDK1 levels begin to drop during 
late mitosis (Bazile et al. 2010). Therefore, PLK1 may ensure the continual compaction 
of chromosomes during later stages of mitosis. This highlights how essential processes 
involved in chromosome organisation and assembly require phosphorylation for their 
appropriate function.     
 
The spatiotemporal regulation of each condensin complex is remarkably different. 
Condensin I can access nuclear chromatin following nuclear envelope breakdown 
(NEBD) and is exported out of the nucleus following mitotic exit (Ono et al. 2004). This 
would suggest that condensin I can only play a role in chromosome compaction during 
mitosis. In contrast, condensin II is present within the nucleus of interphase cells and 
has been reported to begin contributing to chromosome condensation as early as S 
phase (Ono et al. 2004, 2013). Inappropriate condensin activity during S phase is likely 
to have detrimental consequences. Therefore, condensin II interphase function(s) are 
probably tightly regulated. In support of this, a study using Xenopus laevis cell free 
extracts showed that mutations in the human MCPH1 protein resulted in an inhibitory 
function against condensin II activity during interphase. In humans, mutations in MCPH1 
have been shown to result in primary microcephaly, highlighting the potential dangers 
of unregulated compaction of DNA before mitosis onset (Yamashita et al. 2011).  
 
It remains uncertain whether condensin I and II have overlapping roles in chromosome 
organisation. Interestingly, both yeast species Saccharomyces cerevisae and 
Schizosaccharomyces pombe only contain condensin I. In contrast, vertebrates and 
plants contain both condensin I and II (Hirano 2005, 2012). Therefore, questions have 
arisen regarding the need for two condensins, unless they hold distinct functions. 
Depletion experiments across various different model systems have led to conflicting 
results regarding the activity of individual condensin complexes, something referred to 
as the ‘condensin paradox’ (Hirano 2016). However, depletion experiments in human 
HeLa cells demonstrated a need for both condensin I and II complexes in order for 
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correct mitotic chromosome assembly (Ono et al. 2003). Therefore, these experiments 
would imply that the activation and spatiotemporal control of condensin complexes 
remains critical to mitotic chromosome assembly.   
 
1.2.3 Condensin ensures correct centromere/kinetochore structure 
 
In addition to the critical role condensin plays in the assembly of chromosome 
architecture during mitosis, it has also been suggested that the function of condensin at 
the centromere/kinetochore is key to maintaining faithful chromosome segregation. 
Condensin I, and in particular condensin II, have been reported to concentrate at inner 
kinetochore regions (Ono et al. 2003, 2004). This could suggest that condensin plays a 
key role in correct centromere/kinetochore arrangement, especially as spindle pulling 
forces may disrupt chromosome centromere DNA compaction and organisation. The 
depletion of condensin in HeLa cells has been shown to result in kinetochore structure 
and function abnormalities, leading to chromosome misalignment and segregation 
defects (Ono et al. 2004; Samoshkin et al. 2009). Notably, the misalignment defects 
reported were due to errors in KT-MT attachment (Samoshkin et al. 2009). This was 
highlighted as merotelic attachments, which describes how a single kinetochore can 
bind microtubules from both spindle poles rather than one (Gregan et al. 2011). The 
segregation defects reported were due to an increase in chromosome bridge formation 
(Samoshkin et al. 2009). Therefore, condensin could function to correctly arrange 
chromatin composition, possibly at regions of the chromatin beneath kinetochores and 
thereby facilitating correct kinetochore assembly.  
 
In support of this idea, the same study also showed that condensin is required for the 
deposition and maintenance of CENP-A, the centromere specific histone variant that is 
an essential component for kinetochore assembly (discussed in section 1.4). Condensin 
depletion led to a reduction in detectable newly synthesised CENP-A at the centromere 
(Samoshkin et al. 2009). The deposition of CENP-A at centromeres acts as the foundation 
for building the centromere-kinetochore axis (McKinley and Cheeseman 2016). 
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Therefore, a disruption to this assembly may well interfere with centromeric chromatin 
arrangement and consequently effect kinetochore assembly. This could suggest that 
condensin activity at the centromere is required for the establishment and possibly the 
maintenance of correct centromeric chromatin. In support of this idea, Samoshkin et al 
reported that the centromere architecture was altered, leading to the detection of 
centromere/kinetochore stretching. They showed a distortion of both outer kinetochore 
components BUB1 and HEC1, along with CENPA and core centromere region elongation, 
as displayed by CREST staining. The apparent stretching was dependent on microtubule 
tension, as co-treatment with nocodazole abolished the signs of 
kinetochore/centromere distortion (Samoshkin et al. 2009). These findings could 
support the idea that condensin activity may be required to counteract microtubule-
spindle pulling forces. Therefore, condensin activity is probably required for correct 
centromere/kinetochore assembly and maintenance, perhaps by ensuring centromere 
rigidity. 
 
In partial agreement with this idea, it has also been suggested that condensin is 
responsible for determining centromere chromatin stiffness. An absence of condensin 
in chicken DT40 cells has been shown to lead to mitotic delays, caused by a disruption 
in spindle checkpoint silencing. This was attributed to core centromeric chromatin 
deformation and weakening, rather than a disruption to chromatin near the kinetochore 
(Ribeiro et al. 2009). However, a later study described a lack of detectable kinetochore 
phenotypes after condensin depletion (Green et al. 2012). This highlights some of the 
conflicting reports that exist regarding condensin function at the 
centromere/kinetochore. However, the differences reported between core centromere 
distortion and kinetochore stretching could simply be due to disparities in the cellular 
systems examined (HeLa vs. DT40).  
 
In summary, although disparities remain between experimental systems it is generally 
agreed that condensin plays a vital role in mitotic chromosome assembly. In particular, 
condensin ensures that centromeres are correctly arranged, which enables faithful 
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chromosome segregation. However, condensin is not the only factor to ensure 
structural integrity of chromosomes.  
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1.3 Sister-chromatid cohesion is mediated by cohesin   
 
During DNA replication cells must generate identical copies of their genome in order for 
equal transmission into daughter cells. Chromatinisation of the duplicated DNA 
molecules establishes the formation of sister chromatids, which must remain together 
throughout S-phase and only begin separation during anaphase. This physical 
attachment is referred to as sister chromatid cohesion and is essential for chromosome 
biorientation. In particular, chromosome biorientation requires persistent centromeric 
sister chromatid cohesion to counteract the pulling forces generated by microtubules. 
This ensures the correct bipolar alignment of chromosomes during metaphase. 
Therefore, cohesion between sister chromatids can be considered to facilitate the 
symmetrical segregation that occurs during faithful chromosome separation (Peters 
2012). Defects in chromosome cohesion can lead to the unequal distribution of genetic 
material and result in aneuploidy, a major cause of non-viable pregnancies (Munné et 
al. 2007). Therefore, understanding how sister chromatid cohesion is established and 
maintained, is key to explaining how cells prevent such erroneous outcomes. Although 
sister chromatid cohesion can be influenced by more than one factor, such as DNA 
entanglements generated during DNA replication (Holm 1994), the principal mediator 
of cohesion comes from the action of a multi-subunit protein complex called cohesin 
(Nasmyth 2001). 
  
1.3.1 Structural composition of the cohesin complex 
 
Cohesin is a member of the SMC complex family and has structural similarities to 
condensin (Nasmyth and Haering 2005). Much like condensin, cohesin forms a ring-like 
structure, which consists of two SMC coil-coiled arms and a non-SMC containing Kleisin 
subunit. Cohesin features two SMC proteins, SMC1 and SMC3. The Kleisin subunit 
(Scc1/RAD21) forms a bridge between these two SMC arms (Haering et al. 2002). In 
addition to this core structure, cohesin complexes also contain further subunits. These 
include the Scc3 subunit in yeast or stromal antigen SA/STAG in higher eukaryotes. 
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Further still, vertebrates contain at least two SA/STAG proteins, called SA1 and SA2 
(Losada et al. 2000; Sumara et al. 2000). The Scc3/SA subunit binds directly to the Kleisin 
subunit (Scc1/RAD21), whilst several other factors also interact with the Scc1 and 
Scc3/SA subunits. These include PDS5, sororin and WAPL (Nasmyth and Haering 2005) 
(Fig. 1.3a). These additional factors are believed to dictate the dynamic association of 
cohesin on the DNA.  
 
1.3.2 Regulation of cohesin loading onto DNA and its activity  
 
Cohesion of sister chromatids by cohesin ensures that duplicated sister chromatids are 
maintained together until anaphase, a pre-requisite for faithful chromosome 
segregation. Loading of cohesin complexes onto the DNA begins prior to S phase, whilst 
sister chromatid cohesion is only established during DNA replication (Uhlmann and 
Nasmyth 1998). The ring-like structure of cohesin is thought to embrace the duplicated 
DNA molecules (Haering et al. 2008; Nasmyth 2011) and its loading onto the DNA relies 
on ATP hydrolysis (Arumugam et al. 2003). An additional complex, referred to as adherin 
(Furuya et al. 1998), or kollerin (Nasmyth 2011), is further required for cohesin 
recruitment. The adherin/kollerin complex is formed of two subunits, Scc2-Scc4 in 
budding yeast (Ciosk et al. 2000), or NIPBL-MAU2 in mammals (Visnes et al. 2014). It is 
believed that a transient opening of the cohesin ring facilitates its loading (Gruber et al. 
2006), whilst its establishment during S-phase is mediated by the essential 
acetyltransferase activity of Eco1 (ESCO1/2 in mammals) (Fig. 1.3b) (Hou and Zou 2005; 
Ben-Shahar et al. 2008; Skibbens et al. 1999; Tóth et al. 1999). Once fully established, 
cohesin then ensures cohesion of sister chromatids until its timely release during 
mitosis. Without such stable association between duplicated sisters, equal segregation 
of chromosomes would be severely affected. Therefore, along with condensin, cohesin 
also ensures correct chromosome organisation. 
 
 
 
Figure 1.3. Sister chromatid cohesion is established and maintained by cohesin.
a) Diagram shows the key structural components of the SMC complex, cohesin. b) Loading
and establishment of sister chromatid cohesion. NIBPL-MAU2 promotes cohesin loading
during telophase/G1. Acetylation of cohesin by ESCO1/2 acetyltransferase during S phase
leads to cohesin establishment. Sororin acts to inhibit WAPL-dependent cohesin release
(diagrams adapted from Gligoris & Löwe 2016; Peters and Nishiyama 2012).
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1.3.3 A two-step process of cohesin removal during mitosis 
 
The cohesin mediated connection that arises between sister chromatids must be 
disconnected during mitosis, allowing each sister to be transported to opposite poles of 
the cell during anaphase. In vertebrates, the removal of cohesin complexes occurs in a 
two-step process. The majority of arm cohesin is removed during early mitosis, during a 
process referred to as the ‘prophase pathway’ (Waizenegger et al. 2000). In contrast, 
centromeric cohesin continues to remain established during early mitosis (Waizenegger 
et al. 2000). Only following the onset of anaphase do cells allow the timely cleavage of 
centromeric cohesin, along with any remaining arm cohesin complexes via the activation 
of a protein called separase (Uhlmann et al. 1999, 2000). Therefore, cohesin maintains 
chromosome structure throughout S-phase and ensures a stable connection between 
sisters for equal separation during anaphase (Fig. 1.4a, b).   
 
1.3.4 Dissociation of cohesin during the ‘prophase pathway’ 
 
Cohesin removal during interphase and early mitosis is dependent on the activity of 
WAPL (Gandhi et al. 2006; Kueng et al. 2006). Sororin, which acts as an inhibitor of 
WAPL, antagonises WAPL-dependent cohesin removal (Nishiyama et al. 2010; Rankin et 
al. 2005). Sororin is thought to displace WAPL from interacting with PDS5 and the 
resulting conformational change to the cohesin complex is thought to prevent WAPL-
dependent release of cohesin (Fig. 1.4a) (Nishiyama et al. 2010). WAPL is thought to 
remain connected to the cohesin complex as there are no reports to suggest that it 
totally dissociates. This may allow cohesin to be rapidly loaded and released, without 
physical cleavage of cohesin subunits (Fig. 1.4a). This mechanism of cohesin release 
occurs throughout interphase, as WAPL depletion during this time leads to increased 
time of cohesin association to the DNA (Kueng et al. 2006). 
  
Cohesin release during prophase is regulated by WAPL and phosphorylation of the SA2 
subunit (Hauf et al. 2005). This is achieved by the action of the mitotic kinase PLK1 
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(Sumara et al. 2002), although additional kinases such as CDK1 and Aurora B may also 
contribute (Fig. 1.4a) (Losada et al. 2002). Therefore, during mitosis the mitotic kinases 
dictate the release of cohesin, through activation of the ‘prophase pathway’. WAPL is 
antagonised by sororin and sororin inactivation is also dependent on phosphorylation 
(Nishiyama et al. 2010). This has been reported to be achieved by both PLK1 (Zhang et 
al. 2011) and CDK1 (Dreier et al. 2011). Therefore, mitotic kinases promote a reduction 
in sororin activity during mitosis, which leads to an increase in WAPL-dependent cohesin 
release and subsequently activation of the ‘prophase pathway’ (Fig. 1.4a).  
 
In addition, the adherin/kollerin complexes are also removed from chromosomes during 
prophase (Gillespie and Hirano 2004; Watrin et al. 2006), suggesting that cohesin is 
prevented from being loaded onto the DNA during this stage. Therefore, mitotic kinases 
influence both the WAPL-dependent release of cohesin, and cohesin complex 
recruitment. This allows cells to achieve rapid cohesin release during the prophase 
pathway, although some cohesin must remain, in particular centromeric cohesin.    
 
1.3.5 Centromeric cohesin is cleaved by separase 
 
Centromeric cohesin is critical for the bipolar orientation that chromosomes adopt 
during metaphase. The majority of arm cohesin is removed during the prophase 
pathway, whilst centromeric cohesin is maintained (Waizenegger et al. 2000). 
Centromeric cohesin is protected by shugoshin activity, which ensures the maintenance 
of centromeric cohesion until the onset of anaphase (Fig. 1.4a). Shugoshin (SGO1) is a 
centromeric protein, which was shown to influence chromosome segregation and 
depletion experiments demonstrated its protective role in maintaining centromeric 
cohesion (Kitajima et al. 2005; Salic et al. 2004).  
 
Unlike the WAPL-dependent release of cohesin during the prophase pathway, 
centromeric cohesin requires cleavage by a protein called separase (Uhlmann et al. 
1999, 2000). Centromeric cohesin is protected from WAPL-dependent release by 
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shugoshin (SGO1) in a complex with protein phosphatase 2A (PP2A) (Kitajima et al. 
2006). The SGO1-PP2A protein complex is recruited to centromeres, where SGO1 shields 
centromeres from WAPL, whilst PP2A counteracts the phosphorylation of cohesin 
subunits by the mitotic kinases (Fig. 1.4a) (Gutiérrez-Caballero et al. 2012). These 
phosphorylation events would ordinarily promote cohesin release during the prophase 
pathway (see above). However, SGO1-PP2A functions to protect against this and 
ensures centromeric cohesin is maintained until anaphase. Centromeric cohesin can 
only be removed by the action of separase. Separase cleaves the Scc1/RAD21 subunit of 
cohesin and thereby triggers the release of cohesin through the physical opening of its 
ring-like structure (Uhlmann et al. 1999, 2000). Separase activity is suppressed by the 
inhibitory action of its interacting partner securin (Esp1 in S. cerevisiae). Removal of the 
inhibitory signal by securin on separase is associated with anaphase onset (Uhlmann et 
al. 2000) and this is intricately linked to the activation of the mitotic checkpoint (Fig. 
1.4a, b).  
 
1.3.6 Centromere cohesin cleavage is linked to the mitotic checkpoint  
 
Faithful chromosome segregation during anaphase requires the timely cleavage of 
centromeric cohesin by seperase (Hauf et al. 2001). This is only achieved when all 
chromosomes are aligned correctly during metaphase, thereby satisfying the mitotic 
checkpoint. The mitotic checkpoint, otherwise referred to as the spindle assembly 
checkpoint (SAC), functions to survey the status of kinetochore-microtubule (KT-MT) 
attachments (Lara-Gonzalez et al. 2012). Errors in KT-MT attachment maintains 
activation of the SAC, thereby ensuring that cells do not enter anaphase prematurely 
(Rieder et al. 1995). Hence, cells are protected against possible chromosome 
missegregation events due to KT-MT attachment errors and premature segregation.  
 
The SAC is comprised of a group of proteins known as MAD (mitotic-arrest deficient) (Li 
and Murray 1991) and BUB (budding uninhibited by benzimidazole) (Hoyt et al. 1991). 
These are MAD1, MAD2 and BUBR1 (MAD3), along with BUB1 and BUB3. The SAC is 
Figure 1.4. Cohesin release by WAPL and cleavage by seperase.
a) Following cohesin establishment during S-phase, cohesin is released during prophase via
a WAPL-dependent mechanism during the ‘prophase pathway’. The mitotic kinases CDK1
and PLK1 influence WAPL-dependent release of cohesin, by targeting both the SA2 and
sororin subunits of cohesin. In contrast, centromeric cohesin remains established until
anaphase onset. SGO1-PP2A counteracts mitotic kinase phosphorylation at the
centromere, ensuring centromere cohesin remains until commitment to anaphase.
Commitment to anaphase is achieved via the activation of the anaphase promoting
complex/cyclosome (APC/C), which triggers the release of securin, thereby enabling
seperase-dependent cleavage of centromere cohesin. b) Schematic diagram to represent
cohesin release and cleavage during mitotic progression. During S/G2 phase cohesin
remains established. During prophase the WAPL-dependent cohesin release at
chromosome arms occurs, due to the activation of the prophase pathway. The APC/C
remains inactive and securin prevents seperase activity. Commitment to anaphase leads to
APC/C activation and seperase dependent cleavage of centromere cohesin (diagram
adapted from Peters and Nishiyama, 2012).
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active during early mitosis and its primary function is to prevent the precocious 
separation of sister chromatids (Lara-Gonzalez et al. 2012; Musacchio and Salmon 2007; 
Taylor et al. 2004). Specifically, the SAC functions to negatively regulate the anaphase 
promoting complex/cyclosome (APC/C), an E3-ubiquitin ligase that targets proteins for 
degradation via the 26S proteasome (Lara-Gonzalez et al. 2012). The SAC achieves this 
by targeting the APC/C co-activator CDC20, via protein phosphorylation (Ciosk et al. 
2000; Musacchio and Salmon 2007). SAC targeting of CDC20 renders the APC/C unable 
to ubiquitinate its target proteins, thereby preventing them from being signalled for 
proteasomal degradation (Fig. 1.5a).  
 
Once stable bipolar attachment is achieved cells commit to anaphase. At this point SAC 
signalling becomes diminished and the APC/CCDC20 complex forms, which begins to target 
proteins for ubiquitin-dependent proteasomal degradation. One protein that is targeted 
is the separase inhibitor securin. Securin degradation leads to separase activation, which 
promotes the cleavage of the remaining cohesin complexes, in particular centromeric 
cohesin (Fig. 1.5b) (Musacchio and Salmon 2007). Therefore, centromeric cohesin 
cleavage is intricately linked to the mitotic checkpoint and APC/CCDC20 activation.  
 
PLK1 (Cdc5) dependent phosphorylation of the cohesin subunit Scc1/RAD21 acts as a 
regulatory mark for cohesin cleavage (Alexandru et al. 2001). This provides another 
example of how kinases such as PLK1, can play key roles in maintaining correct 
chromosome organisation, through regulating the timely removal of cohesin complexes 
during mitosis.  
 
Overall, accurate chromosome assembly and organisation is achieved by the action of 
both condensin and cohesin complexes, whilst their activity is essential for maintaining 
faithful chromosome segregation. Both complexes are tightly regulated by 
phosphorylation by various kinases, in particular PLK1. This demonstrates how kinase 
function can aid in the regulation of chromosome assembly and maintenance.  
Figure 1.5. The spindle assembly checkpoint (SAC) and the regulation of the anaphase
promoting complex (APC).
a) During early mitosis, various components of the SAC function to monitor the status of
kinetochore-microtubule attachments. If KT-MT attachments remain absent or unstable,
the SAC prevents the activation of the APC/C, via phosphorylation of of its co-activator,
CDC20. When the APC/C remains inactive, securin ensures that the activity of seperase
remains inhibited. b) Following stable KT-MT attachment (metaphase), the SAC becomes
satisfied and no longer phosphorylates CDC20. This allows CDC20 to bind with its partner,
the APC/C, and promotes anaphase progression. The APC/CCDC20 E3-ubiquitin ligase targets
securin for proteasomal degradation, thereby allowing the release of seperase. Seperase
can then actively cleave centromeric cohesin allowing for sister chromatid separation
during anaphase.
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However, despite extensive efforts to understand how both condensin and cohesin 
function to maintain chromosome arrangement, the various multifaceted mechanisms 
that regulate chromosome assembly and arrangement remain a challenge. Future 
studies may help to reveal how chromosome segregation errors arise, whilst the 
centromere and kinetochore remain key targets for further study, as they provide the 
platform for correct chromosome segregation. 
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1.4 Centromere assembly 
 
Faithful chromosome segregation relies on a distinct region within each chromosome 
called the centromere. Centromeres dictate chromosome segregation by acting as a 
connection point for the attachment of the mitotic spindle. They achieve this by 
providing a foundation for the recruitment and assembly of the macromolecular protein 
complex, the kinetochore. The kinetochore forms at opposite sides of the core 
centromere and during microtubule spindle attachment, the kinetochore becomes the 
key player involved in directing chromosome segregation (McKinley and Cheeseman 
2016).  
 
In the majority of eukaryotes, centromeres are established by the presence of highly 
repetitive DNA arrays, such as tandemly repeated satellites or transposable elements. 
In particular, human centromeres contain -satellite repeats, which can extend for 
several megabases (Mb) and contribute to a large percentage of the overall genome 
(Barra and Fachinetti 2018; McKinley and Cheeseman 2016). Although repetitive 
sequence arrays are important for centromere assembly, they are not sufficient for 
centromere identity. Instead, centromere identity relies on epigenetic arrangement, 
which is dictated by the presence of specialised nucleosomes that contain the histone 
H3 variant, CENP-A (centromere protein A) (Earnshaw et al. 2013; Earnshaw and 
Rothfield 1985).  
 
In general, defects to centromere assembly lead to chromosome missegregation and 
aneuploidy (Barra and Fachinetti 2018; McKinley and Cheeseman 2016). Thus, 
emphasising the importance of correct centromere assembly. Errors in centromere 
assembly can lead to numerical chromosome alterations and centromere dysfunction 
can also lead to chromosomal structural alterations. Centromeres have an intrinsic 
fragility that can lead to chromosome breakage. This fragility is probably due to the 
highly repetitive DNA sequence arrangement at the centromere, which requires 
extensive organisation (Barra and Fachinetti 2018). Inaccuracies in centromere 
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organisation can lead to centromeric breakage, which can result in chromosome 
rearrangement, a common feature of several cancer cells (Knutsen et al. 2010). 
Therefore, centromere integrity is key to maintaining chromosome stability and faithful 
segregation.    
 
Cyril Darlington, who first defined the term centromere in 1936, spoke of how 
centromeres “[they] must be considered in terms of function rather than form, since the 
function is evident and the form elusive” (Darlington and Hall 1936). This statement 
continues to resonate with centromere biologists. Despite extensive studies, many 
molecular features of the centromere remain unclear and ongoing work continues to 
uncover greater detail and better understanding of centromere function.  
 
1.4.1 Centromere structure: monocentric (point & regional) 
 
Most eukaryotes, including humans, contain monocentric chromosomes. These are 
identified by the assembly of a single localised centromere structure along each 
chromosome. This is distinctly different to organisms such as the nematode 
(Caenorhabditis elegans), which feature holocentric chromosomes. Holocentric 
chromosomes are comprised of a diffuse centromere that covers the whole 
chromosome, a characteristic phenomenon referred to as holocentricity (Mandrioli and 
Carlo Manicardi 2012). Instead, monocentric chromosomes are distinguished by two key 
variants, either by the formation of point centromeres or alternatively regional 
centromeres.  
 
Point centromeres contain short DNA sequence specific elements that define the 
location of the centromere. These DNA elements are both necessary and sufficient for 
proper kinetochore assembly (Fig. 1.6a). The most studied example of point centromere 
assembly comes from the budding yeast Saccharomyces cerevisiae (Fig. 1.6a) (Clarke 
and Carbon 1980). Various studies have demonstrated that removal or mutation of the 
centromere specific sequence elements promotes chromosome missegregation 
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(Carbon and Clarke 1984; Clarke and Carbon 1983; McGrew et al. 1986). Whereas, 
exchange or orientation change of centromere specific DNA elements is sufficient to 
promote normal chromosome segregation (Carbon and Clarke 1984). Therefore, point 
centromeres rely heavily on DNA sequence for their function.   
 
The majority of regional centromeres also contain repetitive DNA sequences. However, 
unlike point centromeres, the repetitive sequences alone are insufficient for centromere 
function (McKinley and Cheeseman 2016). Regional centromeres are built on highly 
repetitive -satellite arrays or retro transposons (Lower et al. 2018). In particular, 
human regional centromeres consists of 171bp -satellite repeat monomers that are A-
T rich in sequence (Fig. 1.6a). These monomers are arranged tandemly in a head-to-tail 
orientation and each monomer can form further higher order repeats (HORs) (Vissel and 
Choo 1987; Waye and Willard 1985). Blocks of multiple HORs can then produce larger 
domains, which in turn can be repeated several thousands of times. This extensive 
arrangement then gives rise to the Mb sized core centromere (Barra and Fachinetti 
2018; McKinley and Cheeseman 2016). In addition to the core centromere, a 
heterochromatic pericentromere also forms. This flanks the core centromere and 
consists of less ordered satellite repeats (Fig. 1.6b) (McKinley and Cheeseman 2016). 
Therefore, DNA sequence, although not sufficient for centromere assembly, remains an 
important factor for centromere organisation.  
 
Interestingly, -satellite arrays contain only one identified sequence specific binding 
protein, CENP-B (centromere protein B). The CENP-B protein binds to a 17bp sequence 
specific motif within the -satellite repeats, termed the CENP-B box (Fig. 1.6b) 
(Masumoto et al. 1989; Muro et al. 1992). CENP-B has been shown to directly stabilise 
and influence CENP-A nucleosomes (Fujita et al. 2015). Moreover, other studies have 
suggested a possible redundant function(s) for CENP-B, in order to maintain 
chromosome segregation in the absence CENP-A (Hoffmann et al. 2016). Additionally, 
CENP-B may influence other centromere binding proteins, such as CENP-C, to  ensure 
Figure 1.6. Characteristics of monocentric centromeres, including both point and regional
centromeres.
a) Monocentric centromeres are assembled at a single distinct region of the chromosome.
There are two types of monocentric centromere. Either Point centromeres, which are
determined by sequence specific identity (e.g. S. cerevisiae); or alternatively, Regional
centromeres, which contain repetitive DNA arrays (𝛼-satellite DNA) and multiple CENP-A
containing nucleosomes. b) Regional centromere 𝛼-Satellite arrays assemble to form higher
order repeat (HOR) structures, which arrange to form even larger domains to build the core
centromere. These are bound by 𝛼-Satellite array sequence specific binding protein, called
CENP-B. In addition, heterochromatin regions of less ordered satellite repeats flank the
core centromere region, forming the pericentromere (diagrams adapted from McKinley
2016; Jansen 2004; McKinley 2014).
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correct kinetochore function (Fachinetti et al. 2015). However, it remains uncertain how 
important CENP-B is to centromere structure and function.  
 
CENP-B is not well conserved among different species and it has been shown to be non-
essential in mice (Perez-Castro et al. 1998). Furthermore, CENP-B binding is absent from 
the male Y chromosome (Earnshaw et al. 1987; Masumoto et al. 1989). This has led to 
questions around its importance in centromere biology. However, although it may not 
be absolutely essential, CENP-B and the underlying repetitive -satellite arrays are 
undoubtedly required to enhance the fidelity of chromosome segregation.  
 
1.4.2 Centromere identification by CENP-A 
 
Although centromere structure relies on -satellite arrays, this sequence is not sufficient 
to identify centromere assembly. Instead, the formation of centromeres in most, if not 
all eukaryotic cells is largely reliant on the epigenetic arrangement of CENP-A containing 
nucleosomes (McKinley and Cheeseman 2016). CENP-A was first described following its 
identification as a centromere specific antigen that was recognised by auto-antibodies 
from patients with a multisystem connective disorder known as CREST syndrome 
(Earnshaw and Rothfield 1985). During this time, CENP-A was established as a 
component of chromatin (Palmer et al. 1987; Palmer and Margolis 1985). CENP-A was 
later confirmed as a histone variant, displaying similarity to histone H3 (Palmer et al. 
1991; Sullivan et al. 1994). Despite disagreements surrounding its nomenclature 
(Earnshaw et al. 2013; Talbert et al. 2012), CENP-A (or CenH3) is acknowledged as a 
centromere-specific histone variant.  
 
CENP-A can be considered as an epigenetic marker for centromere location. CENP-A is 
found at neocentromeres, which are atypical centromeres capable of forming outside 
the canonical -satellite arrays (Marshall et al. 2008; Voullaire et al. 1993). The existence 
of CENP-A at these sites suggested that CENP-A is a critical element for centromere 
function (Marshall et al. 2008; Tyler-Smith et al. 2002). However, its critical role in 
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centromere function has been questioned by the finding that certain insects, including 
the butterfly and moth, have no CENP-A/(CenH3) (Drinnenberg et al. 2014). Despite this, 
CENP-A is considered crucial for the initial identification of centromeres. Additionally, 
CENP-A plays an essential role in centromere inheritance. The correct inheritance of 
centromeres following cell division must be maintained in order to prevent spurious 
centromere formation, which could otherwise promote erroneous chromosome 
segregation. 
 
1.4.3 Centromere inheritance & regulation of CENP-A deposition 
 
CENP-A nucleosomes epigenetically identify the position of centromeres on each 
chromosome. Therefore, the stability of CENP-A is key to maintaining this mark 
following rounds of cellular division. Importantly, unlike other nucleosomes, CENP-A is 
not exchanged once incorporated at centromeres. Instead, CENP-A nucleosomes are 
conservatively partitioned between the newly replicated sister chromatids during DNA 
replication (Jansen et al. 2007). This was demonstrated by the development of a 
sophisticated fluorescent labelling technique (SNAP-tagged CENP-A), that allowed for 
the direct visualisation of CENP-A association throughout the cell-cycle. The use of this 
technique revealed that CENP-A does not turnover at centromeres once assembled. 
Instead, CENP-A remains associated to centromeres, even during S phase and has been 
shown to dilute between sister chromatids during DNA replication. During telophase 
and early G1, newly synthesised CENP-A is re-deposited (Jansen et al. 2007). This cycle 
of CENP-A propagation ensures that centromere inheritance is maintained following cell 
division (Fig. 1.7a). The deposition of CENP-A at centromeres, also requires the co-
ordinated action of various assembly factors to maintain this inheritance.  
 
CENP-A has a dedicated chaperone. Two-groups simultaneously identified the Holliday 
junction recognition protein (HJURP) as a CENP-A chaperone, which promotes the 
deposition of new CENP-A (Dunleavy et al. 2009; Foltz et al. 2009). Alongside HJURP, a 
tri-subunit complex, known as the MIS18 complex, was also identified as a factor for 
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CENP-A deposition. The MIS18 complex consists of MIS18, MIS18 and MIS18BP1 
(MIS18-binding Protein-1; also known as KNL2), and this complex has been shown to 
further aid in CENP-A deposition (Fujita et al. 2007). The MIS18BP1 subunit also interacts 
with the CENP-A binding protein CENP-C, which becomes an essential interaction for 
MIS18 complex binding during CENP-A deposition (Dambacher et al. 2012; Moree et al. 
2011) (Fig. 1.7b).  
 
This complex assembly of factors involved in the deposition of CENP-A, has been shown 
to be regulated by protein phosphorylation. In human cells, CDKs negatively regulate 
CENP-A deposition. Phosphorylation of MIS18BP1 by CDKs, reduces its potential to 
localise to centromeres outside of G1 (Silva et al. 2012), whilst CDK phosphorylation of 
HJURP has also been reported to disrupt HJURP localisation to centromeres (Müller et 
al. 2014). Despite these negative regulatory phosphorylation events by CDKs, CENP-A 
deposition has also been shown to require a licensing step. Again, phosphorylation plays 
a key role in this, as PLK1-dependent phosphorylation of the MIS18 complex promotes 
MIS18 localisation and stimulates licensing of CENP-A deposition (Fig. 1.7b) (McKinley 
and Cheeseman 2014). Bypassing both regulation of CENP-A deposition, by CDK and 
PLK1 phosphorylation, by constitutively targeting the MIS18 subunit was able to 
promote CENP-A deposition throughout the cell cycle, leading to severe mitotic defects 
(McKinley and Cheeseman 2014). Therefore, inheritance of CENP-A deposition also 
requires strict regulation in order to suppress chromosome missegregation.  
 
In addition to CENP-A’s role in centromere identification and assembly, it is also required 
for kinetochore assembly (Carroll et al. 2009, 2010; Fachinetti et al. 2013; Guse et al. 
2011; Hori et al. 2013; Regnier et al. 2005). Artificial targeting of CENP-A to ectopic loci, 
has been shown to be sufficient to drive kinetochore formation and microtubule 
attachment. Cells were also subsequently shown to undertake chromosome segregation 
(Barnhart et al. 2011; Heun et al. 2006). Therefore, CENP-A appears crucial for 
centromere identity and function, whilst also bridging the gap between the centromere 
and kinetochore assembly. 
Figure 1.7. The centromere is identified by CENP-A deposition during telophase/G1.
a) Following kinetochore assembly and chromosome segregation, new CENP-A deposition
occurs during telophase & G1. CENP-A nucleosomes are partitioned between the newly
replicated sisters during S-phase and subsequently become diluted (Histone H3 occupies
the gaps). CENP-A nucleosomes then mark the position of centromeres for kinetochore
assembly (G2/Mitosis). b) CENP-A deposition relies on MISBP1 and its dedicated chaperone
HJURP. Outside of G1 (e.g. mitosis), CDK1 prevents MIS18BP1 complex assembly and HJURP
recruitment to centromeres. During G1, PLK1 binds to the MIS18 complex to promote
CENP-A deposition at centromeres along with HJURP (diagrams adapted from McKinley
2016; Jansen 2004; McKinley 2014).
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1.5 Kinetochore assembly  
 
The pivotal role of centromeres, in promoting faithful chromosome segregation, is 
established by their role in the assembly of the kinetochore complex. This 
macromolecular protein complex is the attachment site of microtubules of the mitotic 
spindle and acts as a hub for chromosome segregation during mitosis (Cheeseman and 
Desai 2008). It is estimated that a human kinetochore is comprised of more than 100 
proteins (Cheeseman 2014). Hence, kinetochore architectural assembly is not only 
essential for correct chromosome segregation, but also possesses a very complex 
structure. A key element in kinetochore assembly is the establishment of the 
centromere by the centromere specific histone variant CENP-A, which acts as the 
foundation for the building kinetochore complex. Various additional CENP factors are 
recruited to CENP-A, constructing the formation of the inner kinetochore. These 
additional CENP factors form a multi-layered protein complex, referred to as the CCAN 
(constitutive centromere associated network). The CCAN functions to support the 
establishment of further protein recruitment, which helps to build the extending 
kinetochore complex. Outer kinetochore assembly is largely formed of another multi-
layered complex of proteins, termed as the KMN network (KNL-1/MIS12 
complex/NDC80 complex). This network of proteins is then able to support kinetochore-
microtubule attachment and ensures that chromosome segregation occurs with high 
levels of accuracy.  
 
1.5.1 The CCAN forms the link between the centromere and kinetochore 
 
The CCAN identifies the centromere-kinetochore interface and constitutes a group of 16 
proteins that localise to centromeres throughout the cell-cycle (Cheeseman and Desai 
2008). CCAN components have been entitled with alphabetically designated CENP-
names (CENP-C, CENP-H, CENP-I, CENP-K, CENP-L, CENP-M, CENP-N, CENP-O, CENP-P, 
CENP-Q, CENP-U, CENP-R, CENP-T, CENP-W, CENP-S and CENP-X) (Amano et al. 2009; 
Foltz et al. 2006; Hori et al. 2008; Okada et al. 2006).  
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The CCAN components can be further classified into five groups. These form either the 
CENP-C and CENP-L-N complex (Carroll et al. 2009); the CENP-H-I-K-M complex (Foltz et 
al. 2006; Okada et al. 2006); the CENP-O-P-Q-U-R complex (Hori et al. 2007); and finally, 
the CENP-T-W-S-X complex (Nishino et al. 2012). Collectively these proteins function to 
recognise centromeric chromatin and bridge the gap between the centromere and the 
building kinetochore complex.  
 
1.5.2 CENP-C/T (inner kinetochore) links to the outer kinetochore (KMN) 
 
CCAN assembly at the centromere provides a platform for the association of the outer 
kinetochore components. Both CENP-C and CENP-T (inner kinetochore) form parallel 
pathways for the recruitment of the KMN network (KNL-1/MIS12/NDC80) (outer 
kinetochore) (Malvezzi et al. 2013; Nishino et al. 2013; Screpanti et al. 2011).  
 
CCAN protein recruitment is tightly regulated, thereby limiting the CCAN’s ability to 
build a full kinetochore complex prior to mitosis. This regulation is achieved via protein 
phosphorylation. The assembly of CENP-C and MIS12 is promoted by Aurora B kinase 
activity (Kim and Yu 2015). CDK phosphorylation of the NDC80 complex, which is 
sequestered outside the nucleus throughout interphase and therefore incapable of 
CCAN interaction, promotes direct interaction with CENP-T (Fig. 1.8a) (Gascoigne and 
Cheeseman 2013). Again, these examples demonstrate the important role(s) that 
mitotic kinases have on influencing centromere and also kinetochore assembly. 
  
1.5.3 The KMN network links to microtubules 
 
The outer kinetochore KMN network of proteins adds further complexity to centromere-
kinetochore biology and broadens the number of proteins involved in kinetochore-
microtubule attachment. It consists of three sub complexes. The KNL-1 complex consists 
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of KNL-1 (or Blinkin), and ZWINT (Obuse et al. 2004); whilst, the MIS12 complex consists 
of MIS12, NSL1, PMF1 and DSN1 (Hinshaw and Harrison 2018; Kline et al. 2006). Finally, 
the tetramer NDC80 complex is comprised of NDC80 (HEC1), NUF2, SPC24 and SPC25 
(McCleland et al. 2004). The KMN network associates with kinetochores during 
prophase and dissociates from kinetochores during telophase (Varma and Salmon 
2013). The outer end of NDC80, (NUF2/NDC80-(HEC1)), is the primary site for the 
extending microtubule binding. In contrast, the inner region of NDC80 (SPC24/25) 
provides the attachment site to the centromere, via the CCAN (Fig. 1.8a) (DeLuca and 
Musacchio 2012; Hori and Fukagawa 2012).  
 
KNL-1 has also been reported to bind to NDC80, at both outer and inner locations, 
interacting directly with kinetochore-microtubules, or the MIS12 complex, respectively 
(Petrovic et al. 2010). CENP-C links the MIS12 complex to CENP-A chromatin (Hori and 
Fukagawa 2012), whilst both the NDC80 and KNL1 extend outwards from their junctions 
with CENP-T or MIS12 (Fig. 1.8a) (Wan et al. 2009). A number of additional proteins bind 
to the periphery of the outer kinetochore domain, largely dependent on KMN network 
binding. These additional proteins include microtubule-associated proteins (motor 
proteins such as dynein), plus various proteins that control the spindle assembly 
checkpoint (SAC) (Kops and Shah 2012). Hence, kinetochore assembly is very complex, 
largely due to the vast number of proteins involved.  
 
In summary, kinetochores provide the primary site for spindle microtubule connection, 
a pre-requisite for faithful chromosome segregation (Fig. 1.8b). Centromere and 
subsequent kinetochore assembly, are critical for ensuring chromosome biorientation 
during mitosis. However, attachment of spindle microtubules to kinetochores, may also 
lead to erroneous connections. The cell must first detect and destabilise inaccurate 
connections, whilst also suppressing anaphase onset. This sophisticated system ensures 
chromosomes can correctly undergo segregation. A failure to achieve this can result in 
chromosome instability, through errors in faithful chromosome separation. 
 
Figure 1.8. Complex assembly of the centromere-kinetochore axis.
a) The CENP-A nucleosomes determine the centromere region. The constitutive
centromere-associated network (CCAN) is made up of 16 CENP-derived proteins and
associates with CENP-A throughout the cell cycle. During mitosis the CCAN subunits CENP-C
and CENP-T recruit the kinetochore microtubule network (KMN), consisting of KNL1, MIS12
and the NDC80 complex. CDK1 phosphorylation of CENP-T may regulate KMN binding to
CCAN. Unattached kinetochore: The spindle assembly checkpoint proteins (SAC), MAD1/2,
BUB1/BUB3 and BUBR1 recruit to regions of the KMN and propagate SAC activation, before
correct microtubule binding. PLK1 may be involved in CENP-A licencing and also is involved
in phospho-dependent MCC complex regulation. Finally, Aurora B kinase phosphorylates
several targets, including MIS12 of the KMN network, to propagate SAC signalling. b)
Attached kinetochore: The KMN serves as the key kinetochore receptor for spindle
microtubule attachment. Binding of microtubules to the KMN may displace SAC proteins.
PLK1 may also promote PP2A phosphatase recruitment and counteract Aurora B
dependent phosphorylation in order to stabilise MT-KT attachment (diagrams adapted
from McKinley 2016; Jia, et al. 2013; Zitouni, et al. 2014).
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1.6 Kinetochore-microtubule (KT-MT) error correction and SAC activation 
 
In order for cells to achieve stable chromosome biorientation, and therefore promote 
error-free segregation, the KT-MT attachments that occur prior to biorientation, must 
have a certain level of plasticity. Not only do KT-MT connections have to ensure 
sufficient grip between the KT and the MT framework, they also have to be capable of 
releasing KT-MT attachments during stages of inaccurate connection(s) (Fig. 1.9a). 
Therefore, cells not only have to suppress cell cycle progression during inaccurate KT-
MT attachment, but also have to destabilise the erroneous attachments, supporting KT-
MT error correction. When chromosomes either lack, or encounter inaccuracies in KT-
MT attachments, the SAC remains active. This blocks cell cycle progression and allows 
the cell time to resolve the inaccuracies in KT-MT attachment (Lara-Gonzalez et al. 
2012). A primary function of the SAC is to prevent the activation of the anaphase 
promoting complex/cyclosome-CDC20 complex (APC/CCDC20). Suppression of the 
APC/CCDC20 prevents anaphase onset and gives cells time to achieve correct bipolar 
kinetochore attachment. Thus, inaccuracies in SAC activation can lead to undetected 
errors in KT-MT attachment, which in turn can promote missegregation of 
chromosomes. Therefore, the intrinsic link between correct KT-MT attachment and SAC 
activation, is essential for maintaining faithful chromosome segregation. 
 
1.6.1 The mitotic checkpoint complex (MCC) 
 
During prometaphase, kinetochores are targeted for capture by the extending mitotic 
spindle. Consequently, at this early stage of mitosis, the SAC remains active, as 
kinetochores generally remain unattached or unstably attached. The existence of 
unattached kinetochores catalyses the formation of the mitotic checkpoint complex 
(MCC). The MCC is made up of BUBR1, BUB3, MAD2, and the APC/C activator CDC20.   
The assembly of this complex at unattached kinetochores promotes SAC activation 
(Lara-Gonzalez et al. 2012). Subsequently, the SAC suppresses the activation of the 
APC/CCDC20, allowing cells time to establish correct KT-MT attachments (Morrow 2005). 
Figure 1.9. KT-MT attachment and Aurora B dependent KT-MT regulation.
a) MT-KT mis-attachment errors include syntelic, merotelic and unattached chromosomes.
Monotelic attachment is regarded as an intermediately phase before complementary
sister-kinetochore attachment takes place and correct amphitelic attachment is achieved.
b) Aurora B kinase functions to regulate the status of MT-KT attachment during
chromosome biorientation. Unstable or incorrect KT-MT-attachment promotes Aurora B
kinase activity, which phosphorylates KT substrates and promotes the release of unstable
MT attachments. Following stable KT-MT attachment, pulling forces are generated, which
promotes Aurora B kinase to be expelled, leading to APC/C activation and anaphase onset
(diagram adapted from Sarangapani and Asbury 2014).
a
b c
P
P
Centromere
Kinetochore
Weak 
microtubule 
binding
Aurora B
Active 
SAC
Inactive 
APC/C
Without 
force
P
P
Inactive 
SAC
Active 
APC/C
With 
force
Aurora B
Merotelic Monotelic
UnattachedSyntelic Amphitelic
(biorientated)
Strong 
microtubule 
binding
Ch
ro
m
os
om
e
Microtubules
Centrosomes
Centrioles
Sister chromatids
  29 
Surveillance by the mitotic checkpoint is considered so robust, that even a single 
unattached kinetochore is capable of preventing anaphase onset (Rieder et al. 1995) .  
 
Alongside the MCC, additional components help to maintain SAC signalling. These 
include MAD1 and the kinases BUB1, MPS1 (multipolar spindle-1), and in particular 
Aurora-B. The main function of these additional proteins is to amplify the SAC signal 
(Abrieu et al. 2001; De Antoni et al. 2005; Kallio et al. 2002; Tang et al. 2004).  
 
SAC proteins concentrate at unattached kinetochores (Chen et al. 1996, 1998). In 
contrast, their dramatic reduction coincides with microtubule attachment (Howell et al. 
2000; Waters et al. 1998). Concurrently, bipolar spindle attachment leads to SAC 
inactivation, demonstrated by a depletion of detectable SAC protein localisation (Howell 
et al. 2004). However, kinetochore capture can lead to erroneous KT-MT attachments. 
These attachments must be destabilised, whilst also maintaining SAC activation. A key 
protein involved in the regulation of KT-MT error correction is the highly conserved 
protein kinase, Aurora B (Sarangapani and Asbury 2014).   
 
1.6.2 Spindle tension and MT-KT error correction by Aurora B 
 
Inappropriate KT-MT attachment leads to a prolonged activation of the SAC. One key 
reason for this is thought to be due to tension across the centromere-kinetochore axis 
(Nicklas et al. 1995). Following correct bipolar attachment, spindle pulling is thought to 
cause the stretching of centromeric chromatin, leading to an increase in inter-
kinetochore distance. This tension is understood to enhance the stabilisation of KT-MT 
attachment, whereas, the opposite can occur in the absence of tension. Incorrect KT-
MT attachment is thought to limit the tension that can build across the KT-MT axis, and 
therefore, microtubule destabilisation occurs. This is believed to be regulated by the 
action of Aurora B kinase. 
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The current hypothesis states that the increasing inter-kinetochore distance, during 
correct bipolar KT-MT attachment, prevents the inner-centromere located Aurora B 
kinase from acting on kinetochore components (Lampson and Cheeseman 2011; Liu et 
al. 2009). In contrast, during incorrect KT-MT attachment, insufficient tension across the 
centromere-kinetochore axis allows Aurora B to target its substrates at the 
centromere/kinetochore. In turn, this allows Aurora B dependent destabilisation of KT-
MT attachment to occur (Fig. 1.9b) (Lampson et al. 2004; Tanaka et al. 2002). However, 
a precise mechanism to explain Aurora B function during SAC maintenance remains a 
debated topic (Krenn and Musacchio 2015). Nevertheless, tension and Aurora B kinase, 
play a fundamental role in correcting KT-MT mis-attachment.  
 
During prometaphase, the MCC complex; including CDC20 and all other SAC proteins, 
localise to kinetochores, in order to propagate the mitotic checkpoint signal. This 
remarkable surveillance system monitors the status of spindle attachment at 
kinetochores and prevents anaphase onset (Lara-Gonzalez et al. 2012). Once stable 
chromosome biorientation is achieved, chromosome segregation can then advance. 
This demonstrates another sophisticated mechanism to maintain chromosome 
segregation fidelity. Moreover, this complex mechanism is again regulated by the 
activity of several kinases. 
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1.7 Sister chromatid disjunction and the formation of UFBs 
 
As emphasised throughout this thesis, correct chromosome segregation relies on 
complex and intrinsically linked processes for its success. These processes begin with 
the accurate duplication of the genome, whilst also maintaining appropriate 
chromosome organisation (cohesin and condensin activity) and structural features 
(centromere & kinetochore assembly). Thus, defects in any of these, can hinder proper 
chromosome disjunction and may also lead to chromosome instability (CIN). 
Chromosome missegregation is a feature of CIN and in general, it can be observed as 
erroneous chromosome separation during mitosis. These inaccuracies often give rise to 
anaphase DNA bridges or lagging chromosomes (Levine and Holland 2018).  
 
Anaphase bridges form due to a failure of complete separation of chromosomes, 
whereas lagging chromosomes often form when errors in KT-MT attachment occur 
(Cimini et al. 2015; Levine and Holland 2018). Both of these features have been used 
extensively as indicators for the detection of missegregation events. More recently, a 
previously undetected DNA structure has also been visualised in cells that undergo 
errors in chromosome segregation. These structures were termed ultra-fine DNA 
bridges (UFBs) and link errors in DNA replication to mitotic non-disjunction (Baumann 
et al. 2007; Chan et al. 2007).  
 
1.7.1 Classification of ultra-fine DNA bridges (UFBs) 
 
UFBs are a form of stretched DNA linkage that arise during the separation of sister-
chromatids. They are believed to be caused by DNA replication and repair, which can 
promote DNA entanglements that require appropriate resolution. UFBs are not 
detected by conventional staining methods, such as DAPI. Instead, UFBs become 
apparent by the detection of the proteins that associate along them (Baumann et al. 
2007; Chan et al. 2007). Two major proteins were originally attributed to UFB-binding. 
These were the PLK1-interacting checkpoint helicase (PICH) (Baumann et al. 2007) and 
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the Bloom’s syndrome helicase (BLM) (Chan et al. 2007). Both PICH and BLM decorate 
the entire length of UFB structures. Additional proteins have subsequently been found 
to be associated with UFBs. These include topoisomerase III (TOP3A) and the RecQ-
mediated genome instability protein 1 (RMI1) (Chan et al. 2007). BLM, TOP3A and the 
RMI1/2 heterodimer have been shown to form a complex, commonly referred to as the 
BTR-complex (Xu et al. 2008). This complex has been reported to drive branch migration 
of Holliday junctions (HJ) during homologous recombination and repair, whilst also 
promoting resolution of the resulting hemi-catenane, in a pathway called “dissolution” 
(Wu and Hickson 2003). The RIF1 protein has also been identified as a factor for UFB 
binding and resolution (Hengeveld et al. 2015). RIF1 was originally identified as a 
telomere binding protein, but has subsequently been shown to regulate replication 
through the recruitment of PP1 (Hiraga et al. 2014).  
 
It is generally accepted that UFB-binding proteins function in the resolution of ultra-fine 
DNA linkages, which can materialise during chromosome segregation. This prevents 
potential chromatin damage from being transmitted into offspring cells, as the depletion 
of these factors not only increases UFB formation, but also leads to transgenerational 
DNA lesions. These inheritable lesions are marked in daughter cells by 53BP1 nuclear 
bodies in G1 (Harrigan et al. 2011; Lukas et al. 2011). Therefore, UFB resolution and 
repair presents as another key factor for ensuring the maintenance of chromosome 
stability during cellular division.  
 
1.7.2 Types of UFBs 
 
Different types of UFB formation have been described and classified based on their 
underlying structure and distinctive origins. The primary UFB structure is believed to be 
either (1) unresolved double-stranded DNA (dsDNA) catenanes; (2) late replication 
intermediates (LRIs); or, (3) homologous recombination (HR) structures (Fig. 1.10a, b) 
(Chan et al. 2018; Tiwari et al. 2018). UFBs form at four main genomic regions. UFBs 
form at centromeres (C-UFBs), which are the most common site for their formation (Fig. 
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1.10b) (Baumann et al. 2007; Chan et al. 2007). C-UFBs are believed to represent a form 
of unresolved dsDNA catenane structure, which persists due to a lack of topoisomerase 
II (TOP2A) decatenation activity. TOP2A is a type II topoisomerase that relieves the 
topological stress that builds up following DNA unwinding during DNA replication. It 
achieves this by creating transient dsDNA breaks in the DNA and passing one DNA strand 
through another (Fig. 1.10a, b)  (Nitiss 2009). However, C-UFBs may escape TOP2A-
mediated decatenation prior to anaphase onset, due to a persistence of sister chromatid 
cohesion (Baumann et al. 2007; Chan et al. 2007; Wang et al. 2008, 2010). Therefore, 
this makes C-UFBs a common feature of chromosome segregation and demonstrable in 
every mitosis (early anaphase). However, UFBs may not exclusively be due to unresolved 
DNA catenation as many originate from replication intermediates.  
 
Telomeric UFBs (T-UFBs) can form due to an interference of DNA replication of the 
telomere, or by overexpression of the shelterin component, TRF2, which induces end-
to-end telomere fusions (Fig. 1.10b) (Barefield and Karlseder 2012; Nera et al. 2015). 
UFBs have also been shown to form at ribosomal DNA (rDNA) loci (R-UFBs), colocalising 
with UBF, a marker for sites of rDNA (Fig. 1.10b) (Nielsen and Hickson 2016). Finally, 
UFBs also form at fragile site loci (FS-UFBs) and these arise due to late replication 
intermediates; in particular at common fragile site (CFS) regions of the genome. CFSs 
have been defined as late replicating regions of the genome, which are difficult to 
replicate due to their complex DNA structure and/or long genes (Glover et al. 2017). 
Replication of CFS is often delayed, especially under conditions of replicative stress, such 
as during treatment with the DNA polymerase inhibitor aphidicolin (APH). Therefore, 
APH can induce FS-UFBs and these FS-UFBs are distinctly marked by the presence of the 
Fanconi anaemia protein FANCD2 at their termini (Fig. 1.10b)  (Chan et al. 2009).  
 
More recently, unresolved DNA intermediates, due to homologous recombination (HR), 
were also shown to identify a new class of UFB, termed as HR-UFBs. This newly defined 
HR-dependent UFB structure was absent of FANCD2 foci, showing it to be distinct from 
replication stress induced UFB formation. This was confirmed by a reduction in FANCD2 
negative UFBs, after depletion of the HR components RAD51 or BRCA2, whilst FANCD2-
Figure 1.10. Resolution of DNA intertwinements by the UFB binding complex maintains
faithful chromosome segregation.
a) DNA intertwinements can arise following DNA replication and recombination. Double
stranded DNA (dsDNA) catenanes form due to replication intermediates that require
processing by topoisomerase II (TOP2) activity. Alternatively, recombination intermediates
can be resolved by the action of the BTR-complex (BLM, topoisomerase III-alpha and
RMI1/2). b) Anaphase UFBs arise as a result of unresolved DNA intertwinements caused by
DNA replication or homologous recombination. A failure to deal with such DNA intertwining
structures prior to mitosis, leads to the BTR (BLM, TOP3 and RMI1) complex and PICH
associating with UFBs to resolve them. Nucleolytic cleavage can also occur by structure-
specific nucleases, such as MUS81 and GEN1 (diagrams adapted from Fernández-Casañas
2018; Fernandez-Vidal 2017).
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positive UFBs increased (Chan et al. 2018; Tiwari et al. 2018). Therefore, the formation 
of these FANCD2-negative UFBs is dependent of HR, as RAD51 and BRCA2 are crucial 
elements for HR.  
 
1.7.3 PICH (Plk1-interacting checkpoint helicase)  
 
PLK1-interacting checkpoint helicase, PICH, was originally identified through interaction 
studies with the protein kinase PLK1 (Baumann et al. 2007). PICH has been shown to co-
localise with PLK1 at kinetochores, early in mitosis, whilst it is spatiotemporally 
regulated and remains excluded from the nucleus until nuclear envelope breakdown 
(NEBD). PICH is a member of the SNF2 family of SWI/SNF chromatin remodellers and has 
ATPase activity (Fig. 1.11a) (Baumann et al. 2007). Despite PICH being referred as a 
helicase (Baumann et al. 2007), in vitro studies have demonstrated that PICH is unable 
to catalyse strand unwinding of duplex DNA (Biebricher et al. 2013; Ke et al. 2011). 
Instead, the actual catalytic function of PICH is as a translocase. Using an in vitro DNA 
triplex assay, PICH was found to translocase along dsDNA molecules and displace a 
radiolabelled ssDNA oligo substrate from a DNA triplex structure (Fig. 1.11b) (Biebricher 
et al. 2013). PICH DNA translocase activity is dependent on ATP binding or hydrolysis, as 
a mutation within its ATP binding motif (K128A) abolishes its catalytic activity (Biebricher 
et al. 2013). During the same study, PICH was also shown to be unable to bind ssDNA. 
Instead, it was only capable of binding to dsDNA substrates, even if the dsDNA end was 
not ‘free’. PICH was also reported to translocate Holliday junction substrates, promoting 
branch migration of the four-way junction; a characteristic feature of homologous 
recombination (Biebricher et al. 2013). However, the significance of this remains 
unclear.  
 
Despite an increasing amount of knowledge on the catalytic function of PICH, its precise 
cellular role(s) remain less clear. Following its original discovery, PICH was thought to 
regulate the activity of the SAC (Baumann et al. 2007). However, this was later shown 
to be incorrect and previous conclusions made were instead attributed to off-target 
Figure 1.11. PICH an ATP-dependent DNA translocase.
a) Schematic representation of the structural domains of PICH. Amino acid residue K128
denotes the site of ATP-binding, whilst phosphorylation at T1063 enables PLK1 to interact
with PICH. b) A diagram to represent PICH’s translocase activity. PICH has been shown to
displace ssDNA from a triplex DNA substrate, rather than unwind dsDNA substrates
(diagrams adapted from Pitchai, et al. 2017 & Biebricher, et al. 2013).
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effects of siPICH oligonucleotides, which inadvertently targeted the SAC protein MAD2 
(Hübner et al. 2010). PICH has also been reported to promote chromatin remodelling, 
showing a possible histone displacement capability. As mentioned previously, UFBs are 
regarded as histone negative. However, histone positive UFBs were detected during 
PICH depletion, leading to the suggestion that PICH was contributing to the 
displacement of histones at UFB structures (Ke et al. 2011). Nonetheless, this original 
claim was not reproducible by a different group, and therefore, doubts remain regarding 
its ability to participate in histone displacement (Biebricher et al. 2013).  
 
An interesting feature of PICH, is demonstrated by its ability to sense tension. Using 
single-molecule in vitro studies, two groups have demonstrated that PICH binds more 
effectively to dsDNA substrates, following the application of tension (Biebricher et al. 
2013; Sarlós et al. 2018). Notably, tension is almost certain to build between sites of 
stable KT-MT attachment.  In addition, during early anaphase onset, tension will build 
between sister chromatids that remain intertwined by catenation. Therefore, it is 
conceivable that the recruitment of PICH to UFBs is influenced by spindle tension 
(Biebricher et al. 2013).  
 
PICH is considered as the primary sensor for UFB assembly. Alongside that, it probably 
plays a role in the recruitment of other UFB binding proteins, as a depletion of PICH has 
been shown to abolish both BLM and RIF1 binding at UFBs (Hengeveld et al. 2015). 
Recent in vitro reports have also highlighted PICH’s potential as a stimulator of TOP2 
decatenation activity. This may explain a functional role for PICH, through mediating 
TOP2-dependent decatenation of unresolved intertwining DNA molecules between 
sister chromatids, during the metaphase-to-anaphase transition (Nielsen et al. 2015). 
However, whether this is the principal role for PICH on stretched DNA molecules, such 
as UFBs, remains unconfirmed.  
 
It has also been reported that an absence of PICH is embryonically lethal in mice (Albers 
et al. 2018); although, knockout cell lines have been described in both chicken DT40 and 
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human HeLa cells (Nielsen et al. 2015). However, in all cases of PICH absence or 
depletion, DNA metabolism is affected (e.g. mis-segregation errors, condensation 
defects, hypersensitivity to TOP2 inhibition). Therefore, PICH is regarded as a vital 
protein involved in the safeguarding of chromosome segregation and this makes it an 
intriguing protein for further study. 
 
1.7.4 BLM (Bloom’s syndrome helicase) 
 
The Bloom’s syndrome (BS) gene product, BLM helicase, is also found abundant on UFBs. 
BLM is a member of the RecQ family of DNA helicases, with a 3’-5’ directionality (Fig. 
1.12a) (Karow et al. 1997). BLM has been shown to function during DNA replication and 
homologous recombination (Bachrati and Hickson 2008). Germline loss of function 
mutations of the BLM gene causes Bloom’s syndrome (BS) (Ellis et al. 1995), which was 
first described in 1954 and named after its discoverer; the dermatologist David Bloom 
(Bloom 1954). It is a rare autosomal recessive genetic disorder that is characterised by 
prenatal and postnatal growth deficiency. It is associated with short stature, 
photosensitive skin changes, immune deficiency, insulin resistance and an increased risk 
of early onset cancer (Bloom 1954; German 1997; German et al. 1965). Diagnostically 
BLM cells display an increase in sister-chromatid exchanges (SCE) and chromosome 
breaks (Chaganti et al. 1974). SCE’s are a cross-over product, formed between sister 
chromatids and are dependent on HR activity. This highlights that BLM plays a key role 
in HR-mediated DNA repair. Importantly, BLM-deficient cells also display an increase in 
chromosome missegregation, most notably through the formation of bulky anaphase 
bridges, UFBs and lagging chromatin (Chan et al. 2007).  
 
BLM forms a sub-complex with its partner proteins, topoisomerase III (TOP3A) and the 
RecQ-mediated genome instability complex 1 and 2 (RMI1/BLAP75; RMI2/BLAP18), 
which forms the BTR-complex (Mankouri and Hickson 2007; Singh et al. 2008; Xu et al. 
2008). It is thought that BLM is stabilised by its partner proteins, RMI1 and RMI2 
(Raynard et al. 2006), whilst RMI1 has also been found to associate to UFBs (Chan et al. 
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2007). BTR complex formation facilitates a unique DNA resolution event (dissolution), 
which is catalysed by the action of topoisomerase III (TOP3A) (Fig. 1.12b).  
 
TOP3A is a type 1 topoisomerase, which catalyses the transient breakage and re-joining 
of ssDNA substrates. This action relieves the torsional stress that is generated by duplex 
DNA unwinding, particularly following BLM-dependent helicase activity. An example of 
this action is demonstrated by an event where BLM acts in concert with TOP3A in order 
to resolve double-Holliday junctions (dHJs). These unique recombination structures are 
generated during HR-mediated repair of dsDNA breaks, or by fork regression during DNA 
replication (Wu and Hickson 2003). The BLM/TOP3-dependent dHJ dissolution pathway 
exists as a two-step process. First, the BLM helicase within the BTR-complex, catalyses a 
branch migration reaction on the dHJ recombination structure. This promotes the 
formation of a hemi-catenane DNA intermediate, which is then decatenated by TOP3-
(RMI1/2). This dissolution reaction, unlike the cleavage of HJs, exclusively produces non-
crossover recombination products (Wu and Hickson 2003). Therefore, BLM helicase 
activity, along with the rest of the BTR-complex, plays a key role in maintaining genome 
stability.  
 
The DNA unwinding activity of BLM is enhanced by the presence of replication protein 
A (RPA) (Brosh et al. 2000), a single stranded DNA (ssDNA) binding protein. Interestingly, 
RPA is also present at UFB structures and its loading has been shown to be dependent 
on BLM helicase activity (Chan et al. 2018; Hengeveld et al. 2015). More recently, in vitro 
single molecule analysis, using optical tweezers, revealed that RPA binding is exclusive 
of the PICH/BTR complex (Sarlós et al. 2018). Therefore, providing further evidence to 
support the idea that BLM is responsible for the physical unwinding of UFBs and the 
generation of ssDNA, which thereby promotes RPA binding. However, a precise 
mechanism to explain how the UFB-binding complex (PICH/BTR-complex) resolves DNA 
bridging structures remain uncertain.  
 
Figure 1.12. BLM helicase promotes double Holliday junction (dHJ) dissolution.
a) A schematic representation of the core structural domains of BLM. The RecQ core region
contains the super family-2 helicase domain (SF2) and a RecQ conserved domain (RQC). The
T/R site denotes the region of BLM that interacts with topoisomerase III𝛼 and RMI1-2. The
helicase and RNAse D carboxy-terminal domain (HRDC) identifies the region of BLM that is
required for double Holliday junction binding and dissolution reaction. b) BLM and
topoisomerase III𝛼 and RMI1-2 catalyse the dissolution of dHJ recombination
intermediates, favouring the generation of non-crossover products. Minimising the chance
of loss of heterozygosity (LOH), and preventing inappropriate genomic rearrangements.
Alternatively, in the absence of BLM, Holliday junction resolution is mediated by cleavage
by structure-specific endonucleases (SSEs). This can result in the generation of both cross-
over and non-crossover products (not shown), encouraging possible genomic
rearrangement (diagrams adapted from Bizard & Hickson 2014; Martin, et al. 2019).
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Nevertheless, despite uncertainty regarding the precise molecular mechanism of UFB 
resolution, it is conceivable that PICH acts as the primary detector for the presence of 
tension derived UFBs. This in turn may promote the recruitment of BLM and the 
remaining BTR-factors. It is then tempting to speculate that TOP3A decatenation activity 
aids in UFB resolution. However, whether TOP3A is responsible for ssDNA decatenation 
of UFBs remains unclear. A recent study has reported the clinical appearance of a BS-
like disorder, from patients identified with mutations in either TOP3 or RMI1. The 
patient derived cells displayed increased frequencies of mitotic defects, compared to 
both control and parental cells, including an increase in the detection of UFBs, 
micronuclei and transgenerational lesions, marked by 53BP1 nuclear bodies (Martin et 
al. 2018). These findings highlight the significance of the whole BTR-complex in 
maintaining genomic stability.  
 
Overall, this section has highlighted how faithful transmission of the genome relies on 
various processes for its attainment. To ensure the accurate transmission of genetic 
material, cells require the action of a large number of molecular machineries. These 
facilitate the appropriate organisation and arrangement of chromosomes, in order to 
promote correct chromosome biorientation and faithful chromosome segregation. 
These processes require coordination and regulation. A recurring component involved 
in many different aspects of mitotic stability and chromosome segregation, is the action 
of protein phosphorylation. In particular, this is influenced by the activity of the mitotic 
kinase PLK1, which will be discussed further in the next section. 
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1.8 The mitotic regulator polo-like kinase 1 (PLK1) 
 
Commonly regarded as the master regulatory mitotic kinase, mammalian PLK1 plays a 
multitude of roles in regulating mitotic progression. PLK1, or ‘Polo’ as it was described 
following its original discovery in Drosophila Melanogaster (Llamazares et al. 1991; 
Sunkel and Glover 1988), has been shown to function throughout various stages of 
mitosis. This includes mitotic entry, centrosome maturation, bipolar spindle formation, 
chromosome congression and segregation, cytokinesis and mitotic exit (Archambault 
and Glover 2009; Zitouni et al. 2014). Given the multifunctional roles identified for PLK1 
during mitosis, it is not surprising that PLK1 has many cellular substrates. Some of these 
substrates have been largely studied, whilst others undoubtedly remain unidentified. 
 
The activation and recruitment of PLK1 is regulated by its C-terminal polo-box domain 
(PBD), which binds to and recognises phosphorylated serine/threonine residues within 
target proteins (Elia, Cantley, et al. 2003; Elia, Rellos, et al. 2003). Thus, PLK1 substrates 
generally require a ‘priming’ reaction, which refers to the addition of a phosphate group, 
allowing for subsequent PLK1 recruitment. Priming is commonly achieved, although not 
exclusively, by the action of CDK1. However, PLK1 does not always depend on a priming 
reaction for substrate recruitment. Instead, the PBD domain of PLK1 is also capable of 
binding to both non-phosphorylated peptides, and also previous PLK1 phospho-peptide 
sequences (self-priming) (Archambault et al. 2008; Elia, Cantley, et al. 2003). 
Phosphorylation by PLK1 can lead to various outcomes for PLK1 targets. Although, in 
general, PLK1 promotes either the inhibition or stimulation of target protein activity 
(Archambault and Glover 2009; Zitouni et al. 2014). 
 
PLK1 protein level and activity appears to peak on mitotic entry. Thus, studies have 
largely concentrated on exploring the roles of PLK1 during mitosis. Notably, a loss of 
PLK1 has been shown to cause severe mitotic defects. These include abnormal 
centrosome formation and a failure of mitotic cells to correctly undergo chromosome 
biorientation (Barr et al. 2004). How PLK1 facilitates these processes is still not fully 
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understood. Therefore, PLK1 remains an intriguing protein to study, with great 
potential, as many unidentified roles are yet to be determined.  
 
1.8.1 PLKs a family of serine/threonine kinases 
 
PLK1 belongs to a family of serine/threonine protein kinases (PLKs), which function to 
perform vital roles involved in cellular progression. There are five mammalian PLK 
paralogues, PLK1-5 (Fig. 1.13). PLK1 is generally recognised as the principal member of 
this kinase family and has been implicated in various aspects of cellular regulation, 
including DNA replication and mitotic fidelity (Schmucker and Sumara 2014; Song, Liu, 
and Liu 2012; Yim and Erikson 2009). Much less is known about the other PLK members.  
 
PLK2 is primarily expressed in G1 and has been suggested to provide a functional role(s) 
in the G1-S phase transition of the cell cycle, through centriole duplication. PLK2 may 
also have links to cytokinesis progression (Simmons et al. 1992; Warnke et al. 2004). 
PLK3 is continuously expressed throughout the cell cycle. Therefore, it has been 
suggested that PLK3 may support a role(s) in G1-S phase transition, along with a possible 
DNA replication function. PLK3 has also been reported to function during cellular stress 
responses, including the DNA damage response (Xie et al. 2001). PLK4 has a role in 
centriole biogenesis, acting as a centriole assembly factor. It is only present in species 
that contain centrioles (Habedanck et al. 2005). Finally, PLK5 is abundant in non-
proliferative cells, such as neurons. Hence, PLK5 is largely found expressed in the brain. 
PLK5 contains an inactive kinase and lacks important residues for substrate recognition 
within its polo-box domain (de Cárcer, Escobar, et al. 2011; de Cárcer, Manning, et al. 
2011). Therefore, the biological function(s) of PLK5 may be distinctly different from 
other PLK family members (PLK1-4). 
 
Structurally, all PLK members display similarities in their protein domain architecture 
(Jana et al. 2012). This includes an amino-terminal serine/threonine kinase domain and 
a carboxy-terminal polo-box domain (PBD). The PBD of each PLK contains either one or 
Figure 1.13. The structural domains of PLK1-5.
In general PLK’s are structurally very similar. Each contain a catalytic core (helicase
domain), and either one or two polo-box domains (PBD). These are required for PLK
substrate targeting. PLK1-3 have the most similar kinase domains among the PLK’s, whilst
PLK4 has a divergent sequence and PLK5 features a pseudo-kinase domain, absent of
catalytic activity. PLK1 also features a destruction box (D-box) sequence, which is essential
for PLK1 degradation (diagram adapted from Zitouni, et al. 2014).
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two polo-box domains. The kinase domains of PLK1-3 are considered the most similar 
among the PLK family. In contrast, PLK4 has a divergent sequence within its kinase 
domain, and PLK5 contains a pseudo-kinase domain (Zitouni et al. 2014). The structural 
similarities within the kinase domain of PLK1-3 means they can all display sensitivity to 
small-molecule competitive inhibitors of ATP. This includes a potent PLK1 inhibitor, 
known as BI2536 (IC50 = 0.83nM) (Lénárt et al. 2007). Therefore, despite the substantial 
specificity to PLK1, the use of such inhibitors (i.e. BI2536) may affect the catalytic activity 
of all three kinases (PLK1-3) at once. Overall, PLKs, and in particular PLK1, are critical 
kinases in order to promote cellular progression and survival. Thus, their catalytic 
activity is highly regulated. 
 
1.8.2 Regulation of PLK1 activity 
 
The activation cycle of PLKs is largely understood from studies examining PLK1. 
Therefore, only the regulatory processes of PLK1 activation will be discussed in detail. 
PLK1 is largely activated during the G2-M transition and its activity is maximised during 
mitosis. PLK1 activation involves phosphorylation at two key residues, which are 
positioned within the catalytic domain or ‘T-loop’ (Thr210) and the hinge region of the 
kinase domain (Ser137) (Bruinsma et al. 2012, 2013). In general, Aurora A, along with its 
co-factor BORA, are responsible for PLK1 activation.  
 
The cytoplasmic scaffold BORA binds to Aurora A and PLK1, which promotes PLK1 T-loop 
phosphorylation (Thr210). BORA functions to ‘unlock’ the access of the T-loop of PLK1, 
thus promoting Aurora A dependent phosphorylation of PLK1 at Thr210 (Fig. 1.14a) 
(Macůrek et al. 2008; Seki, Coppinger, Jang, et al. 2008). Active PLK1 is then able to 
phosphorylate several mitotic entry network factors, including CDK1, which functions to 
promote mitotic entry (Lindqvist et al. 2009). In addition, CDK1 activation also 
determines a positive feedback loop involved in PLK1 activation. It does this by 
phosphorylating BORA (priming) at the PBD-docking site and facilitates the PLK1-BORA 
interaction. Subsequently, Aurora A dependent phosphorylation of PLK1 is promoted 
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(Vigneron et al. 2018). Surprisingly, the activation of PLK1 also stimulates bulk BORA 
degradation, via PLK1 dependent phosphorylation of BORA, despite BORA acting as an 
activator of PLK1. PLK1 phosphorylation generates a phospho-degron signal on BORA, 
which is recognised by the S phase Kinase associated Protein 1 (SKP1)-cullin-1-F-box -
Transducin repeat Containing Protein (TrCP) (SCFTrCP). This E3-ubiquitin ligase complex 
targets BORA for proteasomal degradation prior to mitotic entry (Seki, Coppinger, Du, 
et al. 2008). Thus, mitotic entry relies on a two-tiered control of PLK1 and Aurora A, 
which is dependent on BORA activity. This culminates in the activation of PLK1 and CDK1, 
with the concomitant degradation of BORA. PLK1 ‘T-loop’ phosphorylation (Th210) 
remains throughout mitosis and is therefore refractory to de-phosphorylation, despite 
Aurora A depletion. A small level of BORA remains, which is considered sufficient to 
maintain the required level of PLK1 activity throughout mitosis (Bruinsma et al. 2013).  
 
Apart from being the primary substrate recruitment site for PLK1 localisation, the PBD 
is also responsible for controlling the catalytic activity of PLK1. The PBD functions to 
achieve this via an auto-inhibitory mechanism. The PBD binds to the catalytic domain of 
PLK1 in such a conformation to result in the mutual inhibition of both of their functional 
activities (Fig. 1.14a) (Bruinsma et al. 2012). Currently, it is understood that PLK1 kinase 
activity is suppressed through three identified regulatory methods. One is through the 
PBD itself, which functions to reduce the flexibility of the hinge region of the kinase 
domain, where Ser137 is located. Subsequently, phosphorylation at Ser137, achieved by 
activating kinases, such as Aurora A/BORA, allows for PLK1’s inhibitory signal to be 
released. Secondly, PLK1 kinase activity can be inhibited by the Inter-domain Linker 
(IDL). This links the kinase domain with the PBD and sequesters access to the T-loop 
(Thr210). Conversely, the prevention of T-loop sequestration, by protein partner binding 
of the PBD, can prevent this inhibition of PLK1 activity. Finally, studies using the 
Drosophila melanogaster Polo, have revealed that binding of an inhibitory protein, 
called MAP205, to the PBD of Polo, can also regulate the catalytic activation of Polo 
(Archambault et al. 2008; Xu et al. 2013). Alleviation of the inhibitory effect on Polo by 
MAP205 can be achieved by phosphorylation of MAP205 itself (Fig. 1.14a). However, it 
is important to note, currently no orthologue of MAP205 has been identified in human 
Figure 1.14. The activation and degradation cycle of PLK1.
a) Inactive PLK1: In the resting state, PLK1 is inactive. The PBD domains bind to the kinase
domain in such a way that it sequesters access to two key residues of PLK1, which are
required for its activation, Thr210 and Ser137. In addition, MAP205 may bind to PLK1 and
also inhibit PLK1’s catalytic activity. Release of MAP205 inhibition on PLK1 requires CDK1-
dependent phosphorylation of MAP205. Active PLK1: Activation of PLK1 is achieved via
phosphorylation of key residues, Thr210 (‘T-loop’) and Ser137 by Aurora A kinase (maybe
also Aurora B). Aurora A, along with its binding partner BORA, encourages a conformational
change in the structure of PLK1 and release of the PBD from the catalytic core, allowing
Aurora A-dependent phosphorylation of PLK1. Alternatively, PLK1 can become active via
pre-primed (CDK1) phospho-peptide binding, which encourages release of the PBD and
subsequently Aurora A kinase dependent activation. b) During exit from mitosis, PLK1 is
signalled for degradation via the APC/CCDH1 dependent ubiquitination pathway, which
signals PLK1 for destruction via the 26S proteasome. (Diagrams adapted from Zitouni, et al.
2014)
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cells (Normandin et al. 2016). Despite the absence of MAP205 in human cells, ectopic 
expression of MAP205 in HEK293T cells, has been shown to effectively inhibit PLK1 
activity. To alleviate this inhibition on PLK1, MAP205 requires phosphorylation by CDK1 
for its displacement (Normandin et al. 2016), much like in Drosophila melanogaster Polo 
MAP205 regulation. Therefore, PLK1 regulation contains various levels of control in 
order for its activation, whilst its degradation cycle is also highly ordered. 
 
In the resting state, PLK1 remains inactive. However, during mitosis, the independent or 
sequential phosphorylation of Thr210 and Ser137, leads to either partially or fully active 
PLK1. Phosphorylation by Aroura A, along with the recruitment of the Aurora A cofactor 
BORA, promotes a conformational change to the PBD of PLK1 and induces the release 
of the kinase domain away from the PBD; thereby triggering the activation of PLK1 
(Zitouni et al. 2014). In contrast, during mitotic exit, PLK1 proteolytic degradation 
begins. This is triggered by the activation of a ubiquitin-dependent proteasomal 
degradation pathway, that targets PLK1 for destruction. The E3-ubiquitin ligase, APC/C, 
works in conjunction with its co-factor CDH1 (APC/CCDH1). Together they recognise a 
destruction box (D-box) signal within PLK1. Ubiquitylation of PLK1 by APC/CCDH1 at this 
D-box marks PLK1 for proteasomal degradation and subsequently, PLK1 protein levels 
dramatically fall during exit from mitosis (Fig. 1.14b) (Lindon and Pines 2004).  
 
Overall, PLK1 activity is considered essential for mitotic progression. Once active, PLK1 
has been implicated in various processes involved in mitotic advancement. In particular, 
PLK1 influences centrosome maintenance and also supports KT-MT attachment, two key 
features that if compromised, can affect the status of accurate chromosome alignment.   
 
1.8.3 PLK1 function during centrosome maturation 
 
In its original identification in Drosophila melanogaster (Polo), PLK1 was shown to 
localise to centrosomes (Golsteyn et al. 1995). This highlights PLK1’s probable functional 
influence on centrosome maintenance. Centrosomes are small cytoplasmic organelles 
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that consist of a pair of barrel-shaped centrioles, which are surrounded by pericentriolar 
material (PCM) (Conduit et al. 2015). Centrosomes act as the microtubule (MT) 
organising centre for microtubule nucleation. Microtubules are responsible for the 
capture and alignment of chromosomes during mitosis, which is a key process of mitotic 
fidelity.  
 
The centrosome is duplicated during S phase and creates a pair of centrosomes that 
begin separating during prophase (Conduit et al. 2015). Each separated centrosome 
positions itself at opposing sides of the chromosome mass and act as the two poles for 
the mitotic spindle. This promotes the bipolar arrangement of chromosomes during 
metaphase (chromosome biorientation), whilst also supporting equal chromosome 
segregation. Although the role of centrosomes in acting as the organising centre for the 
mitotic spindle is well established, its precise contribution to cell division remains a 
debated topic. Cells ablated of centrosomes have been reported to still be capable of 
undergoing chromosome biorientation (Khodjakov et al. 2000). This suggests that cells 
may have a centrosome-independent bipolar spindle formation capacity. However, a 
disruption to centrioles and therefore, a disruption to correct centrosome biogenesis, 
has also been shown to lead to defects in bipolar spindle assembly (Sir et al. 2013). 
Despite these differences in conclusions, it is generally understood that centrosomes 
provide a robustness to bipolar spindle formation and chromosome segregation, whilst 
PLK1 has been reported to provide a functional role to support this. 
 
Centrosomes go through a process of maturation, which involves the recruitment of -
tubulin. This occurs during prophase and is essential for microtubule nucleation from 
mitotic centrosomes. PLK1 is involved in centrosome maturation and is believed to 
facilitate -tubulin recruitment (Casenghi et al. 2005; Lane and Nigg 1996; Oshimori et 
al. 2006). PLK1 inactivation commonly leads to a disruption in -tubulin detection at 
centrosomes, highlighting an essential role for -tubulin during centrosome maturation. 
It also suggests that PLK1 activity influences both centrosome establishment and 
maintenance (Lénárt et al. 2007; Peters et al. 2006; Santamaria et al. 2007). In addition, 
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an absence of PLK1 activity has also been shown to prevent bipolar spindle formation, 
with cells displaying a prometaphase-like stage arrest (van Vugt et al. 2004). This implies 
that PLK1 provides a function that influences microtubule nucleation from centrosomes, 
which is likely to ensure correct mitotic spindle formation.  
 
Contrasting reports have suggested that centrosomes can function normally, despite an 
ablation of PLK1’s PBD domain, which subsequently causes an absence of PLK1 
recruitment to centrosomes (Hanisch 2006). However, the same study also reported 
defects in chromosome congression when PLK1 activity was compromised (Hanisch 
2006). Therefore, despite the contradictory studies regarding PLK1 function during 
centrosome maintenance, PLK1 is required for accurate chromosome alignment. 
 
1.8.4 PLK1 function in kinetochore-microtubule attachment stability 
 
PLK1 has also been shown to accumulate at kinetochores during early mitosis (Seong et 
al. 2002). Kinetochores function as the molecular platforms for which microtubules 
attach to chromosomes during chromosome congression. Moreover, PLK1 localisation 
at KTs has led to the suggestion that PLK1 plays a functional role in KT-MT maintenance. 
In support of this, PLK1 inactivation studies have shown that microtubule attachment at 
kinetochores are affected when PLK1 is inactivated. Studies using indirect fluorescent 
microscopy techniques were able to demonstrate a decline in stable KT-MT attachment 
(K-fibres), following the inactivation of PLK1 (Hanisch 2006; Lénárt et al. 2007; 
Santamaria et al. 2007).  
 
In addition, PLK1 activity has been reported to affect the regulation of the mitotic 
checkpoint. The inactivation of PLK1, using the small-molecule inhibitor BI2536 (IC50 = 
0.83nM), has been shown to prolong SAC activation, due to the existence of unattached 
kinetochores (Lénárt et al. 2007; Steegmaier et al. 2007). Therefore, increasing evidence 
implies that PLK1 is required for KT-MT attachment and probably also for its 
maintenance.  
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The expression of PLK1 begins during S phase and peaks during mitosis, whilst its 
detection at sister-kinetochores can occur during the G2 phase of the cell cycle 
(Hamanaka et al. 1994; Kang et al. 2006). PLK1 recruitment to kinetochores has been 
shown to be dependent on PBIP1 (CENP-50) (Kang et al. 2006). It has been reported that 
PLK1 ‘self-primes’ PBIP1 via protein phosphorylation and in doing so, PLK1 generates its 
own docking site (T78) for PBD binding. This subsequently supports PLK1’s recruitment 
to kinetochores. PLK1 is also reported to promote the  degradation of PBIP1 early in 
mitosis, despite PLK1 persisting at kinetochores until telophase (Kang et al. 2006). 
Therefore, it is conceivable that additional factors may contribute to PLK1 stabilisation 
at kinetochores.  
 
The SAC protein, BUB1 (kinase), has been shown to interact with PLK1 following an initial 
‘priming’ reaction by CDK1.  This phospho-dependent interaction is believed to influence 
PLK1 recruitment to kinetochores (Qi et al. 2006). PLK1 has also been shown to interact 
with INCENP, a member of the chromosomal passenger complex (CPC) (Goto et al. 
2006). The CPC is made up of INCENP, Aurora B, Borealin and survivin. Its primary 
functions include KT-MT attachment maintenance and SAC activation (Carmena et al. 
2012). This suggests that PLK1 localisation to kinetochores depends on several factors. 
However, elucidating the role each factor plays remains challenging. For example, 
depletion of BUB1 can lead to secondary effects, such as kinetochore structural 
alterations (Meraldi and Sorger 2005). Therefore, these potential effects may indirectly 
influence PLK1 localisation. Also, self-priming by PLK1 on different proteins may be a 
factor for PLK1 localisation to kinetochores, much like the mechanism of PBIP1-
dependent kinetochore localisation of PLK1. Thus, PLK1 activity and multiple factors are 
likely responsible for PLK1 localisation to kinetochores.   
 
Kinetochore complexes are made up of over 100 different proteins (Cheeseman 2014). 
Therefore, following PLK1 localisation to kinetochores, PLK1 can phosphorylate a vast 
repertoire of targets. In addition to BUB1, obvious targets of PLK1 phosphorylation 
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would be additional components of the SAC. PLK1 levels have been shown to increase 
at kinetochores that remain unattached (Ahonen et al. 2005). Therefore, it is 
conceivable that PLK1 plays a role in regulating the activity of the SAC. PLK1 has also 
been shown to phosphorylate BUBR1, another recognised member of the SAC (Elowe et 
al. 2007). However, this phosphorylation is probably independent of SAC regulation, 
because PLK1 inactivation studies have demonstrated that the SAC remains active in the 
absence of PLK1 (Lénárt et al. 2007; Santamaria et al. 2007; Sumara et al. 2004). 
Therefore, PLK1 is not directly responsible for SAC activation. Instead, the PLK1-
dependent phosphorylation of BUBR1 has been shown to indirectly link PLK1 to ensuring 
correct KT-MT attachment. PLK1 dependent phosphorylation of BUBR1 generates a 
binding site on BUBR1, supporting the recruitment of the protein phosphatase-2A-B56 
complex (PP2A-B56) (Suijkerbuijk et al. 2012). The recruitment of PP2A-B56 at 
kinetochores acts to counteract Aurora B-mediated phosphorylation of the KMN-
network. This promotes the stabilisation of KT-MT attachments (Kruse et al. 2013), as 
Aurora B phosphorylation of the KMN-network reduces MT-binding affinity to 
kinetochores, thereby encouraging KT-MT error correction (Lampson and Cheeseman 
2011). Thus, PLK1 and Aurora B activity may act antagonistically to achieve bipolar 
spindle attachment. Phosphorylation of substrates by Aurora B acts to destabilise MT-
KT attachment, whilst PLK1-dependent phosphorylation may indirectly act to stabilise 
MT-KT attachment.  
 
PLK1 also interacts with the ‘tension sensing’ protein PICH (Baumann et al. 2007). PICH 
has been shown to colocalise with PLK1 at KTs following NEBD (Baumann et al. 2007), 
although the significance of this PICH-PLK1 interaction remains unclear. PICH was 
originally identified as a SAC effector, however, the same group later confirmed this to 
be incorrect (Hübner et al. 2010). Therefore, a precise function for PICH at KTs continues 
to remain elusive. However, because of its localisation and interaction with PLK1 at KTs, 
PLK1 presents as a strong candidate for the regulation of PICH.  
 
PICH stabilisation at kinetochores has been reported to be dependent on PLK1. 
Depletion, or expression of a kinase inactive version of PLK1, led to PICH re-localisation 
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away from kinetochores and recruitment along the chromosome arms (Baumann et al. 
2007). This is supported by an independent study which showed that both PICH and 
PLK1 became localised to chromosome arms during PLK1 inactivation, using a then novel 
PLK1 inhibitor; ZK-Thiazolidinone (Santamaria et al. 2007). This led to the suggestion 
that PICH might target PLK1 to chromosome arms, when PLK1 activity becomes 
compromised. PICH is able to target PLK1 to chromosome arms, dependent on 
phosphorylation of PICH at T1063 (Leng et al. 2008). The significance of this PLK1-PICH 
re-localisation away from kinetochores to chromosome arms remains unclear, but it 
highlights a possible regulatory link between PLK1 and PICH.  
 
Both PLK1 and PICH are required to ensure stable chromosome alignment and 
segregation during mitosis. A disruption to the activity of either protein leads to mitotic 
defects, including errors in KT-MT attachment and chromosome mis-segregation (Lénárt 
et al. 2007; Nielsen et al. 2015). Thus, further studies of PLK1 and its interacting proteins, 
may help to uncover how cells ensure correct chromosome alignment and faithful 
segregation. 
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1.9 Summary 
 
Faithful chromosome segregation relies on an extremely complex series of processes, 
both prior to and after mitotic entry. These include DNA duplication and the 
establishment of sister chromatid cohesion, whilst commitment to mitosis also requires 
the refined manipulation of chromosome architecture through chromosome 
condensation. In addition, intricate processes are involved in the identification and 
assembly of the centromere and building of the kinetochore complex. A sophisticated 
surveillance system also exists in order to monitor kinetochore attachment, by the 
microtubules that emanate from spindle poles. This ensures correct chromosome 
bipolarity, before sister chromatid disjunction can occur. Cells also rely on molecular 
machinery to ‘decatenate’, or ‘resolve’ DNA intertwining structures that can link sister 
chromatids. The recruitment of the UFB-binding complex to DNA linkages that appear 
during anaphase, promotes chromosome disjunction and prevents further genome 
damage. Understanding how each of these processes are activated and regulated 
remains an ongoing topic for scientific discovery. However, it seems clear that most, if 
not all of these processes involve PLK1 kinase activity.  
 
Therefore, this project aimed to further investigate the roles of PLK1, in particular during 
mitotic progression, whilst also considering the potential regulatory role of its 
interacting proteins, including PICH and BLM. This research has led to the discovery that 
PLK1 plays an unexpected function in the protection of centromere integrity (Addis 
Jones et al. 2019). Inhibition of PLK1 kinase activity leads to a mis-regulation of the UFB-
binding complex at the centromere, which results in catastrophic DNA breakage of 
centromeric chromatin. In particular, both BLM helicase and PICH translocase have been 
implicated as key drivers for this catastrophic centromere destruction (Addis Jones et al. 
2019). We hypothesis that PLK1 activity prevents such deformation via direct phospho-
dependent regulation of the UFB-binding complex, although this is yet to be confirmed. 
Additionally, PLK1 may play a role in DNA structural integrity and in its absence, 
centromeric DNA can become weak and susceptible to deformation.  
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Overall, the results detailed within this thesis highlight the importance of PLK1 kinase, 
to ensure the maintenance of genomic stability, via a previously undescribed pathway 
for the protection of centromeres. 
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Chapter 2: Materials & Methods  
2.1 DNA plasmid construction 
 
All cloning reactions involved the use of chemically competent E. coli DH5 cells (New 
England Biolabs). Either High- or Sub-cloning efficiency DH5 cells were used, depending 
on the cloning application. 
 
2.1.1 DNA plasmids  
 
eGFP-C1-BLM 
eGFP-C1-BLMQ672R 
eGFP-C1-PICH 
eGFP-C1-PICHK128A 
siRES-PICH(GeneArt) 
pSYC-181 – psCMV-NLS-eGFP-P2A-NEO-T7-SV40pA (Neomycin cassette inserted)  
 
2.1.2 Oligonucleotides for cloning  
 
Primer 
number 
Primer name Sequence 
1 GFP_BLM_F-AscI GCTACCTTGGCGCGCCATGGTGAGCAAGG 
2 GFP_BLM_R-AgeI GAGATTCGGACCGGTTGAGAATGCATATGAAGGC 
3 siRES_PICH_F-AfiII CCTAATGGACCTACTTAAGAGG 
4 siRES_PICH_R-SacI TCCTCGATTGTAAAGAGCTC 
5 GFP_PICH_F-AgeI CTAGCGCTACCGGTCGCCA 
6 GFP_PICH_R-SmaI GTGGATCCCGGGTGAATTGTTATTAAG 
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2.1.3 Bacterial transformation  
 
All bacterial transformation reactions followed the manufacturers protocol involving the 
use of chemically competent E. coli DH5 cells (New England Biolabs). In brief, 
chemically competent E. coli DH5 cells (50l) were thawed on ice and incubated with 
the required amount of purified DNA for 30 mins. Cells were then heat shocked at 42C 
for exactly 30 seconds, before returning them back on ice for 5 minutes. 450l of SOC 
media was added to the cells and then incubated at 37C for up to 60 minutes, whilst 
shaking in an Eppendorf thermomixer. Finally, cells were plated on to pre-warmed LB-
Agar plates (supplemented with the required antibiotic for selection) at varying dilutions 
and incubated overnight at 37C.  
 
2.1.4 Plasmid preparation and purification  
 
Preparation of plasmid DNA was achieved by selecting a single transformed bacterial 
colony and inoculating in 5ml of LB (Luria-Bertani) media, supplemented with the 
necessary antibiotics. The inoculated colonies were incubated overnight at 37C, whilst 
shacking at 220rpm in a C25 incubating shaker (New Brunswick Scientific). The following 
day, 500l of the culture was collected and added to 500l of 50% glycerol in cryo-vials 
(Thermo Fisher), in order to prepare bacterial glycerol stocks (stored at -80C). The 
remaining culture was then harvested by centrifugation at >4000rpm for 5 minutes at 
room temperature. The pelleted cells were then directly used for plasmid extraction, 
following the manufacturers protocol using either a QIAprep Spin Mini or Midi prep kit 
(Qiagen), depending on the required DNA amount and downstream application(s). The 
DNA concentration was measured using a NanoDrop (ND-1000 UV-Vis 
Spectrophotometer) and the purified plasmid DNA was stored at -20C. 
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2.1.5 Restriction enzyme digestion  
 
Restriction enzyme digestion was performed using New England Biolab restriction 
enzymes, alongside the recommended buffer composition, according to the 
manufacturers guidelines (NEB). Typically, for a 25l reaction, 2.5l of the 
recommended 10x buffer was used with around 1g of purified plasmid DNA. 0.5-1l of 
restriction enzyme was added and incubated at 37C for 15-60 minutes, before 
analysing on an agarose gel. 
 
2.1.6 Thermocycling (Polymerase Chain Reaction) 
 
All polymerase chain reactions (PCR) were performed using an Eppendorf PCR machine. 
PCR primer oligonucleotides were purchased from Eurofins Genomics and dissolved for 
use in all PCR reactions at a concentration of 10M in ultra-pure water. All DNA 
fragment amplification reactions were performed using Phusion polymerase (New 
England Biolabs), following the manufacturer’s guidelines. 
  
2.2 Human Cellular assays 
 
2.2.1 Human cell culture  
 
Unless stated, all human cell lines used were obtained from the Cell Bank at the Genome 
Damage & Stability Centre, which were originally purchased from ATCC. All cell lines 
passed regular testing for mycoplasma contamination (Lonza Mycoplasma testing kit). 
RPE1 (PLK1as cells) derivative cell lines were a gift from Mark Burkard (University of 
Wisconsin). HAP1 and knockout BLM (HAP1) cells were a gift from Marcel van Vugt 
(University of Groningen). Stable cell lines created during this study include: 
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Cell line name Parental 
GFP-BLM DeltaBLM-HAP1 
GFP-BLM(Q672R) - Helicase dead  DeltaBLM-HAP1 
GFP-PICH-(siRES)  HCT116 
GFP-PICH(K128A)-(siRES) - Translocase dead HCT116 
 
In brief, all human cell lines were maintained at 37C in a humidified incubating 
chamber, containing 5% CO2. All cell lines were grown in their necessary growth medium 
(see table, 2.3.2), supplemented with foetal calf serum (FCS) and antibiotics (Penicillin-
Streptomycin). To maintain healthy cell growth, cells were passaged every two-three 
days. In brief, cells were washed in PBS before adding 0.25% Trypsin-EDTA (Sigma 
T4049). Cells were then incubated at 37C for 1-2 minutes to allow cells to detach from 
the cell culture flasks. Cells were then neutralised with fresh pre-warmed medium and 
centrifuged at 1200rpm for 2 minutes. Cells were then resuspended in fresh culture 
medium and plated into new flasks at a low-medium density. 
 
2.2.2 Cell lines (parental)  
 
Cell line Morphology 
Culture 
medium 
Karyotype Origins 
RPE1 hTERT Epithelial 
(like) 
DMEM F12  
15% FCS  
Pen-Strep 
46 
(Diploid) 
Normal 
HCT116  Epithelial McCoys 5A   
15% FCS  
Pen-Strep 
46 
(Diploid) 
Colorectal carcinoma 
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HeLa Epithelial DMEM   
10% FCS  
L-Glutamine 
Pen-Strep 
70-164 
(Polyploid) 
Adenocarcinoma 
HAP1 Fibroblast-
like 
IMDM   
10% FCS  
Pen-Strep 
23 
(Haploid) 
 
Chronic myelogenous 
leukaemia (CML) 
 
2.2.3 Drugs & Inhibitors  
 
Drug/Inhibitor Target/Function Source Concentration 
3-MB-PP1 ATP-analogue Abcam 1M 
BI2536 PLK1 Cayman 
chemical 
60nm/250nm 
G418 Antibiotic  Sigma 0.6-1.2mg/ml 
Nocodazole Microtubule spindle 
poison 
Sigma 100ng/ml 
ProTAME APC/C  R&D systems 12M 
Thymidine G1/S arrest Sigma 2mM 
 
2.2.4 Transfection of human cells 
  
2.2.4.1 Electroporation (transient & stable transfection) 
 
Cells were trypsinised at 37C for approximately 2-5 minutes, before neutralisation with 
fresh medium. Cells were centrifuged at 1200rpm for 2 minutes and the pellet 
resuspended in 5-10ml of fresh medium for counting. The volume required for 4x105 
cells was taken and washed in 5ml of PBS, before again pelleting via centrifugation. After 
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removing the supernatant, cells were resuspended in 20l of Buffer R (pre-warmed to 
RT). A range of between 1-5g/l of purified DNA was added to the cells in a maximum 
of 2.5l volume. Using the Neon Transfection System 10l kit (ThermoFisher, MPK1025), 
the DNA mixture was pipetted into the needle and electroporated at 1350V, for 20ms 
with 2 pulses, and added to a 6-cm dish containing 5ml of pre-warmed culture medium. 
This was repeated for a second time and the DNA complex again added to the culture 
medium, before the cells were incubated at 37C in a 5% CO2 cell culture incubator. Cells 
were either examined after 24-48 hours of transfection (transient plasmid expression) 
or, alternatively, for stable cell line creation, cells were re-plated after approximately 48 
hours and allowed to re-adhere to the surface (16-24 hours). Once recovered the cells 
were then subjected to antibiotic selection pressure for 2-14 days, depending on the 
antibiotic used (Puromycin 2-3 days, G418 a minimum of 10-14 days). Following 
antibiotic selection, cells were either seeded at a very low density (500-2000 cells) in a 
large cell culture dish (e.g. 15cm) for single colony selection, or alternatively, sorted 
using a BD Melody cell sorter (see below, Flow Cytometry 2.3). 
  
2.2.4.2 Lipid mediated delivery (transient & stable transfection) 
 
FuGENE HD (Promega) was used to transfect plasmid DNA into human cells, if 
electroporation was not required. The manufacturers guidelines were used for all 
FuGENE HD transfections. In brief, cells were plated in a 6-well dish (approximately 
2x105 cells) a day before transfection (approximately 16 hours before). In general, 2g 
of purified plasmid DNA was used for transfection at a 3:1 or 4:1 ratio of transfection 
reagent to DNA. Cells were either examined after 24-48 hours post transfection 
(transient expression), or alternatively, re-plated in a larger cell culture dish and 
subjected to antibiotic selection pressure for up to 14 days (see stable cell line creation, 
2.2.5). Successful clones were either isolated by single colony isolation or by FACS cell 
sorting, using a BD Melody cell sorter. 
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2.2.4.3 Protein depletion using RNA interference (RNAi) 
 
Depletion of proteins was achieved by using Lipofectamine RNAi MAX transfection 
reagent (ThermoFisher, 13778075), whilst following the manufacturers guidelines. In 
brief, following cell seeding (approximately 75% confluency), cells were transfected with 
siRNA oligos (see RNAi oligo sequences, 2.2.4.4) using RNAi MAX, for up to 24-72 hours 
in order to deplete the target protein. Fresh siRNA-RNAi MAX complex was added for 
transfections over 24 hours every 24-48 hours. Protein depletion was measured via 
Western Blot or Immunofluorescent analysis. 
   
Culture dish siRNA (20M) RNAi MAX OPTI-MEM Final volume 
6-well plate 1.25l  1.25l 250l (each) 2ml 
6cm plate 2.5l 2.5l 500l (each) 4ml 
10cm plate 6.25l 6.25l 1250l (each) 10ml 
 
2.2.4.4 RNA interference Oligonucleotide sequences 
 
RNAi 
Target 
Sequence Supplier 
BLM  GGAUGACUCAGAAUGGUUA Dharmacon ON-TARGET plus 
Individual  
(J-007287-08-0005) 
CTRL UGGUUUACAUGUCGACUAA; 
UGGUUUACAUGUUGUGUGA; 
UGGUUUACAUGUUUUCUGA; 
UGGUUUACAUGUUUUCCUA 
Dharmacon ON-TARGET plus  
Non-targeting Pool  
(D-001810-10-05) 
PICH AAUUCGGUAAACUCUAUCCACAGCU Invitrogen 
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PLK1 GCACAUACCGCCUGAGUCU; 
CCACCAAGGUUUUCGAUUG; 
GCUCUUCAAUGACUCAACA; 
UCUCAAGGCCUCCUAAUAG 
Dharmacon ON-TARGET plus 
SMARTpool  
(L-003290-00-0005) 
RAD51 CCACCAGACCCAGCUCCUUUAUCAA 
 
Invitrogen 
SGO1 CAGCCAGCGUGAACUAUAA; 
GUUACUAUCUCACAUGUCA; 
AAACGCAGGUCUUUUAUAG; 
GUGAAGGAUUUACCGCAAA 
Dharmacon ON-TARGET plus 
SMARTpool  
(L-015475-00-0005) 
 
2.2.5 Stable cell line generation 
 
2.2.5.1 Complementation of WT & helicase dead (Q672R) GFP-BLM  
 
DeltaBLM (HAP1) cells were created by PCR amplifying the GFP-BLM sequence from the 
GFP-BLM bacterial plasmid (see bacterial plasmids, 2.1.2). Oligos were designed to 
include restriction enzymes in both the forward and reverse direction (AscI & AgeI, 
respectively), whilst also removing the stop codon from the GFP-BLM sequence (see 
oligo sequences 2.1.3). The PCR fragment was then used for restriction cloning into the 
pSYC-181(NEO) vector, using the AscI & AgeI sites. In brief, both the PCR fragment (2-
5g DNA of GFP-BLM & GFP-Q672R) and vector (10g DNA of pSYC181-(NEO)) were 
digested in a 50l reaction for 6-8 hours, using AscI & AgeI restriction enzymes according 
to the manufacturers reaction guidelines (NEB). The digested PCR product was PCR 
purified (QIAquick PCR purification Kit, Qiagen), whilst the digested vector was then de-
phosphorylated with (5l) Antarctic phosphatase (NEB) and gel extracted, according to 
the manufacturer’s guidelines (QIAquick Gel Extraction Kit, Qiagen). The digested 
products were then ligated together in a 1:3 ratio of vector (500ng) to insert using T4 
DNA Ligase (NEB). The ligation reaction was heat de-activated at 65C for 10mins, before 
3l of ligated RXN mixture was then transformed into High-efficiency DH5 cells (New 
England Biolabs). Following transformation and successful isolation of clones via sanger 
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sequencing (ATGC), purified plasmid DNA (MIDI prep) was then transfected into 
DeltaBLM (HAP1) cells using FuGENE transfection reagent, following the manufacturers 
guidelines. After 48hours of transfection, antibiotic selective pressure in the form of 
G418 was applied to the cell medium, for a minimum of 2 weeks (1.2mg/ml). After 2 
weeks of antibiotic selection, cells were then sorted for GFP expression using the BD 
Melody FACS cell sorter, which isolated a polyclonal population of GFP-BLM or GFP-BLM 
(Q672R) cells. 
   
2.2.5.2 PICH RNAi resistant stable cell line 
 
In order to generate an RNAi resistant copy of the PICH gene for stable cell expression, 
it was necessary to change the DNA sequence that the PICH siRNA oligo targeted (see 
RNAi oligo sequences, 2.2.4.4), whilst maintaining the original amino acid sequence. A 
gene synthesis service by Thermo Fisher (Gene Art) was used to generate a 589bp 
sequence of the PICH gene, which contained 10 nucleotide variations within the 20 
nucleotide RNAi targeting region, whilst maintaining the same amino acid sequence. The 
synthesised DNA sequence was also designed to include flanking restriction enzymes 
(AfiII & SacI, New England Biolab, NEB) for further cloning needs. The synthesised 
sequence was then PCR amplified and digested (2-5g DNA in a 50l RXN for 6-8hrs), 
targeting the AfiII and SacI sites for downstream cloning. Alongside this the GFP-PICH & 
GFP-K128A vectors were digested with AfiII and SacI (10g DNA in a 50l RXN for 6-8hrs) 
and then de-phosphorylated using 5l of Antarctic phosphatase (NEB). The PCR product 
was purified (QIAquick PCR purification Kit, Qiagen) and the vector underwent gel 
extraction (QIAquick Gel Extraction Kit, Qiagen). The vector (~8Kb) and insert (~500bp) 
fragment were then ligated using T4 DNA Ligase (NEB) according to the manufacturer’s 
guidelines in a 1:3 ratio, using 500ng of vector DNA for 2hrs at RT. The ligation reaction 
was heat de-activated at 65C for 10mins, before 3l of the ligation RXN mixture was 
transformed into High-efficiency DH5 cells (New England Biolabs). Following mini-
preparation of plasmid DNA, GFP-PICH & GFP-K128A (including the mutated RNAi 
targeting site) plasmids were PCR amplified with specific oligos (see oligonucleotides, 
2.1.3), which contained both AgeI & SmaI restriction enzyme sites, whilst also removing 
  60 
the stop codon. This fragment was then cloned into the pSYC-181(NEO) vector using 
restriction enzyme digestion (AgeI & SmaI, NEB) and T4 DNA ligase (NEB). Following 
transformation and confirmation of clones via sanger sequencing (ATGC), purified 
plasmid DNA (MIDI prep) was then transfected into HCT116 cells using FuGENE. After 
48hours of transfection antibiotic selection pressure in the form of G418 (0.7mg/ml) was 
applied to cell medium for 2 weeks. After 2 weeks of antibiotic selection, cells were then 
sorted for GFP expression using the BD Melody FACS.  
 
2.3 Flow cytometry and fluorescent activated cell sorting (FACS) 
 
2.3.1 Flow cytometry cell cycle analysis   
 
In order to analyse cell cycle profiles, cells were subjected to propidium iodine (PI) 
staining and Flow Cytometry analysis (BD Accuri C6). In brief, cell culture medium was 
collected and cells were then washed in PBS. Again, this was collected, before cells were 
trypsinised at 37C for approximately 2-5 minutes. The collected medium was used to 
neutralise the cells before centrifugation at 1200 rpm for 2 minutes. Cells were then 
resuspended in 5-10ml PBS and centrifuged again. The S/N was removed before cells 
were gently resuspended by flicking. Cells were then fixed in 1ml of Ice cold EtOH (70%), 
adding dropwise whilst vortexing at high force. Samples were stored at -20C O/N and 
then stained in FACS-PI buffer. For PI staining, fixed cells were centrifuged at 4000 rpm 
in a 1.5ml Eppendorf tube for 5 minutes. The S/N was then removed and cells were 
resuspended in (300-800l) FACS-PI staining buffer (9.5ml 1x PBS, 400l Propidium 
Iodine solution [1mg/ml] & 100l RNAseA [10mg/ml]). The resuspended cells were then 
passed through a Falcon cell strainer, into a 5ml round bottom tube (Falcon Corning, 
352235) ready for Flow Cytometry analysis. The BD Accuri C6 machine was used for cell 
cycle analysis, following the manufacturer’s instructions. A minimum of 20,000 events 
were recorded for each sample. 
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2.3.2 Cell sorting (FACS)  
 
Cell sorting was used to isolate a population of cells stably expressing a detectable 
protein (e.g. GFP-tagged protein). Following successful transfection (see Human cell 
transfection, 2.3.4) cells were subjected to FACS cell sorting using a BD Melody cell 
sorter. In brief, cells were trypsinised at 37C for approximately 2-5 minutes. Cells were 
then neutralised in fresh medium before centrifugation at 1200 rpm for 2 minutes. Cells 
were then resuspended in fresh medium containing only 1% serum (FCS), and passed 
through a Falcon cell strainer into a 5ml round bottom tube (Falcon Corning, 352235), 
ready for FACS. A 5ml Polystyrene collection tube was also needed (Falcon Corning, 
352003), containing approximately 2-3ml of fresh pre-warmed medium (containing the 
full amount of serum e.g. 10-15%). First, the parental cell line (prior to fluorescently-
tagged protein transfection) was passed through the machine to examine any 
background fluorescence. Next, the fluorescently tagged expressing cell line was passed 
through the machine and the detection of GFP was gated and collected into the 
collection tube. Cells were then added to fresh pre-warmed medium to amplify the 
isolated fluorescently expressing stable cell line and incubated at 37C in a humidified 
incubating chamber, containing 5% CO2. Cells were also quarantined and examined for 
mycoplasma testing following each FACS experiment (all samples passed testing).  
 
2.4 Antibodies 
 
2.4.1 Primary Antibodies (Immunofluorescence & Western blot) 
Immunofluorescence  
Antibody 
Host 
species 
CAT Number Source Dilution 
BUB1 Mouse ab54893 Abcam 1:400 
BLM Goat  C-18 Santa Cruz 1:100 
BLM Rabbit ab2179 Abcam 1:100 
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CENP-A Mouse Ab13939 Abcam 1:100 
CENP-B Rabbit Ab25734 Abcam 1:400 
H2AX Mouse JBW-301 Millipore 1:400 
GFP-Atto488 Nanobody GBA488 Chromotek 1:200 
PICH Mouse H00054821-B01P Abnova 1:100 
PICH Rabbit H00054821-D01P Abnova 1:100 
SMC2 Rabbit A300-058A Bethyl 1:200 
TOP2- Goat (S20)-5348 Santa Cruz 1:100 
RPA-(32) Mouse ab2175 Abcam 1:200 
RPA-(70) Rabbit Ab79398 Abcam 1:200 
PLK1 Mouse (E2)-55504 Santa Cruz 1:100 
-tubulin Rabbit Ab18251 Abcam 1:600 
Centromere Human HCT-0100 Immuno Vision 1:400 
Pericentrin Rabbit Ab4448 Abcam 1:400 
NUF2 Rabbit Ab122962 Abcam 1:200 
FLAG Mouse M2 Sigma 1:400 
 
Western blotting  
Antibody 
Host 
species 
CAT Number Source Dilution 
PICH Mouse H00054821-B01P Abnova 1:500 
BLM Goat  C-18 Santa Cruz 1:300 
BLM Rabbit ab2179 Abcam 1:1000 
KU80 Rabbit  Ab80592 Abcam 1:8000 
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-actin Mouse  Sigma 1:5000 
GFP Rabbit Ab290 Abcam 1:2000 
RAD51 Rabbit Ab63801 Abcam 1:1000 
 
2.4.2 Secondary Antibodies (Immunofluorescence & Western blot) 
Immunofluorescence  
Target IgG Host species Conjugation Source Dilution 
Mouse Donkey Alexa Fluor 
488 
Invitrogen 1:500 
Rabbit Donkey Alexa Fluor 
488 
Invitrogen 1:500 
Goat Donkey Alexa Fluor 
488 
Invitrogen 1:500 
Mouse Donkey Alexa Fluor 
555 
Invitrogen 1:500 
Rabbit Donkey Alexa Fluor 
555 
Invitrogen 1:500 
Goat Donkey Alexa Fluor 
555 
Invitrogen 1:500 
Human  Goat Alexa Fluor 
550 
Abcam 1:500 
Mouse  Donkey Alexa Fluor 
647 
Invitrogen 1:500 
Rabbit  Donkey Alexa Fluor 
647 
Invitrogen 1:500 
Human  Goat Alexa Fluor 
650 
Abcam 1:500 
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Western blotting 
Target IgG 
Host 
species 
Conjugation 
CAT 
Number 
Source Dilution 
Mouse Goat  Horseradish 
peroxidase 
(HRP) 
Ab6789 Abcam 1:25000 
Rabbit Donkey Horseradish 
peroxidase 
(HRP) 
NA92340 ECL 1:20000 
Goat Rabbit Horseradish 
peroxidase 
(HRP) 
P0160 Agilent 1:10000 
 
2.5 Western blotting  
 
Cells were washed in PBS before trypsinisation at 37C for approximately 2-5 minutes. 
Cells were then neutralised in fresh medium, before centrifugation at 1200 rpm for 2 
minutes. Cells were washed in 5-10ml of PBS and again pelleted. Cells were then lysed 
on ice for 10-15mins in ice cold lysis buffer (50mM Tris pH 7.5, 300mM NaCl, 5mM EDTA, 
1% Triton X-100, 1.25 mM DTT, 1mM PMSF and cOmpleteTM protease inhibitor cocktail). 
After 10-15mins of lysis, cells were then centrifuged at 15,000rpm for 20mins, at 4C. 
The S/N was added to pre-chilled Eppendorf tubes and the protein concentration was 
measured using a Bradford Assay (Bio-Rad). In brief, BSA [1mg/ml] was added (0, 2, 4, 
6, 8l) to a final volume of 800l of ultra-pure water to plastic cuvettes, to generate a 
standard curve. 1l of each protein lysate was added to a final volume of 800l of ultra-
pure water, into individual plastic cuvettes. Finally, 200l of Bradford reagent was added 
to each cuvette and vortexed to mix. A spectrophotometer (595nm ) was used to 
measure light absorption and this was then calculated to protein concentration, using 
GraphPad Prism 7 software against the standard curve. Protein lysates were then diluted 
in 4x Laemmli sample buffer (Bio-Rad, 1610747), with 5% -mercaptoethanol (Sigma, 
  65 
M6250), so that each lysate contained the same protein concentration. Around 30-75g 
of protein was loaded into SDS-Page gels, using a Tris/Glycine/SDS buffer for protein 
separation at 80-120V for 1-3hours, depending on protein size and separation required. 
Separated proteins were then transferred onto Amersham Hybond PVDF membranes, 
0.2m (GE Healthcare Lifesciences, 10600021). Protein transfer was performed for 60-
90mins at 100V in ice cold Tris/Glycine buffer, containing 15% MeOH. Following protein 
transfer, membranes were then blocked in 10% Milk PBS-T (0.1% Tween-20) for 1-1.5 
hours. In general, primary antibody incubations were performed O/N at 4C in 10% Milk 
PBS-T, whilst rotating slowly. A minimum of 5 washes were performed in 1% Milk PBS-T 
whilst shacking (medium-fast). Secondary antibody incubations were performed for 30-
45mins in 10% Milk PBS-T whilst rotating slowly. Again, washing was performed a 
minimum of 5 times in 1% Milk PBS-T, before a final wash in PBS-T. Proteins were then 
detected using chemiluminescent Clarity Western ECL substrate reagents (Bio-Rad, 
1705060S) and developed using X-ray film.  
 
2.6 High resolution microscopy  
 
2.6.1 Immunofluorescent staining (including Pre-extraction protocol) 
 
Typically, immunofluorescent staining involved seeding cells (2-4x105 cells) onto #1.5 or 
1.5H coverslips (0.16-0.19mm or 0.17-0.18mm, respectively). In brief, cells were fixed in 
4% PFA, containing Triton X-100 (250mM HEPES pH7.4, 1xPBS, 0.1% Triton X-100 & 4% 
methanol-free paraformaldehyde) at 4°C for 20mins. Cells that required pre-extraction 
prior to fixation were submerged into ice-cold pre-extraction buffer for 10-15 seconds, 
whilst remaining on ice (20mM HEPES pH7.4, 0.5% Triton X-100, 50mM NaCl, 3mM 
MgCl2, 300mM sucrose). Following pre-extraction, cells were then fixed in 4% PFA 
(250mM HEPES pH7.4, 1xPBS & 4% methanol-free paraformaldehyde) at RT for 10mins. 
All PFA fixed cells were then washed 4-5 times in 1xPBS to remove any remaining PFA. 
Cells were then permeabilised for 20mins at RT (1x PBS, 0.5% Triton X-100 & 0.5% FCS) 
and washed a further 4-5 times in 1x PBS. Following washing, cells were then blocked 
for 20-30 minutes at RT (1x PBS & 0.5% FCS) before primary antibody staining. Primary 
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antibodies were prepared in blocking solution at the required dilution (see primary 
antibodies, 2.4.1) and incubated at 37C for approximately 1.5hrs. Cells were then 
washed a further 5 times in 1xPBS, before secondary antibody incubation. Again, 
secondary antibodies (see secondary antibodies, 2.4.2) were prepared in blocking 
solution and incubated at RT for approximately 30 mins. Finally, cells were washed in 
1xPBS, before a final submersion in ultra-pure water and coverslips were airdried before 
mounting using Vectashield (Vectashield) containing DAPI.   
 
2.6.2 DNA bridge immunofluorescent staining 
 
Immunostaining for ultrafine DNA structures followed the rule as described previously 
for all immunofluorescent staining procedures. However, to minimise the loss of mitotic 
cell populations (less adherent), agitation during washing was kept to a minimum, with 
a slow rotating action of a 6-well plate after addition of 1xPBS.  
 
2.6.3 K-fibre immunofluorescent staining 
 
To immunostain for K-fibre attachment (kinetochore attached tubulin fibres), prior to 
fixing the cells, a 6-well plate containing cells seeded onto coverslips (previously 
described, 2.6.1) was placed on ice for 10 mins. Coverslips were then carefully pre-
extracted and fixed as previously described and immunostained as before. 
    
2.6.4 5-Ethynyl-2’-deoxyuridine (EdU) Click-iT staining 
 
In order to detect replicating cells (S-phase), the thymidine analogue 5-Ethynyl-2’-
deoxyuridine (EdU) was added to cell cultures, prior to fixation. The incorporated EdU 
could then be later detected during microscopy. Following fixation and cell 
permeabilisation, EdU Click-iT chemistry was performed according to the 
manufacturer’s instructions. Immunofluorescent staining was also performed on cells 
after EdU Click-iT chemistry, before fluorescent microscopy analysis. 
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2.6.5 Acquisition of immunofluorescent imaging  
 
All image acquisition was carried out using a Zeiss Axio Observer Z1 epifluorescence 
microscope, using either a 40x / 1.3NA, 60x / 1.4NA or 100x / 1.4NA oil Plan-Apochromat 
objective for fluorescent imaging. The Zeiss Axio Observer Z1 microscopy system is fitted 
with a Hamamatsu ORCA-Flash 4.0 LT camera and is aligned and calibrated using 200nm 
diameter Tetra Speck microsphere beads (Thermo Fisher). Typically, all imaging involved 
covering a range of 2-8m, using a varying range of Z-stack intervals at 0.2m. Post 
processing of images involved the use of both ZEN Blue (Zeiss) software and ImageJ (FiJI).   
 
2.6.6 Widefield live cell microscopy 
 
Cells were seeded into 2-or 4- well on cover glass II chamber slides (2-3 x 105 cells) 
(Sarstedt). In order to stain nuclei, SiR-DNA (Spirochrome) was added to the cell culture 
medium (1:1000) for a minimum of 4 hours before imaging. Cell cycle progression was 
monitored by using a Zeiss Axio Observer Z1 microscopy system, equipped with a 
heating (37C) and CO2 chamber (5%) and fitted with a Hamamatsu ORCA-Flash 4.0 LT 
camera for image acquisition. Image acquisition relied on the use of either a 40x/0.6 
Plan-Neofluar or 40x/1.3 oil Plan-Apochromat objective, whilst acquiring images every 
5-7 minutes. A maximum of 6 z-stacks with 2m intervals were used to cover the cell 
depth and analysed using both ZEN Blue (Zeiss) and ImageJ (FiJI) software. 
 
2.6.7 Deconvolution (Huygens professional) 
 
Image deconvolution was carried out using Huygens Professional (SVI Huygens) 
deconvolution software, using a measured point spread function (PSF), generated using 
the 200nm diameter Tetra Speck microsphere beads. Minimal iteration sampling was 
used between 10-60, with a range of 20-50 signal-to-noise being applied.   
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2.7 Cytogenic analysis  
 
2.7.1 Chromosome spread preparation  
 
Typically, a 10cm dish was used for chromosome spread preparation with the cell 
medium being collected into 15ml Falcon tubes (Falcon Corning) before washing the 
cells in PBS. Again, this was collected prior to trypsinisation at 37C, for approximately 
2-5 minutes. Cells were then neutralised with the collected medium and centrifuged at 
1000 rpm for 5 mins. Approximately 500l of the S/N was kept to allow for cells to be 
resuspended by gentle tapping of the pellet. Cells were then subjected to pre-warmed 
hypotonic solution (7ml, 0.075M KCL, 37C) in a dropwise motion whilst also being 
gently mixed and allowed to incubate at 37C for approximately 5-10mins. Again, cells 
were centrifuged at 1000rpm for 5mins before again approximately 500l of the S/N 
was kept to allow for cells to be resuspended by gentle tapping of the pellet. Cells were 
then fixed and washed with 7ml of a 3:1 ratio of Methanol:Acetic acid solution, again in 
a dropwise motion whilst gently mixing. Cells were again centrifuged at 1200 rpm for 5 
mins and washed/fixed in Methanol:Acetic acid solution a further two times. After the 
final wash, cells were then resuspended in up to 1ml of fresh Methanol:Acetic acid 
solution and dropped onto glass slides for analysis or stored at -20°C. 
 
2.7.2 Centromere & Telomere FiSH (ctFiSH) 
 
Peptide nucleic acid (PNA) probe hybridisation of pre-aged (minimum 2-3 days) 
chromosome spreads followed the manufacturers guidelines (DAKO Agilent & PNAbio). 
In summary, chromosome spreads were washed in TBS before being fixed in 3.7% PFA 
and dehydrated using an increasing ethanol wash series (ice cold 70%, 90%, 100%EtOH). 
Slides were then air-dried prior to PNA probe addition to the spread. A small coverslip 
(18x18mm) was added to the probe and the slide was co-denatured at 80C for 1min to 
1min 15 seconds and incubated in a humidifying chamber for 1-3 hours at RT. Spreads 
were then wash (65-70C) and dehydrated again in the ice-cold ethanol series, before 
air drying and mounting and counterstaining using Vectashield with DAPI. 
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Chapter 3: PLK1 activity promotes metaphase maintenance 
 
3.1 Introduction 
 
A key cellular feature of transformed cells, such as cancer cells, is their tendency to mis- 
segregate their chromosomes during mitosis (Funk et al. 2016). This often leads to the 
unequal distribution of genetic material, which consequently results in changes of 
ploidy. This imbalanced distribution of chromosome number is referred as aneuploidy 
and is a characteristic feature of both cancer and rare congenital disease. How cells 
acquire such genomic instability remains a long-unanswered question.  
 
A strong case can be made for further investigation into chromosome alignment itself, 
or chromosome biorientation. Cells rely on a complex series of events to successfully 
orientate their chromosomes during mitosis. Crucially, correct chromosome alignment 
requires the stable capture of each and every centromere by mitotic spindle 
microtubules (MT). These emanate from opposite centrosomes and manoeuvre each 
chromosome in order to establish the metaphase plane. In addition, centromere 
capture also requires the prior assembly of kinetochores (KT) at each centromere. This 
macromolecular protein complex assembles at both sides of the core centromere, 
forming sister kinetochores (Cheeseman 2014). Apart from KT assembly at centromeres, 
chromosome biorientation also relies on several other molecular mechanisms for its 
accomplishment. These include maintaining sister chromatid cohesion and the 
regulation of the mitotic checkpoint machinery (Hengeveld et al. 2017; Musacchio and 
Salmon 2007). Sister chromatid cohesion is mediated by cohesin complexes, which 
physically embrace sister chromatids until anaphase, and this supports bipolar MT 
attachment. The mitotic spindle checkpoint or spindle assembly checkpoint (SAC), 
monitors spindle mis-attachments and acts as a protective surveillance system, that 
functions to prevent cells from prematurely initiating anaphase, if for example KT-MT 
attachment errors exist (Musacchio and Salmon 2007). Activation of the SAC is achieved 
by the disruption of stable bipolar microtubule spindle attachment to kinetochores, and 
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its regulation is so robust that even a single unattached kinetochore is enough to trigger 
its activation (Rieder et al. 1995). Without such a system, cells are likely to enter 
anaphase with misaligned chromosomes, which can lead to chromosome mis-
segregation and unequal distribution of genetic material in the subsequent daughter 
cells; a prominent cause for cellular disease progression, such as cancer (Funk et al. 
2016). Chromosome biorientation is also facilitated by another regulatory mechanism, 
the chromosomal passenger complex (CPC). The CPC consists of INCENP, survivin, 
borealin and Aurora B kinase. Its primary function is to detect and resolve improper KT-
MT attachments through phosphorylation of multiple kinetochore associated proteins 
by Aurora B kinase. However, the precise mechanism for the role of Aurora B during 
erroneous KT-MT attachment remains a debated topic (Hengeveld et al. 2017; Krenn 
and Musacchio 2015).  
 
Another key protein influencing stable KT-MT attachment, is the mitotic kinase, Polo-
like kinase 1 (PLK1) (Krenn and Musacchio 2015; O’Connor et al. 2016). PLK1 activity is 
required to phosphorylate factors associated with the activation and maintenance of 
the SAC (Elowe et al. 2007; Lénárt et al. 2007). Inhibition of PLK1 activity leads to severe 
chromosome misalignment patterns, which have been attributed to a failure of accurate 
KT-MT attachment and maintenance (Lénárt et al. 2007). This was highlighted by the 
evidence of defects in chromosome congression and the direct detection of unattached 
kinetochore complexes, which was concomitant with the accumulation of SAC proteins 
at KTs (Lénárt et al. 2007). Depletion of PLK1 using RNAi results in unattached 
kinetochores, with cells displaying strong MAD2 signals at their kinetochores; a hallmark 
feature of SAC activation (Hanisch 2006). However, despite these observations, it 
remains uncertain how PLK1 precisely functions during metaphase establishment. 
Orthologs of the mammalian PLK1, including the yeast Cdc5 (S. cerevisiae) and Plo1 (S. 
pombe), are not required for kinetochore function (Lee et al. 2005). This reflects the 
differences of PLK1’s spatiotemporal regulation and function across different species, 
and highlights that PLK1 function(s) may not be necessarily limited to KT-MT 
stabilisation. Therefore, it is of great interest to study PLK1 activity during chromosome 
alignment.  
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This basic overview of the regulation and complex protein involvement during KT-MT 
attachment, demonstrates the importance of chromosome biorientation to guarantee 
faithful chromosome segregation. Chromosome biorientation is not only key to equal 
chromosome distribution, but also provides a safeguarding mechanism for mitotic 
progression. PLK1 loss of function experiments have widely implicated PLK1 to be 
responsible for stabilising KT-MT attachment, during chromosome biorientation. 
However, understanding how PLK1 promotes the stable KT-MT attachment required to 
support chromosome biorientation remains uncertain. This study has focused on further 
understanding the role(s) of PLK1 during mitotic progression, in particular, exploring the 
effects of the loss of PLK1 activity during chromosome congression and biorientation. 
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3.2 Results  
 
3.2.1 Inhibition of PLK1 by a small-molecule inhibitor, BI2536, arrests cells in 
mitosis  
 
A small-molecule inhibitor, BI2536 was used to study the loss of function(s) of PLK1 
during mitosis (Lénárt et al. 2007; Steegmaier et al. 2007). This very potent and largely 
specific PLK1 inhibitor has been previously reported to effectively prevent PLK1 kinase 
activity in nanomolar concentrations (IC50 = 0.83nM) (Lénárt et al. 2007; Steegmaier et 
al. 2007). A recognised phenotype of PLK1 inactivation is a mitotic arrest. Therefore, to 
confirm that BI2536 was effectively inhibiting PLK1 kinase activity, and cells were 
arresting in mitosis, cell cycle analysis of RPE1 hTERT cells was performed using FACS. 
Asynchronously growing RPE1 cells showed an expected cell cycle profile during FACS 
analysis (Fig. 3.1, i). In order to enrich for a mitotic population for study, cells were 
treated with thymidine [2mM] to initially arrest them at the G1/S boundary before 
release (Fig. 3.1, ii). Following release from a thymidine arrest (G1/S arrest), it was 
possible to demonstrate that the majority of cells were successfully progressing through 
S phase (Fig. 3.1, iii). To examine whether BI2536 arrested cells in a mitotic stage, BI2536 
[60nm] was added after 6 hours release from a thymidine arrest and fixed after 8 hours. 
FACS analysis confirmed that BI2536 treated cells were arresting at the G2/M stage of 
the cell cycle (Fig. 3.1, iv). Notably, BI2536 was added at 6 hours after a thymidine arrest 
and release, to ensure that the majority of cells had completed S phase before the 
addition of the PLK1 inhibitor. To confirm that cells were arresting at the G2/M boundary 
after BI2536 treatment, an additional sample was fixed after 10 hours (Fig. 3.1, v). The 
resulting FACS data confirmed that BI2536 treatment led to an enrichment of cells at 
the G2/M phase of the cell cycle. This was consistent with a previous study using BI2536 
in HeLa cells (Steegmaier et al. 2007). Additionally, a control sample (DMSO treated) 
showed that cells were capable of re-entering G1, after releasing them from a thymidine 
arrest (Fig. 3.1, vi). Therefore, BI2536 is an effective way of inhibiting PLK1 kinase activity 
for future PLK1 loss of function studies. Furthermore, as this dosage of BI2536 [60nm] 
used showed effective signs of a mitotic arrest, the majority of further experiments were 
completed using this concentration. 
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Figure 3.1. BI2536 arrests cells in G2/M.
Experimental outline to describe the cell-cycle progression of RPE1 hTERT cells after a
single thymidine block and release; or after a mitotic arrest using BI2536 treatment. FACS
experimental design and cell-cycle profile of (i) Asynchronous RPE1 cells; (ii) G1/S arrest
after single-thymidine block (STB) treatment; (iii) S-phase progression after 4hrs post
release from STB; (iv & v) mitotic arrest and enrichment after the addition of BI2536 at 6
hrs and FACS at either 8hrs, or 10hrs post release from STB; (vi) re-entry into G1 10hrs after
STB in the absence of PLK1i.
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3.2.2 Cells remain capable of metaphase establishment when PLK1 activity is 
inhibited 
 
Typically, studies exploring the mitotic function of PLK1 have used fixed samples for their 
analysis. However, the use of live-cell time lapse microscopy may uncover the temporal 
detail regarding the fate of cells entering mitosis when PLK1 activity is inhibited by 
BI2536. In particular, it would be possible to examine chromosome arrangement as cells 
enter and progress through mitotic stages. Therefore, to enrich for a large mitotic 
population for study, RPE1 hTERT cells were synchronised at early G1/S using thymidine. 
Following release into fresh media, the cells were treated with different mitotic 
inhibitors in order to examine the fate of mitotic entry and progression (Fig. 3.2a). As 
expected, control cells (DMSO treated) were able to proficiently enter mitosis and 
segregate their chromosomes without any obvious signs of impairment (Fig. 3.2b, c). In 
contrast, cells treated with nocodazole, the microtubule spindle poison, arrested in a 
prometaphase like stage and showed no sign of further mitotic progression (Vasquez et 
al. 1997). Cells treated with the APC/C inhibitor, ProTAME, progressed through the early 
stages of mitosis (prophase-prometaphase), before arresting at metaphase (Fig. 3.2b, c) 
(Zeng and King 2012). Live-cell imaging confirmed that BI2536 treated cells arrested in 
mitosis, however, unexpectedly the majority of these cells showed signs of competent 
chromosome alignment during early stages of mitosis (Fig. 3.2b, c).  
 
BI2536 treated RPE1 cells displayed normal mitotic entry and progression through 
prophase. They were also able to progress past prometaphase and undergo 
chromosome alignment during metaphase. Remarkably, of the BI2536 treated cells 
analysed, approximately 80% of them appeared to align their chromosomes at 
metaphase (Fig. 3.2c). This led to the speculation that in contrast to previous studies 
(Lénárt et al. 2007; Steegmaier et al. 2007), PLK1 may not be completely required in 
order for cells to establish bipolar KT-MT attachments. However, BI2536 treated cells 
did eventually display signs of metaphase collapse. Intriguingly, the collapsed cells 
showed a distinctly different collapse pattern to what had previously been described as 
the “polo” chromosome morphology (Lénárt et al. 2007). Instead, what was observed 
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was a chromosome misalignment pattern that resembled a ‘figure-of-8’ like shape (Fig. 
3.2b, e.g. BI2536 treated cells T=152 and Fig.3.3c for further examples). Therefore, it 
could be possible that PLK1 plays a role in the long-term stability, or maintenance of KT-
MT attachment, in addition to its proposed establishment function. 
 
BI2536 treated cells also showed signs of a prolonged metaphase stage (chromosome 
alignment), when compared against untreated cells (DMSO treated) (Fig. 3.2d). This 
finding supports the idea that RPE1 cells are capable of forming bipolar spindle 
attachment during metaphase, despite the absence of PLK1 activity. As expected, cells 
treated with ProTAME displayed with even more extended metaphase alignment 
durations (Fig. 3.2d). Therefore, these observations suggested that PLK1 activity is 
required for mitotic progression, but may not be essential for metaphase establishment, 
at least in RPE1 hTERT cells. This led to further questions regarding the status of mitotic 
cells, when PLK1 kinase activity was absent. 
 
Previous studies reported that PKL1 inactive cells result in a “polo” stage mitotic arrest 
(Lénárt et al. 2007; Steegmaier et al. 2007). This has largely been attributed to cells being 
unable to undergo stable bipolar KT-MT attachment, as a result of either monopolar 
spindle attachment, or a complete absence of KT-MT attachment altogether. However, 
the results of the live-cell imaging data suggested that cells were capable of establishing 
bipolar attachment, despite the absence of PLK1 activity. Therefore, to further support 
this, analysis of bipolar spindle attachment was also investigated in fixed cells.  
 
RPE1 hTERT cells were enriched in mitosis by synchronisation at early G1/S using 
thymidine. Following release into fresh media, cells were treated with either DMSO or 
BI2536, before being subject to indirect immunofluorescence staining analysis (Fig. 
3.3a). As expected, K-fibre staining, which identify stably bound KT-MT attachments in 
fixed cells, confirmed that BI2536 treated cells were capable of establishing bipolar 
spindle attachment, similarly to untreated cells (Fig. 3.3b). Therefore, this analysis, 
taken together with the live-cell imaging data, would suggest that PLK1 activity is not 
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Figure 3.2. Cells fail to maintain metaphase alignment during PLK1 inhibition.
a) Experimental outline of cell-synchronisation and live-cell time lapse microscopy, after
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absolutely required for the initial formation of KT-MT attachment, at least in RPE1 cells. 
Although, it cannot be ruled out that these results could be due to incomplete PLK1 
inhibition when using BI2536. However, a consistently observed feature of PLK1 
inhibition, during BI2536 treatment, showed that cells eventually do succumb to a form 
of metaphase collapse, implying that PLK1 activity is compromised. The metaphase 
collapse pattern resembled either the previously reported “polo” chromosome 
morphology (Lénárt et al. 2007), or the newly described ‘figure-of-8’ like pattern (Fig. 
3.3c). Most interestingly, further examination of the ‘figure-of-8’ collapse pattern led to 
an unexpected observation. This unexpected observation will be discussed below.   
 
3.2.3 PLK1 inactivation leads to a DNA linkage during metaphase collapse  
 
In an attempt to better understand what might be happening during the observed 
‘figure-of-8’ metaphase collapse, during PLK1 inhibition, the localisation of the PLK1 
protein at different stages of mitosis was examined. Previous studies identified PLK1s 
recruitment patterns during mitosis; in particular its recruitment to centrosomes and 
kinetochores (Golsteyn et al. 1995; Seong et al. 2002). However, to confirm PLK1 protein 
association during mitosis in this study, immunofluorescent staining for PLK1 was 
performed on RPE1 hTERT cells. Untreated mitotic cells showed the expected 
localisation patterns of PLK1 at both centrosomes and kinetochores (Fig. 3.4a, b). In 
anaphase, surprisingly it was also possible to observe PLK1 localising to PICH positive 
UFBs (Fig. 3.4a, b). This is believed to be the first report of PLK1 localising directly to 
UFBs. These DNA structures arise during sister-chromatid separation and remain 
undetectable by conventional DNA staining methods, such as DAPI. Instead, they are 
only detectable by protein association (Baumann et al. 2007; Chan et al. 2007). PLK1 
appeared to localise alongside the recognised UFB binding protein, PICH (Polo-like 
kinase 1 interacting checkpoint helicase), which was originally identified through its 
interaction with PLK1 (Baumann et al. 2007). This could therefore imply that PLK1 has a 
role in regulating UFB proteins such as PICH. However, this currently remains as 
speculation, as it could be argued that PLK1 is simply associating to inter-polar spindles. 
However, there are no reports to suggest that PICH binds to microtubule structures and 
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therefore, due to the PLK1-PICH localisation pattern displayed, it is likely that PLK1 is a 
component of the UFB binding complex. 
 
Most remarkably, immunofluorescent staining of PLK1 in BI2536 treated cells, where 
PLK1 activity is inhibited, showed that the PLK1 protein was unexpectedly associating to 
structures that inter-linked the chromatin of mitotic cells (Fig. 3.5a, b). In general, this 
occurred in cells that presented with the ‘figure-of-8’ metaphase collapse shape. 
Alongside PLK1, both PICH and the single-stranded DNA (ssDNA) binding protein, RPA 
(Replication protein A), were also shown to associate along these chromatin linking 
structures (Fig. 3.5a, b). Further still, it was also apparent that PLK1 and PICH localisation 
appeared to overlap with each other, whereas RPA detection was generally shown to be 
exclusive of PICH localisation (Fig. 3.5a, b).  
 
The presence of PICH and RPA suggested that these inter-linking structures consisted of 
DNA molecules, as both proteins bind to double- and single-stranded DNA substrates, 
respectively. RPA binds ssDNA regions, especially during DNA replication and repair (Wu 
et al. 2016). The PICH protein has been reported to be capable of DNA manipulation and 
preferentially localises to DNA that encounters tension (Biebricher et al. 2013). 
Therefore, it is conceivable that the inter-linking structures are DNA assemblies, which 
have generated due to PLK1 inactivation. In addition, these DNA linkage structures 
originate from centromeres as they were positive for centromere staining at their 
termini (Fig. 3.5a, b). Since the centromere is the principal point of tension during 
chromosome biorientation, it was speculated that spindle tension influenced the 
formation of these unexpected DNA linkages, during PLK1 inactivation.  
 
We hypothesised that the structures were a result of centromeric DNA being aberrantly 
revealed due to the inhibition of PLK1 activity. PICH, RPA, and from this study also PLK1, 
have been identified as factors that associate to UFB structures during anaphase. This 
suggested that they function to aid in their resolution. We therefore tested whether 
additional UFB-binding proteins also localise to these DNA assemblies, during PLK1 
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inhibition. Both BLM helicase and its partner protein topoisomerase III alpha (TOP3A) 
were also shown to localise along these DNA assemblies (Fig. 3.5c). Again, as with PICH, 
RPA localisation was largely exclusive of BLM or TOP3A (Fig. 3.5c), implying that ssDNA 
was exposed along these DNA assemblies.   
 
Despite these new DNA assemblies showing similarities to the previously described UFB 
structures that arise during anaphase, it is important to note that these cells are unable 
to enter anaphase, due to the chemical inhibition of PLK1 during BI2536 treatment. 
Therefore, it was decided to term these new structures as ‘pre-anaphase DNA threads’, 
in order to distinguish them from the previously reported anaphase UFBs.  
 
3.2.4 Pre-anaphase DNA threads are not a result of protein mis-localisation to 
cellular cytoskeleton structures 
 
The surprising formation of pre-anaphase DNA threads led to many questions regarding 
their validity. Thus, it was important to confirm that the appearance of pre-anaphase 
DNA threads during PLK1 inactivation, was not due to artefactual antibody staining, or 
as a result of protein mis-localisation. Therefore, firstly, to confirm that pre-anaphase 
DNA threads were not due to artefactual antibody staining, an RPE1 cell line that stably 
expressed a GFP-tagged PLK1 protein was examined. Under control conditions (DMSO 
treatment), the GFP-tagged PLK1 protein was shown to localise to known PLK1 
subcellular recruitment sites during early mitosis (i.e. the centrosomes and 
kinetochores) (Fig. 3.6a, b). In addition, the GFP-PLK1 protein was also shown to localise 
to the midzone and cleavage furrow, during anaphase and telophase, respectively (Fig. 
3.6b). This confirmed that the recruitment pattern of GFP-PLK1 resembles the known 
PLK1 subcellular recruitment pattern seen using only a PLK1 antibody. Importantly, 
following treatment with BI2536, GFP-PLK1 protein localisation displayed a similar 
pattern of recruitment, as in control cells (centrosome and kinetochore recruitment) 
(Fig. 3.6b). It was also possible to detect GFP-PLK1 protein localisation along pre-
anaphase DNA threads, following metaphase collapse (Fig. 3.6b). Therefore, these 
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Figure 3.5. PLK1, PICH, RPA, BLM and TOP3A decorate centromere linkages during PLK1
inhibition.
a) Immunofluorescent images of BI2536 treated mitotic RPE1 cells (experimental outline of
cell-synchronisation and immunofluorescent staining as of (Fig. 3.4a)). Pre-anaphase RPE1
cell (above) after BI2536 treatment, showing PLK1 (Green) and PICH (Red) associated inter-
chromatin linkage (arrows). RPE1 cell (below) after BI2536 showing PICH (Green) and RPA
(Red) (arrows) associated inter-chromatin linkage between centromeres (Blue)
(arrowheads). b) Quantification of different protein associated centromeric inter-chromatin
linkages (PLK1, PICH or RPA), termed ‘Pre-anaphase DNA threads’ in RPE1 cells (mean ±SD
is shown from three independent experiments; student t-test was used for p-value
calculation; n=number of cells analysed; scale bar 5µm). c) RPE1 cell (above) after BI2536
treatment, showing BLM (Green) and RPA (Red) associated inter-chromatin linkage
(arrows). RPE1 cell (below) after BI2536, showing TOP3A (Green) and RPA (Red) associated
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findings ruled out that PLK1 recruitment to pre-anaphase DNA threads is due to 
artefactual immunofluorescent staining of PLK1 protein.   
 
Next, it was important to rule out that pre-anaphase DNA threads were due to PLK1 
protein mis-localisation, during its inactivation. Notably, PLK1 has also been reported to 
associate to cytoskeletal structures, including the microtubule based central spindle 
(Burkard et al. 2007). Thus, it was envisaged that pre-anaphase DNA threads may be 
caused by PLK1 protein mis-localisation to cytoskeletal structures, particularly when its 
catalytic activity was compromised. However, it was also possible to exclude this idea, 
as GFP-PLK1 protein localisation, in cells treated with BI2536, was distinctly different 
when compared to alpha-tubulin staining patterns (Fig. 3.6b). Further still, the ssDNA 
binding protein, RPA, was also shown to display distinct localisation patterns when 
compared with alpha-tubulin. RPA was shown to localise distinctly on pre-anaphase 
DNA threads, which had arisen due to PLK1 inactivation (Fig. 3.6c).  
 
Therefore, based on these findings, it was concluded that PLK1 functions to suppress 
metaphase collapse. In its absence, cells suffer from the formation of centromeric pre-
anaphase DNA threads, which are bound by various factors of the UFB-binding complex.  
 
3.2.5 Pre-anaphase DNA thread formation is not cell type specific  
 
As all of the previous experiments were performed using RPE1 hTERT cells, it was also 
of interest to confirm whether pre-anaphase DNA thread formation, during BI2536 
treatment, was cell line specific. Thus, alternative cell lines were also examined for their 
ability to form pre-anaphase DNA threads, following synchronisation using thymidine 
and subsequent BI2536 treatment (Fig. 3.7a). Both HCT116 (cancer) and 82-6 hTERT 
(non-cancerous) cells also displayed PICH and RPA positive pre-anaphase DNA threads 
during BI2536 treatment, although their frequencies did vary (Fig. 3.7b, c). A possible 
explanation for this may be the different dependencies on the activity of PLK1, between 
different cell lines. However, there remains a lack of evidence to support this idea. 
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Figure 3.6. Centromere linkages are protein coated DNA structures.
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Figure 3.7. PLK1 suppresses pre-anaphase DNA threads in various different cell lines.
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Despite this, it is tempting to speculate that certain cell lines may rely more on PLK1 
kinase activity. Hence, when considering the current findings, it would be inviting to 
suggest that 82-6 hTERT cells are more dependent on PLK1 kinase activity, when 
compared with RPE1, or HCT116 cells. The 82-6 hTERT cells may have an intrinsic 
weakness in maintaining stable KT-MT attachments, in particular during PLK1 
inactivation. Thus, an absence of PLK1 activity in 82-6 hTERT cells may prevent stable 
KT-MT attachment and thereby preclude the formation of pre-anaphase DNA threads. 
Furthermore, the hypothesis that cells may rely on different levels of PLK1 activity for 
mitotic function(s), could also explain earlier reports that suggested that PLK1 
inactivation leads to errors in KT-MT establishment (Lénárt et al. 2007; Steegmaier et al. 
2007). PLK1 inhibition using BI2536 in HeLa cells led to a “polo” mitotic state. This was 
attributed to the cells inability to form stable KT-MT attachments, due to PLK1 
inactivation. Thus, it is possible that like 82-6 hTERT cells, HeLa cells also rely more on 
the activity of PLK1 to establish and maintain stable KT-MT attachments. During this 
study, RPE1 cells also displayed evidence of the typical “polo” collapse. Therefore, a 
balance of requirement for PLK1 may exist, which could explain a role of PLK1 activity in 
the long-term stability of KT-MT attachment during mitosis.  
 
3.2.6 PLK1 inhibition causes both centromere and kinetochore disassembly  
 
Immunofluorescent staining experiments showed that pre-anaphase DNA threads arise 
from centromeric regions. Consequently, further examination of the 
kinetochore/centromere complex was performed. It was speculated that pre-anaphase 
DNA threads may be centromeric DNA, which becomes disorganised and protrudes out 
from the centromere during PLK1 inactivation. If this prediction was correct, the 
centromere and/or kinetochore complex may display signs of disassembly during 
metaphase. Therefore, RPE1 hTERT cells were synchronised and treated with BI2536 
and analysed for possible centromere/kinetochore disassembly (Fig. 3.8a). Both the 
outer kinetochore component, NUF2, and the centromere specific histone variant, 
CENP-A, were used to examine the status of centromeres/kinetochores during PLK1 
inactivation. As expected, both NUF2 and CENP-A localised as pairs on each centromere, 
  80 
in both control cells (DMSO) and BI2536 treated mitotic cells, during the early stages of 
mitosis (prometaphase-metaphase) (Fig. 3.8b, c). However, following the examination 
of BI2536 treated cells after metaphase (collapse), both CENP-A and NUF2 began to 
display an abnormal distribution at the centromeres and kinetochores, respectively (Fig. 
3.8b, c). This abnormal distribution at the centromere, was generally displayed with the 
loss of one side of the sister kinetochore signal, either NUF2 or CENP-A. These 
observations could imply that the centromeres, and/or kinetochores, were suffering 
from disassembly during PLK1 inactivation. Moreover, the loss of NUF2 or CENP-A signal 
generally coincided with a strong focus of either PICH or RPA, which was predicted to be 
the start of pre-anaphase DNA thread formation (Fig. 3.8b, c).  
 
Additionally, although very rare, the outer kinetochore component NUF2 was shown to 
remain attached to a short PICH thread that also remained attached to the core 
centromere (Fig. 3.8d). It is predicted that this pattern of protein localisation may 
represent the early signs of aberrant centromere protrusion, whilst also suggesting that 
MT-tension may directly promote this centromeric aberration. Therefore, cells absent 
of PLK1 may be unable to counteract microtubule spindle forces and promptly result in 
centromere/kinetochore disassembly, which eventually displays as pre-anaphase DNA 
threads.  
 
It was also speculated that centromeric DNA damage may occur during metaphase 
collapse during BI2536 treatment. Therefore, to test this, RPE1 cells were again enriched 
in mitosis, before being treated with BI2536 (Fig. 3.9a). The DNA damage response 
marker, H2AX (Rogakou et al. 1998), was used to determine possible centromeric DNA 
damage, following PLK1 inactivation. There was only a minimal detection of H2AX at 
the centromere of cells examined during prometaphase (26%). However, as the cells 
progressed into metaphase, when kinetochores became subjected to spindle pulling 
forces, nearly all cells showed H2AX foci forming at their centromeres (81%) (Fig. 3.9b, 
c). All the collapsed cells that were positive for pre-anaphase DNA threads, displayed 
with H2AX foci at their centromeres.  
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Thus, these data suggest that in the absence of PLK1 kinase activity, 
kinetochores/centromeres suffer from disassembly, which can also trigger a DNA 
damage response, as observed by the detection of H2AX foci at the centromere. 
Therefore, it is predicted that PLK1 functions to suppress a centromere deformation 
pathway and enables cells to maintain chromosome biorientation during metaphase.   
 
3.2.7 A mitotic function of PLK1 suppresses centromere deformation   
 
Although PLK1 is largely regarded as a mitotic regulator, it has also been reported to be 
involved in various processes throughout earlier stages of the cell cycle. For example, 
PLK1 has also been identified as a promoting factor in order to initiate DNA replication 
at dormant origins, in particular during conditions of replicative stress (Song, Liu, Davis, 
et al. 2012). Therefore, it was speculated that pre-anaphase DNA thread formation, after 
PLK1 inactivation, maybe due to a potential interference of an S-phase function(s) of 
PLK1. Thus, PLK1 inhibition may be affecting DNA replication, in particular at 
centromeres, and therefore in its absence, centromeric pre-anaphase DNA threads may 
form. Centromeres are difficult regions of the genome to replicate (Barra and Fachinetti 
2018). Thus, it is possible that PLK1 function(s) could be required for their efficient 
duplication. Another consideration was that throughout previous experimental set-ups, 
cell-synchronisation by thymidine was used and thymidine is known to induce low levels 
of replicative stress (Darzynkiewicz et al. 2011). Therefore, thymidine addition could 
conceivably influence pre-anaphase DNA thread formation during PLK1 inactivation.  
 
Therefore, to rule out that thymidine was responsible for pre-anaphase DNA thread 
formation during PLK1 inhibition, a control experiment was performed. Asynchronously 
growing RPE1 hTERT cells were treated with BI2536 for just 1 hour, before fixation and 
immunofluorescent analysis (Fig. 3.10a). In the absence of thymidine, around 14% 
(n=115) of mitotic pre-anaphase cells were positive for centromeric PICH/RPA pre-
anaphase DNA threads (Fig. 3.10b). This implies that thymidine is not a determining 
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influence on the formation of pre-anaphase DNA threads during PLK1 inactivation. 
However, the frequency of pre-anaphase DNA thread formation was much lower when 
compared to synchronised cells (ranges from 50-75% in RPE1 hTERT cells; see previous 
Fig. 3.5 for comparison). This could be due to the short treatment of BI2536, as late 
mitotic cells may be able to bypass PLK1 inhibition and progress into anaphase, thereby 
reducing the chance of observing pre-anaphase DNA thread formation in that 
population of cells. Although, it cannot be ruled out that thymidine may also exacerbate 
pre-anaphase DNA thread formation, during PLK1 inactivation.  
 
Next, in order to determine whether a disruption to PLK1 activity during S-phase was a 
contributing factor to the formation of pre-anaphase DNA threads, an experiment was 
designed to analyse only mitotic cells that had completed S-phase, prior to the addition 
of BI2536. In order to achieve this, RPE1 hTERT cells were pre-synchronised as before, 
and released into fresh medium. Based on earlier cell-cycle analysis profiles after 
thymidine release, it was predicted that at 6 hours post G1/S release, the majority of 
cells would be in either late S-phase, or G2/M stage (for cell cycle profiles see previous 
Fig. 3.1). Therefore, at this time, both BI2536 and the thymidine analogue, EdU, were 
added to cell cultures and incubated for a further 2-3 hours. Cells were then fixed and 
subjected to immunofluorescent staining, combined with Click-iT EdU detection (Fig. 
3.10c). EdU incorporates into the nascently replicating DNA.  Therefore, it was used as 
a determinant for cells that remained in S-phase, during BI2536 addition. Analysis 
showed that 69% (4%) of cells (n=385) remained positive for pre-anaphase DNA 
threads, but absent for EdU detection (Fig. 3.10d). Therefore, this result implies that 
PLK1 inactivation during S phase, is not the principal cause of pre-anaphase DNA thread 
formation during metaphase collapse. Instead, PLK1 function(s) is required during either 
G2 or M, in order to suppress pre-anaphase DNA thread formation.  
 
Further experiments were able to dissect a more precise mitotic stage in which PLK1 
function is required to suppress metaphase collapse and pre-anaphase DNA thread 
formation. By arresting cells at metaphase, using the APC/C inhibitor ProTAME, and 
adding BI2536 for just 30 mins before fixing the cells (Fig. 3.11a), it was possible to 
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address the question of whether PLK1 inactivation was sufficient to promote pre-
anaphase DNA thread formation in fully established metaphase cells. The resulting 
immunofluorescent analysis showed that BI2536 addition for just 30 minutes in 
established metaphase cells, is sufficient to drive cells into a metaphase collapse and 
promote the formation of pre-anaphase DNA threads, positive for PICH/RPA (Fig. 3.11b, 
c).  
 
Overall, these data strongly suggest that pre-anaphase DNA thread formation is not due 
to an effect of PLK1 inactivation on PLK1s possible role(s) during S-phase. Instead, it 
suggests that PLK1 activity is required during mitosis for metaphase maintenance and 
stability. 
  
3.2.8 Bipolar spindle attachment promotes centromere deformation during 
PLK1 inhibition    
 
Experiments were then designed to further dissect the mechanism(s) behind pre-
anaphase DNA thread formation. A consistent feature of previous findings is that MT-KT 
attachment and possibly tension remain, despite the inhibition of PLK1 kinase activity. 
In particular, this was highlighted during experiments that observed both centromere 
and kinetochore disassembly, where the pulling out of one side of the kinetochore 
complex was seen, whilst also remaining attached to the core centromere (see Fig. 
3.8d). Consequently, it was predicted that spindle pulling forces may be the basis for 
pre-anaphase DNA thread formation during PLK1 inactivation.  
 
To investigate this further, RPE1 cells were synchronised as before and treated with 
BI2536, or a combined treatment of BI2536 and the microtubule spindle poison 
nocodazole (Fig. 3.12a). Immunofluorescent analysis demonstrated that spindle pulling 
forces are necessary for pre-anaphase DNA thread formation as pre-anaphase DNA 
thread formation was completely absent in cells co-treated with BI2536 and nocodazole 
(Fig. 3.12b-d).  
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This experiment was unable to confirm that microtubule attachment is sufficient to 
promote pre-anaphase DNA thread formation, during BI2536 treatment. Therefore, to 
investigate whether spindle-attachment alone was sufficient for pre-anaphase DNA 
thread formation following BI2536 treatment, cells were pre-synchronised as before 
and treated with BI2536, or BI2536 and monastrol (Fig. 3.13a). Monastrol acts as a 
kinesin-Eg5 inhibitor, which prevents the ATP turnover of the spindle motor protein 
kinesin-Eg5. This leads to monopolar spindle attachment at the centromere (Mayer et 
al. 1999). Immunofluorescent analysis of BI2536 and monastrol treated cells showed the 
complete absence of pre-anaphase DNA thread formation, in contrast to control cells 
(BI2536), which continued to display pre-anaphase DNA thread formation (Fig. 3.13b-
d). Thus, it can be concluded that pre-anaphase DNA thread formation requires both 
bipolar spindle attachment and MT-tension, in concert with PLK1 inactivation.  
 
Interestingly, despite the abolishment of pre-anaphase DNA threads after BI2536 in 
monastrol co-treated cells, strong RPA foci were detected at the centromeres (Fig. 
3.13b). This observation was not apparent during the analysis of BI2536 and nocodazole 
co-treated cells, suggesting that MT-attachment alone may be sufficient to initiate 
centromere deformation. Further investigation of this idea will be examined in later 
chapters. 
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3.3 Discussion  
 
Experiments discussed in this chapter confirm that PLK1 activity provides an essential 
role(s) for the maintenance of mitotic progression. Previous reports have suggested that 
PLK1 activity is crucial for both the establishment and maintenance of chromosome 
biorientation, during metaphase (Lénárt et al. 2007; Steegmaier et al. 2007). However, 
unexpectedly, this study revealed that in RPE1 hTERT cells, PLK1 activity may not be 
absolutely required for the initial establishment of chromosome biorientation, as the 
majority of cells absent of PLK1 activity were able to achieve this (80%). Despite this, 
RPE1 hTERT cells did eventually display evidence of metaphase collapse, during PLK1 
inactivation. However, the metaphase collapse pattern largely exhibited the newly 
reported “figure-of-8” chromosome morphology, rather than the previously reported 
“polo” pattern (Lénárt et al. 2007). The “polo” chromosome morphology is attributed to 
errors in KT-MT attachment when PLK1 activity was inhibited. This implies that PLK1 was 
required for metaphase establishment. Fundamentally in agreement to previous 
reports, this study suggests that PLK1 may be necessary for the long-term maintenance 
of chromosome biorientation, rather than biorientation establishment. However, a 
precise mechanism remains unclear. 
 
More remarkably, this study revealed that PLK1 activity is required for the suppression 
of a previously unreported centromere deformation phenotype. An absence of PLK1 
activity during mitosis leads to cells exhibiting a DNA linkage structure, which was shown 
to originate from the centromere of cohesed chromatin. These aberrant DNA structures 
have been referred to as ‘pre-anaphase DNA threads’, which are seen during metaphase 
collapse. Pre-anaphase DNA threads become apparent via the direct recruitment of the 
PLK1 protein itself. PLK1 has been shown to decorate along these centromeric DNA 
structures, alongside various other factors of the UFB-binding complex (including PICH, 
BLM, TOP3A, RPA), indicating that the DNA make-up of pre-anaphase DNA threads may 
be similar to that of anaphase UFBs.  
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This study has also described how the centromere/kinetochore may suffer from 
disassembly, which occurs concomitantly with the formation of pre-anaphase DNA 
thread formation. Thus, following a metaphase collapse during PLK1 inactivation, both 
the centromere component CENP-A and the outer kinetochore protein NUF2 become 
largely undetectable. In particular, one side of each sister kinetochore displays signs of 
CENP-A, or NUF2 absence. Therefore, it is proposed that the centromere/kinetochore 
disassembly, during the inactivation of PLK1, could be the underlying cause of the 
formation of pre-anaphase DNA threads.  
 
Pre-anaphase DNA thread formation was shown to be dependent on spindle tension, 
which supports the idea that spindle pulling forces influence any potential 
centromere/kinetochore disassembly, when PLK1 activity is compromised.   
 
Overall, these unexpected observations have led to some key fundamental questions. 
First, how does PLK1 activity suppress such a drastic centromere deformation pathway? 
Secondly, why do cells not encounter such spindle-tension dependent centromere 
impairment when PLK1 remains active? In an attempt to answer these questions, 
previously reported functions of PLK1 may help to elucidate why pre-anaphase DNA 
threads form when PLK1 activity is compromised and are discussed below. 
 
PLK1 has been implicated in various processes involved in mitotic progression, including 
bipolar spindle formation, chromosome congression and chromosome segregation 
(Archambault and Glover 2009; Zitouni et al. 2014). In its absence or catalytic 
inactivation, unwanted cellular outcomes arise, such as the previously reported mitotic 
arrest phenotype and KT-MT mis-attachment issues (Lénárt et al. 2007; Steegmaier et 
al. 2007). It is now tempting to include the novel centromere deformation pathway, 
which has been shown to promote the formation of pre-anaphase DNA threads.  
 
Apart from PLK1 itself, pre-anaphase DNA thread formation leads to the recruitment of 
various UFB-binding proteins, notably PICH. Based on the current knowledge 
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surrounding the function of PICH, it is tempting to speculate that PICH recruitment to 
pre-anaphase DNA threads, occurs because the DNA make-up is similar to anaphase 
UFBs. However, it is worth noting that the precise DNA make-up of both anaphase UFBs, 
and the newly reported pre-anaphase DNA threads, remains unconfirmed. A plausible 
explanation for PICH recruitment to pre-anaphase DNA threads and/or anaphase UFBs, 
is the preference of PICH to recruit to DNA that is subject to tension (Biebricher et al. 
2013). During PLK1 inactivation, pre-anaphase DNA thread formation was shown to be 
dependent on MT-spindle pulling forces. Therefore, MT-spindle pulling forces may lead 
to an increase in DNA tension at the centromere and also explain the recruitment of 
PICH to centromeres during unperturbed conditions. However, a precise function for 
PICH at the centromere remains unconfirmed. Nevertheless, the loss of PLK1 activity, 
alongside building MT-spindle tension during chromosome biorientation, promotes the 
formation of centromeric pre-anaphase DNA threads, which PICH is subsequently able 
to recruit to.  
 
The question remains as to why an interference of PLK1 activity promotes such 
centromere-specific deformation in the first place. One possible suggestion is that 
centromere compaction, or condensation, is affected during the absence of PLK1 
activity. It is generally accepted that mitotic chromosome assembly and organisation is 
primarily accomplished by the action of condensin proteins (T. Hirano 2005). 
Additionally, phosphorylation of condensin complexes is reported to promote their 
activity (Bazile et al. 2010). In particular, PLK1 has been reported to influence mitotic 
chromosome compaction, via phosphorylation of the non-SMC subunit of condensin II, 
CAP-H2 (Kagami et al. 2017). Therefore, correct centromere compaction may become 
affected during PLK1 inactivation, culminating in the formation of pre-anaphase DNA 
threads, due to a lack of condensation activity. Also, centromeric chromatin is known to 
consist of tandem arrays of repeating -satellite DNA, which is further organised to form 
extensive higher order repeat (HOR) structures (McKinley and Cheeseman 2016). Hence, 
it is also conceivable that the centromere region requires extensive compaction for its 
correct assembly. Therefore, PLK1 inactivation may compromise correct chromosome 
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compaction at the centromere, which may be required in order to withstand MT-spindle 
tension, in particular, during chromosome biorientation.  
 
In support to this hypothesis, depletion of condensin has been shown to result in similar 
outcomes to the phenotypes during PLK1 inactivation. Previous condensin depletion 
experiments have been shown to effect overall mitotic chromosome assembly (Ono et 
al. 2003). More specifically, centromere structural alterations have been described. In 
particular, following the depletion of condensin in HeLa cells (Samoshkin et al. 2009). 
This later study showed that both the core centromere and outer kinetochore are 
susceptible to stretching, following the depletion of condensin (SMC2). Most 
importantly, this centromere stretching was also dependent on spindle microtubule 
pulling forces (Samoshkin et al. 2009). These findings could therefore provide support 
to the idea that continual compaction of centromeric DNA, by the action of condensin 
complexes, may be required to counteract the forces applied by microtubule spindle 
pulling at the centromere. However, it is also worth noting that the centromere 
stretching phenotype reported after condensin depletion, is relatively mild compared to 
the formation of pre-anaphase DNA threads during PLK1 inactivation. Therefore, 
although condensin may provide essential function(s) for the correct assembly of mitotic 
chromosomes and centromere architecture, it may not be the single factor that is 
required to ensure the suppression of pre-anaphase DNA threads, following PLK1 
inactivation.  
 
Since PLK1 inactivation and pre-anaphase DNA thread formation maybe caused by 
multifactorial processes, another key observation worth discussion is the apparent 
disassembly of the centromere and in particular CENP-A.  
 
CENP-A is key to specifying centromere identity, and therefore also kinetochore 
establishment. Its deposition is cell cycle dependent, occurring only after mitosis and 
primarily during the G1 phase of the cell-cycle (Jansen et al. 2007). Interestingly, a report 
has suggested a role for PLK1 during new CENP-A deposition. This study describes how 
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PLK1 activity is crucial for the localisation of the MIS18 complex, and the HJURP 
chaperone to centromeres, both of which aid in ensuring that new CENP-A deposition 
occurs during G1 (McKinley and Cheeseman 2014). However, despite this PLK1 
dependent role for CENP-A deposition, it is unlikely that this represents a determining 
factor to explain the centromere disassembly observed in this study, as it was shown 
that even a transient inactivation of PLK1 (30 minutes), in fully established mitotic 
chromosomes, is sufficient to trigger pre-anaphase DNA thread formation. Thus, 
centromere disassembly cannot be explained by an effect on the regulation of CENP-A 
deposition by PLK1. Although, at this stage, it cannot be ruled out that PLK1 may have 
an influence on the maintenance of CENP-A during mitosis. It could be proposed that 
during an absence of PLK1 activity, centromeres become fragile, possibly due to a break 
down in the maintenance of CENP-A stability, or through a lack of chromosome 
compaction. Either of which may lead to centromeres being unable to withstand MT-
spindle pulling tension, and therefore leading to centromere deformation.  
 
This study has also shown that centromeric regions exhibit a DNA damage response, 
when PLK1 activity is compromised as H2AX foci were detected at centromeric regions 
after BI2536 treatment. This occurs prior to and post pre-anaphase DNA thread 
formation. This suggests that centromeres exhibit some form of fragility during PLK1 
inactivation. However, it remains uncertain what causes this apparent weakness.  
 
Therefore, in order to gain further insight into the effects of centromere deformation 
during the inactivation of PLK1, cytogenetic analysis of isolated chromosomes was 
performed. This led to new revelations to further explain the fate of centromeres during 
PLK1 inactivation, which will subsequently be discussed in the next chapter. 
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Chapter 4: PLK1 suppresses whole chromosome arm breakage 
 
4.1 Introduction 
 
The formation of pre-anaphase centromeric DNA threads and various other signs led to 
the suggestion that centromeres were being subjected to extensive DNA strain, 
following the inactivation of PLK1. In particular, the detection of H2AX foci at 
centromeres, following PLK1 inhibition, strongly implied that a DNA damage response 
was elicited. The H2A histone variant, H2AX, becomes phosphorylated at serine-139 in 
order to generate H2AX, which is regarded as a cellular indicator for the presence of 
DNA double-stranded breaks (DSBs) (Rogakou et al. 1998). Phosphorylation of H2AX is 
achieved by the activation of the phosphatidylinositol 3-kinase related kinases (PIKKs), 
including ATM (ataxia-telangiectasia mutated); ATR (ataxia-telangiectasia and Rad3 
related); or DNA-PKcs (DNA-dependent protein kinase catalytic subunit). The resulting 
phosphorylation event that generates H2AX leads to signal amplification at the site of 
damage, and this acts as a docking site for the accumulation and initiation of key DNA 
damage response proteins (Ciccia and Elledge 2010). Therefore, H2AX detection is 
widely linked to DNA damage and its appearance can be associated with the generation 
of DNA DSBs. 
 
During this study, following the inactivation of PLK1, cells were shown to display an 
increasing formation of H2AX foci at centromeric regions, when cells progressed 
through mitosis. This increase in the formation of H2AX foci was thought to be caused 
by PLK1 inactivation, combined with the building microtubule spindle forces at 
centromeres, during chromosome biorientation. In support of this prediction, by the 
time cells had progressed to metaphase, around 75% of centromeres displayed H2AX 
foci. The detection of H2AX foci at the centromere could imply that the centromeric 
DNA was subjected to damage, possibly in the form of DNA breakage. This DNA damage 
may promote centromere fragility and lead to centromere breakage. However, to 
directly show this by using conventional immunofluorescent imaging was an impossible 
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challenge. In general, fixed cells for immunofluorescent analysis maintain their mitotic 
chromosome arrangement. Consequently, this results in a large mass of mitotic 
chromosomes sitting directly on top of each other, making it almost impossible to 
identify any specific chromosomal breakage patterns. To overcome this technicality, 
cytogenetic analysis was performed. This method allows for the examination of 
individual chromosomes, to determine whether PLK1 inactivation was promoting 
centromeric breakage. Cytogenetic analysis of chromosomes is widely used in both 
clinical and basic research science, and it provides an intricate level of detail of various 
potential chromosome abnormalities. This can include karyotypic changes, 
chromosomal breakage patterns and even chromosomal translocations. Cytogenetic 
analysis is also commonly paired with the technique of fluorescent in situ hybridisation 
(FISH). This method can provide visual identification of site-specific regions within the 
genome (such as centromeres), through the hybridization of specific DNA probes. 
Therefore, chromosomal analysis, combined with FISH, was used to determine whether 
PLK1 kinase inactivation promoted centromere chromosome damage.  
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4.2 Results 
 
4.2.1 PLK1 kinase activity is required to suppress chromosome fragmentation  
 
To determine the status of individual isolated chromosomes during PLK1 inactivation, 
mitotic chromosome spreads were prepared, using RPE1 hTERT cells treated with or 
without BI2536. RPE1 cells maintain a near diploid karyotype (46 chromosomes) (Bodnar 
et al. 1998), which is unlike many cancer-derived cell lines that can display considerable 
fluctuations in ploidy (Nicholson and Cimini 2013). Thus, as expected, analysis of mitotic 
chromosome spreads following a thymidine-block and release, showed that control cells 
exhibited average chromosome numbers very close to a diploid karyotype (DMSO=46.5 
& nocodazole=45.5 per spread) (Fig. 4.1a-c). Notably, due to the synchrony of mitotic 
entry after a thymidine-block and release, colcemid treatment, which acts as a non-
reversible mitotic arresting agent was omitted and deemed unnecessary during 
preparation.  
 
Surprisingly, close examination of mitotic spreads following BI2536 treatment showed 
that the average number of chromosomes per spread was significantly increased 
(BI2536=58.5; mean chromosome number per spread) (Fig. 4.1a-c). This led to the 
suggestion that the loss of PLK1 activity induce a form of chromosome fragmentation. 
In mitotic spreads co-treated with BI2536 and nocodazole, fragmentation rescue was 
evident, as chromosome numbers reverted to a near diploid karyotype, much like 
control cells (BI2536+NOC=48.3) (Fig. 4.1a-c). Importantly, none of the 90 chromosome 
spreads analysed for chromosome counting after BI2536, displayed signs of sister-
chromatid separation (Fig. 4.1d). This rules out the possibility that the increase in 
chromosome numbers after BI2536 treatment is a result of counting individual sisters, 
rather than cohesed chromosomes.  
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Figure 4.1. PLK1 inhibition causes chromosome fragmentation.
a) Experimental outline of cell-synchronisation and chromosome spread preparation,
following indicated inhibitor treatments. b) Examples of chromosome spread images
following indicated inhibitor treatments. DAPI was used to stain chromosomes. c)
Quantification of chromosome number per spread after indicated inhibitor treatment
(overall mean is shown from three independent experiments; student t-test was used for p-
value calculation; n=number of cells analysed; scale bar 5µm; different colours indicate
each experiment). d) Enlarged example image of a single chromosome, and DAPI intensity
scanline plot profile, after either DMSO or BI2536 treatment (0/90 chromosome spreads
showed evidence of sister-chromatid separation).
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Overall, these data supported the idea that PLK1 kinase activity functions to suppress a 
form of chromosome fragmentation, which seems to be mediated by microtubule 
spindle pulling forces.  
 
4.2.2 PLK1 suppresses centromere breakage - ‘centromere dislocation’ 
 
Since PLK1 inactivation leads to pre-anaphase centromeric DNA thread formation and 
centromere/kinetochore distortion, it was speculated that the fragmentation of 
chromosomes may be caused by damage at centromeric chromatin. Therefore, to 
further investigate this idea, chromosome spreads from cells treated with or without 
BI2536, were subject to centromere and telomere fluorescent in situ hybridisation (ct-
FISH) (Fig. 4.2a).  
 
Analysis of chromosome spreads after ct-FISH clearly showed that the breakage of 
chromosomes after BI2536 treatment was not a random event. As predicted, following 
nocodazole treatment, chromosome spreads displayed an absence of chromosome 
fragmentation. Each chromosome analysed appeared as expected, displaying two pairs 
of telomere signals at each chromosome termini, whilst also containing an obvious 
centromere signal, within the flanking telomere signals (Fig. 4.2b-d). In contrast, BI2536-
treated chromosome spreads displayed a centromere specific breakage pattern (Fig. 
4.2b-d), strongly implying that PLK1 was required to suppress this chromatin damage 
phenomena.  
 
The breakage pattern was classified into two distinct classes. BI2536 treatment could 
result in a complete centromere breakage pattern, which resembled the formation of 
telocentric chromosomes. This was shown as a centromere signal at one chromosome 
terminus and a pair of telomere signals at the opposite end (Fig. 4.2d). This breakage 
pattern was referred to as ‘centromere dislocation’, emphasising the complete 
separation of the short and long arm of individual chromosomes. In addition, BI2536 
treatment led to ‘partially’ separated centromeres. In contrast to the complete 
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centromere breakage pattern (centromere dislocation), ‘partially’ separated 
chromosomes presented as stretching of the centromere, with both the short and long 
arm of the chromosome clearly remaining tethered together (Fig. 4.2d). This stretching 
scenario was categorised as distinctly different from the complete breakage pattern 
(centromere dislocation). It was tempting to predict that the ‘partial’ separation of 
centromeres resembled the initial stage of centromere breakage, during PLK1 inhibition.  
 
Based on these current findings, it was proposed that the spindle-mediated tension 
applied to centromeres during chromosome biorientation, promoted deformation or 
fragility at the centromere, when PLK1 function is compromised. In support of this, 
following the co-treatment of BI2536 and nocodazole, centromere dislocation was 
largely reduced (Fig. 4.2b-d). This implies that spindle-mediated tension and PLK1 
inactivation are able to promote centromere deformation. Additionally, these results 
were consistent with the earlier experiments, which showed pre-anaphase DNA threads 
were abolished, following the co-treatment of BI2536 and nocodazole (see previous Fig. 
3.12). Therefore, it was concluded that MT spindle attachment and MT pulling forces, 
influenced the centromere deformation pathway following the inactivation of PLK1. 
 
In order to confirm that PLK1 inactivation leads to chromatin breakage, specifically at 
the core centromere, all broken chromosomes were closely examined for the existence 
of a centromere FISH signal at their termini. Over 300 individual centromeres were 
examined and approximately 99% of each broken chromosome displayed a centromeric 
FISH signal at one end (Fig. 4.3a-c). Hence, it was concluded that PLK1 is required to 
suppress the formation of a (peri)-centromere specific DNA breakage pattern. 
 
4.2.3 Centromere deformation is specifically suppressed by the activity of 
PLK1  
 
Throughout this study, all experimental analysis investigating the loss of PLK1 activity, 
was performed using the small-molecule inhibitor BI2536. Despite being reported as a 
ab
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highly potent and specific inhibitor of PLK1 activity (IC50 = 0.83nm), it may also non-
specifically interfere with the activity of other family members of Polo-like kinases, for 
instance PLK2 and PLK3 (Lénárt et al. 2007; Steegmaier et al. 2007). Therefore, it was 
important to confirm that the centromere deformation phenotypes reported during this 
study, were not due to off-target effects of BI2536, or unwanted effects that may be 
caused by trapping of inactive PLK1 to it substrates.  
 
To determine whether the suppression of centromere deformation was specifically 
dependent on PLK1 function, the effects of inhibiting PLK1 activity using a previously 
developed RPE1 PLK1 analogue sensitive (PLK1as) cell line was investigated (Burkard et 
al. 2007). The RPE1 PLK1as cell line was developed by conditional targeting of wild-type 
PLK1, and replacement with a GFP-tagged PLK1as mutant allele (Fig. 4.4a). Amino acid 
substitutions at PLK1’s gatekeeper residue that lines the ATP-binding pocket (L130G), in 
combination with a suppressor mutation in the amino-terminal of the ATP-binding 
pocket (C67V), results in an increase in the size of the catalytic ATP-binding pocket of 
PLK1. This renders PLK1as cells sensitive to large bulky purine analogues, such as 3-MB-
PP1. However, due to the size increase of the ATP-binding pocket in the mutant PLK1as 
protein, small-molecule inhibitors – including BI2536, are no longer effective at 
inhibiting PLK1 activity, as they are unable to be retained within the catalytic site of 
PLK1as. Therefore, by analysing mitotic RPE1 PLK1as cells during treatment with the 
large purine analogue 3-MB-PP1, it would be possible to determine whether PLK1 
activity was required to suppress the centromere deformation phenotypes reported 
(Fig. 4.4b).  
 
Both RPE1 wild-type and RPE1 PLK1as cells were synchronised as before, and treated 
individually with either BI2356, or 3-MB-PP1 (Fig. 4.5a). As expected, during BI2536 
treatment, pre-anaphase DNA threads were shown to form in wild-type RPE1 cells, but 
not in RPE1 PLK1as cells (Fig. 4.5b, c). PLK1as cells were insensitive to BI2536 and instead 
were able to progress through mitosis and successfully underwent anaphase, 
demonstrating that BI2536 is unable to influence PLK1as protein activity (Fig. 4.5b, c). 
Importantly, during 3-MB-PP1 addition, wild-type RPE1 cells displayed no evidence of 
ab
Figure 4.4. An alternative approach at targeting PLK1 kinase activity using PLK1as cells.
a) A diagram to demonstrate how RPE1 hTERT cells, which contains wild-type PLK1, are
sensitive to the small-molecule inhibitor BI2536. However, wild-type PLK1 is insensitive to
the large bulky ATP analogue, 3-MB-PP1. The RPE1 PLK1as cells are only sensitive to the
large bulky 3-MB-PP1 molecule and insensitive to the small-molecule BI2536. b) A
schematic to demonstrate that wild-type RPE1 cells contain two copies of PLK1, which each
have a kinase domain (sensitive to BI2536) and a PBD domain. PLK1as RPE1 cells have two
copies of a GFP-tagged PLK1 analogue sensitive PLK1. PLK1as cells have a functional mutant
kinase domain (sensitive to 3-MB-PP1) and a PBD domain.
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pre-anaphase DNA thread formation, whereas the RPE1 PLK1as cells were shown to 
exhibit them (Fig. 4.5b, c). This confirmed that RPE1 PLK1as cells treated with 3-MB-PP1, 
recapitulate the effects of treating wild-type RPE1 cells with BI2536. Importantly, it 
further supports the hypothesis that PLK1 activity is specifically required to suppress 
DNA thread formation and the phenotypes are not due to an interference to other 
kinases. 
 
These data do not rule out that PLK1 inactivation via either BI2536, or 3-MB-PP1 may 
cause trapping of PLK1 to its substrates, and thus lead to the centromere deformation 
phenotypes. Accordingly, to rule out that trapping of PLK1 to its targets may promote 
pre-anaphase DNA thread formation, PLK1 protein depletion using RNAi was performed. 
This could show whether an absence of PLK1 protein is sufficient to promote metaphase 
collapse and pre-anaphase DNA thread formation.  
 
RPE1 cells were treated with specific siRNA oligo sequences that target PLK1 mRNA. The 
targeting of PLK1 by RNAi was performed for a short period before, and during cell-
synchronisation using thymidine, in order to achieve sufficient depletion (Fig. 4.6a). 
Following 25 hours of RNAi treatment, RPE1 cells were released into fresh media, prior 
to fixation and indirect immunostaining analysis. Cells are known to arrest in mitosis 
following the interference of PLK1 activity, either through chemical inhibition, or via 
protein depletion. As anticipated, the majority of RPE1 cells began to display a mitotic 
arrest after 25 hours of RNAi treatment, thus implying an effective depletion of PLK1. 
This was confirmed by indirect immunostaining of the PLK1 depleted cells, which 
showed the majority of cells were absent for PLK1 detection (Fig. 4.6b). The mitotic cells 
also displayed a metaphase collapse, which resembled that observed after BI2536 
treatment, whilst also displaying PICH positive pre-anaphase DNA thread formation (Fig. 
4.6b). Taken together, these results strongly suggested that the activity of PLK1 is 
responsible for suppressing the formation of pre-anaphase DNA threads. It therefore 
rules out that pre-anaphase DNA thread formation is due to an interference of other 
PLKs (i.e. PLK1-3), or trapping of PLK1 to its substrates.  
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Figure 4.5. PLK1 kinase activity supresses pre-anaphase DNA thread formation.
a) Experimental outline of cell-synchronisation and immunofluorescent staining using wild-
type, or PLK1as, RPE1 cells. b) Immunofluorescent images of either BI2536, or 3-MB-PP1
treated mitotic RPE1 and PLK1as cells. Cells positive for pre-anaphase DNA threads are
indicated (arrows). Antibody staining for GFP-PLK1 (Green), RPA (Red) and centromeres
(Blue). c) Quantification of DNA threads observed in indicated cell lines, treated with either
BI2536, or 3-MB-PP1 (mean ±SD is shown from three independent experiments; student t-
test was used for p-value calculation; n=number of cells analysed; scale bar 5µm).
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4.2.4 Artificial tethering of PLK1 to the centromere/kinetochore fails to rescue 
centromere deformation 
 
In order to further validate that cells require PLK1 activity to suppress centromere 
deformation, ectopic expression of wild-type PLK1 protein in the analogue sensitive 
RPE1 PLK1as cells (Lera et al. 2016), during 3-MB-PP1 treatment was tested, as it would 
be predicted to suppress centromere deformation (Fig. 4.7a, b). Pre-anaphase DNA 
threads were shown to form in the RPE1 PLK1as cells, following the addition of 3-MB-
PP1, whilst the stable ectopic expression of a wild-type PLK1 protein (PLK1as + WT) 
suppressed pre-anaphase DNA thread formation (Fig. 4.8a-c). This further emphasises 
the important role that PLK1 plays in preventing centromere deformation.  
 
PLK1 is known to require its PBD domain for substrate targeting and its downstream 
function(s). Therefore, it was predicted that an interference to PLK1’s PBD domain will 
render cells sensitive to centromere deformation phenotypes (i.e. pre-anaphase DNA 
thread formation). Examination of RPE1 PLK1as+∆PBD cells, which ectopically expressed 
a modified PLK1 protein, containing a wild-type kinase domain but with a mutant PBD 
domain (see previous Fig. 4.7a, b), showed them to no longer be capable of suppressing 
pre-anaphase DNA thread formation during 3-MB-PP1 treatment (Fig. 4.8b, c). 
Therefore, these data show that the catalytic function of wild type PLK1, along with its 
PBD domain, is required to suppress pre-anaphase DNA thread formation.  
 
Throughout mitosis, PLK1 has been reported to localise and function within discrete 
regions along the centromere/kinetochore axis (Lera et al. 2016). Therefore, it was 
speculated that in order to suppress centromere deformation, PLK1’s catalytic activity 
may be required to function at specific site(s) along this centromere/kinetochore axis. 
In an attempt to define the specific site, three previously developed RPE1 PLK1as cell 
lines were examined for their ability to suppress pre-anaphase DNA thread formation 
during 3-MB-PP1 treatment (Lera et al. 2016). Each modified RPE1 PLK1as cell line 
featured a catalytically active form of PLK1, which was artificially tethered to either 
BUBR1 (PLK1-∆c-BubR1 – outer kinetochore region); KIF2c (PLK1-∆c-Kif2c – outer 
ab
Figure 4.7. Schematic of domain structure & localisation of centromere tethered PLK1as
cell lines.
a) A schematic diagram of the different PLK1as cell lines. PLK1as cells were stably infected
with either an empty FLAG vector (PLK1as EV), or with a FLAG-tagged PLK1 (PLK1as+WT), a
FLAG-tagged PLK1 that has a mutated PBD domain (PLK1as+DPBD); or finally a variety of
derivatives that have a FLAG-tagged kinase domain, absent of their PBD and instead
tethered to either -BubR1, -Kif2c or -H2B. Note that both alleles of PLK1as(EV) are sensitive
to 3-MB-PP1, whereas all further cell line derivatives have one copy of the PLK1as allele,
which is sensitive to 3-MB-PP1, and the other copy (wild-type PLK1 kinase domain) is
sensitive to BI2536. b) A schematic diagram of the centromere/kinetochore axis,
highlighting the localisation of the PLK1-∆c-tethered constructs.
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kinetochore and inner centromere); or, histone H2B (PLK1-∆-H2B – chromatin) (see 
previous Fig. 4.7a, b). The artificial tethering of an active form of PLK1 to either BUBR1, 
KIF2c or H2B was tested to determine if it could suppress centromere deformation, 
when PLK1as activity was compromised by 3-MB-PP1 treatment. 
 
Indirect immunofluorescent analysis showed none of each of the tethered PLK1-∆c(-
BubR1, -Kif2c or -H2B) cell lines could fully suppress pre-anaphase DNA thread 
formation, during the addition of 3-MB-PP1 (Fig. 4.8b, c). Interestingly, PLK1-∆-H2B cells 
did display a significant reduction in the percentage of mitotic cells positive for pre-
anaphase DNA threads, when compared to control cells (PLK1as) (Fig. 4.8b, c). This could 
suggest that PLK1 is required to function at the level of chromatin, in order to suppress 
pre-anaphase DNA thread formation.  
 
In addition to the indirect immunofluorescent analysis, cytogenetic examination of each 
of the RPE1 PLK1as cell lines was also performed in order to determine centromere 
dislocation frequencies. Mitotic chromosome spreads were prepared during 3-MB-PP1 
treatment, for each of the PLK1as cell lines (including all derivatives) and subjected to 
ct-FISH.  
 
As expected, during 3-MB-PP1 treatment, PLK1as cells displayed an increase in 
centromere dislocation patterns, whilst PLK1as+WT cells showed a significant reduction 
in centromere dislocations (Fig. 4.9a, b). These results supported previous findings on 
pre-anaphase DNA thread formation in the same cell lines. Consistent with previous 
findings, PLK1as+PBD cells displayed high numbers of centromere dislocations, whilst 
each of the three PLK1-tethered cell lines (PLK1-C-BubR1, PLK1-C-Kif2c and PLK1-C-
H2B) also showed significant levels of centromere dislocation, during 3-MB-PP1 
treatment (Fig. 4.9a, b). This confirms that PLK1 activity is crucial to suppress 
centromere dislocations, whilst fusion of an active form of PLK1 to BUBR1, KIF2c or H2B, 
appears insufficient to suppress centromere deformation. 
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Interestingly, following close examination of the PLK1-C-H2B cell line, it was noticed 
that a significantly lower percentage of chromosome spreads were positive for one or 
more centromere breakages, when compared to control cells (PLK1as) (Fig. 4.10a, b). 
Therefore, fusion of PLK1 to the histone variant H2B, can lead to a mild suppression of 
centromere deformation phenotypes, despite overall PLK1 inactivation during 3-MB-
PP1 treatment. Thus, these findings support the suggestion that PLK1 functions at the 
level of chromatin in order to suppress centromere deformation. However, further 
investigation into the possible substrate targets of PLK1 is needed to elucidate the 
mechanism of centromere deformation suppression by PLK1. 
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4.3 Discussion     
 
In this chapter, careful cytogenetic analysis has demonstrated that the loss of PLK1 
activity can lead to an unexpected spindle-mediated centromere breakage 
phenomenon during mitosis, which is referred to as ‘centromere dislocation’. In Chapter 
3, earlier immunofluorescent experiments suggested that centromeres suffer from 
serious DNA damage, as revealed by the presence of H2AX foci at centromeres, 
following the inhibition of PLK1 activity (see previous Fig. 3.9b, c). This suspected 
centromere damage was confirmed by detailed chromosome examination, using 
centromere and telomere FISH (ct-FISH). Here, we show that whole chromosome arm 
breakage is displayed after PLK1 inhibition and this can be largely suppressed when 
spindle attachment and tension is abolished using nocodazole (Fig. 4.2b-d). This 
highlights that MT-spindle forces influence centromere breakage during PLK1 
inactivation.   
 
In addition, the whole chromosome arm breakage pattern is non-random, with the 
break point specific to the core-centromere region(s). Therefore, it is tempting to 
suggest that centromere dislocation is the culmination of pre-anaphase DNA thread 
breakage, although the mechanistic process of this remains uncertain. Whether pre-
anaphase DNA thread formation, and the resulting centromere breakage phenomenon, 
induced by PLK1 inactivation, is simply due to microtubule spindle forces or the result 
of additional factors/active mechanisms, remains to be discovered. Further analysis into 
the possible PLK1 substrates at the centromere may help to uncover greater detail and 
to explain how PLK1 functions to suppress such centromere deformation.  
 
The study of cell lines artificially tethering PLK1 to various sites of the centromere-
kinetochore axis was inconclusive, but continues to hold promise. Further studies are 
required to investigate the effects of tethering PLK1, either directly to chromatin, or 
alternatively to additional sites along the centromere/kinetochore axis. This may help 
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to uncover possible PLK1-kinase targets that function to suppress centromere 
deformation.  
 
The lack of centromere deformation rescue using the current selection of PLK1 tethered 
cell lines (PLK1-C-BubR1, PLK1-C-Kif2c and PLK1-C-H2B), may be due to various factors. 
Each PLK1 tethered cell line has been reported to be kinase active, but it remains to be 
seen whether they are fully capable of mimicking wildtype PLK1 function and/or 
localisation (Lera et al. 2016). Therefore, the PLK1-tethered cell lines examined may not 
be sufficient to suppress such centromere deformation. PLK1 is anticipated to have 
multiple targets at the centromere. Hence, current PLK1-tethered cell lines may not be 
able to satisfy the full plethora of PLK1 targets required to suppress centromere 
deformation. Thus, future examination into different locations of PLK1 tethering, or 
even tethering active PLK1 to multiple sites, may help to dissect how PLK1 functions in 
centromere maintenance.  
 
Interestingly, tethering PLK1 to the histone variant, H2B showed a partial rescue of 
centromere deformation. Despite cells displaying centromere breakage following PLK1 
kinase inhibition using 3-MB-PP1, there was a significant reduction in centromere 
dislocations. This mild rescue of centromere breakage may imply that PLK1 acts directly 
at the level of chromatin in order to suppress centromere deformation. Thus, it is 
speculated that PLK1 may actively phosphorylate histones in order to provide rigidity to 
chromatin structure, particularly at the centromere. Subsequently, PLK1-dependent 
phosphorylation of histones may ensure centromeric chromatin rigidity, which could be 
required in order to counteract the microtubule-spindle pulling forces encountered 
during KT-MT attachment and chromosome biorientation. However, it must be 
emphasised that this is speculation and PLK1 is most likely required to phosphorylate 
multiple factors in order to suppress centromere deformation.  
 
Results presented in this chapter could imply that microtubule-spindle pulling forces 
may not be the only factor responsible for centromere deformation, during PLK1 
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inactivation. Previous immunofluorescent experiments showed that pre-anaphase DNA 
threads are abolished when cells were co-treated with BI2536 and either the 
microtubule spindle-poison, nocodazole, or the Eg-5 inhibitor, monastrol (Fig 3.12-
3.13). This would imply that microtubule spindle tension may drive the formation of pre-
anaphase DNA threads, during the inhibition of PLK1 kinase activity. However, 
cytogenetic analysis during this chapter has revealed a more detailed outlook. Through 
careful analysis of centromere FISH signals, it was possible to observe two distinct 
centromere deformation scenarios, either centromere breakage (centromere 
dislocations); or, partial splitting of the centromere. Notably, the partial splitting 
phenotype was reminiscent of centromere stretching. Thus, partial separation of the 
centromere may be attributed to an early stage of centromere deformation, prior to 
complete breakage (centromere dislocation) (Fig. 4.2c, d).  
 
Intriguingly, experiments investigating the co-treatment of microtubule-spindle poison 
(nocodazole), alongside PLK1 inhibition, showed that such co-treatment, leads to a 
significant reduction in centromere dislocations. However, when comparing against 
PLK1 inactivation alone, partial splitting of the centromere was not significantly reduced, 
during the co-treatment of BI2536 and nocodazole (Fig. 4.2c, d). Therefore, it was 
speculated that additional influences may play a role in centromere deformation, 
independent of MT-spindle pulling forces, and these could promote the initial stages of 
centromere deformation during PLK1 inhibition.  
 
Consistent with this idea, previous experiments showed that pre-anaphase DNA thread 
formation could be suppressed during the co-treatment of BI2536 and monastrol 
(monopolar MT-spindle attachment). However, close analysis of these cells showed RPA 
focus formation at the centromeres. This was not detected in cells co-treated with 
BI2536 and nocodazole (no MT-spindle attachment). Therefore, it was speculated that 
MT-attachment may promote structural changes to centromeric chromatin in the 
absence of PLK1, which could be sufficient to trigger the initial stages of centromere 
deformation. However, the centromeric structural alterations that may occur during 
PLK1 inactivation and MT-spindle attachment remain unknown. Since RPA foci form in 
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these cells, centromeric DNAs are probably exposed by an active mechanism, which 
likely results in the formation of ssDNA. This could then promote centromere fragility. 
Consequently, centromere deformation may not be simply accredited to MT-spindle 
pulling forces, but additional influences must also be considered. 
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Chapter 5: Catalytic activity of BLM and PICH promote 
centromere deformation during PLK1 inactivation  
 
5.1 Introduction 
 
In previous chapters it was shown that mitotic PLK1 activity is required to suppress a 
centromere deformation pathway, which takes the form of centromeric pre-anaphase 
DNA threads and centromere specific chromatin breakage. It was established that 
centromere deformation develops through the co-action of microtubule spindle pulling 
forces and PLK1 inactivation. Therefore, it is predicted that PLK1 inactivation affects 
centromeric chromatin structure, which may cause a weakness to the centromere. This 
potential centromeric weakness is then exposed during mitotic spindle attachment and 
tension. Based on this prediction, it was necessary to investigate a mechanistic link 
between centromeric chromatin structural changes and PLK1 inactivation.  
 
Initially, chromosome condensation was predicted to be affected when PLK1 activity 
became compromised. This was considered a strong candidate to explain the cause of 
centromere deformation during PLK1 inactivation. Chromosome compaction is achieved 
via the action of condensin complexes. This function of condensin is considered crucial 
for the correct assembly of mitotic chromosomes (Ono et al. 2003). It has also been 
reported that PLK1-dependent phosphorylation of condensin II (CAP-H2 subunit) is 
required to support the correct assembly of mitotic chromosomes during prophase 
(Kagami et al. 2017). Therefore, it could be predicted that in the absence of PLK1 activity, 
mitotic chromosome compaction may become compromised and in particular, at the 
centromere. This could lead to alterations to centromeric chromatin arrangement, thus 
promoting centromere fragility. Subsequently, centromeric chromatin may no longer be 
able to withstand MT-spindle pulling forces. Therefore, cells will display the centromere 
deformation phenotypes described (pre-anaphase DNA threads and centromere 
dislocation).  
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It has been shown that following the depletion of SMC2 (condensin complex), 
centromere elongation occurs, which resembles a form of centromere stretching 
(Samoshkin et al. 2009). This centromere stretching, after condensin depletion, could be 
considered similar to the early formation of pre-anaphase DNA threads during PLK1 
inactivation. The same study also reported that centromere stretching after condensin 
depletion, can be suppressed during the addition of nocodazole, similarly to centromere 
deformation suppression during PLK1 inactivation. Therefore, based on these findings, 
it could be speculated that PLK1 functions in regulating condensin activity at the 
centromere to ensure centromere rigidity. Furthermore, it is anticipated that this rigidity 
is necessary to counteract MT-spindle pulling forces and facilitate the correct 
centromere structure during chromosome biorientation. 
 
Other studies have also revealed that condensin depletion can lead to an increase in 
inter-kinetochore distance following microtubule spindle attachment (Gerlich et al. 
2006; Ribeiro et al. 2009). Again, this supports the idea of a centromere-specific role for 
condensin to sustain centromere rigidity, especially during bipolar spindle attachment 
and tension. However, despite a probable function for condensin activity in supporting 
centromere rigidity, there remains a lack of evidence of chromatin rupture following 
depletion of condensin. This is in contrast to centromere deformation during PLK1 
inactivation, where pre-anaphase DNA thread formation and centromere breakage is 
observed. PLK1 likely has multiple roles at the centromere in order to suppress 
centromere deformation, but a PLK1-dependent function in regulating condensin 
activity is worthy of future consideration as part of a centromeric PLK1 function.  
 
In addition, given that centromeric pre-anaphase DNA thread formation is also linked to 
the recruitment of the ultra-fine DNA bridge (UFB)-binding complex and in particular 
PICH and BLM, it was predicted that the activity of these proteins may affect 
centromeric chromatin structure. Therefore, the role that the UFB-binding complex 
proteins plays in centromere deformation was investigated, with the aim to further 
explain how centromere deformation may arise during PLK1 inactivation.   
  106 
 
The manifestation of UFBs results from DNA replication and repair activities, which can 
promote DNA entanglements, and these require resolution by the action of the UFB-
binding complex (Fernández-Casañas and Chan 2018). Two of the principle UFB-binding 
factors, PICH and BLM, are required for UFB resolution (Baumann et al. 2007; Chan et 
al. 2007).  
 
PICH is a member of the SNF2 family of DNA helicase-like proteins and has been shown 
to co-localise with PLK1 at kinetochores following NEBD during prophase (Baumann et 
al. 2007). A phospho-specific residue (T1063) in PICH supports an interaction between 
PICH and PLK1 (Ke et al. 2011). PICH acts as a DNA translocase and requires ATP binding 
and/or hydrolysis for its activity (Biebricher et al. 2013). This implies a catalytic function 
for PICH at DNA substrates. However, despite its initial discovery over 10 years ago and 
knowledge of its biochemical action, the precise function(s) of PICH remain enigmatic. 
One function of PICH is to support the recruitment of additional proteins at UFB 
structures (Hengeveld et al. 2015), particularly the BLM helicase.  
 
BLM is a member of the RecQ family of DNA helicase proteins that is capable of 
unwinding DNA substrates with a 3’-5’ directionality (Karow et al. 1997). A major 
function of BLM is in a unique HR-mediated dissolution pathway, during DNA replication 
and repair (Wu and Hickson 2003). BLM is also a prominent factor of the UFB-binding 
complex and displays a matching localisation pattern with PICH along anaphase UFB 
DNA linkages. Therefore, it is believed that BLM functions in combination with PICH, in 
the maintenance and resolution of UFB-structures. BLM helicase activity is probably 
necessary to unwind the ultra-fine DNA structure and aid in their resolution, although a 
precise mechanism remains uncertain. However, studies have shown that BLM helicase 
activity promotes UFB unwinding, which triggers the recruitment of another UFB-
binding factor; the ssDNA binding protein RPA (Chan et al. 2018; Sarlós et al. 2018).  
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In this study, RPA foci formed at the centromeres of mitotic cells and co-treated with 
BI2536 and monastrol (see previous Fig. 3.13b). Cells treated with monastrol have been 
shown to form monopolar spindle attachments, and therefore MT-spindle pulling forces 
are limited. RPA was not detected at centromeres of mitotic cells co-treated with BI2536 
and nocodazole. This suggests that monopolar spindle attachment, alongside PLK1 
inactivation (BI2536 and monastrol treatment), is sufficient to promote the recruitment 
of RPA to centromeres during mitosis.  
 
This interesting observation was the basis for experiments aimed to uncover why 
centromeres encounter such severe deformation during PLK1 inactivation. During early 
mitosis, if PICH and BLM were to inadvertently target tension derived DNA substrates 
(such as centromeres), when PLK activity is absent, unsolicited processing of 
centromeric DNA may result. This would suggest a causative link between PLK1 
inhibition and the action of the UFB-binding proteins, in particular PICH and BLM, in 
promoting centromere fragility and subsequent deformation.  
 
This chapter will aim to explore a mechanistic link between centromere deformation 
during PLK1 inactivation and explain how the action of the UFB-binding complex 
promotes this unexpected centromere fragility. Specifically, after PLK1 inactivation, the 
careful analysis of mitotic cells reveals how both BLM and PICH are able to catalytically 
drive this unexpected centromere deformation. 
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5.2 Results  
 
5.2.1 PLK1 suppresses the aberrant formation of PICH, BLM and RPA at 
centromeres during metaphase  
 
It has recently been reported that phospho-RPA can be detected at the centromeres of 
unperturbed mitotic cells (Kabeche et al. 2018). In contrast, during the current study, 
RPA was largely undetectable at the centromeres of RPE1 cells during metaphase (Fig. 
5.1a, b). However, following the inhibition of PLK1 kinase, abundant levels of RPA foci 
formation were detected at the centromeres of metaphase cells, implying that ssDNA 
may be forming at the centromeres (Fig. 5.1a, b, arrowheads). Thus, it was speculated 
that during PLK1 inactivation additional factors, such as the UFB-binding complex, may 
be responsible for this unexpected RPA foci formation at centromeres. 
 
To investigate this idea further, the recruitment patterns of BLM helicase were 
examined during metaphase. BLM has been reported to be a centromere associating 
factor during mitosis (Rouzeau et al. 2012). However, during this study there was little 
evidence to suggest that BLM is an abundant centromere-associating protein during 
mitosis. BLM was shown to be largely undetectable at the centromeres of metaphase 
cells during unperturbed conditions (Fig. 5.1c). In contrast, following PLK1 inhibition 
using BI2536, BLM foci were shown to be abundant at the centromeres of metaphase(-
like) cells (Fig. 5.1c, arrowheads). This implies that PLK1-inhibition can promote the 
aberrant recruitment of both RPA and BLM to centromeres.  
 
By co-culturing wild-type RPE1 and RPE1 PLK1as cells, it was possible to determine 
whether the apparent increase in RPA at the centromeres was dependent on PLK1 
activity, and not simply due to immunofluorescent staining variations between samples. 
As previously described, wild-type RPE1 cells are sensitive to the small-molecule 
inhibitor BI2536, but insensitive to the ATP-analogue 3-MB-PP1. In contrast, PLK1as cells 
are sensitive to 3-MB-PP1 and insensitive to BI2536 (see previous Fig. 4.5). Therefore, 
by co-culturing the two cell types together and treating the cultures with either BI2536 
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Figure 5.1. PLK1 inhibition promotes recruitment of BLM & RPA at the centromeres
during metaphase.
a) Experimental outline of cell-synchronisation and immunofluorescent staining using RPE1
cells. b) Immunofluorescent images of metaphase(-like) RPE1 cells after either DMSO, or
BI2536 treatment. Enlarged regions demonstrate the presence of RPA foci (arrows).
Antibody staining for DAPI (Grey), CENPA (Green), RPA (Red) and centromeres (Blue).
Quantification (right) of RPA foci at centromeres. c) Immunofluorescent images of
metaphase(-like) RPE1 cells after either DMSO, or BI2536 treatment. Enlarged regions
demonstrate the presence of BLM foci (arrows). Antibody staining for DAPI (Grey), CENPA
(Green), BLM (Red) and CENPB (Blue). Quantification (right) of BLM foci at centromeres
(overall mean is shown from three independent experiments; student t-test was used for p-
value calculation; n=number of cells analysed; scale bar 5µm).
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(targeting only the wild-type RPE1 cells), or 3-MB-PP1 (targeting only the PLK1as cells), 
it was possible to show that under the same coverslip, only the PLK1 kinase inhibited 
cells displayed a detectable increase in RPA at the centromeres. The two cell lines are 
distinguishable because the PLK1as protein is GFP-tagged, unlike the wildtype PLK1 
protein. PLK1as cells could be distinguished from wildtype RPE1 cells, through the 
detection of GFP-PLK1as positive centrosomes (see examples in Fig. 5.2b, arrows).  
 
In agreement with previous findings, detailed examination of the co-culture cells 
showed that RPA foci formation is aberrantly increased at centromere regions only 
when PLK1 is inhibited (Fig. 5.2a-c). Consistently, RPA foci was undetectable at 
centromeres in cells that maintained an active PLK1 kinase (Fig. 5.2b, c). These results 
provide strong evidence to suggest that PLK1 inactivation leads to the aberrant 
recruitment of RPA at the centromeres of mitotic cells. This is possibly linked to the 
regulation of the UFB-binding complex proteins, most likely BLM helicase, due to its DNA 
unwinding capabilities. 
 
Together with the aberrant recruitment of RPA and BLM at centromeres following PLK1 
inhibition, PICH recruitment is also increased at centromeres. PICH is known to recruit 
to kinetochore/centromeres following NEBD (Baumann et al. 2007).  Therefore, unlike 
with RPA and BLM, it was expected that PICH would be readily detectable at the 
centromeres. However, following treatment with BI2536, the intensity of centromeric 
PICH foci appeared to be increased at the centromeres when compared to cells with 
active PLK1. This suggests that PLK1 may influence the level of PICH recruitment to 
centromeres. To investigate this further, quantitative imaging was performed using the 
co-cultured system of RPE1-WT and PLK1as cells. PICH became more readily detectable 
at centromeres after the inactivation of PLK1 using BI2536 (Fig. 5.3a-b). Furthermore, 
the fluorescence intensity of PICH focal formation at centromeres was also shown to be 
increased following PLK1 inhibition (Fig. 5.3c). This implied that PLK1 may negatively 
regulate the level of PICH recruitment to centromeres, and in its absence, more PICH 
molecules are loaded to the centromeres following NEBD.  
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Figure 5.2. PLK1 kinase suppresses aberrant recruitment of RPA at the centromere during
metaphase.
a) Experimental outline of cell-synchronisation and immunofluorescent staining, using co-
cultures of wild-type RPE1 and GFP-PLK1as cells. b) Immunofluorescent images of
metaphase(-like) wild-type RPE1 and PLK1as cells, after either BI2536, or 3-MB-PP1
treatment. Positive GFP-PLK1 detection of centrosomes (arrows) distinguish PLK1as cells
from wild-type RPE1 cells. Antibody staining for DAPI (Grey), GFP-PLK1 (Green), RPA (Red)
and centromeres (Blue). c) Quantification of RPA foci at centromeres of metaphase(-like)
cells after indicated inhibitor treatment (overall mean is shown; n=number of cells
analysed; scale bar 5µm).
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Figure 5.3. PLK1 kinase may limit the loading of PICH at the centromere during
metaphase.
a) Immunofluorescent images of metaphase(-like) wild-type RPE1 and PLK1as cells, after
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Based on these findings, it was speculated that PLK1 activity is required to regulate the 
recruitment of BLM and PICH at the centromere during mitosis, either directly or 
indirectly. In addition, it also suggested that BLM activity and possibly PICH, may be 
responsible for the physical unwinding of centromeric DNA at the centromeres, when 
PLK1 activity is compromised.  
 
This hypothesis may explain why RPA becomes readily detectable at centromeres during 
PLK1 inactivation. Unsolicited DNA unwinding at the centromere, due to the aberrant 
recruitment and activity of BLM and PICH during PLK1 inactivation, may promote 
centromeric ssDNA formation. This could trigger the loading of RPA for its protection, 
explaining why RPA is detected at centromeres following PLK1 inhibition. Further 
experiments were required to test this theory. Additional factors such as MT-spindle 
tension, together with PLK1 inactivation, should not be overlooked, as they may also be 
the basis for the aberrant recruitment of RPA and BLM at centromeres.  
 
5.2.2 MT-spindle tension promotes aberrant RPA foci formation at the 
centromere during PLK1 inhibition 
 
The formation of pre-anaphase DNA threads and centromere breaks during PLK1 
inhibition were shown to be dependent on bipolar spindle attachment and MT-tension 
(see previous Figs. 3.12 & 3.13). Hence, it was predicted that RPA foci formation at the 
centromere could also be dependent on MT-tension, during the inactivation of PLK1.  
 
To investigate this idea, individual mitotic cells were examined for centromere 
associated RPA recruitment following BI2536 treatment. Each distinct mitotic stage from 
prophase to metaphase was analysed and both RPA foci number and fluorescence 
intensity was recorded. Finally, an additional sample was prepared, which was subject 
to the co-treatment of both BI2536 and the MT-poison, nocodazole. This would help to 
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determine whether PLK1 activity and MT-spindle tension are both required for the 
aberrant formation of RPA at the centromere.  
 
Following cell synchronisation and treatment with BI2536 (Fig. 5.4a), RPA foci formation 
at the centromeres of mitotic cells was consistent with previous findings. The RPA foci 
was shown to increase in both number and fluorescence intensity as cells progressed 
from prophase to metaphase (Fig. 5.4b-d). This could suggest that during PLK1 
inactivation, the increasing MT-tension from prophase to metaphase, enhanced the 
aberrant recruitment of RPA. Abolishing MT-tension by co-treatment of BI2536 and 
nocodazole led to both a significantly reduced number of RPA foci and fluorescent 
intensity at their centromeres (Fig. 5.4b-d). This suggested that the reduction in RPA foci 
following the co-treatment of BI2536 and nocodazole, is most likely due to a lack of 
spindle attachment and therefore tension.  
 
The same experimental method was used to examine whether the reported increase in 
PICH loading to centromeres during PLK1 inhibition was also dependent on MT-spindle 
tension (Fig. 5.5a). PICH foci formation was apparent at the centromeres of mitotic cells 
and displayed an increasing loading fashion from prophase to metaphase (Fig. 5.5b-d). 
Both the number of PICH foci and the fluorescent intensity of centromeric PICH was 
shown to peak during metaphase. However, following co-treatment with BI2536 and 
nocodazole, PICH foci number and intensity showed no significant change (Fig. 5.5b-d). 
Therefore, PICH loading to centromeres, during PLK1 inactivation, is unlikely to be 
enhanced by MT-spindle pulling forces. Instead, the increasing level of detection of PICH 
at centromeres during mitosis is most likely due to the increased accessibility of PICH to 
mitotic chromatin, following NEBD during prophase.  
  
It was also possible to examine whether MT-attachment alone was sufficient for the 
aberrant recruitment of RPA, during PLK1 inhibition. Nocodazole treatment should 
generate an absence of KT-MT attachments. Therefore, although spindle pulling forces 
would be abolished during nocodazole treatment, this treatment is unable to disprove 
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Figure 5.4. The aberrant recruitment of RPA after PLK1 inhibition is dependent on
spindle-pulling forces.
a) Experimental outline of cell-synchronisation and immunofluorescent staining using RPE1
cells. b) Immunofluorescent images of mitotic RPE1 cells after BI2536 treatment; or BI2536
plus Nocodazole. Antibody staining for DAPI (Grey), RPA (Red) and centromeres (Blue).
Enlarged regions highlight centromeres with RPA foci (scale bar 5µm). c) Quantification of
RPA foci number (left) at centromeres of different mitotic stages during BI2536 treatment;
plus, after addition of BI2536 and Nocodazole (different colours indicate each experiment;
n=number of cells analysed; overall mean is shown from three independent experiments;
student t-test was used for p-value calculation). d) Quantification of RPA foci intensity
(right) at centromeres of different mitotic stages during BI2536 treatment; plus, after
addition of BI2536 and Nocodazole (n=number of RPA foci analysed; overall mean is shown
from three independent experiments; student t-test was used for p-value calculation).
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Figure 5.5. The aberrant loading of PICH during PLK1 inhibition is independent on spindle-
pulling forces.
a) Experimental outline of cell-synchronisation and immunofluorescent staining using RPE1
cells. b) Immunofluorescent images of mitotic RPE1 cells after BI2536 treatment; or BI2536
and Nocodazole. Antibody staining for DAPI (Grey), PICH (Green) and centromeres (Blue).
Enlarged regions highlight centromeres with PICH foci. c) Quantification of PICH foci
number (left) at centromeres of different mitotic stages during BI2536 treatment; plus,
after addition of BI2536 and Nocodazole (different colours indicate each experiment;
n=number of cells analysed). d) Quantification of PICH foci intensity (right) at centromeres
of different mitotic stages during BI2536 treatment; plus, after addition of BI2536 and
Nocodazole (n=number of PICH foci analysed; overall mean is shown from three
independent experiments; student t-test was used for p-value calculation; scale bar 5µm).
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the theory that MT-attachment alone may promote centromere deformation during 
PLK1 inactivation. Therefore, in order to determine whether MT-attachment alone was 
sufficient to promote the aberrant formation of RPA at centromeres during PLK1 
inactivation, mitotic cells were co-treated with BI2536 and monastrol. Consistent with 
earlier findings, metaphase cells treated with BI2536 displayed clear signs of RPA foci 
formation at their centromeres (Fig.5.6a-d). Following the co-treatment of BI2536 and 
monastrol, mitotic cells displayed both a similar overall number and intensity of RPA 
foci, as cells treated with BI2536 alone (Fig.5.6a-d). In contrast, RPA foci number and 
fluorescent intensity were both significantly reduced in samples co-treated with BI2536, 
monastrol and nocodazole, compared to both BI2536 alone, and BI2536 plus monastrol 
cells (Fig.5.6a-d).  
 
Overall, these data would suggest that mitotic spindle attachment, bipolar or monopolar 
attachment, during the inactivation of PLK1, promotes the aberrant recruitment of RPA 
at the centromere. Thus, KT-MT attachment may alter the DNA architecture at the 
centromere and by doing so, cause BLM to target centromeric DNA, when PLK1 activity 
is compromised. This idea could begin to explain how centromere deformation 
originates. 
 
5.2.3 BLM promotes centromere deformation during PLK1 kinase inhibition 
 
The current data would support the suggestion that PLK1 kinase activity functions to 
suppress the unsolicited unwinding of centromeric DNA, possibly through the regulation 
of BLM helicase. This prediction is based on data that show that aberrant levels of BLM 
foci are detected at centromeres during metaphase, when PLK1 is inactivated. 
Centromeric BLM localisation may promote centromeric DNA unwinding, which could 
lead to pre-anaphase DNA thread formation during bipolar spindle pulling. Therefore, 
the depletion of BLM by RNA interference (RNAi) was predicted to abolish centromere 
deformation, caused by inhibition of PLK1 activity.  
 
Figure 5.6. KT-MT attachment promotes the aberrant recruitment of RPA at the
centromere during PLK1 inhibition.
a) Experimental outline of cell-synchronisation and immunofluorescent staining using RPE1
cells. b) Immunofluorescent images of mitotic RPE1 cells after BI2536 treatment
(Metaphase), BI2536 and Monastrol, or BI2536, Monastrol and Nocodazole. Antibody
staining for DAPI (Grey), RPA (Red) and centromeres (Blue). Enlarged regions highlight
centromeres with RPA foci (arrowheads) (scale bar 5µm). c) Quantification of RPA foci
number (left) at centromeres of different mitotic stages during BI2536 treatment, plus,
after addition of Monastrol, and Monastrol plus Nocodazole (different colours indicate each
experiment; n=number of cells analysed; overall mean is shown from three independent
experiments; student t-test was used for p-value calculation). d) Quantification of RPA foci
intensity (right) at centromeres of different mitotic stages during BI2536 treatment; plus,
after addition of Monastrol, and Monastrol plus Nocodazole (n=number of RPA foci
analysed; overall mean is shown from three independent experiments; student t-test was
used for p-value calculation).
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Initial experiments with siRNA-mediated depletion of BLM for greater than 24 hours, 
prevented RPE1 cells from entering mitosis. This was predicted to be due to an increase 
in replicative stress during cell synchronisation using thymidine, which may require BLM 
activity to overcome this. BLM is required for replication fork restart and recovery, in 
particular during  conditions of replicative stress (Davies et al. 2007). Therefore, BLM 
depletion, combined with the addition of thymidine, may generate levels of replicative 
stress that require BLM for effective recovery of replication fork restart. To overcome 
this, BLM was only partially depleted in RPE1 cells (less than 24 hours), whilst also 
synchronising the cells at the G1/S border using thymidine (Fig. 5.7a).  
 
The limited depletion time was sufficient to significantly reduce the level of BLM protein, 
as judged by protein level following western blot analysis (Fig. 5.7b). Crucially, BLM 
depleted cells displayed a significant reduction in the formation of pre-anaphase DNA 
threads during BI2536 treatment, when compared to control cells (Fig. 5.7c). In addition, 
BLM depletion was also shown to suppress centromere breakage, despite the inhibition 
of PLK1 (Fig. 5.7d). Therefore, these results suggest that BLM is responsible for 
centromere deformation when PLK1 activity is compromised.  
 
Moreover, BLM depletion was also shown to significantly reduce the number of 
detectable centromeric RPA foci during metaphase, when compared against control 
cells during BI2536 treatment (Fig. 5.8a). It is also worth noting that despite a depletion 
of BLM, metaphase cells remained positive for PICH protein localisation, demonstrating 
that the depletion of BLM does not disrupt PICH recruitment (Fig. 5.8b).  
 
Together, these data strongly support the idea that BLM participates in centromere 
deformation during PLK1 inactivation. However, additional influences and/or factors, 
including PICH, may also be responsible. 
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Figure 5.7. BLM-helicase promotes centromere deformation during PLK1 inhibition.
a) Experimental outline of RNAi during cell-synchronisation, western blot analysis,
immunofluorescent staining and ctFISH, using RPE1 cells. b) Western blot analysis using
anti-BLM antibody, showing wild-type BLM levels (siCTRL) and depletion (siBLM) after RNAi.
Anti-KU80 was used as a loading control. c) Immunofluorescent images of pre-anaphase
DNA threads (arrows) in RPE1 cells after either siCTRL, or siBLM, during BI2536 treatment.
Antibody staining for DAPI (Grey), PLK1 (Green), RPA (Red) and centromeres (Blue).
Quantification shows the percentage of cells positive for pre-anaphase DNA threads after
RNAi and during PLK1 inhibition using BI2536 (mean ±SD is shown from three independent
experiments). d) Chromosome spread and ctFISH images of centromere dislocations
(arrowheads) in RPE1 cells after either siCTRL, or siBLM during BI2536 treatment. DAPI
(Grey) was used to stain chromosomes, specific PNA FISH probes were used for centromere
(Green) and telomere (Red) detection. Quantification of centromere dislocations after RNAi
and during PLK1 inhibition using BI2536 (overall mean is shown from three independent
experiments; student t-test was used for p-value calculation; n=number of cells analysed;
scale bar 5µm; Tomisin Olukoga completed an experimental replicate of both pre-anaphase
DNA thread and centromere dislocation analysis).
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Figure 5.8. The aberrant loading of RPA at centromeres is dependent on BLM during PLK1
inhibition.
a) Immunofluorescent images of RPA foci (arrowheads) at centromeres of metaphase(-like)
RPE1 cells after RNAi of either siCTRL, or siBLM during BI2536 treatment. Antibody staining
for DAPI (Grey), RPA (Red) and centromeres (Blue). Quantification shows the number of
RPA foci at centromeres after RNAi and during PLK1 inhibition, using BI2536 (overall mean
is shown from three independent experiments; student t-test was used for p-value
calculation; n=number of cells analysed). b) Immunofluorescent images of PICH (white
arrowheads) and BLM (yellow arrowheads) foci at centromeres of metaphase(-like) RPE1
cells after RNAi of either siCTRL, or siBLM during BI2536 treatment. Antibody staining for
DAPI (Grey), BLM (Green), PICH (Red) and centromeres (Blue) (scale bar 5µm).
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5.2.4 PICH acts upstream of BLM during centromere deformation  
 
In order to investigate whether PICH was also responsible for promoting centromere 
deformation during PLK1 inhibition, siRNA targeting of PICH was also performed (Fig. 
5.9a, b). Cells depleted of PICH showed an almost complete absence of pre-anaphase 
DNA thread formation following BI2536 treatment (Fig. 5.9c), whilst the frequency of 
centromere dislocations were also significantly reduced (Fig. 5.9d).  
 
In addition, similar to results observed after the depletion of BLM, PICH depletion also 
led to a significant reduction in the number of RPA foci at the centromere of metaphase 
cells (Fig. 5.10a). This initially implied that along with BLM recruitment, PICH may also 
be responsible for the formation of RPA at the centromere. However, following the 
depletion of PICH, BLM became virtually undetectable at the centromeres of metaphase 
cells (Fig. 5.10b). Therefore, it is likely that PICH acts upstream of BLM, and in its 
absence, BLM can no longer bind to centromeres during PLK1 inhibition.  
 
These data strongly imply that PLK1 kinase functions to suppress centromere 
deformation, by preventing the untimely recruitment and/or activity of mitotic BLM, 
and/or PICH.  
 
5.2.5 PLK1 activity protects against PICH/BLM-dependent metaphase collapse 
 
Since PICH and BLM were identified as key drivers for centromere deformation during 
PLK1 inhibition, it was predicted that their depletion may suppress metaphase collapse, 
even in the absence of PLK1 activity. Therefore, to test this theory, live-cell time lapse 
microscopy was performed to assess the total duration of metaphase stage in RPE1 cells, 
depleted of either PICH or BLM by RNAi, during treatment with BI2536 (Fig. 5.11a).  
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Figure 5.9. PICH promotes centromere deformation during PLK1 inhibition.
a) Experimental outline of RNAi during cell-synchronisation, western blot analysis,
immunofluorescent staining and ctFISH, using RPE1 cells. b) Western blot analysis using
anti-PICH antibody showing wild-type PICH levels (siCTRL) and depletion (siPICH) after RNAi.
Anti-KU80 was used as a loading control. c) Immunofluorescent images of pre-anaphase
DNA threads (arrows) in RPE1 cells after either siCTRL, or siPICH during BI2536 treatment.
Antibody staining for DAPI (Grey), PLK1 (Green), RPA (Red) and centromeres (Blue).
Quantification shows the percentage of cells positive for pre-anaphase DNA threads after
RNAi and during PLK1 inhibition using BI2536 (mean ±SD is shown from three independent
experiments). d) Chromosome spread and ctFISH images of centromere dislocations
(arrowheads) in RPE1 cells after either siCTRL, or siPICH during BI2536 treatment. DAPI
(Grey) was used to stain chromosomes, specific PNA FISH probes were used for centromere
(Green) and telomere (Red) detection. Quantification of centromere dislocations after RNAi
and during PLK1 inhibition using BI2536 (overall mean is shown from three independent
experiments; student t-test was used for p-value calculation; n=number of cells analysed;
scale bar 5µm; Tomisin Olukoga completed an experimental replicate of both pre-anaphase
DNA thread and centromere dislocation analysis).
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Figure 5.10. PICH functions upstream of BLM during centromere deformation when PLK1
is absent.
a) Immunofluorescent images of RPA foci (arrowheads) at centromeres of metaphase(-like)
RPE1 cells after RNAi of either siCTRL, or siPICH during BI2536 treatment. Antibody staining
for DAPI (Grey), RPA (Red) and centromeres (Blue). Quantification shows the number of
RPA foci at centromeres after RNAi and during PLK1 inhibition, using BI2536. b)
Immunofluorescent images of BLM foci (arrowheads) at centromeres of metaphase(-like)
RPE1 cells after RNAi of either siCTRL, or siPICH, and BI2536 treatment. Antibody staining
for DAPI (Grey), BLM (Green) and centromeres (Blue) (overall mean is shown from three
independent experiments; student t-test was used for p-value calculation; n=number of
cells analysed; scale bar 5µm).
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Results showed that metaphase durations were extended in both PICH and BLM 
depleted cells treated with BI2536, when compared against control cells (Fig. 5.11b, c). 
This supports the suggestion that centromeres are capable of counteracting MT-spindle 
pulling forces when PICH or BLM are absent, even if PLK1 activity is compromised.  
 
To further confirm the RNAi results, a knockout BLM cell line (HAP1 BLM) was also 
investigated for centromere deformation phenotypes, during PLK1 inhibition 
(Hengeveld et al. 2015). Western blot analysis confirmed the absence of BLM protein 
expression in BLM cells, when compared against the parental cells (HAP1) (Fig. 5.12a, 
b).  
 
To investigate centromere deformation phenotypes, cell synchronisation by thymidine 
block and release were performed as before, and cells were then subject to BI2536 
treatment. The parental HAP1 cells showed pre-anaphase DNA thread formation during 
BI2536 treatment, albeit at a lower frequency (25-30%) when compared to RPE1 cells 
(50-70%) (Fig. 5.12c; compared with Fig. 3.5b). This variation is consistent with the 
variation seen in HCT116 and 82-6 hTERT cells (see previous Fig. 3.7c), and may reflect 
a different dependency of PLK1 activity between various cell types. 
 
In contrast, BLM cells showed no signs of pre-anaphase DNA thread formation, 
following the analysis of mitotic cells during BI2536 treatment (Fig. 5.12c), supporting 
the BLM depletion results. Additionally, centromere dislocations were almost 
completely absent in the BLM cells, whilst the parental HAP1 cells showed a significant 
number of centromere dislocations per spread analysed (Fig. 5.12d). The BLM cells 
also showed low levels of centromeric and arm breakage, along with the formation of 
dicentric chromosomes (Fig. 5.12d); reflecting the unstable nature of the cell line. 
Overall, these results further support the hypothesis that BLM is responsible for driving 
centromere deformation during mitosis, when PLK1 activity is absent. 
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Figure 5.11. Both PICH & BLM promote metaphase collapse during PLK1 inhibition.
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Quantification of the overall duration of metaphase(-like) alignment after indicated RNAi
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Figure 5.12. BLM promotes centromere deformation during PLK1 inhibition.
a) Experimental outline of cell-synchronisation, western blot analysis, immunofluorescent
staining and ctFISH, using HAP1 (wild-type) and knockout BLM (DBLM) cells. b) Western
blot image using anti-BLM antibody showing wild-type BLM levels (HAP1) and absence of
BLM detection (DBLM) in knockout cells. Anti-KU80 was used as a loading control. c)
Immunofluorescent images of pre-anaphase DNA threads (arrows) in HAP1 and DBLM cells
after BI2536 treatment. Antibody staining for DAPI (Grey), PICH (Green), RPA (Red) and
centromeres (Blue). Quantification shows the percentage of cells positive for pre-anaphase
DNA threads after PLK1 inhibition using BI2536 (mean ±SD is shown from three
independent experiments). d) Chromosome spread and ctFISH images of centromere
dislocations (arrowheads) in HAP1 and DBLM cells after BI2536 treatment. Arm breaks (red
arrow) and dicentric chromosomes (white arrows) were detected in DBLM cells. DAPI
(Grey) was used to stain chromosomes, specific PNA FISH probes were used for centromere
(Green) and telomere (Red) detection. Quantification of centromere dislocations after
BI2536 addition (overall mean is shown from three independent experiments; student t-
test was used for p-value calculation; n=number of cells analysed; scale bar 5µm).
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5.2.6 BLM helicase activity actively unwinds centromeric DNA during PLK1 
inhibition 
 
To test if centromere deformation during PLK1 inactivation was due to the catalytic 
activity of BLM, the HAP1 BLM cells were complemented with a GFP-tagged wildtype 
BLM, or a helicase-dead (Q672R) mutant. Initially, protein expression was confirmed in 
both the complemented cell lines using western blot analysis (Fig. 5.13a). In addition, it 
was also shown that following HU treatment, both cell lines displayed recruitment of 
GFP-BLM at sites of replication, colocalising with RPA; a known cellular response marker 
to replicative stress (Fig. 5.13b) (Ouyang et al. 2013).  
 
Next the requirement for BLM helicase activity to induce centromere deformation was 
tested. Each cell line was synchronised as before and examined for their ability to form 
pre-anaphase DNA threads, during BI2536 treatment (Fig. 5.14a). The expression of a 
wild-type copy of BLM (GFP-BLM) in the BLM cells; which did not previously exhibit 
pre-anaphase DNA thread formation, led to the formation of pre-anaphase DNA threads 
following the addition of BI2536 (Fig. 5.14b). However, in contrast, the ectopic 
expression of a helicase inactive BLM mutant (Q672R) did not induce the formation of 
pre-anaphase DNA threads, during BI2536 treatment (Fig. 5.14b). Thus, these results 
strongly suggested that BLM helicase activity is essential for promoting the formation of 
pre-anaphase DNA threads, induced by the inhibition of PLK1.  
 
To further test that BLM helicase activity is required for centromere deformation, 
chromosome spreads were also examined for centromere breakage during BI2536 
treatment. Interestingly, a significant reduction in centromere dislocations was 
observed in the mutant GFP-Q672R cells, when compared to wild-type GFP-BLM cells 
(Fig. 5.14c). Although, it is worth noting, that the mutant GFP-Q672R complemented 
cells continued to show signs of the occasional centromere breakage, characteristic of 
the BLM parental cell line.  
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Figure 5.13. Creation of a BLM-helicase inactive stable cell line.
a) Western blot image using anti-BLM antibody (above), showing BLM expression levels in
HAP1 cells, GFP-BLM and GFP-Q672R cell lines. Anti-KU80 was used as a loading control.
Western blot image using anti-GFP antibody (below), showing GFP expression levels in GFP-
BLM and GFP-Q672R cell lines. Anti-KU80 was used as a loading control b)
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treatment for 16hrs. Enlarged region highlights the co-localisation between GFP-BLM and
RPA in both WT GFP-BLM and helicase inactive GFP-Q672R cell lines. Antibody staining for
GFP (Green) to detect BLM expression, RPA (Red) and centromeres (Blue) (scale bar 5µm).
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Figure 5.14. BLM helicase activity promotes centromere deformation during PLK1
inhibition.
a) Experimental outline of cell-synchronisation, immunofluorescent staining and ctFISH,
using HAP1-DBLM+GFP-BLM (wild-type) and HAP1-DBLM+GFP-Q672R (helicase inactive
mutant) cells. b) Immunofluorescent images of pre-anaphase DNA threads (arrows) in GFP-
BLM and GFP-Q672R cells after BI2536 treatment. Antibody staining for DAPI (Grey), GFP-
BLM (Green), RPA (Red) and centromeres (Blue). Quantification shows the percentage of
cells positive for pre-anaphase DNA threads after PLK1 inhibition using BI2536 (mean ±SD is
shown from three independent experiments). c) Chromosome spread and ctFISH images of
centromere dislocations (arrowheads) in GFP-BLM and GFP-Q672R cells after BI2536
treatment. DAPI (Grey) was used to stain chromosomes, specific PNA FISH probes were
used for centromere (Green) and telomere (Red) detection. Quantification of centromere
dislocations after BI2536 addition (overall mean is shown from three independent
experiments; student t-test was used for p-value calculation; n=number of cells analysed;
scale bar 5µm).
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It was noted that the mutant version of GFP-Q672R protein had lower expression levels, 
when compared against the expression level of the wild-type GFP-BLM protein (see 
previous Fig. 5.13b).  
 
To check that this did not influence the observed result, both cell lines were re-sorted 
using florescence activated cell sorting (FACS). A new population of GFP-BLM cells were 
selected, which displayed expression levels lower than the endogenous BLM protein 
expression levels in the parental HAP1 cells. In parallel, mutant GFP-Q672R cells were 
selected for higher than wild-type GFP-BLM protein expression levels (Fig. 5.15a).  
 
Consistent with the previous results, pre-anaphase DNA threads were shown to be 
absent in the re-sorted BLM helicase mutant cell line GFP-Q672R (High), whilst wild-type 
GFP-BLM (Low) cells continued to show pre-anaphase DNA thread formation after 
BI2536 treatment (Fig. 5.15b). Therefore, it was concluded that the catalytic activity of 
BLM is required in order to promote centromere deformation, when PLK1 activity is 
absent.   
 
It was also noticed that both BLM and GFP-Q672R cells were largely absent in RPA foci 
formation at their centromeres, during PLK1 kinase inhibition. In contrast, the parental 
HAP1 and GFP-BLM cells were positive for RPA at their centromeres, during BI2536 
treatment. The presence of RPA at the centromere supports the idea that BLM helicase 
activity is responsible for the formation of RPA foci at the centromere, due to 
centromeric DNA unwinding, during the inhibition of PLK1.  
 
To test this idea, GFP-BLM and GFP-Q672R cells treated with BI2536 were examined for 
GFP-fluorescent intensity, alongside centromeric RPA-fluorescent intensity, which is 
more abundant after PLK1 kinase inhibition (Fig. 5.16a).  
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Figure 5.15. Low BLM expression is sufficient to promote centromere deformation during
PLK1 inhibition.
a) Western blot image using anti-BLM antibody (above), showing BLM expression levels in
HAP1 cells and BLM expression in GFP-BLM (lower than wild-type) and GFP-Q672R FACS re-
sorted cell lines. Anti-KU80 was used as a loading control. Western blot image using anti-
GFP antibody (below), showing GFP expression levels in GFP-BLM and GFP-Q672R cell lines.
Anti-KU80 was used as a loading control (scale bar 5µm). b) Immunofluorescent images of
pre-anaphase DNA threads (arrows) in GFP-BLM (low expression) and GFP-Q672R (high
expression) cells after BI2536 treatment. Antibody staining for DAPI (Grey), GFP-BLM
(Green), RPA (Red) and centromeres (Blue). Quantification shows the percentage of cells
positive for pre-anaphase DNA threads after PLK1 inhibition using BI2536 (mean ±SD is
shown from three independent; student t-test was used for p-value calculation; n=number
of cells analysed; scale bar 5µm).
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In GFP-Q672R cells there was an overall reduction of GFP-signal intensity at the 
centromere, although this was minor and not significant when compared to the GFP-
BLM cells (Fig. 5.16b). Importantly however, the mutant GFP-Q672R cells showed an 
almost complete absence of RPA signal intensity at centromeres, whereas the GFP-BLM 
cells were largely positive for RPA signals (Fig. 5.16c). Therefore, these results would 
strongly imply that the catalytic activity of BLM, is responsible for the active unwinding 
of centromeric DNA during BI2536 treatment.  
 
It is also worth noting that even the high expressing GFP-signals in the mutant GFP-
Q672R cells showed an absence of RPA signals (Fig. 5.16c) (red triangles to the right-
hand side of X-axis). In contrast, low GFP-signal intensity in GFP-BLM cells remained 
positive for RPA signal (Fig. 5.16c) (green circles to the left-hand side of X-axis). This 
suggests that even a low level of catalytically active BLM is able to trigger RPA formation 
at centromeres, when PLK1 is inhibited.  
 
These findings strongly support the theory that the catalytic activity of BLM is 
responsible for the unwinding of centromeric DNA, during PLK1 inactivation and this 
results in RPA loading at the centromere.  
 
5.2.7 BLM and Topoisomerase III (TOP3A) may act together to promote 
centromere deformation during PLK1 inhibition 
 
While it is clear that BLM’s catalytic activity is responsible for driving centromere 
deformation when PLK1 activity is compromised, additional contributing factors could 
not be ruled out. As a result of this, attempts were made to investigate whether there 
were possible secondary factors involved in pre-anaphase DNA thread formation. The 
obvious candidates to investigate further were other members of the BTR-complex and 
in particular topoisomerase III (TOP3A). BLM is a recognised component of the BTR-
complex, which also includes TOP3A, and both the RecQ-mediated genome instability 
proteins 1 & 2 (RMI1/2) (Mankouri and Hickson 2007; Singh et al. 2008; Xu et al. 2008). 
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Figure 5.16. BLM helicase actively unwinds centromeric DNA during PLK1 inhibition.
a) Immunofluorescent images of centromeric GFP-tagged BLM detection in GFP-BLM (low
expression) and GFP-Q672R (high expression) cells, after BI2536 treatment. Antibody
staining for DAPI (Grey), GFP-BLM (Green), RPA (Red) and centromeres (Blue). Centromeric
RPA (arrowheads) is only detected in GFP-BLM cells. b) Bar charts show the average
centromeric GFP foci intensity (left) and the average centromeric RPA foci intensity (right)
in GFP-BLM (low expression) and GFP-Q672R (high expression) cells, after BI2536
treatment (mean ±SD is shown from three independent; student t-test was used for p-
value calculation; n=number of cells analysed; scale bar 5µm. c) Scatter plot of individual
centromeric GFP signal, compared against centromeric RPA signal from GFP-BLM (low
expression) and GFP-Q672R (high expression) cells, after BI2536 treatment (n=number of
centromeric GFP foci counted).
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Topoisomerases are known to process DNA, whilst acting to resolve DNA topological 
states during DNA replication and repair. They achieve this via the catalysis of transient 
breaks and re-joining of DNA molecules and are categorised depending on their ability 
to create either a single-strand (type I), or double strand (type II) DNA break (Nitiss 
2009). Topoisomerase III (TOP3A) is a type IA topoisomerase, and is consequently 
understood to be able to functionally catalyse the formation and re-ligation of ssDNA 
breaks (Wang 2002).  
 
As TOP3A is recognised to form a complex with BLM, it was speculated that during PLK1 
inactivation, TOP3A may be required for BLM to actively unwind centromeric DNA. Since 
BLM and TOP3A work together (Hu 2002; Wu et al. 2000), loss of one may disrupt the 
others molecular action. However, it has also been reported that TOP3A-RMI1 may have 
a BLM (Sgs1) independent role, during the resolution of DNA recombination (Kaur et al. 
2015). Therefore, the absence of TOP3A, using RNAi, was investigated for its ability to 
promote centromere deformation during BI2536 treatment.  
 
The depletion of TOP3A was confirmed by western blot and RPE1 cells were then 
synchronised as before, prior to examining centromere deformation phenotypes (Fig. 
5.17a, b). Similar to earlier experiments where BLM or PICH protein had been depleted, 
the depletion of TOP3A also led to the absence of pre-anaphase DNA thread formation 
during BI2536 treatment. As expected, control cells remained positive for pre-anaphase 
DNA thread formation, following the addition of BI2536 (Fig. 5.17c). These results 
implied that TOP3A may functionally support centromere deformation when PLK1 
activity is absent.  
 
Analysis of centromeric TOP3A focal formation, showed that TOP3A was readily 
detectable at centromeres in control cells treated with BI2536 (siCTRL). In contrast, 
following TOP3A depletion and BI2536 treatment (siTOP3), TOP3A signals were shown 
to be significantly reduced (Fig. 5.18a). In addition, centromeric RPA signals were also 
examined, following TOP3A depletion and BI2536 treatment. As expected, control cells 
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Figure 5.17. TOP3A promotes centromere deformation during PLK1 inhibition.
a) Experimental outline of RNAi during cell-synchronisation, western blot analysis and
immunofluorescent staining, using RPE1 cells. b) Western blot image using anti-TOP3A
antibody shows wild-type TOP3A levels (siCTRL) and depletion (siTOP3A) after RNAi. Anti-
beta actin was used as a loading control. c) Immunofluorescent images of pre-anaphase
DNA threads (arrows) in RPE1 cells after either siCTRL, or siTOP3A during BI2536 treatment.
Antibody staining for DAPI (Grey), TOP3A (Green), RPA (Red) and centromeres (Blue).
Quantification shows the percentage of cells positive for pre-anaphase DNA threads after
RNAi and during PLK1 inhibition using BI2536 (mean ±SD is shown from three independent
experiments; student t-test was used for p-value calculation; n=number of cells analysed;
scale bar 5µm).
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showed an abundance of RPA signals at the centromeres of metaphase cells treated 
with BI2536, whereas, following TOP3A depletion, this was largely abolished (Fig. 
5.18b).  
 
Therefore, the loss of RPA at the centromeres during BI2536 treatment and TOP3A 
depletion, resembled the effects of earlier BLM or PICH depletion experiments. Thus, it 
was initially suspected that TOP3A may functionally regulate centromere deformation 
during PLK1 inactivation. However, following the examination of the recruitment of BLM 
to centromeres during BI2536 treatment and TOP3A depletion, it then became clear 
that an absence of TOP3A leads to the loss of BLM recruitment to the centromere (Fig. 
5.18c). Therefore, TOP3A depletion most likely indirectly rescues the formation of pre-
anaphase DNA threads during PLK1 kinase inhibition. The loss of TOP3A may lead to a 
destabilising effect on the BTR-complex as a whole. Thus, it is suggested that in the 
absence of a complete BTR-complex, BLM is no longer capable of recruiting to the 
centromere, and aberrant DNA unwinding is lost, during the inactivation of PLK1.  
 
The depletion of BLM using RNAi, also led to a significant reduction in detectable TOP3A 
foci number at centromeres of metaphase cells, during BI2536 treatment (Fig. 5.18d). 
These results support the suggestion that the BTR complex probably requires the 
presence of both BLM and TOP3A, in order to correctly function. However, further 
investigation is required to confirm this idea, as it cannot be ruled out that TOP3A plays 
a functional role in pre-anaphase DNA thread formation, during PLK1 inactivation. In the 
future it would be interesting to examine whether a catalytically inactive version of 
TOP3A, may prevent centromere deformation during PLK1 inactivation. 
 
5.2.8 PICH activity promotes centromere deformation when PLK1 activity is 
absent 
 
PICH has been shown to interact with BLM (Ke et al. 2011) and this study has also found 
that PICH is required for BLM to target to centromeres, in particular during PLK1 
a b
c d
Figure 5.18. BLM requires its partner protein TOP3A for centromere recruitment.
a) Immunofluorescent images of TOP3A foci (yellow arrowheads) at centromeres of
metaphase(-like) RPE1 cells after RNAi showing either siCTRL, or siTOP3A during BI2536
treatment. Antibody staining for DAPI (Grey), TOP3A (Green) and centromeres (Blue).
Quantification shows the number of TOP3A foci at centromeres after RNAi and during PLK1
inhibition, using BI2536. b) Immunofluorescent images of RPA foci (white arrowheads) at
centromeres of metaphase(-like) RPE1 cells after RNAi showing either siCTRL, or siTOP3A
during BI2536 treatment. Antibody staining for DAPI (Grey), RPA (Red) and centromeres
(Blue). Quantification shows the number of RPA foci at centromeres after RNAi and during
PLK1 inhibition, using BI2536. c) Immunofluorescent images of BLM foci (red arrowheads)
at centromeres of metaphase(-like) RPE1 cells after RNAi showing either siCTRL, or siTOP3A
during BI2536 treatment. Antibody staining for DAPI (Grey), BLM (Green) and centromeres
(Blue). Quantification shows the number of BLM foci at centromeres after RNAi and during
PLK1 inhibition, using BI2536. d) Immunofluorescent images of TOP3A foci (arrowheads) at
centromeres of metaphase(-like) RPE1 cells after RNAi showing either siCTRL, or siBLM
during BI2536 treatment. Antibody staining for DAPI (Grey), TOP3A (Green) and
centromeres (Blue). Quantification shows the number of TOP3A foci at centromeres after
RNAi and during PLK1 inhibition, using BI2536 (overall mean is shown from three
independent experiments; student t-test was used for p-value calculation; n=number of
cells analysed; scale bar 5µm).
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inactivation. However, it remains unclear whether this is through a direct recruitment, 
or alternatively, if it requires the catalytic activity of PICH. Therefore, PICH translocase 
mutant cells (K128A) were examined for their ability to promote pre-anaphase DNA 
threads during BI2536 treatment.  
 
In order to achieve this, two stable cell lines were created which harboured ectopic 
copies of the PICH gene. The ectopic PICH cDNA was modified so that it assumed 
resistance to a PICH siRNA oligo, and therefore no longer responded to RNAi (Fig. 5.19a). 
Individually, each cell line stably expressed either an RNAi resistant copy of a wild-type 
GFP-PICH gene, or a translocase mutant version of PICH, GFP-K128A. Subsequently, it 
was possible to deplete endogenous PICH by using a specific PICH siRNA oligo and then 
examine the cellular effects of PICH translocase activity, during PLK1 inactivation.  
 
To achieve an effective depletion of endogenous PICH, two rounds of RNAi were 
performed over a period of nearly 72 hours, whilst cells were also arrested and released 
using thymidine as before (Fig. 5.19b). Western blot analysis showed that the PICH 
siRNA oligo was able to effectively deplete endogenous PICH levels in each of the 
HCT116 cell-lines; and most importantly, this included the mutant cell lines. Crucially, 
both individual clones of GFP-PICH and GFP-K128A were shown to express an extra copy 
of PICH, which displayed at a higher molecular weight due to GFP-tagging, and most 
importantly, this extra copy of PICH was largely refractory to the effects of PICH siRNA 
targeting (Fig. 5.19c). Therefore, these cells were then used to test whether PICH 
translocase activity was necessary to promote centromere deformation, during PLK1 
inhibition using BI2536.  
 
Following cell synchronisation, both wild-type HCT116 cells and the modified GFP-PICH 
cell lines were released into the presence of BI2536 and fixed in order to analyse the 
frequency of pre-anaphase DNA thread formation. Two individual clones of each RNAi 
resistant wild-type (PICH-A1 & -D1) and translocase inactive (K128A-D1 & -I1) cell lines 
were examined against the parental cells (HCT116), during BI2536 treatment.  
PICH
GFP-PICH
Ku80
PICH-A1 PICH-D1 K128A-D1 K128A-I1HCT116
BI2536
siRNA-PICH + + + + +- - - - -
a
b
c
+Thymidine+1st RNAi-PICH
(53 hours) (18 hours)
G1 
phase
arrest (6 hours)
Release +BI2536
[60nm]
(2-3 hours)
+2nd RNAi-PICH
siCTRl
siPICH
Western blot
IF
Figure 5.19. Creating PICH-translocase inactive RNAi resistant stable cell lines.
a) A diagram to highlight the specific nucleotide changes to the ectopic PICH expression
plasmid, which rendered the stably expressing ectopic PICH resistant to a specific PICH
siRNA oligo sequence. Two stable cell lines were created with siRNA resistance in HCT116
cells. First, a wild-type GFP-PICH and secondly, a translocase inactive mutant, GFP-K128A.
b) Experimental outline of siRNA oligo targeting of endogenous PICH during cell-
synchronisation before western blot analysis and immunofluorescent staining, using
HCT116 cells. c) Western blot image using anti-PICH antibody, showing both endogenous
PICH and ectopic PICH expression levels, before and after RNAi. Two clones of each stable
cell line are included (GFP-PICH clones – A1 and D1; GFP-K128A – D1 and I1). Anti-KU80 was
used as a loading control.
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As expected, following BI2536 treatment, control HCT116 cells (siRNA CTRL) displayed 
the formation of pre-anaphase DNA threads. Importantly however, following the 
depletion of PICH, HCT116 cells were absent of pre-anaphase DNA thread formation 
(Fig. 5.20a, b). This demonstrates that PICH depletion in HCT116 cells was sufficient to 
prevent pre-anaphase DNA thread formation, consistent with previous results in RPE1 
hTERT cells.  
 
Cells stably expressing an ectopic GFP-PICH wildtype protein (clones A1 & D1), were also 
shown to be capable of forming pre-anaphase DNA threads during BI2536 treatment, 
when subject to either control siRNA oligo transfection or depletion of endogenous PICH 
(Fig. 5.20a, b). These results demonstrated that the wildtype GFP-tagged PICH protein 
was active. The HCT116 translocase-dead mutant cells (GFP-K128A) (clones D1 & I1) 
remained positive for the formation of pre-anaphase DNA threads, during control siRNA 
conditions and BI2536 treatment (Fig. 5.20a, b). However, following the depletion of 
endogenous PICH, both the translocase-dead mutant GFP-K128A clones (D1 & I1) failed 
to induce pre-anaphase DNA threads, during BI2536 treatment (Fig. 5.20b). Therefore, 
these results imply that in addition to BLM helicase activity, PICH-translocase activity is 
also required for driving centromere deformation, when PLK1 activity becomes 
compromised. It remains to be seen whether BLM recruitment to centromeres is 
affected during the inactivation of PICH translocase activity and BI2536 treatment. 
However, this would be a subject for future investigation. 
 
It remains unclear exactly how centromeric integrity is affected. PLK1 may directly 
regulate PICH and/or BLM via protein phosphorylation. In agreement with others, PLK1 
was found to contribute to the phosphorylation of both BLM and PICH during a mitotic 
arrest (Fig. 5.21a, b) (Baumann et al. 2007; Dutertre et al. 2000, 2002; Lera et al. 2016). 
As in vitro experiments have shown that PLK1 activity has no influence on the catalytic 
activity of PICH (Kaulich et al. 2012), BLM was considered a more promising candidate 
for further investigation.  
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Figure 5.20. PICH translocase activity promotes centromere deformation during PLK1
inhibition.
a) Immunofluorescent images of pre-anaphase DNA threads (arrows) in HCT116, GFP-PICH
(clones A1 & D1) and GFP-K128A (clones D1 & I1) cells, after either siCTRL, or siRNA
targeting of endogenous PICH during BI2536 treatment. Antibody staining for DAPI (Grey),
GFP-PICH (Green), RPA (Red) and centromeres (Blue). b) Quantification of the percentage
of cells positive for pre-anaphase DNA threads after either siCTRL, or siRNA targeting of
endogenous PICH, during BI2536 treatment (mean ±SD is shown from three independent
experiments; student t-test was used for p-value calculation; n=number of cells analysed;
scale bar 5µm).
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BLM has been shown to be detectable at UFB DNA during anaphase (Chan et al. 2007). 
Therefore, it was speculated that PLK1 activity may prevent the recruitment of BLM to 
DNA, prior to anaphase onset. PICH, BLM and RPA are readily detectable at anaphase 
UFBs induced by the addition of the topoisomerase II (TOP2) inhibitor; ICRF-193 (Fig. 
5.22a, b). This was compared to the depletion of SGO1 via RNAi, where centromeric 
cohesin becomes prematurely lost. This occurs prior to anaphase onset and leads to the 
premature separation of sister-chromatids. Under these conditions premature c-UFBs 
that are decorated with PICH protein are formed (Fig. 5.22a). However, consistent with 
previous findings, both BLM and RPA were largely undetectable at these premature 
forming c-UFBs, despite the existence of PICH (Fig. 5.22a, c, d) (Chan et al. 2007). 
Therefore, mitotic hyperphosphorylation of BLM may prevent BLM chromatin 
association and/or possibly its activity, prior to anaphase. Hence, PLK1-dependent 
phosphorylation of BLM may temporarily restrict the recruitment of BLM to chromatin 
during early mitosis. Loss of PLK1 activity allows BLM to bind to chromatin prematurely 
during mitosis and subsequently promote centromere deformation.  
 
In agreement to this idea, SGO1 depletion also showed that BLM and RPA associated to 
premature c-UFBs following a 30-minute treatment with the PLK1 inhibitor, BI2536 (Fig. 
5.22a, c, d). This implies that PLK1 activity suppresses BLM recruitment to chromatin 
prior to anaphase onset and supports the theory that PLK1 regulates the spatiotemporal 
chromatin association of BLM during mitosis. 
 
 
 
 
 
 
 
ab c d
Figure 5.22. BLM recruitment to mitotic chromatin may be regulated by phosphorylation.
a) Immunofluorescent images of an anaphase cell after ICRF-193 treatment (left), positive
for anaphase UFBs. A mitotic cell after SGO1 depletion using RNAi, undergoing premature
sister-chromatid separation (middle), positive for PICH-associated UFBs (arrows), but
absent of BLM. High exposure image also included (below). Finally, a mitotic cell after both
SGO1 depletion and BI2536 treatment (right), showing both PICH and BLM positive UFB
association. Antibody staining for DAPI (Grey), BLM (Green), PICH (Red) and centromeres
(Blue). b) Quantification of the percentage of cells positive for BLM, or RPA UFBs after ICRF-
193 treatment in RPE1 hTERT cells. c) Quantification of the percentage of cells positive for
BLM pre-anaphase DNA threads, due to premature sister separation after SGO1 depletion.
d) Quantification of the percentage of cells positive for RPA pre-anaphase DNA threads,
due to premature sister separation after SGO1 depletion (mean ±SD is shown from three
independent experiments; student t-test was used for p-value calculation; n=number of
cells analysed; scale bar 5µm).
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5.3 Discussion 
 
The experiments described in this chapter support the theory that PLK1 functions to 
suppress the aberrant recruitment and activity of BLM helicase at the centromere during 
early mitosis. In the absence of PLK1 kinase activity, BLM helicase promotes the 
catastrophic deformation of centromeres. 
 
Centromere deformation initially becomes apparent by the uncharacteristic increase in 
RPA formation at centromeres, in particular during metaphase, when PLK1 activity is 
compromised. The induction of RPA foci at the centromere coincides with an increase 
in BLM protein recruitment to the centromeres. This suggests that BLM actively unwinds 
centromeric DNA, which leads to ssDNA exposure, RPA loading and centromere fragility.  
 
Microtubule spindle pulling forces were shown to exacerbate this centromere fragility. 
Cells absent of PLK1 activity still undergo chromosome biorientation, and therefore 
centromeres must encounter MT-spindle tension. However, the MT-spindle tension also 
helps drive the formation of pre-anaphase DNA threads. Therefore, PLK1 inactivation, 
the UFB-binding complex and MT-spindle pulling forces promote centromere 
deformation, which can eventually culminate in severe centromere damage. This 
centromere specific damage results in the complete separation of chromosome arms, 
appearing as a chromosome break. 
 
In support of the theory that the UFB-binding complex, and in particular PICH and BLM 
promote centromere deformation during PLK1 inactivation, cells undergo extended 
metaphase durations when either BLM or PICH are depleted (Fig. 5.11b, c). Therefore, 
expression of BLM and PICH jeopardises the integrity of centromeric DNA configuration 
during chromosome biorientation, when PLK1 activity is absent and this results in 
centromere deformation.  
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Additionally, the results also predict that PICH is required for more than BLM 
recruitment to centromeres during PLK1 inactivation, as the data also suggest a 
dependency on PICH translocase activity. PICH translocase inactive cells show an 
absence of pre-anaphase DNA thread formation, after PLK1 kinase inhibition. This 
highlights the importance of the catalytic activity of both PICH and BLM in generating 
such centromere destruction when the activity of PLK1 is affected.  
 
PICH and BLM have been shown to be phosphorylated in a PLK1 dependent manner. 
Therefore, in the future, it would be interesting to test whether PLK1-dependent 
phospho-mutant versions of BLM and/or PICH, are capable of re-capitulating the 
phenotypes of centromere deformation, in cells where PLK1 activity remains. 
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Chapter 6: General discussion and future directions 
 
6.1 Summary of key findings 
 
This thesis has reported that the activity of PLK1 in mitosis is essential for the stability 
of chromosome biorientation. Following chromosome biorientation, PLK1 functions to 
protect centromeres against a previously unreported centromere-specific deformation 
scenario. Cells absent of PLK1 activity can undergo bipolar KT-MT attachment and 
chromosome alignment during metaphase. However, chromosome alignment becomes 
compromised due to centromeric DNA unwinding, leading to metaphase collapse. 
Centromeric DNA unwinding is dependent on the catalytic activity of both BLM and 
PICH, which illegitimately unwind centromeric DNA and cause centromere deformation. 
This leads to the formation of pre-anaphase DNA threads, that are also dependent on 
tension generated by microtubules. Furthermore, an absence of PLK1 activity is also 
shown to result in centromere-specific breakage, which is believed to be the culmination 
of pre-anaphase DNA thread breakage. Therefore, PLK1 activity is essential for 
maintaining centromere architecture and protects against the catalytic activity of BLM 
and PICH to support chromosome biorientation during microtubule tension. 
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6.2 General discussion  
 
Overview of centromere deformation caused by the inactivation of PLK1  
PLK1 function is critical to cellular progression and survival. In its absence, cells display 
severe mitotic arrest and alignment defects, which can eventually lead to mitotic 
catastrophe (Lénárt et al. 2007; Steegmaier et al. 2007). Chromosome alignment 
defects, during PLK1 inactivation, have been attributed to errors in kinetochore-
microtubule (KT-MT) attachment. Cells lacking PLK1 activity arrest due to monopolar 
spindle attachment. This has been described as the “polo” phenotype (Lénárt et al. 
2007). Detailed analysis presented in this thesis has revealed an additional reason for 
why PLK1 is so critical for chromosome alignment and faithful mitotic progression.  
 
Instead of attributing the phenotype to KT-MT attachment errors, this study reveals that 
some cells lacking PLK1 activity are able to undergo chromosome congression during 
metaphase. The majority of cells analysed were able to achieve bipolar spindle 
attachment and align their chromosomes during metaphase. However, PLK1 inhibited 
cells do eventually display a metaphase collapse pattern. This collapse pattern can be 
observed as either the previously described “polo” chromosome morphology (Lénárt et 
al. 2007); or alternatively, as the currently reported “figure-of-8” shape collapse. 
Interestingly, cells capable of chromosome alignment, during PLK1 inactivation, 
generally succumb to the “figure-of-8” shape collapse. These cells are believed to 
successfully achieve bipolar KT-MT attachment. Therefore, it is speculated that PLK1 
activity is required for the long-term stability of KT-MT attachment, rather than its initial 
establishment (Fig. 6.1 predicted model, left).  
 
Detailed analysis of PLK1 localisation in the figure-of-8 collapsed cells, showed that the 
PLK1 protein decorated thread-like structures that connected chromatin masses during 
mitosis. The UFB-binding proteins PICH, BLM, TOP3A and the ssDNA binding protein 
RPA, were also identified as recruiting to these thread-like structures. The recruitment 
of RPA strongly suggested that these structures were of DNA in origin. Therefore, as 
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PLK1 inactivation or depletion prevents cells from progressing into anaphase, these 
thread-like structures were termed as pre-anaphase DNA threads. This term was not 
only used to identify them as DNA in composition, but also to help distinguish them from 
the previously identified anaphase UFBs. Although pre-anaphase DNA threads and UFBs 
feature ultra-fine DNA structures and therefore their appearance can be considered 
very similar, they are formed by distinctly different mechanisms. Anaphase UFBs 
originate between sister chromatids and only become apparent during chromosome 
segregation. In contrast, pre-anaphase DNA thread formation is a result of centromeric 
DNA being exposed from intact cohesed chromosomes. Furthermore, pre-anaphase 
DNA thread formation is specific to centromeres, providing the initial link between 
metaphase collapse and centromere deformation during PLK1 inactivation.  
 
The absence of PLK1 activity also led to the aberrant recruitment of BLM to centromeres 
during mitosis. This was linked to BLM-dependent centromeric DNA unwinding and 
centromere deformation. Centromere deformation was further augmented by MT-
pulling forces. This suggests that BLM drives centromere fragility when PLK1 activity is 
compromised and the combined action of BLM-dependent centromeric DNA unwinding 
with MT pulling forces, was responsible for centromere fragility during PLK1 
inactivation. Centromere fragility was shown to culminate in the complete separation 
of whole chromosome arms. This was termed as ‘centromere dislocation’ and highlights 
a centromere-specific breakage pattern that requires PLK1 activity for its suppression. 
Therefore, PLK1 activity functions to suppress a previously unreported centromeric DNA 
deformation pathway and suggests that PLK1 functions as a centromere guardian (Fig. 
6.1 predicted model, right).  
 
Pre-anaphase DNA threads 
One of the most striking cellular features of PLK1 inactivation, is the formation of protein 
bound pre-anaphase DNA threads. These show a strong resemblance to the previously 
identified UFBs, which can arise between sister-chromatids during anaphase (Baumann 
et al. 2007; Chan et al. 2007). The associated proteins, which include PICH, BLM, TOP3A 
Figure 6.1. A model to demonstrate how PLK1 suppresses PICH/BLM-mediated centromere
deformation.
Cells require active PLK1 for mitotic progression. PLK1 functions to promote correct bipolar spindle
attachment and also suppress a newly described centromere deformation pathway. An absence of
PLK1 activity can lead to two possible mitotic outcomes. Left: MT-KT attachment error occurs, which
lead to a “polo” like collapse due to monopolar spindle attachment. Right: cells that maintain bipolar
spindle attachment suffer from an centromere deformation pathway, caused by the aberrant
recruitment of BLM to centromeres. This promotes a metaphase collapse pattern that resembles a
‘figure-of-8’ shape. BLM-helicase actively unwinds the centromeric DNA, resulting in a protein coated
‘pre-anaphase DNA thread’ bound by various proteins, including PLK1, PICH, BLM, TOP3 and RPA.
Eventually, cells undergo ‘centromere dislocation’, which appears as the complete separation of
whole chromosome arms.
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and RPA are also similar. This supports the idea that anaphase UFBs and pre-anaphase 
DNA threads are similar in DNA composition. However, their formation is distinctly 
different from each other.  
 
The initial formation of pre-anaphase DNA threads during PLK1 inactivation, is believed 
to be through the co-action of MT-KT attachment and tension, combined with the 
illegitimate recruitment and catalytic activity of certain UFB binding factors. In 
particular, centromeric DNA is actively unwound by the activity of BLM helicase, 
following MT-KT attachment and PLK1 inactivation. This conclusion is based on the 
observation that strong RPA foci form at centromeres during PLK1 inactivation, but only 
when catalytically active BLM is present. Furthermore, it is predicted that MT-pulling 
forces promote the stretching of centromeric DNA, which could explain how pre-
anaphase DNA threads form during PLK1 inactivation. However, what PLK1 is doing to 
prevent such centromere deformation remains unclear. This discussion will explore 
some of the possible scenarios. 
 
Does PLK1 activity regulate the recruitment of BLM to centromeres? 
Following PLK1 inactivation, the catalytic activity of BLM has been shown to promote 
the recruitment of RPA at centromeres. Therefore, during PLK1 inactivation, the 
catalytic activity of BLM is responsible for centromere deformation. Interestingly, 
although BLM has previously been reported to recruit to centromeres of unperturbed 
cells (Rouzeau et al. 2012), it was not readily detectable during this study. Only after 
PLK1 activity became compromised did BLM become clearly noticeable at centromeres. 
Therefore, PLK1 may function to regulate the spatiotemporal recruitment of BLM to 
centromeres during mitosis, which may explain how PLK1 functions to suppress 
centromere deformation. Thus, in the absence of PLK1 activity, the temporal regulation 
of BLM recruitment to centromeres is absent, leading to premature loading of BLM, 
which promotes centromere deformation.  
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However, whether BLM is recruited to centromeres prior to mitotic entry remains 
ambiguous. The previous study showed BLM localises to centromeres of mitotic cells 
using Bloom’s syndrome (BS) patient derived cells ectopically expressing GFP-BLM, or, 
alternatively, examining endogenous BLM via antibody detection in chromosome 
spreads of HeLa cells (Rouzeau et al. 2012). It could be argued that the ectopic 
expression of GFP-BLM in BS cells may lead to a mis-interpretation of BLM detection at 
centromeres, due to the overexpression of the ectopic construct. Furthermore, antibody 
detection of BLM on chromosome spreads may not be representative of BLM’s 
spatiotemporal recruitment to centromeres of intact fully condensed mitotic 
chromosomes. Therefore, it remains unclear whether BLM is a centromere associated 
protein in unperturbed cellular conditions or whether PLK1 plays a role in regulating the 
recruitment of BLM to centromeres.  
 
Cells may require a small level of BLM at centromeres in order to deal with 
recombination structures that may persist into mitosis. BLM is required for processing 
recombination intermediates that arise during S-phase, and for the dissolution of 
double-Holliday junctions (dHJ) in DSB repair. Therefore, it is conceivable that the 
complex DNA composition at centromeres would require processing by factors such as 
BLM, before chromosome segregation can proceed, as supported by Rouzeau et al. 
(2012).  
 
If BLM is genuinely a centromere associating protein, it would imply that PLK1 does not 
prevent BLM recruitment to centromeres. Instead, PLK1 activity may be required to 
regulate the level of BLM recruitment or retention to centromeres. This is likely via 
protein phosphorylation. Various lines of research, including within this thesis, have 
shown that BLM is hyperphosphorylated following a mitotic arrest (Dutertre et al. 2000, 
2002; Leng et al. 2006). PLK1 contributes to the hyperphosphorylation status of BLM 
during a mitotic arrest (Fig. 5.21a), showing that PLK1 contributes to BLM 
phosphorylation. A quantitative mass spectrometry analysis revealed evidence for a 
direct PLK1-dependent phosphorylation event on BLM at Ser539 (Grosstessner-Hain et 
al. 2011). Therefore, PLK1 may directly regulate BLM activity, or its spatiotemporal 
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localisation through protein phosphorylation. PLK1 has also been shown to directly 
interact with BLM following an MPS-1 dependent phosphorylation event at BLM-Ser144 
and this PLK1-BLM interaction was enhanced following a mitotic arrest using nocodazole 
(Leng et al. 2006).  
 
The hyperphosphorylated form of BLM is considered to represent the early mitotic 
status of BLM (Dutertre et al. 2002). The hyperphosphorylated mitotic BLM is found only 
in a soluble fraction and excluded from the nuclear matrix (Dutertre et al. 2000). 
Although, it remains unknown whether this BLM is active. Therefore, it could be 
speculated that BLM is hyperphosphorylated during early mitosis and this prevents BLM 
from associating with chromatin during this stage. This could explain why BLM was not 
readily detectable at centromeres of unperturbed pre-anaphase stage mitotic cells 
during this study. However, it cannot be ruled out that cells require small levels of BLM 
at the centromere throughout mitosis, in order to deal with sister-chromatid disjunction 
issues (Rouzeau et al. 2012).  
 
Catalytically active BLM is required during anaphase for UFB processing (Baumann et al. 
2007; Chan et al. 2007; Chan et al. 2018). Therefore, it is predicted that early mitotic 
BLM is hyperphosphorylated and this largely prevents BLM from binding to chromatin. 
Following anaphase onset, BLM hyperphosphorylation is lost and BLM is then able to 
recruit to chromatin, in particular centromeres and UFBs.    
 
This potential spatiotemporal coordination of BLM recruitment and activity would 
require tight regulation. Therefore, it is conceivable that PLK1 dependent 
phosphorylation of BLM could function to safeguard against the untimely recruitment 
and activity of mitotic BLM. In support of this idea, BLM has been shown to poorly 
associate to premature PICH bound c-UFBs, which can be induced by a depletion of the 
centromeric cohesin protector, shugoshin (SGO1) (see previous Fig. 5.22) (Baumann et 
al. 2007; Chan et al. 2007).  
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However, it remains unclear whether PLK1-dependent phosphorylation of BLM alters 
the catalytic potential of BLM. It would be of great interest in the future to examine and 
identify the exact PLK1-dependent phosphorylation sites of BLM. The creation and 
experimentation of BLM phospho-mutants may help to reveal greater detail regarding 
PLK1’s potential as a regulator of BLM recruitment and catalytic activity during mitosis.  
 
Does PLK1 regulate the catalytic activity of PICH to promote centromere deformation?  
During PLK1 inactivation, PICH alone was insufficient to drive centromere deformation. 
Instead, the catalytic activity of PICH may be responsible for the initiation of centromere 
deformation. Exactly how this occurs remains unknown. BLM helicase activity has been 
identified as being responsible for the DNA unwinding activity at the centromere, during 
the inactivation of PLK1. However, BLM requires PICH for its subcellular localisation to 
centromeres. Therefore, it is possible that PICH is responsible for initiating the early 
events that promote BLM-dependent DNA unwinding, during PLK1 inactivation.  
 
Inactivation of the catalytic activity of PICH suppressed pre-anaphase DNA thread 
formation, when PLK1 activity was compromised. However, it must be noted that due 
to time constraints, whether the catalytically inactive PICH mutant protein remains 
capable of recruiting BLM to centromeres was not determined. Therefore, although 
catalytically inactive PICH cells no longer display centromere deformation phenotypes 
(pre-anaphase DNA threads), this could be due to an absence of BLM recruitment to 
centromeres. Hence, the most immediate future experiment would be to examine 
whether catalytically inactive PICH mutant cells are able to recruit BLM to centromeres, 
during PLK1 inhibition.   
 
Both the current study and previous reports have identified that PICH is a substrate of 
PLK1 (Fig. 5.21b) (Baumann et al. 2007; Lera et al. 2016). However, a comprehensive in 
vitro report on the regulation of PICH has shown that the inhibition of PLK1, using the 
PLK1 inhibitor ZK-Thiazolidinone (TAL), did not have an inhibitory effect to PICH’s ATPase 
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activity (Kaulich et al. 2012). Therefore, it is probable that PLK1 is not responsible for 
regulating the catalytic activity of PICH.  
 
PICH clearly has an influential role to play in promoting centromere deformation during 
PLK1 inactivation and in its absence, centromere deformation is abolished. It remains 
unclear whether PICH just facilitates the recruitment of BLM to centromeres or whether 
the catalytic activity of PICH directly promotes centromere deformation. If BLM is 
capable of recruiting to centromeres of catalytically inactive PICH mutants, the catalytic 
activity of PICH may lead to the creation of a DNA substrate, which BLM can then act 
upon. Subsequently, this could lead to the initiation of centromere deformation during 
PLK1 inhibition. In support of this idea, it has been reported that PICH has chromatin 
remodelling capabilities (Ke et al. 2011). This may help to explain how pre-anaphase 
DNA threads form.  
 
A surprising feature observed during this study was the apparent disassembly of the 
centromere, as shown by the loss of CENPA (inner centromere) following a metaphase 
collapse. CENPA is a centromere specific histone variant and makes up part of 
centromere located nucleosomes (Earnshaw and Rothfield 1985). CENP-A containing 
nucleosomes remain present throughout the cell cycle. Therefore, it’s apparent absence 
after PLK1 inactivation is unexpected and suggests that the core centromere was being 
dismantled. Thus, pre-anaphase DNA threads may be due to a dechromatinisation of 
centromeric DNA. This could be driven by the activity of PICH, which may also explain 
the progressive absence of CENPA after metaphase collapse during PLK1 inactivation.  
 
Furthermore, it was also possible, although very rare, to observe centromeres that 
maintained intact sister-kinetochore complexes (NUF2). One side remained anchored to 
the core centromere via a short PICH associated DNA thread. This could represent a 
scenario in which the core centromere is being pulled out from beneath the kinetochore 
complex and this may be driven by PICH remodelling the chromatin at this site. PICH has 
previously been implicated in a role that involves histone eviction (Ke et al. 2011), so 
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PICH may function to remodel centromeric chromatin, which could lead to centromere 
fragility in the absence of PLK1 activity. However, this remains as speculation, as the 
catalytic activity of PICH may simply be required for BLM recruitment to centromeres. 
   
Does PLK1 inhibition result in an inappropriate centromeric DNA configuration?  
Another possible explanation of how centromere deformation arises is that PLK1 
inactivation results in changes to centromeric DNA structure or configuration. PLK1 has 
a vast number of substrates.  In particular, PLK1 targets various centromere and 
kinetochore associated factors. Therefore, PLK1-dependent phosphorylation of 
currently unknown factor(s), may enhance centromeric DNA rigidity, thereby protecting 
centromeres from deformation. Thus, during PLK1 inhibition, centromeres may feature 
an intrinsic fragility.   
 
It would be interesting to test which PLK-dependent centromere/kinetochore target(s) 
may affect centromere structure or configuration. However, due to the extensive 
repertoire of targets PLK1 has, identifying which one is responsible for maintaining 
correct centromere configuration is not simple. Furthermore, it may be a combination 
of targets involved. A strong candidate for future investigation would be to examine if 
PLK1 influences centromeric chromatin organisation, through a direct phosphorylation 
of histones.  
 
During this study, a very partial rescue of centromere deformation was observed when 
active PLK1 was directly tethered to chromatin (PLK1-C-H2B). This could imply that PLK1 
activity modulates chromatin arrangement. Therefore, the direct phosphorylation of 
histones may promote chromatin rigidity, particularly at the centromere. However, 
extensive investigation into PLK1-dependent phosphorylation events of histones are 
needed to test this idea. 
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Does an absence of PLK1 activity effect chromosome condensation at centromeres? 
An alternative explanation for how centromeric DNA configuration could become 
incorrectly altered during PLK1 inactivation, may be due to changes in the activity of 
chromosome condensation. PLK1 inactivation prevents cells from progressing into 
anaphase. This results in a prolonged mitotic arrest and the appearance of short hyper-
condensed chromosomes, due to continual condensation of chromosomes by the action 
of condensin complexes. Condensation of mitotic chromosomes ensures correct 
chromosome organisation, beginning at prophase and peaking during metaphase 
(Hirano 2005). However, during prolonged mitotic arrests, such as during PLK1 
inhibition, the continual compaction of chromosomes may negatively affect DNA 
arrangement and promote unwanted changes to DNA configuration, in particular at 
centromeres.   
 
Vertebrates require the action of both condensin I and II for correct chromosome 
assembly during mitosis (Hirano 2005). Depletion of condensin factors results in 
chromosome morphological changes and errors in segregation (Ono et al. 2004). This 
highlights the importance of condensin complexes for cellular homeostasis.  
 
Condensin I has been described to compact sister chromatids laterally (i.e. inwards), 
whilst condensin II supports axial compaction (i.e. shortening of chromosome length) 
(Hirano 2012). Therefore, it is conceivable that the continual compaction of mitotic 
chromosomes during PLK1 inactivation, whether lateral or axial, may cause stress build 
up and tension within the centromeric domain of chromosomes. In particular, excessive 
axial compaction could generate excessive tension due to compression within the 
centromeric region of the chromosomes. This idea can be conceptually recreated by 
twisting a piece of string at each end in opposite directions. Eventually the tension builds 
at the middle part of the string, representative of the centromere. Therefore, PLK1 
inactivation may indirectly promote centromere distortion due to structural changes, 
driven by excessive chromosome condensation. It could also be speculated that PICH 
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detects such DNA configuration changes caused by excessive condensation, particularly 
at centromeres.  
 
The most important experiment to explore this theory would be to examine the effects 
of condensin depletion. The depletion of condensin complexes may help to limit the 
hyper-condensation of mitotic chromosomes during PLK1 inhibition, which may then 
display signs of centromere deformation rescue.  
 
Alternatively, the absence of PLK1 activity may promote inappropriate chromosome 
compaction at the centromere, possibly caused by a lack of PLK1-dependent regulation 
of condensin activity. Chromosome condensation is considered to be regulated by 
protein phosphorylation. CDK1-dependent phosphorylation of condensin II (CAP-D3) 
promotes the early stages of chromosome condensation, whilst additional mitotic 
kinases further influence condensin activity (Abe et al. 2011; Bazile et al. 2010). This 
includes the PLK1-dependent phosphorylation of condensin II, which has been reported 
to regulate both condensin II abundance and activity (CAP-H2) (Kagami et al. 2017). 
Therefore, a disruption to the activity of PLK1 could alter the action of condensin 
complexes.  
 
Additionally, it has also been suggested that condensin II is enriched at the inner 
kinetochore region (Ono et al. 2004). This highlights a possible requirement for 
condensin II activity at centromere regions. Centromere specific CENP-A containing 
nucleosome arrays have been reported to be more condensed than canonical DNA 
arrays (Panchenko et al. 2011), again highlighting the importance of correct 
chromosome condensation, specifically at the centromere. Hence, an absence of PLK1 
activity could affect the levels of chromosome compaction at the centromeres. This 
could promote an intrinsic fragility of the centromere/kinetochore region, especially 
during KT-MT attachment and tension during metaphase.  
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Depletion of condensin has been shown to promote errors in KT-MT attachment, along 
with segregation defects (Hirano 2012). Moreover, condensin has been shown to be 
directly involved in the correct assembly of centromeric DNA (Samoshkin et al. 2009). 
The same study also revealed phenotypes that resemble the cellular outcomes reported 
during this study, when PLK1 is inhibited. Following condensin depletion, metaphase 
alignment becomes disorganised and centromeric regions display signs of stretching, 
which could be rescued by addition of nocodazole. Additionally, CENP-A detection 
becomes diminished following condensin depletion (Samoshkin et al. 2009). Each of 
these observations resemble the findings in the current study, when PLK1 activity has 
been compromised. Therefore, it is possible that the activity of both PLK1 and condensin 
complexes are essential for maintaining the correct centromere organisation during 
mitosis.  
 
The incorrect compaction of centromeric DNA during the depletion of condensin 
complexes or PLK1 inactivation, may therefore promote centromere deformation. This 
could become apparent due to the pulling forces of the mitotic spindle, during KT-MT 
attachment and tension. The incorrect compaction of centromeric DNA could lead to a 
fragility at the centromere, which results in an inability of centromeres to counteract 
spindle pulling forces. This could result in the exposure of centromeric DNA via 
stretching. This stretched DNA may become a target for proteins such as PICH and BLM. 
This could provide an explanation for the reported centromere deformation pathway 
during PLK1 inactivation, but extensive investigation is required to confirm this.  
 
It would be interesting to confirm whether condensin depletion resulted in a similar 
phenotype to the current findings caused by PLK1 inactivation. Additionally, it would 
also be interesting to determine whether condensin depletion during PLK1 inactivation 
was able to rescue centromere deformation.  
 
Overall, this study has revealed a previously unreported centromere deformation 
pathway that is suppressed by the activity of PLK1. Despite identifying the main 
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contributing factors of centromere deformation, notably the catalytic activity of PICH 
and BLM, questions remain unanswered. These include whether PLK1 activity regulates 
the recruitment and/or activity of BLM and/or PICH. Additionally, further research is 
required to explore how centromere configuration may become disorganised during 
PLK1 inactivation. Future investigation would aim at trying to address some of these 
unanswered questions that remain. 
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PLK1 facilitates chromosome biorientation by
suppressing centromere disintegration driven by
BLM-mediated unwinding and spindle pulling
Owen Addis Jones1, Ankana Tiwari1,2, Tomisin Olukoga1,2, Alex Herbert 1 & Kok-Lung Chan 1
Centromeres provide a pivotal function for faithful chromosome segregation. They serve as a
foundation for the assembly of the kinetochore complex and spindle connection, which is
essential for chromosome biorientation. Cells lacking Polo-like kinase 1 (PLK1) activity suffer
severe chromosome alignment defects, which is believed primarily due to unstable
kinetochore-microtubule attachment. Here, we reveal a previously undescribed mechanism
named ‘centromere disintegration’ that drives chromosome misalignment in PLK1-inactivated
cells. We ﬁnd that PLK1 inhibition does not necessarily compromise metaphase establish-
ment, but instead its maintenance. We demonstrate that this is caused by unlawful
unwinding of DNA by BLM helicase at a speciﬁc centromere domain underneath kine-
tochores. Under bipolar spindle pulling, the distorted centromeres are promptly decompacted
into DNA threadlike molecules, leading to centromere rupture and whole-chromosome arm
splitting. Consequently, chromosome alignment collapses. Our study unveils an unexpected
role of PLK1 as a chromosome guardian to maintain centromere integrity for chromosome
biorientation.
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Chromosome mis-segregation has wide implications incancer and rare congenital disorders1. To achieve faithfulchromosome segregation, condensed chromosomes need
to be properly aligned prior to disjunction through a mitotic
process called chromosome biorientation. This requires a stable
connection of spindle microtubules (MTs) emanating from
opposite centrosomes to centromeres via the macromolecular
complex of kinetochores (KTs)2. A single unattached chromo-
some can activate the spindle assembly checkpoint, inhibiting the
anaphase promoting complex/cyclosome (APC/C)3, and hence
blocks anaphase onset4,5. This elegant system allows cells to
correct possible KT-MT attachment errors and prevent chro-
mosome mis-segregation. During chromosome biorientation,
centromeres and KTs are inevitably under constant spindle
pulling tension, due to the persistence of sister chromatid cohe-
sion. The centromere architecture is presumably maintained
through chromosome condensation, whilst the KT-MT stable
attachment requires activity of a key mitotic kinase, Polo-like
kinase 1 (PLK1)6–8. In early mitosis, PLK1 localises pre-
dominantly at KTs and centrosomes. Inactivation of PLK1 has
been shown to induce severe chromosome misalignment, which is
generally attributed to a failure in building stable KT-MT
attachment. However, how PLK1 promotes chromosome bior-
ientation still requires investigation
Once biorientation is achieved on every chromosome, the
spindle checkpoint is satisﬁed. This leads to the activation of
APC/C and cleavage of cohesin, allowing the poleward movement
of sister chromatids9. Interestingly, studies show that despite their
separation, sister chromatids can remain intertwined by DNA
linkage molecules that manifest as so-called ultraﬁne DNA
bridges (UFBs)10,11. Generally, UFBs are thought to be unre-
solved double-stranded DNA catenanes, especially those that
arise at centromeres12. However, studies have also shown that
incomplete replication intermediates and homologous recombi-
nation (HR) structures can give rise to UFB structures13–16.
Regardless of their origins, UFBs are recognised by a UFB-
binding complex comprising of PICH (Plk1-interacting check-
point helicase) translocase, BLM (Bloom’s syndrome) helicase
and its interacting factors, including TOP3A and TOP210,11,17–19.
However, the precise molecular mechanism of UFB resolution is
not yet fully understood
Chromosome biorientation not only plays a critical role to
ensure equal chromosome segregation, but also facilitates the
regulation of the spindle checkpoint and mitotic progression.
Many studies have shown that PLK1 is essential for chromosome
biorientation; however, the underlying mechanism(s) is still not
fully clear. In the current study, unexpectedly, we ﬁnd that PLK1
in fact can protect centromere integrity for chromosome bior-
ientation maintenance. We demonstrate that in the absence of
PLK1, the UFB-binding complex aberrantly targets and unwinds
centromeres, leading to their rupture in concerted action with
bipolar spindle pulling. As a consequence, cells lose centromere
integrity and fail to maintain metaphase alignment. Therefore,
our study provides an alternative mechanism of chromosome
misalignment in PLK1-defective cells. Importantly, it also reveals
a previously undescribed pathway of centromere protection
during mitosis
Results
PLK1 inactivation leads to collapse of metaphase alignment. It
is well-documented that cells cannot achieve proper chromosome
alignment without PLK1 activity6. Consistent with this, inhibition
of PLK1 using a well-characterised small molecule inhibitor,
BI2536 (IC50= 0.83 nM)20, induced severe chromosome mis-
alignment in hTERT-immortalised human RPE1 cells. The
BI2536-induced mitotic arrest manifested in a way similar to
treatments of the spindle poison (nocodazole) and kinesin inhi-
bitor (Monastrol) (Supplementary Fig. 1a). However, live-cell
time-lapse microscopy on pre-synchronised RPE1 cells revealed
that, unlike nocodazole and monastrol treatments, BI2536 did not
fully prevent chromosome congression (Fig. 1a and Supplemen-
tary Fig. 1b). Nearly 80% of BI2536-treated RPE1 cells managed
to align their chromosomes in the metaphase plane, but shortly
after, succumbed to a loss of maintenance; namely chromosomes
drifting away from the equator and scattering into a ‘Fig-8’ or
‘polo’21-like pattern (Fig. 1a–c, Supplementary Fig. 1c and Sup-
plementary Movie 1). We referred to this phenomenon as
‘metaphase collapse’. In contrast, cells treated with the APC/C
inhibitor, ProTAME, remained arrested at metaphase for exten-
ded periods (Fig. 1c)
Formation of centromeric DNA linkages between chromo-
somes. Strikingly, in the metaphase-collapse cell population, we
observed a threadlike structure that was decorated by the PLK1
protein (Fig. 2a; arrows). It was not present in DMSO-treated
pre-anaphase cells (i.e., prometaphase and metaphase) (Fig. 2a).
As the threadlike structure was reminiscent of anaphase
UFBs10,11, we investigated whether they were DNA molecules; or
a mis-localisation of PLK1 to cytoskeleton structures. Immuno-
ﬂuorescence co-staining showed that PICH translocase, a well-
known UFB marker, was present along the PLK1-coated threads
induced by BI2536 (Fig. 2b and Supplementary Fig. 1d). Fur-
thermore, other known UFB-associated factors including BLM
helicase and replication protein A (RPA) were also present
(Fig. 2c). It is worth noting that RPA decorates the threads
without necessarily following the PICH/BLM signals, and it can
also be found on regions where no or weak PICH/BLM signals
were detected (Fig. 2c; arrows). Similar results were obtained by
using different antibodies against BLM and different subunits of
RPA (Fig. 2d). This localisation pattern is similar to recent reports
showing the binding of RPA to stretched DNA molecules, or
DNA bridges, is not always coupled with the PICH/BLM
complex12,22. Therefore, the RPA association likely represents the
presence of single-stranded DNA. To validate the immuno-
ﬂuorescence staining results, we examined Bloom’s syndrome
ﬁbroblast cells stably expressing a GFP-tagged BLM, and
RPE1 cells expressing a GFP-tagged PLK1. We found both GFP-
tagged proteins were also present along the thread molecules
induced by BI2536 (Supplementary Fig. 1e, f; arrows). In addition
to this, we also found that PLK1 indeed associated with UFBs in
anaphase cells (Supplementary Fig. 1g; arrows). Together, these
data suggest that the BI2536-induced thread molecules are highly
likely a form of DNA structure; and possibly composed of both
single-stranded and double-stranded DNA. As predicted, the
threadlike structures did not co-localise with mitotic MTs (Sup-
plementary Fig. 1h)
Next, we investigated the origin of the DNA threads. We found
that all of the DNA threads analysed linked to centromeric
regions, either through one or both of their termini (Fig. 2e). In
some optical sections, it was apparent that two separating
centromeres were inter-connected by a DNA thread (Fig. 2e;
arrows). Since PLK1 inhibition prevents anaphase onset, these
DNA threads cannot be explained as the centromeric UFBs
coming from disjoined sister chromatids. However, another
possibility is that PLK1 inhibition might induce precocious sister
chromatids separation; an effect similar to Shugosin 1 (SGO1)
depletion23,24 (Supplementary Fig. 2a), which exposes UFBs
before anaphase11 (Supplementary Fig. 2b; arrows). This
proposal, however, is very unlikely because PLK1 has been
shown to be required for the release of arm cohesin; its
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inactivation in fact blocks premature loss of cohesion25–27.
Consistent with these studies, we conﬁrmed that BI2536 did not
induce premature separation of sister chromatids in RPE1 cells
(Supplementary Fig. 2c). More importantly, by co-staining with
topoisomerase 2alpha (TOP2A), a chromatid-axis marker, we
visualised that cohesed chromosomes were linked by the DNA
threads, induced by PLK1 inhibition (Fig. 2f; arrows). Therefore,
the absence of PLK1 activity leads to the formation of a DNA
linkage structure that strikingly connects centromeres between
cohesed chromosomes. Because of the concomitant occurrence of
metaphase collapse and centromere DNA linkages, we speculate
that the failure of chromosome alignment in PLK1-inactivated
cells may not be merely attributed to unstable KT-MT
attachments as previously thought.
Mitotic loss of PLK1 causes centromeric DNA linkages. The
DNA linkages induced by BI2536 arise predominantly at cen-
tromeres—a genomic region composed of highly repetitive
sequences. We sought to test if they might be caused by potential
disturbance of DNA replication (or HR) during the course of
BI2536 treatment. We used EdU labelling to distinguish between
cells that were in an ongoing, or post DNA replication stage, whilst
under BI2536 treatment (Supplementary Fig. 3a). If centromere
DNA threads are a by-product of abnormal DNA replication, we
expected to observe their formation only in the EdU-positive, but
not negative, mitotic population. Contrary to this hypothesis, we
found that the majority of EdU-negative mitotic cells (69 ± 4%),
which were presumably in G2/M while BI2536 was applied,
remained positive for DNA thread formation (Supplementary
0%
Un
tre
ate
d
Bl2
53
6
Pro
TA
ME
No
co
da
zo
le
Mo
na
str
ol
20%
40%
60%
80%
100%
%
 P
ro
ph
as
e 
ce
lls
Establish metaphase(-like) stage
Progress into anaphase
Un
tre
at
ed
N
oc
od
az
ol
e 
(50
 
n
g/
m
l)
M
on
as
tro
l (1
00
 
μM
)
BI
25
36
 
(60
 
n
M
)
Pr
oT
AM
E 
(12
 μM
)
0′
0:00 1:00 2:00 3:00 4:00 5:00 6:00 7:00
1
5
9
13
17
21
Ce
ll i
de
nt
ity Metaphase
duration
0:00 1:00 2:00 3:00 4:00 5:00 6:00 7:00
1
4
7
10
13
16
Ce
ll i
de
nt
ity
Metaphase-like
duration
Collapse
a b
c Untreated
+BI2536
+ ProTAME
5′ 10′ 15′ 20′ 25′
30′ 35′ 40′ 45′ 50′ 55′
60′ 65′ 70′ 75′ 80′ 85′
0′ 5′ 10′ 15′ 20′ 25′ 30′
35′ 40′ 45′ 50′ 55′ 60′ 65′
70′ 75′ 80′ 85′ 90′ 95′ 100′
105′ 110′ 115′ 120′ 125′ 130′ 135′
0′ 5′ 10′ 15′ 20′ 25′ 30′
35′ 40′ 45′ 50′ 55′ 60′ 65′
70′ 75′ 80′ 85′ 90′ 95′ 100′
105′ 110′ 115′ 120′ 125′ 130′ 135′
0′ 5′ 10′ 15′ 20′ 25′ 30′
35′ 40′ 45′ 50′ 55′ 60′ 65′
70′ 75′ 80′ 85′ 90′ 95′ 100′
105′ 110′ 115′ 120′ 125′ 130′ 135′
0′ 5′ 10′ 15′ 20′ 25′ 30′
35′ 40′ 45′ 50′ 55′ 60′ 65′
70′ 75′ 80′ 85′ 90′ 95′ 100′
105′ 110′ 115′ 120′ 125′ 130′ 135′
0:00 1:00 2:00 3:00 4:00 5:00 6:00 7:00
1
5
9
13
17
Live-cell imaging starts at 8 h
post G1/S release (hh:mm)
Ce
ll i
de
nt
ity
Metaphase-like
duration
Collapse
+Thymidine
(18 h)
t = 5 h
G1/S release
RPE1
t = 8 ht = 0 h
Live-cell imaging
+Inhibitors
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Fig. 3b). Moreover, inhibition of PLK1 in early mitotic RPE1 cells
obtained through a release from RO3306-induced G2 arrest also
induced centromere DNA threads (Supplementary Fig. 3c). In
addition, treating asynchronous RPE1 cells with BI2536 for 1 h
also caused centromere DNA thread formation, albeit with a lower
frequency (Supplementary Fig. 3d). These data indicate that the
formation of centromere DNA linkages likely results from a loss of
M-phase speciﬁc function of PLK1. However, thymidine pre-
treatment and/or synchronistic mitotic entry may enhance the
phenotype appearance
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Using the same treatment protocol, we also found that
BI2536 induced centromere DNA threads in all other examined
cell types, though with different frequencies (Supplementary
Fig. 4a). They included 1BR3 primary ﬁbroblasts (31%), 82-6
hTERT-immortal ﬁbroblasts (24%), HCT116 colon (69%) and
HeLa cervical cancer cells (21%). Since the DNA thread
formation occurs following metaphase collapse, the different
frequencies between cell lines, (e.g., RPE1 vs. HeLa), may relate to
their ability to establish metaphase. In agreement with this, time-
lapse microscopy revealed that, as compared to RPE1, HeLa cells
poorly progressed into a metaphase(-like) stage under BI2536
treatment (Supplementary Fig. 4b). These data are consistent with
other studies27,28, and may indicate that the formation of bipolar
spindle attachment in HeLa cells is more sensitive to the loss of
PLK1 activity
PLK1 inactivation induces whole-chromosome arm splitting.
As shown above, centromere DNA threads cannot be described as
originating from the DNA entanglements between sister chro-
matids/centromeres. We thus investigated other possible cause(s).
PICH translocase binds with a high afﬁnity to DNA molecules
under tension29. This could indicate that the DNA threads may
be a form of abnormally stretched centromeric chromatin.
Interestingly, we detected activation of DNA damage responses at
(peri)centromeric regions, as labelled by γH2AX staining, fol-
lowing BI2536 treatment (Supplementary Fig. 5a). The damage
response was mainly observed in metaphase collapse populations
rather than in early mitotic cells (e.g., prophase/early prometa-
phase) (Supplementary Fig. 5a). As expected, γH2AX was mostly
not detected at (peri)centromeric regions in DMSO-treated
mitotic cells (Supplementary Fig. 5b).
To determine if this was caused by chromatin damage, we
examined mitotic chromosome spreads (Supplementary Fig. 6a).
In control RPE1 cells (DMSO- and nocodazole-treated), their
chromosomes displayed normal conﬁgurations and their average
numbers were very close to 46 (diploid) (Supplementary Fig. 6b,
c). In contrast, chromosomes of BI2536-treated cells exhibited a
shorter and more compact structure, but strikingly, their
chromosome numbers increased to an average of 59 (Supple-
mentary Fig. 6b, c). This increment cannot be explained by
chromosome mis-segregation, because PLK1 inactivation blocks
anaphase onset. Thus, a plausible explanation is chromosome
fragmentation. Moreover, we found that the increase in
chromosome numbers in BI2536-treated cells was suppressed
by co-treatment with nocodazole (Supplementary Fig. 6b, c),
implying a spindle (or tension)-dependent process. Furthermore,
centromere-telomere ﬂuorescence in situ hybridisation (ctFISH)
analysis conﬁrmed that the mitotic chromosomes in BI2536-
treated cells were indeed broken (Fig. 3a and Supplementary
Fig. 7). Notably, the broken chromatin largely resembled
telocentric chromosomes; namely the centromere residing at
one end of the chromatin, but lacking the telomere signals
(Fig. 3a, middle panels—asterisks and Supplementary Fig. 7a,
middle panels). This pattern suggests that the breakage occurs
either at, or very close to the centromere. Supporting this, we also
observed partial centromere splitting (Fig. 3a, middle panels—
arrowheads and Supplementary Fig. 7a), and occasionally, saw a
CEN DNA thread linking two separating broken chromosome
arms (Fig. 3a, middle panels—connecting arrow and Supplemen-
tary Fig. 7a). Nocodazole treatment again suppressed chromo-
some arm breakages, but seemed to have a lesser effect on the
partial splitting of centromeres (Fig. 3b). Together, these results
demonstrate that the loss of PLK1 activity induces centromere
rupture in a spindle-dependent manner. In agreement to this, we
found that nearly all the broken chromatin (99.6%) retained
centromere sequences (Fig. 3c and Supplementary Fig. 7b),
indicating that most, if not all of the breakages, occur within the
core centromere.
Our results from both cytological and cytogenetic analyses
suggest that the centromere DNA threads induced by PLK1
inhibition are highly likely caused by abnormal stretching of the
core centromere chromatin by the spindle pulling forces. As
predicted, nocodazole suppressed both centromere splitting and
DNA thread formation (Fig. 3b and Supplementary Fig. 8). Given
that centromeric DNA threads arise mostly after metaphase
establishment, we postulated that rather than by spindle-
dependent chromosome movement, they are likely mediated by
the tension exerting across the centromeres due to ‘bipolar’
spindle attachment. We thus used Monastrol, the Eg5 inhibitor,
to prevent bipolar spindle establishment while keeping MT
attachment30. As predicted, ‘monopolar’ spindle attachment is
not sufﬁcient to induce centromere DNA threads (Supplementary
Fig. 8). Therefore, centromere splitting requires bipolar spindle
pulling forces.
To our knowledge, this striking phenomenon of spindle-
mediated centromere rupture has never been described; we thus
termed this ‘centromere dislocation’. Using multi-colour FISH
(mFISH) analysis, we further validated that PLK1 inactivation can
cause whole-chromosome arm separation (Fig. 3d). In some
cases, the separated whole-arms were located in close vicinity
(Fig. 3d; e.g., chromosomes 7p–7q, 12p–12q and 17p–17q), which
may imply a residual physical connection, presumably through
the ultraﬁne centromeric DNA threads. In addition, centromere
dislocation tended to occur more frequently on longer chromo-
somes (Fig. 3d, inset). Collectively, our data show that, in the
absence of PLK1 activity, centromere chromatin fails to withstand
Fig. 2 Formation of centromere DNA linkages after PLK1 inactivation. a Experimental outline (top) and representative images showing the
immunoﬂuorescent staining of PLK1 in DMSO- and BI2536-treated RPE1 pre-anaphase cells (prometaphase and metaphase). BI2536 induced the formation
of a PLK1-decorated threadlike structure (arrows) in the ‘metaphase collapse’ cell. Enlarged region is shown at right. Quantiﬁcation (bottom) showing the
percentage of cells positive for PLK1-coated threads (mean ± S.D. is shown; n= 3 independent experiments analysing 75 and 224 pre-anaphase cells in
DMSO- and BI2536-treated conditions, respectively). b The experimental setup is same as in (a). PICH co-localises with PLK1 on the threadlike structures
induced by BI2536. Quantiﬁcation (below) showing the percentage of cells positive for PICH-coated threads (mean ± S.D. is shown; n= 3 independent
experiments analysing 120 and 308 pre-anaphase cells in DMSO and BI2356 treated conditions, respectively). c Representative images showing the
association of the UFB-binding complex (PICH, BLM and RPA70) along the threadlike molecules induced by BI2536. Enlarged regions of both z-projected
(below) and single z-planes (right) are shown. Eighty-eight thread structures were examined and all were positive for PICH, BLM and RPA70 staining.
Arrows showing regions where the RPA70 staining is strong but with no or weak PICH/BLM signals. Note: BLM was stained by a goat antibody (C-18).
d RPA32 localises on the thread regions where BLM signal is weak (arrows). Note: BLM was stained by a rabbit antibody (ab2179). e DNA threads link
between centromeres (arrows). Enlarged regions of z-projection and single z-planes are shown below. Note: all DNA threads examined (171/171 in 10 cells;
100%) are positive for centromere linkages at either one or both of their termini. f Representative images showing cohesed sister chromatids as labelled
by TOP2A (arrows) are linked by DNA threads at their centromeres (arrowhead). The enlarged region is shown below. DNA was stained by DAPI. Scale
bars= 5 μm
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bipolar spindle tensions and the core axis is transformed into an
ultraﬁne DNA threadlike structure. Indeed, we were able to detect
condensin, a chromosome axial element, associating along the
stretched DNA threads (Fig. 3e; arrows). The disintegration of
centromeres therefore causes whole-chromosome arm splitting
and explains why cells simultaneously lose their metaphase
alignment (Fig. 3f).
PLK1 kinase activity suppresses centromere disintegration.
Thus far, most of the experiments were carried out using the
PLK1 inhibitor, BI2536. To rule out potential off-target effects,
such as inhibition to other PLK members20, we employed an
engineered RPE1 cell line in which the endogenous wild-type
(WT) PLK1 has been replaced with an analogue-sensitive allele,
PLK1as. The catalytic cavity of the PLK1as protein has been
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modiﬁed such that it no longer binds to BI2536; instead only to
the unrelated ATP-analogue, 3-MB-PP131 (Supplementary
Fig. 9a). As predicted, BI2536 failed to induce metaphase collapse
and centromere DNA thread formation in the engineered PLK1as
cells. Importantly, these mitotic defects were recapitulated by
using 3-MB-PP1 analogue (Supplementary Fig. 9a–d). In addi-
tion, depletion of the PLK1 protein in RPE1 cells by RNA
interference (RNAi) also induced centromere DNA threads and
dislocations (Supplementary Fig. 9e, f), which further rules out
the potential dominant effect as a result of trapping an inactive
form of PLK1 onto chromatin by the small molecule inhibitors.
Therefore, PLK1 kinase activity per se is essential to suppress
centromere disintegration.
Aberrant association of UFB-binding factors to KTs. The fail-
ure of centromeres to withstand bipolar spindle pulling in the
absence of PLK1 function might indicate that centromere chro-
matin structure is impaired. We thus analysed the centromeres in
the BI2536-treated RPE1 cells before metaphase collapse occurs.
We found that there was a progressive formation of RPA foci at
or near KTs; from early prometaphase to metaphase(-like) stages
(Fig. 4a). This was also sensitive to nocodazole treatment
(Fig. 4a). In control, we rarely detected RPA foci at centromeres
in normal metaphase cells (Fig. 4b). More interestingly, we also
found increased accumulations of BLM and PICH foci at or near
the KTs in the metaphase(-like) cells, again only after BI2536
treatments (Fig. 4c and Supplementary Fig. 10a). Occasionally,
PICH was found at the inner centromeres of untreated cells
(Supplementary Fig. 10a; yellow arrows), perhaps reﬂecting the
unresolved DNA entanglements between sister centromeres as
proposed previously10,11,13,18,32. Earlier studies have reported that
(phospho)-RPA and BLM foci are observed at centromeres of
cytospun chromosomes33,34. However, under our experimental
conditions, both RPA and BLM foci were rarely detected at
centromeres in normal intact mitotic cells (Fig. 4b, c). In contrast,
PICH foci were consistently visualised at KTs in normal mitotic
cells10 (Supplementary Fig. 10a). To conﬁrm that PLK1 inacti-
vation also enhances PICH loading, we performed quantitative
imaging analysis on co-cultured RPE1 cells, using a mixture of
cells expressing either a WT PLK1 or GFP-tagged PLK1as pro-
tein. This allowed us to directly compare the relative amount of
PICH at KTs. Under BI2536 treatment, there was a marked
increase in both intensity and number of PICH foci at KTs in WT
PLK1, but not in the GFP-PLK1as cells (Supplementary
Fig. 10b–d). Conversely, 3-MB-PP1 induced PICH accumulation
at KTs in the GFP-PLK1as cells (Supplementary Fig. 10b–d). As
expected, PICH, BLM and RPA foci were mostly co-localised at
KTs (Supplementary Fig. 10e; arrows). Therefore, the UFB-
binding complex is aberrantly recruited to KT regions when
PLK1 function is compromised. Since BLM and PICH possess
activities of DNA unwinding and of DNA displacement,
respectively29,35, this led us to speculate that the increase in
centromeric RPA foci formation may be due to illegitimate DNA
unwinding.
Centromere distortion underneath KTs. The localisation of
PICH to KTs is independent of PLK118,28 (Supplementary
Fig. 9e). Our data show that inactivating PLK1 even increases the
binding of PICH, BLM and RPA to KTs. Whether the complex
actually targets the centromere chromatin, or is aberrantly enri-
ched at KTs is unclear. To address this, we employed high-
resolution microscopy to precisely locate the complex within the
territory of centromeres (Supplementary Fig. 11a). We found that
PICH localised in centromeres at a position ~160 nm away from
the outer KT component, as marked by NUF2 (Supplementary
Fig. 11b, d). In a control measurement, the inner KT component,
CENPA, was mapped ~100 nm inwards from NUF2 in metaphase
cells (Supplementary Fig. 11c, d). The CENPA-NUF2 distance
was reduced (~80 nm) in anaphase cells (Supplementary Fig. 11c,
d), probably due to a reduction of intra-KT tension following
sister chromatids cohesion loss36,37. This inward position of
PICH suggests that it likely locates at centromere chromatin.
Further co-staining of PICH and CENPA conﬁrmed that PICH
resides at a centromeric domain ~100 nm beneath CENPA
(Fig. 4d and Supplementary Fig. 11d). Likewise, both BLM and
RPA foci, were mapped underneath CENPA, with distances of
~120 and ~150 nm, respectively (Fig. 4d and Supplementary
Fig. 11d). All of these proteins displayed mirror localisation
patterns, reﬂecting a typical symmetry of sister centromere-KT
organisation. We referred to this speciﬁc centromere site as
‘kinetochore-chromatin’ or ‘K-chromatin’ (Fig. 4e).
The K-chromatin localisation ﬁnding is consistent with our
notion that centromeric chromatin is probably targeted by the
UFB-binding complex after PLK1 inhibition. If the increased
formation of RPA foci at K-chromatin reﬂects aberrant DNA
unwinding, this may weaken centromere rigidity to counteract
spindle pulling forces. Notably, we observed detachments of KT
complex in a small population of centromeres (<4%) in
metaphase(-like) cells prior to collapse. Intriguingly, some of
the KTs remained connected by a short thread, as labelled by
Fig. 3 PLK1 inactivation induces spindle-dependent centromere dislocation. a Experimental outline (top) and representative deconvolved images showing
chromosomes isolated from RPE1 cells under the indicated treatment. Chromosomes were hybridised with FISH DNA probes against centromeres (green)
and telomeres (red). Left panels: examples of normal chromosome conﬁguration (+nocodazole). Middle panels: examples of BI2536-induced ‘centromere
dislocations’ (asterisks; 1–5), ‘partial centromere splitting’ (arrowhead; 3), and a centromere DNA thread linking two separate chromosome arms
(connecting arrow; 5). Right panels: chromosomes with ‘partial centromere splitting’ (arrowhead) after BI2536 and nocodazole co-treatment. Note: also
see Supplementary Fig. 7 for the whole-chromosome spread images. b Quantiﬁcation of ‘chromosome arm dislocations’ (left) and ‘partially centromere
splitting’ (right) under the indicated inhibitor treatment (n= 3 independent experiments analysing 75 spreads in each condition; the means of each
experiment are shown). c A diagram depicting the outcomes of chromosome breakage within or outside centromeres. (i) Breakage at centromeres
generates both broken arms (100%) positive for CEN FISH signal; (ii) breakage at pericentric or arm regions generates one of the broken arms (50%)
positive for a CEN FISH signal. Quantiﬁcation (right) of the examined broken chromosome arms with or without centromere FISH signal at their termini
(524 broken chromosome arms were scored from 11 separate chromosome spreads showing the highest centromere dislocation frequency). d
Experimental outline (top) and mFISH karyotyping of RPE1 cells. BI2536 induced chromosome ‘p’- and ‘q’-arm separation. Note: there is a marker ‘M’
chromosome with a translocation of chromosome X and 10 in RPE1 cells. Bar graph (bottom) showing the frequency of ‘centromere dislocations’ among
individual chromosomes. Inset graph showing the positive correlation between chromosome length and ‘centromere dislocation’ frequency (23 spreads
were analysed). Note: acrocentric chromosomes were not determined and the length of the ‘marker’ chromosome is unknown. e Condensin (SMC2) is
detected on some PLK1-associated DNA threads (arrows). Scale bars= 5 μm. f A model of centromere dislocation induced by PLK1 inactivation in a
spindle-dependent manner. Spindle-mediated tension causes decompaction of centromere axis, the formation of centromere DNA threads and whole-
chromosome arm separation
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PICH or RPA staining (Fig. 5a, b; arrows). Centromere staining
was sometimes evident along the short thread (Fig. 5a; arrows),
implying a protrusion of centromeric DNA. We postulated that
this might be the early sign of centromere disintegration.
Further analysis of the centromere-KT integrity revealed that
there was a large percentage of centromeres losing one of the
two sister KTs after metaphase collapse (Fig. 5b–d). The side of
the centromere where a KT was missing was concomitant with
the formation of DNA thread linkages (Fig. 5c; connecting
arrows). Therefore, there are apparent alterations on the
centromere-KT conﬁguration prior to and during centromere
disintegration.
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Fig. 4 PLK1 inactivation increases PICH, BLM and RPA foci at K-chromatin. a Increased RPA foci formation at centromeres during mitotic progression after
PLK1 inhibition (from prophase to metaphase-like stage). Right: Quantiﬁcation of the numbers of RPA foci at centromeres in the indicated mitotic stages
and treatments (n= 3 independent experiments analysing a total of 30 cells in each stage of early, mid prometaphase and metaphase; and of 29 cells in the
nocodazole-treated condition; average mean is shown). b BI2536 increased the formation of centromeric RPA foci in precollapsed metaphase-like cells.
Representative images comparing RPA foci at centromeres in DMSO- (left) and BI2536-treated (right) metaphase-like cells. Enlarged images of the
selected regions are shown at right. Arrows indicate centromeric RPA foci. Quantiﬁcation of RPA foci number at centromeres of metaphase (DMSO), and
metaphase(-like) (BI2536) cells (n= 3 independent experiments analysing 47 cells per condition). c Same as (b), but stained with BLM (n= 3 independent
experiments analysing 59 and 60 cells in DMSO- and BI2536-treated conditions; means of each experiment are shown). dMapping the locations of PICH/
BLM/RPA complex at centromeres. Representative images showing the relative locations of PICH (top), BLM (middle) and RPA (bottom) at the
centromeres, comparing to the inner kinetochore marker, CENPA. Proﬁle plots of signal intensity accompanies each example. Right: graphs showing the
relative position of each protein at both sides of the centromere. e A model depicts the localisation of the PICH/BLM/RPA complex at a speciﬁc domain of
centromeres, named kinetochore-chromatin/K-chromatin. Note: all RPE1 cells analysed were pre-synchronised at G1/S by a single thymidine block. Drugs
were added at 6 h post-release. After 2 h treatment, cells were subject to immunoﬂuorescence staining. Scale bars= 5 μm
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Fig. 5 Loss of kinetochore attachment at centromeres after dislocation. a Representative images showing the kinetochore complex detaches from the core
centromere, whilst remaining connected by PICH- or RPA-coated DNA threads (arrows) in BI2536-treated metaphase-like RPE1 cells. Inner and outer
kinetochores were labelled by CENPA and NUF2, respectively. b Examples showing the majority of centromeres retain two kinetochores in pre-collapsed
mitotic populations (prometaphase and metaphase-like cells) after BI2536 treatment. c Representative image showing the metaphase-collapse cells losing
kinetochore complex at one side of the centromere. Note: the side without the kinetochore is concomitant with the formation of PICH-associated DNA
linkages (arrows). Enlarged images (1 and 2) highlight the loss of CENPA signal at regions of where PICH-decorated DNA linkages form (arrows).
d Quantiﬁcation of the numbers of CENPA- and NUF2-labelled kinetochores at centromeres in prometaphase, metaphase-like and collapse stages after
BI2536 treatment (n= 3 independent experiments analysing a total of 3020 CENPA-labelled centromeres and 3625 NUF2-labelled centromeres; mean ± S.
D. is shown). Note: all RPE1 cells analysed were pre-synchronised at G1/S by single thymidine block. Drugs were added at 6 h post-release. After 2 h
treatment, cells were subject to immunoﬂuorescence staining. Scale bars= 5 μm
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BLM helicase activity mediates centromere disintegration.
Next, we examined whether centromere disintegration is medi-
ated by BLM and PICH. We knocked down BLM by RNAi before
BI2536 treatment (Fig. 6a). Silencing BLM for longer than 48 h in
RPE1 cells reduced the efﬁciency of thymidine release, therefore
we treated cells with siBLM oligos for only 24 h prior to G1/S
release (Supplementary Fig. 12a). Despite partial depletion
(Supplementary Fig. 12b–d), we found that ﬁrst, BLM knock-
down signiﬁcantly reduced the formation of RPA foci at K-
chromatin induced by BI2536 (Fig. 6b); second, it also diminished
both centromere DNA thread formation and centromere dis-
location (Supplementary Fig. 12e, f). BLM depletion did not
impair PICH centromeric localisation (Supplementary Fig. 12g),
suggesting that, without BLM, PICH alone is not sufﬁcient to
drive centromere disintegration. To conﬁrm the speciﬁcity of
BLM knockdown, we performed our analyses on HAP1 cells in
which the endogenous BLM was knocked out by CRISPR genome
editing38 (Supplementary Fig. 13a, b). Consistently, BLM
knockout abolished centromere DNA thread formation and
centromere dislocations (Fig. 6c, d). Though, occasionally, chro-
matid breaks were observed in ΔBLM HAP1 cells, the breakpoint
was not at the centromere (Fig. 6d, arrow). Therefore, in addition
to the bipolar spindle pulling forces, BLM is a key driver of
centromere disintegration after the loss of PLK1 activity.
Centromere disintegration might be initiated through unlawful
DNA unwinding by BLM. Thus, we determined if BLM’s helicase
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activity is required. We generated polyclonal cell lines from the
ΔBLM HAP1 cells, which stably express either a GFP-tagged WT
or a helicase-dead (Q672R) BLM protein. The expression of the
GFP-Q672R protein was similar to the endogenous BLM level in
HAP1 cells; whereas, the GFP-WT was over-expressed (Supple-
mentary Fig. 13b). In agreement with our notion, the helicase-
dead (Q672R) BLM failed to induce centromere DNA threads
and dislocations caused by BI2536 treatments (Fig. 6c, d).
However, as the expression level of the GFP-Q672R mutant was
lower than the WT control; to perform a better comparison, we
re-sorted the WT GFP-BLM cells to obtain a cell population with
a lower BLM expression (Supplementary Fig. 13c). Despite a
much lower abundance, the WT GFP-BLM protein was still
capable of driving centromere DNA thread formation (Supple-
mentary Fig. 13d). More importantly, the GFP-Q672R mutant
protein no longer induced RPA foci formation, despite its
aberrant enrichment at centromeres following PLK1 inhibition
(Fig. 6e). Therefore, we conclude that centromere disintegration is
mediated by BLM-dependent DNA unwinding at centromeres.
Next, we investigated the role of PICH. Knockdown of PICH,
like BLM, also suppressed BI2536-induced centromere DNA
thread formation and centromere dislocations (Fig. 7a–c).
However, it also abolished BLM localisation and RPA formation
at K-chromatin. (Fig. 7d). Therefore, PICH acts upstream to
facilitate the recruitment of BLM to centromeres after PLK1
inactivation. Taken together, our data suggest that PLK1 has an
important function to protect centromeres from unlawful DNA
unwinding, mediated by the PICH/BLM complex. The structural
change probably impairs centromere rigidity and causes the
failure to withstand bipolar spindle pulling forces. Consequently,
centromeres are torn apart, leading to whole-chromosome arm
splitting and chromosome biorientation failure.
Centromeric tethering of BLM does not induce metaphase
collapse. Both PICH and BLM interact with PLK1 and are
hyperphosphorylated during mitosis10,39–41. Hyperpho-
sphorylation of PICH and BLM is partially dependent on PLK142
(Supplementary Fig. 14). It has been proposed that hyperpho-
sphorylation of BLM can prevent its association with mitotic
chromosomes41,43. Thus, we sought to test whether the abnormal
loading of BLM to centromeres, presumably due to the loss of
PLK1-mediated phosphorylation, might cause centromeric DNA
unwinding and dislocation. We tethered BLM to centromeres in
HeLa cells by fusing a truncated CENPB (1–158) to a GFP-tagged
BLM. Transient expression of the WT GFP-BLM and the
CENPB-GFP-BLM fusion proteins showed that the WT GFP-
BLM exhibited diffused localisation pattern and was mostly
excluded from mitotic chromosomes after nuclear envelope
breakdown. In contrast, the CENPB-GFP-BLM fusion protein
was enriched at core centromeres throughout mitosis (Supple-
mentary Fig. 15a). However, we did not ﬁnd that tethering BLM
to centromeres induced obvious mitotic defects such as mitotic
arrest, as observed by PLK1 inhibition. Time-lapse live-cell
imaging showed that the CENPB-GFP-BLM transfected cells, like
the WT GFP-BLM, progressed successfully into anaphase, with-
out metaphase collapse (Supplementary Fig. 15b). Moreover, RPA
(ssDNA) formation was not detected at centromeres where the
CENPB-GFP-BLM protein was enriched (Supplementary
Fig. 15c). Therefore, artiﬁcially over-loading BLM at centromeres
seems not sufﬁcient to trigger DNA unwinding and centromere
disintegration when PLK1 remains active. Though speculative,
the triggering of centromere dislocation in PLK1-inactivated cells
might be caused by mis-regulation of BLM (and PICH) activity;
and/or because of improper formation of centromere structures
that mis-activates the PICH/BLM complex prior to chromosome
disjunction.
Constitutive PLK1 activity for centromere integrity main-
tenance. To test if centromere disintegration might be caused by
centromere malformation during early mitosis, we inhibited
PLK1 only after mitotic cells had fully formed their chromosomes
and progressed into metaphase, whilst in the presence of active
PLK1. RPE1 cells stably expressing a GFP-tagged PLK1 were ﬁrst
blocked at metaphase using the APC/C inhibitor, ProTAME.
Time-lapse live-cell imaging recorded that upon the addition of
BI2536, the fully bioriented chromosomes started losing their
alignment. Most importantly, this was accompanied by the for-
mation of DNA threads (Fig. 8a and Supplementary Movies 2 and
3), indicating the occurrence of centromere dislocation. Fur-
thermore, we found that centromere dislocation can happen
rapidly, as within 30 min of BI2536 addition, more than 60% of
the metaphase-arrested cells generated centromere DNA threads
(Fig. 8b). As centromere dislocation depends on bipolar spindle
pulling, this would imply that the KT-MT attachment is not
instantly destroyed, at least in those centromeres with DNA
threads. Therefore, rather than due to an initial malformation,
centromere disintegration is likely triggered because of a defect in
centromere structure maintenance.
Depletion of PICH and BLM prolongs metaphase alignment.
Thus far, our data indicates that apart from the proposed model
of KT-MT destabilisation, a failure in centromere integrity
maintenance is another cause of chromosome misalignment. To
further test this, we examined if suppression of centromere dis-
location, by PICH and BLM depletion, might rescue the
Fig. 6 BLM helicase activity triggers centromere disintegration. a Western blot showing BLM depletion after RNAi treatment in RPE1 cells. Ku80 is used as
a loading control. b BLM depletion reduced centromeric RPA foci formation induced by BI2536 in pre-collapsed metaphase(-like) cells. Representative
images showing the loss of RPA, but not PICH foci, at centromeres in siBLM cells. Right: quantiﬁcation of centromeric RPA foci in metaphase(-like) cells
(n= 3 independent experiments analysing 60 cells per condition; mean ± S.D. is shown). c Representative images and quantiﬁcation of DNA thread
formation in wild-type (HAP1) cells, BLM knockout cells (ΔBLM), and ΔBLM HAP1 cells complemented with a wild-type GFP-BLM (WT) and a BLM-
helicase mutant (Q672R) protein under BI2536 treatment (n= 3 independent experiments analysing a total of 291, 218, 204 and 184 cells in HAP1, ΔBLM,
WT and Q672R cell lines; mean ± S.D. is shown). d Representative chromosome images of ‘centromere dislocations’ (yellow asterisks) in the indicated
HAP1 cells shown in (c). Note: occasional arm breaks (arrow) were observed in ΔBLM cells. Quantiﬁcation of centromere dislocation is shown below
(n= 3 independent experiments analysing a total of 60, 60, 51 and 51 spreads in HAP1, ΔBLM, WT and Q672R cell lines; means of each experiment are
shown). e Centromeric RPA foci formation in ΔBLM HAP1 cells expressing wild-type GFP-BLM (WT) and a BLM helicase-dead mutant (GFP-Q672R)
following BI2536 treatment. Representative images showing the lack of RPA foci at centromeres in the GFP-Q672R cells. Right: bar graphs showing the
average ﬂuorescence intensities of centromere GFP and RPA foci, respectively, in GFP-BLM and GFP-Q672R cells (mean+ S.E.M. is shown). A scatter plot
of RPA foci intensity by GFP foci intensity at centromeres (total numbers of centromere foci analysed: GFP-BLM, n= 582; and GFP-Q672, n= 481). All
RPE1 and HAP1 cells, including their derivatives, were pre-synchronised at G1/S by single thymidine block. Drugs were added at 6 h post-release. After 2 h
treatment, cells were subject to immunoﬂuorescence staining. RNAi treatment of RPE1 cells was performed for 23 h before G1/S release. Scale bars= 5 μm
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metaphase alignment defect in PLK1-inhibited cells. Knocking
down PICH or BLM had no adverse effect on metaphase estab-
lishment in RPE1 cells under BI2536 treatments. However, it
signiﬁcantly prolonged the metaphase(-like) stage as compared to
control cells (Fig. 8c and Supplementary Movies 4–6). Although
the metaphase chromosomes inevitably misaligned after long
delays in the PICH/BLM-depleted cells, they dispersed more like
a ‘polo’ pattern, rather than the ‘Fig-8’ collapsed shape. As we
showed that PICH/BLM depletion abolished centromere dis-
locations, we believe that the ultimate alignment failure is likely
caused by KT-MT destabilisation. Nevertheless, it seems that even
in the absence of PLK1 activity, the centromeres and KTs remain
competent to support chromosome biorientation, at least in
RPE1 cells, as long as the PICH/BLM complex is inactivated.
Moreover, our data also implies that KT-MT destabilisation, if it
occurs, seems to do so at a relatively slow rate as compared to
centromere disintegration.
In summary, we report an unexpected role of PLK1 during
chromosome biorientation, which prevents centromeres from
destruction, mediated by the co-action of DNA unwinding by
BLM helicase and bipolar spindle pulling (Fig. 9).
Discussion
One of the key mitotic functions of PLK1 is to promote stable
attachments between spindle MTs and KTs6. In the current study,
we reveal a hitherto undescribed role of PLK1 as a centromere
guardian for chromosome alignment. We show that the lack of
PLK1 activity leads to the failure of centromeres to withstand
bipolar spindle pulling tension. As a consequence, centromere
chromatin is stretched into a threadlike structure, resulting in
centromere splitting, whole-chromosome arm separation and loss
of metaphase alignment. Further experiments demonstrate that
the disintegration of centromeres is not a passive process, but is
actively driven through illegitimately unwinding of centromeric
DNA by the PICH/BLM complex. Our results highlight a PLK1-
dependent pathway for centromere maintenance during mitosis.
BLM is the key molecular driver of centromere disintegration,
but it remains unclear how PLK1 counteracts its mediated
destruction. Given that both BLM and PICH proteins are sub-
strates of PLK1, a reasonable speculation is that PLK1 can reg-
ulate the activity of PICH/BLM complexes during mitosis.
Previous studies have shown that before anaphase onset, BLM
poorly associates with mitotic chromosomes41,43 and on UFBs
generated from prematurely disjoined sister chromatids11. The
chromatin exclusion of BLM, presumably by hyperpho-
sphorylation, could limit its DNA transaction activity. However,
artiﬁcially tethering BLM to centromeres is not sufﬁcient to
induce DNA unwinding and centromere dislocation, which may
suggest that either the BLM protein remains inactive, or addi-
tional factors such as PICH activation and/or chromatin
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Fig. 7 PICH acts upstream of BLM in centromere disintegration. a Experimental outline of RNAi depletion, in combination with thymidine synchronisation
and drug treatment. Right: western blot showing PICH protein level in siCTRL and siPICH treatment. Ku80 is used as a loading control. b Centromeric DNA
thread formation in siCTRL and siPICH cells under BI2536 treatment. Quantiﬁcation of DNA thread formation in RPE1 cells after siCTRL and siPICH
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Representative images of mitotic spread chromosomes from cells prepared in (a) showing centromere dislocations (asterisks) and partial centromere
splitting (arrow). Quantiﬁcation of centromere dislocation is shown at right (n= 3 independent experiments analysing 64 and 61 dislocated chromosome
arms in siCTRL and siPICH conditions, respectively; means of each experiment are shown). d Reductions of BLM and RPA foci formation at centromeres in
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remodelling are required. Alternatively, PLK1 may protect cen-
tromeres through facilitating normal condensation of cen-
tromeres, a process if compromised might create a DNA substrate
that mis-activates the PICH/BLM complex. However, impairing
chromosome condensation by condensin depletion, which leads
to abnormal stretching of sister centromeres44,45, does not trigger
similar phenotypes of centromere rupture and chromosome
misalignment as induced by PLK1 inhibition. In addition, the fact
that centromere disintegration can be induced in ‘mature’ mitotic
cells; namely those cells that have fully formed normal metaphase,
would suggest that rather than due to an initial chromatin mal-
formation, it is probably caused by centromere maintenance
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Fig. 8 Constitutive PLK1 activity suppresses centromere disintegration. a Experimental outline and time-lapse live-cell images of GFP-tagged PLK1
RPE1 cells treated with BI2536 after metaphase establishment. Cells were arrested at metaphase by ProTAME after G1/S release. High-resolution movies
were recorded immediately after the addition of BI2536. The formation of DNA threads is revealed by GFP-PLK1 protein (arrows). b Experimental outline
and quantiﬁcation of DNA thread formation in metaphase-arrested RPE1 cells. BI2536 was added in ProTAME-arrested metaphase cells for 30min.
Centromeric DNA threads were labelled by PICH, BLM and RPA staining. BLM thread counting (n= 3 independent experiments analysing a total of 188 and
189 cells in ProTAME and ProTAME+ BI2536 conditions, respectively. RPA thread counting (n= 3 independent experiments of a total of 174 and 187 cells
in each condition; mean ± S.D. is shown). c Depletion of PICH or BLM, prolongs the metaphase-(like) stage of RPE1 cells under PLK1 inactivation. Time-
lapse microscopy images showing the mitotic progression of RPE1 cells treated with the indicated siRNA oligos, and BI2536. Red bars indicate the
metaphase(-like) stage; yellow bars indicate ‘metaphase collapse’. Quantiﬁcation (right) of the overall duration of metaphase(-like) stage in control, PICH-
and BLM-depleted cells, following BI2536 treatment (n= 3 independent experiments analysing 50, 60 and 57 cells in siCTRL, siPICH and siBLM conditions;
means of each experiment are shown). Scale bars= 5 μm
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therefore fail to maintain chromosome biorientation and result in metaphase collapse with a ‘Fig-8’ like misalignment pattern. Alternatively, if the spindle
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impairment. Nevertheless, no matter if there is a structural defect,
loss of PLK1 does not seem to greatly compromise chromosome
biorientation, at least in RPE1 cells, as long as the PICH/BLM
complex is inactivated. We postulate that PLK1 may protect
centromeres through both chromatin structure maintenance and
the regulation of the PICH/BLM complex activity. Further
experiments will need to dissect the underlying mechanism(s).
Another very intriguing ﬁnding is that when acting in concert
with bipolar spindle tension, the PICH/BLM complex can pro-
mote decompaction of the centromere axis. This converts the
centromeric chromatin into an ultraﬁne DNA structure, remi-
niscent of anaphase UFBs10,11, leading to whole-chromosome
arm separation. Conceivably, if such decompaction activity is
applied at a chromosomal region where sister DNA intertwine-
ments persist, it may be able to relieve the entangling constraints
and facilitate the poleward separation of sister chromatids during
anaphase. Though this is speculative, this ﬁnding could provide
an alternative clue to understand how the UFB-binding complex
may function during chromosome disjunction, and potentially
also explain why a long region of UFBs is always coated by the
PICH/BLM complex. In principle, such powerful action would
need to be under a tight control before anaphase onset, otherwise
it could lead to pathological damage at chromatin sites where
tension is exerted; namely the centromere. Finally, the identiﬁ-
cation of a centromere-speciﬁc breakage pathway, independent of
chromosome mis-segregation46,47, also offers an alternative
direction in understanding the origin of complex chromosome
rearrangements, such as whole-chromosome arm rearrange-
ments, which are observed in many human tumours and rare
genetic disorders48–51.
In conclusion, our study unveils an unexpected participation of
PLK1 and the UFB-binding complex in the safeguard of cen-
tromere integrity during mitosis, which is critical for faithful
chromosome segregation and chromosome stability.
Methods
Cell culture. RPE1-hTERT, 82-6-hTERT normal diploid cell lines, 1BR3 primary
ﬁbroblasts, HCT116 colon and HeLa cancer cells were obtained from the Genome
Damage and Stability Centre (GDSC) Cell Bank. All cell lines were authenticated
by STR genotyping from European Collection of Cell Cultures. RPE1-hTERT
derivative cells were generated and supplied by Mark Burkard (University of
Wisconsin). Bloom’s syndrome ﬁbroblasts (GM08505) were obtained from Phillip
North (University of Oxford). HAP1 cells and HAP1 ΔBLM cells were obtained
from Marcel van Vugt (University of Groningen). All cell lines passed mycoplasma
tests (Lonza MycoAlert kit). RPE1-hTERT and its derivative cells were grown in
DMEM/F-12 medium (Sigma) containing 15% foetal calf serum (FCS) and Pen/
Strep antibiotics (P/S). 82-6 Fibroblast cells were grown in DMEM/F-12 medium
containing 15% FCS and P/S. HAP1 cells were grown in IMDM (Gibco) containing
10% FCS and P/S. 1BR3 primary cells were grown in MEM (Gibco) containing
2mM L-glutamine, 15% FCS and P/S. HCT116 cells were grown in McCoy’s 5A
(Gibco) containing 15% FCS and P/S. Bloom’s syndrome ﬁbroblasts (GM08505)
were transfected with a pEGFP-hBLM construct and selected by 700μg/ml G418
for 14 days. A single clone was isolated and maintained in MEM (Gibco) con-
taining 2 mM L-glutamine, 10% FCS, P/S and G418. Cell cultures were maintained
at 37 °C in a humidiﬁed atmosphere containing 5% CO2. GFP-BLM(WT) and
GFP-BLM(Q672R) HAP1 cells were generated by stable transfection with the
corresponding constructs in HAP1 ΔBLM cells by using FuGene HD (Promega)
according to the manufacturer’s guidelines. The DNA constructs were created by
sub-cloning EGFP-hBLM (WT) or Q672R (helicase dead mutant) fragments into a
pSYC-181-(NEO) vector. Following a 1.2 mg/ml of G418 selection for 14 days,
GFP-positive populations were sorted and isolated using a FACS cell sorter (BD
FACSMelody).
Cell synchronisation and drug treatments for mitotic cell analysis. Cells were
treated with 2 mM of thymidine for 18 h to enrich cells at the G1/S boundary. Cells
were then released into S-phase by washing three times with pre-warmed culturing
medium, or pre-warmed 1× PBS and released into fresh medium. Totally, 5–6 h
post-G1/S release, indicated inhibitors were added. At approximately 8–9 h post
the G1/S release, mitotic cells were ﬁxed or enriched for analyses.
RNA interference. Cells were transfected with siRNA oligonucleotides using
Lipofectamine RNAiMAX transfection reagent (Thermo Fisher Scientiﬁc) follow-
ing the manufacturer’s guidelines. Cells underwent 1 or 2 rounds of siRNA
transfection as necessary.
Non-targeting siRNA pool (Dharmacon ON-TARGET plus Non-targeting Pool
—D-001810-10-05. UGGUUUACAUGUCGACUAA; UGGUUUACAUGUUG
UGUGA; UGGUUUACAUGUUUUCUGA; UGGUUUACAUGUUUUCCUA)
PLK1 siRNA sequence (Dharmacon ON-TARGET plus SMARTpool—L-
003290-00-0005. GCACAUACCGCCUGAGUCU; CCACCAAGGUUUUC
GAUUG; GCUCUUCAAUGACUCAACA; UCUCAAGGCCUCCUAAUAG)
Sgo1 siRNA sequence (Dharmacon ON-TARGET plus SMARTpool—L-
015475-00-0005. CAGCCAGCGUGAACUAUAA; GUUACUAUCUCACAU
GUCA; AAACGCAGGUCUUUUAUAG; GUGAAGGAUUUACCGCAAA)
BLM siRNA sequence (Dharmacon ON-TARGET plus Individual—J-007287-
08-0005. GGAUGACUCAGAAUGGUUA)
PICH siRNA sequence (Invitrogen—AAUUCGGUAAACUCUAUCCAC
AGCU)
Fluorescence immunostaining. For immunostaining analyses, cells were seeded
onto No. 1.5 or No. 1.5H cover glass and ﬁxed with Triton X-100-PFA buffer (250
mM HEPES, 1× PBS, pH7.4, 0.1% Triton X-100, 4% methanol-free paraf-
ormaldehyde) at 4 °C for 20 min, or with PBS–PFA buffer (1× PBS, 4% methanol-
free paraformaldehyde) at room temperature for 10 min. Pre-extraction was carried
out in indicated experiments before ﬁxation by incubation of the cover glass in pre-
extraction buffer (20 mM HEPES pH7.4, 0.5% Triton X-100, 50 mM NaCl, 3 mM
MgCl2, 300 mM sucrose) for 10–15 s. Cells were incubated in permeabilisation
buffer (0.5% Triton X-100, 1XPBS) for 20 min on ice followed by blocking with
foetal calf serum for 15 mins at room temperature. Cells were incubated with
primary antibody at 37 °C for 90 min followed by secondary antibody incubation at
room temperature for 30 min. Slides were washed with 1× PBS for 5 times at room
temperature after antibody incubation. Cells were mounted using DAPI-containing
Vectashield mounting medium.
Primary antibodies used: anti-PICH (Abnova; H00054821-B01P, 1:100), anti-
PICH (Abnova; H00054821-D01P, 1:100), anti-BLM (Santa Cruz; sc-7790, 1:50),
anti-BLM (Abcam; ab2179, 1:200), anti-γH2AX (Upstate; JBW-301, 1:400), anti-
TOP2A (Santa Cruz; sc-5348, 1:100), anti-SMC2 (Bethyl Lab; A300-058A, 1:200),
anti-RPA70 (Abcam; ab79398, 1:200), anti-RPA32 (Abcam; ab2175, 1:200), anti-
CENPA (Abcam; ab13939, 1:100), anti-CENPB (Abcam; ab25734, 1:800), anti-
NUF2 (Abcam; ab122962, 1:200), anti-PLK1 (Santa Cruz; sc-55504, 1:100), anti-
pericentrin (Abcam; ab4448, 1:400), anti-centromere (ImmunoVision; HCT-0100,
1:400) and GFP booster (ChromoTek; gba-488, 1:200). Secondary antibodies used:
donkey anti-mouse Alexa Fluor 488, 555 and 647; donkey anti-rabbit Alexa Fluor
488, 555 and 647; donkey anti-goat Alexa Fluor 488 and 555; goat anti-human
DyLight 550 and 650 (All secondary antibodies are purchased from ThermoFisher
and used at 1:500 dilution).
High-resolution deconvolution microscopy. Images were acquired under a Zeiss
AxioObserver Z1 epiﬂuorescence microscopy system with 40×/1.3 oil Plan-Apoc-
hromat, 63×/1.4 oil Plan-Aprochromat and 100×/1.4 oil Plan-Aprochromat
objectives and a Hamamatsu ORCA-Flash4.0 LT Plus camera. The system is
calibrated and aligned by using 200 nm-diameter TetraSpeck microspheres (T7280,
ThermoFisher). Ten to ﬁfty z-stacking images were acquired at 200 nm intervals
covering a range from 2 to 10 μm by using ZEN Blue software.
Deconvolution was carried out using Huygens Professional deconvolution
software (SVI) with a measured point-spread-function generated by 200 nm
diameter TetraSpeck microspheres. Classical maximum likelihood estimation
method with iterations of 40–60 and signal-to-noise of 20–60 was applied.
Time-lapse Live-cell microscopy. Cells were seeded on 2-well or 4-well tissue
culture chambers coverglass II (Sarstedt). SiR-DNA (Spirochrome) was added for
at least 5 h prior to live-cell imaging. Images were acquired under a Zeiss
AxioObserver Z1 epiﬂuorescence microscopy system equipped with a heating and
CO2 chamber (Digital Pixel) by using 40×/0.6 Plan-Neoﬂuar or 40×/1.3 oil Plan-
Apochromat objectives and a Hamamatsu ORCA-Flash4.0 LT Plus camera. For
mitotic progression analysis, 5–10 z-stacking images with 2 μm intervals were taken
with the indicated time intervals by using ZEN Blue software. Images were pro-
cessed using ImageJ software and in-focus z-plane images were manually extracted
to make image montages. For imaging of DNA thread formation in live cells, 40×/
1.3 oil Plan-Apochromat objective was used to capture eight z-stack images with
800 nm intervals and in-focus z-plane images were extracted using ImageJ
software.
Chromosome spread preparation. Following synchronisation using thymidine,
cells were treated with pre-warmed hypertonic solution for 5–10 min at 37 °C
(0.075M KCL). The swollen cells were then ﬁxed and washed twice with methanol:
acetic (3:1 ratio), before ﬁnally being re-suspended in fresh methanol:acetic solu-
tion. Chromosome spreads were dropped onto glass slides and either counter-
stained with Vectashield plus DAPI, or stored at room temperature for
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forthcoming FISH hybridisation. Colcemid was omitted in all mitotic spread
preparations.
Centromere and telomere peptide nucleic acid (PNA) FISH. Centromere
(CENPB-FAM; PNABio) & Telomere (Tel-Cy3 PNA FISH kit; DAKO, Agilent)
PNA probes were hybridised according to the manufacturer’s instructions. Brieﬂy,
chromosome spreads were rehydrated in 1× TBS prior to ﬁxation in 3.7% PFA
solution. Slides were then washed and pre-treated before dehydration using a
gradient ice-cold ethanol wash (70, 90 and 100%). Slides were air dried and PNA
probes were added. Slides were then co-denatured at 80 °C for 1 min and incubated
for 2 h at room temperature. Slides were then washed in FISH Wash solution (Tel-
Cy3 PNA FISH kit; DAKO, Agilent) for 5 min at 65 °C following by dehydration
using a series of ethanol wash before counterstaining using DAPI Vectashield.
Multi-colour FISH. mFISH was performed by using 24XCyte Human Multicolour
FISH probe (MetaSystems) according to the manufacturer’s instructions. Images
were acquired by MetaSystems using a Zeiss AxioObserver Z1 epiﬂuorescence
microscopy system with a CoolCube CCD camera and 100×/1.4 oil Plan-
Aprochromat objective. Multi-colour FISH (mFISH) karyotyping was carried out
by using ISIS Imaging software.
Immunoblotting. Cells were trypsinized and lysed on ice for 15–20 min with lysis
buffer (50 mM Tris pH 7.5, 300 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1.25
mM DTT, 1 mM PMSF and cOmpleteTM protease inhibitor cocktail). Protein
concentration was quantiﬁed using a Bradford assay (Bio-Rad). Immunoblotting
(IB) was performed following standard procedures. Primary antibodies used for IB
in this study: anti-BLM (Abcam, ab2179, 1:2000), anti-PICH (Abnova; H00054821-
B01P, 1:300), anti-GFP (Abcam, ab290, 1:1000) and anti-Ku80 (Abcam, ab80592,
1:10000). All uncropped blot scans are available in the Supplementary excel
data ﬁle.
Flow cytometry. Cells were trypsinised, washed with PBS and ﬁxed with 70% ice-
cold ethanol. For cell cycle analysis, cells were washed with PBS and re-suspended
in propidium iodide/RNaseA staining buffer. FACS proﬁles were then determined
and analysed using BD Accuri C6 sampler.
KT/centromere foci measurement. Samples were subjected to pre-extraction in
pre-extraction buffer (20 mM HEPES pH7.4, 0.5% Triton X-100, 50 mM NaCl, 3
mM MgCl2, 300 mM sucrose) for 10–15 s followed by ﬁxation and immuno-
ﬂuorescent staining as described above. Thirty to ﬁfty z-stacking images with 200
nm intervals were acquired and deconvolved using Huygens Professional decon-
volution software (SVI). KT foci on each single z-plane were marked and measured
using the ImageJ Plugins detailed below.
ImageJ measurement of KT foci coordinates, distances and intensities. Spot
Pair Distance Tool: Measures the distance between spots in two channels of an
image. The tool searches within a focus/box radius, typically± 5px, for a local
maxima in the two pre-selected analysis channels. The centre-of-mass around each
maxima, typically± 2px, is computed as the centre of intensity for each channel.
Dragging from the clicked point creates a reference direction. The Euclidean dis-
tance between the centres is reported, optionally with the signed XY distance and
angle relative to the reference direction. Visual guides are overlaid on the image to
assist in spot selection and direction orientation. Available in the latest GDSC
ImageJ plugins.
Spot Fit Tool: Fits a 2D Gaussian to a spot in an image. The tool searches within
a box radius, typically± 3px, for a local maxima in the pre-selected analysis
channel. A 3 × 3 smoothing ﬁlter is applied before identiﬁcation of the maxima. A
2D Gaussian function is then ﬁtted to the data using non-linear least-squares ﬁtting
and poor ﬁts rejected using a signal-to-noise ratio. The parameters for the ﬁt are
reported including the total intensity under the Gaussian function and the local
background value. Visual guides are overlaid on the image to show the ﬁtted
location. Available in the pre-release GDSC SMLM ImageJ plugins.
Statistics. Statistical analysis was performed using GraphPad Prism 7 software by
two-tailed unpaired Student’s t test and two-way ANOVA as per the experimental
requirement.
Recombinant DNA and transfections. CENPB (1–158aa) cDNA fragment was
PCR ampliﬁed from a PLK1 plasmid in which the C-terminal PBD domain was
replaced with the ﬁrst 158 amino acids of CENPB (pQCXIN-Flag-Plk1deltaC-
CENPB(1–158)) (a gift from Mark Burkard) and cloned into full length pEGFP-
hBLM and pEGFP-hBLM(Q672) plasmids at AgeI site to generate N-terminally
tagged CENPB (1–158aa) fusion proteins. Transfections of DNA plasmids were
performed using FuGene HD (Promega) according to the manufacturer’s guide-
lines. All plasmids and their sequences are available upon request. Forward primer:
(CENPB-For1) 5′-TAAGCAACCGGTATGGGCCCCAAGAGGCGACAG-3′;
Reverse primer: (CENPB-linker-Rev1)5′-TAAGCAACCGGTCTAGCACTT
GCGCCCCCAGCACTTGCTCCACCGGCCGGACTG GCAGGCGCCGC-3′
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that the data supporting the ﬁndings of this study are available
within the paper and its Supplementary information ﬁles. Raw imaging data are available
from the corresponding author upon reasonable request.
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ARTICLE
53BP1 can limit sister-chromatid rupture and
rearrangements driven by a distinct ultraﬁne DNA
bridging-breakage process
Ankana Tiwari1, Owen Addis Jones1 & Kok-Lung Chan 1
Chromosome missegregation acts as one of the driving forces for chromosome instability and
cancer development. Here, we ﬁnd that in human cancer cells, HeLa and U2OS, depletion of
53BP1 (p53-binding protein 1) exacerbates chromosome non-disjunction resulting from a new
type of sister-chromatid intertwinement, which is distinct from FANCD2-associated ultraﬁne
DNA bridges (UFBs) induced by replication stress. Importantly, the sister DNA intertwine-
ments trigger gross chromosomal rearrangements through a distinct process, named
sister-chromatid rupture and bridging. In contrast to conventional anaphase bridge-breakage
models, we demonstrate that chromatid axes of the intertwined sister-chromatids rupture
prior to the breakage of the DNA bridges. Consequently, the ruptured sister arms remain
tethered and cause signature chromosome rearrangements, including whole-arm
(Robertsonian-like) translocation/deletion and isochromosome formation. Therefore, our
study reveals a hitherto unreported chromatid damage phenomenon mediated by sister
DNA intertwinements that may help to explain the development of complex karyotypes in
tumour cells.
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Gross chromosome rearrangements, as a result of chro-mosomal instability (CIN) is a hallmark of most, if not all,tumour cells; however, the underlying mechanism is not
fully understood. It is generally accepted that CIN contributes to
the initiation of tumorigenesis, metastasis progression and mul-
tidrug resistance1,2. One of the major causes of CIN can be
attributed to defects in mitosis such as chromosome mis-
alignments and chromatid non-disjunction, which manifest in
the form of lagging chromosomes and anaphase bridges. Gen-
erally, lagging chromosomes are generated because of
kinetochore-microtubule attachment errors, which not only leads
to imbalanced chromosome transmission3, but also to structural
chromosome rearrangements in both a cytokinesis-dependent
and cytokinesis-independent manner4,5. Additionally, anaphase
bridges are generated by abnormal conﬁgurations of chromo-
somes, such as fusions of chromosomes/sister-chromatid arms, or
via dysfunctional telomeres6. It has been proposed by McClintock
that anaphase bridges drive chromosomal rearrangements
through a so-called breakage-fusion-bridge (BFB) cycle, where
multiple rounds of the joined chromatid bridges break apart
during telophase (or cytokinesis) and re-fusing occurs7,8.
Recently, an elegant study has shown that the breakage of chro-
matin bridges can be triggered by a cytoplasmic nuclease, TREX1,
at telophase-G1 transition and leads to chromothripsis9.
Previously, we and others have shown that replication of stress-
induced DNA entanglements, which are associated with the
FANCD2/I dimer, can be carried into mitosis, manifesting as so-
called ultraﬁne DNA bridges (UFBs) in human anaphase
cells10–15. The resolution of which also leads to DNA damage in the
daughter offspring cells16–18. It is speculated that this is a result of
the separation of DNA intertwining structures at under-replicated
regions between sister chromatids19. Therefore, the accumulation
of DNA entanglements arising during DNA replication and/or
homologous recombination (HR) should be limited; otherwise, this
could pose substantial threats to chromosome segregation and
genome integrity. It is conceivable that this could be more pro-
blematic to cancerous cells that bear high intrinsic DNA replica-
tion/recombination activities. In fact, a recent study has shown the
association of replication stress and CIN20. Nevertheless, it remains
enigmatic how ultraﬁne DNA bridging structures may affect
faithful chromosome segregation and genome stability.
Here, we have determined that human cancer cells (HeLa and
U2OS) rely heavily on a non-homologous end-joining (NHEJ)
factor 53BP121,22, for chromosome segregation, by limiting the
formation of a new type of sister DNA intertwining structure that
is not associated with FANCD2, but is dependent of RAD51.
Intriguingly, we demonstrate that these sister DNA entangle-
ments drive a novel chromatid damage phenomenon, which
induces a rupture of the sister-chromatid axes prior to the
breakage of the intertwining DNA bridges. As a result, the rup-
tured sister chromatids remain tethered by the ultraﬁne DNA
molecules and failed to fully disjoin. Depending on the rupture-
bridging positions, this process drives typical and signature
chromosome rearrangements, including whole-arm (Robertso-
nian-like) translocations and isochromosome formation, which
are commonly observed in tumour cells. The chromatid rupture-
bridging phenomenon is also observed in several unmodiﬁed
cancer cell lines, suggesting that this alternative mitotic damage
action may contribute to the evolution of their karyotypes. In this
study, we reveal a new ultraﬁne DNA bridge-breakage process
that drives gross chromosomal rearrangements in cultured
human cancer cells, which is regulated by 53BP1.
Results
53BP1 co-localises adjacently to FANCD2 in normal S phase.
The Fanconi anaemia (FA) pathway is activated during S-phase
progression23. Previously, we showed that, under replication
stress, foci of the FANCD2/I heterodimer persist into mitosis, and
subsequently associates with a subclass of UFBs in anaphase
cells10. Furthermore, the defects in the FA pathway increase
chromosome missegregation11, implying their roles in the for-
mation of DNA intertwining structures. Unresolved DNA
entanglements can interfere with faithful chromosome segrega-
tion and genome stability. Therefore, to gain insight into how
cells prevent DNA entanglements arising during replication, we
searched for proteins that co-localise with FANCD2 during
unperturbed S phase. We found that 53BP1 forms spontaneous
nuclear foci during DNA replication in both normal diploid and
cancer cells (Supplementary Fig. 1a, b), where more than half of
them surround the FANCD2 foci (Supplementary Fig. 1c, d). This
observation suggests that 53BP1 may also participate in the
process of DNA replication and/or HR.
Generation of 53BP1Δ and 53BP1hypo cancer and normal cells.
To explore the role of 53BP1, we generated 53BP1 knockouts in
HeLa cervical carcinoma cells, U2OS osteosarcoma cells and
hTERT-immortalised RPE1 diploid cells by CRISPR-cas9 genome
editing technology. Two guide-RNAs targeting exon 2 and exon
14 of 53BP1 were used. Targeting exon 2 failed to eliminate
53BP1 expression completely in HeLa and RPE1 cells, where
residual full-length like protein, and/or small 53BP1 foci were still
detectable (Supplementary Fig. 2a–d). However, exon 2 targeting
successfully eliminated 53BP1 in U2OS cells (Supplementary
Fig. 2e, f). In contrast, targeting exon 14 efﬁciently eliminated
53BP1 expression in the above three cell lines (Supplementary
Fig. 2c, e–h). DNA sequence analysis on the 53BP1 hypomorphic
(53BP1hypo) HeLa cells detected no wild-type exon 2 sequence,
but three new mutations; all leading to premature translation
termination (Supplementary Fig. 3a–c). We thus speculated that
the 53BP1 hypomorphic expression in HeLa and RPE1 cells
might be due to a leaky expression through a downstream
alternative translation site (Supplementary Fig. 3d). Collectively,
the 53BP1Δ and 53BP1hypo in both cancer and normal cell lines
provide us with useful tools to dissect the functions of 53BP1
during DNA replication.
53BP1 depletion in HeLa and U2OS cells compromises chro-
mosome segregation and cell growth. In the absence of any
exogenous DNA assaults, we found that knocking out 53BP1
(53BP1Δ) caused pronounced chromosome missegregation phe-
notypes, including anaphase bridge and lagging chromatin for-
mation in both U2OS and HeLa cancer cells (Fig. 1a, b). These
mitotic defects were also observed in the HeLa cells expressing
hypomorphic 53BP1 protein (Fig. 1b). In addition, all 53BP1-
depleted U2OS and HeLa cancer cells, including the 53BP1hypo
cells, displayed apparent proliferation retardation (Supplementary
Fig. 4a, b). Notably, 53BP1hypo HeLa cells grew slightly better
than the complete 53BP1Δ cells (Supplementary Fig. 4c), sug-
gesting that a residual activity of 53BP1hypo protein may remain.
The mitotic and growth defect phenotypes, however, were either
not or only moderately detected in 53BP1hypo and 53BP1Δ
RPE1 cells (Fig. 1c & Supplementary Fig. 4d), indicating that
HeLa and U2OS cells exhibit a higher reliance on 53BP1 for
optimal cell division. Stable overexpression of an EGFP-tagged
53BP1 in 53BP1hypo HeLa cells largely rescued the phenotypes of
slow growth and anaphase bridges, but unexpectedly, not lagging
chromatin formation (Supplementary Fig. 5 & see explanation in
Fig. 5f–h below).
53BP1 has been shown to facilitate DNA double-stranded
break (DSB) repair mediated by the NHEJ pathway. We,
therefore, investigated whether the missegregation phenotypes
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observed might relate to the incompetency of NHEJ. In
agreement to other reports22, we found that 53BP1Δ HeLa (D4
& D10) and U2OS (B4, B18, D29 and D30) displayed increased
sensitivities to ionisation radiation (IR) treatments (Supplemen-
tary Fig. 6a, b). Similarly, moderately increased IR sensitivities
were also detected in RPE1 53BP1Δ cells (D6 and D24)
(Supplementary Fig. 6c), although they did not show severe
mitotic and growth defects. Intriguingly, we found that HeLa
53BP1hypo cells, which exhibited elevated chromosome misse-
gregation, were not sensitive to IR treatments (Fig. 1d). As
predicted, we observed colocalisation of γH2AX and hypo-
morphic 53BP1 protein at damage foci, but of a much smaller size
(Fig. 1e). In addition, the recruitment of 53BP1 to its binding
partner, hRIF124–26, was still evident in these cells
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(Supplementary Fig. 6d). Consistently, RPE1 53BP1hypo cells also
maintained IR resistance despite having very-low 53BP1 expres-
sion (Supplementary Fig. 6e). Telomere-end fusion assays
revealed that HeLa 53BP1hypo cells still exhibited a higher activity
of end-joining compared with 53BP1Δ cells, but slightly lower
than the parental HeLa cells (Fig. 1f).27,28. These results indicate
that the hypomorphic 53BP1 protein remains competent, at least
partially, in NHEJ repair of exogenously induced DSBs. There-
fore, we conclude that the increased susceptibilities to the mitotic
defects in HeLa and U2OS cancer cells after 53BP1 depletion
cannot be merely attributed to NHEJ incompetency. The high
reliance of 53BP1 activities in these cancer cell lines, is likely not
only because of its necessity for NHEJ repair, but also for a
function in facilitating chromosome segregation under physiolo-
gical growth conditions.
53BP1 suppresses sister DNA intertwining in cultured cancer
cells. We noticed that there were distinct chromatid non-
disjunction features in 53BP1-depleted cancer cells, namely a
delay of chromosome separation, manifesting as bridge-like
structures (Fig. 2a; arrows) and the formation of multiple lagging
chromatin, notably existing as a symmetric pair (Fig. 2a, b;
arrowheads). These non-disjunction patterns indicated that they
might be caused by ultraﬁne DNA intertwinements that we and
the others previously identiﬁed12,13. Immunoﬂuorescence stain-
ing of UFB-binding proteins, such as PICH and hRIF112,29,
revealed that the characteristic anaphase bridge(-like) structures
and lagging chromatin pairs were indeed tethered by UFBs
(Fig. 2c, d). As predicted, the frequency and number of UFBs
were signiﬁcantly increased in both 53BP1Δ and 53BP1hypo
cancer cells (Fig. 2e, f), suggesting that 53BP1 is required for the
suppression of UFB formation.
Chromatin bridges in anaphase can be caused by inter-
chromosomal linkage formed in dicentric or radial chromosomes,
or via sister-chromatid intertwining. To distinguish these, we
developed a protocol using EdU to differentially label one of the
two sister chromatids in mitotic cells (Fig. 3a, b). To avoid
complications arising from NHEJ malfunction, we performed
most of our investigation using HeLa 53BP1hypo cells, which, as
demonstrated above, largely maintain the NHEJ pathway.
Remarkably, almost all anaphase bridges (98%) in the HeLa
53BP1hypo cells displayed a symmetric (but opposite) staining
pattern (Fig. 3c), showing either EdU labelling on one-half of the
DNA bridge (Fig. 3d), or resembling sister-chromatid exchange
(SCE) patterns (Fig. 3e). Similarly, the lagging chromatin pairs
also displayed the symmetric labelling patterns (Fig. 3f), highly
suggesting that the non-disjoined chromatin structures are
composed of sister chromatids. Therefore, we conclude that
53BP1 acts to suppress DNA intertwinements, arising mainly
between sister chromatids. In agreement with this conclusion,
dicentric or radial chromosomes were rarely observed in
metaphase spreads of both 53BP1hypo and 53BP1Δ HeLa cells
(Fig. 3g). We henceforth name this phenomenon as “sister-
chromatid bridging” to distinguish it from the general terminol-
ogy of anaphase bridges.
The FANCD2 non-associated sister UFB is RAD51-dependent.
DNA catenation, (sister-)telomere fusion or replication stress can
lead to UFB formation19,30–32. The fact that 53BP1 accumulates
adjacently to FANCD2 foci during S phase led us to speculate that
its deﬁciency might exacerbate replication stress particularly in
these cancer cells, mimicking the effect of DNA polymerase
inhibition induced by aphidicolin treatments, which causes the
accumulation of late replication intermediates (LRIs) and the
formation of UFBs positive for FANCD2 foci10,11 (Supplemen-
tary Fig. 7a). Contrary to our hypothesis, we found that 53BP1
depletion in HeLa and U2OS cells signiﬁcantly increased ana-
phase populations having FANCD2-negative UFBs (Fig. 4a). In
contrast to aphidicolin-induced replication stress, it mainly
increased anaphase cells with FANCD2-positive, but not the
FANCD2-negative UFBs (Supplementary Fig. 7a). Consistently,
most of the UFBs (56–86%) detected in the 53BP1-depleted cells
are FANCD2 negative, except when the 53BP1hypo cells were pre-
treated with aphidicolin, which increased the proportion of UFBs
positive for FANCD2 foci from 14 to 55% (Fig. 4b & Supple-
mentary Fig. 7b). These results suggest that a new subclass of
sister DNA bridge arises in these cancer cells when 53BP1
activities become limiting. Moreover, this also indicates that the
FA pathway is not compromised in 53BP1hypo cells, which is
further supported by the fact that, like the parental HeLa, aphi-
dicolin treatment readily elevated mitotic FANCD2 foci in the
53BP1hypo cells (Supplementary Fig. 7c, d). The lack of increased
replication stress phenotypes, including spontaneously elevated
FANCD2 mitotic foci, abnormal S phase accumulation and
increased common fragile site (CFS) expression (Supplementary
Fig. 7c–f), highly suggests that the induction of FANCD2-
negative UFB formation in the 53BP1-depleted cells is unlikely
caused by the same mechanism of replication stress, induced by
DNA polymerase inhibition.
A very characteristic feature of the anaphase bridge observed in
the 53BP1hypo cells is that the sister-chromatid arms are tethered
by UFBs. We found that nearly 75% of the associated
chromosomes were positive for γH2AX signal (Fig. 4d, e),
implicating a DNA damage response acting in this phenomenon.
The fact that most of the UFB-tethered chromatin bridges arise
originally from sister chromatids and negative of FANCD2
binding infers that their formation may associate with HR
activity. To test this, we knocked down RAD51, a key initiation
factor of HR33 in HeLa 53BP1hypo cells (Fig. 4f). As shown
previously, RAD51 depletion led to increased replication stress10,
and hence elevated the anaphase population having FANCD2-
postive UFBs (Fig. 4g, h). Crucially, the RAD51 knockdown
Fig. 1 53BP1 depletion leads to increased chromosome non-disjunction in human cancer cells. Quantitation of anaphase bridge and lagging chromatin in
53BP1Δ and 53BP1hypo cells a U2OS, b HeLa and c RPE1. Numbers of cell counted: U2OS= 529, B4= 327, B18= 344, D29= 372; HeLa= 540, B2= 351,
D4= 426, D10= 317; RPE1= 435, B7= 449, D6= 382, D24= 458 from 3–4 separate preparations. d IR sensitivity assay on HeLa and B2 (53BP1hypo) cells
(N= three independent experiments). Statistical signiﬁcance was determined by two-way ANOVA. e The formation of IR-induced DNA damage foci in
HeLa and B2 (53BP1hypo) cells. Thirty minutes post 2 Gy IR, the cells were immunostained with anti-53BP1 and anti-γH2AX antibodies. Enlarged regions
demonstrating the recruitment of 53BP1 (red) at the IR-induced DNA breaks, marked by γH2AX (green). f Representative image of telomere fusions on
metaphase chromosomes of B2 (53BP1hypo) cells overexpressing TRF2ΔBΔM. An example of fusions on single (arrowheads) and both (arrows) sister
telomeres indicated (left). Middle: percentage of chromosome fusion events in HeLa, B2 (53BP1hypo), D4 and D10 (53BP1Δ) cells, >75 metaphases of each
cell line were analysed from three independent experiments. Right: histogram showing telomere fusion events in HeLa, B2 (53BP1hypo), D4 and D10
(53BP1Δ). Total number of chromosomes analysed in HeLa= 3890, B2= 3792, D4= 4720 and D10= 4790 from >60 metaphase spreads. Statistical
signiﬁcance was determined by T-test (* p< 0.0, ** p< 0.01, *** p< 0.001, ns nonsigniﬁcant). Error bars represent s.d. of three independent experiments.
Scale bars, 5 μm
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Fig. 2 Chromosome non-disjunction in 53BP1-depleted cancer cells is mediated by ultraﬁne DNA bridges. a Representative images of DAPI-stained HeLa
D4 (53BP1Δ), HeLa B2 (53BP1hypo) and U2OS B18 (53BP1Δ) cells showing anaphase bridges, bridge-like structures and lagging chromatin pairs
(arrowheads). Insets show enlarged view of the numbered cells exhibiting bridge-like (arrows; 1 & 3), bridge structures (arrow; 2). b Increased formation of
multi-lagging chromosomes in HeLa B2 (53BP1hypo) cells as compared to HeLa. Quantiﬁcation of single or multiple lagging chromatin in HeLa and B2
(53BP1hypo) cells. more than 100 cells with lagging chromatin were counted from three separate preparations. c Deconvolved high-resolution images
showing the two separating chromatin arms (red) connected by PICH-UFBs (green) in HeLa B2 (53BP1hypo, Left) and in U2OS B18 (53BP1Δ, Right). Insets
shows enlarged views of the selected region. d Deconvolved image showing hRIF1 (red) localises at a PICH-coated UFB (green), intertwining a pair of
lagging chromatin in HeLa B2 (53BP1hypo). Inset shows enlarged view of selected region. e Percentage of mid-anaphase cells with PICH-UFBs in U2OS B18
(53BP1Δ), HeLa D4 (53BP1Δ) and HeLa B2 (53BP1hypo). Numbers of anaphase counted: U2OS= 91, B18= 90; HeLa= 123, D4= 105; HeLa= 138, B2= 139
from three separate preparations. f Average number of PICH-UFB per mid-anaphase cell in U2OS B18 (53BP1Δ), HeLa D4 (53BP1Δ) and HeLa B2
(53BP1hypo). Error bars represent s.d. of three independent experiments. Statistical signiﬁcance was determined by T-test (* p< 0.05, ** p< 0.01,
*** p< 0.001). Scale bars, 5 μm
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signiﬁcantly diminished the percentage of the 53BP1hypo
anaphase cells having the FANCD2-negative UFBs (Fig. 4i).
These results indicate that the increased formation of FANCD2-
negative sister DNA bridges in 53BP1hypo cells is dependent on
the HR activity. It is plausible that (partial) loss of 53BP1 function
may increase a distinct type of replication difﬁculty, which is
converted into the sister DNA intertwinements by HR reaction.
Alternatively, 53BP1 may prevent the formation of, or facilitate
resolution of, HR intermediates (Fig. 4j). In fact, we detected
increases in SCEs in the 53BP1hypo HeLa cells (Supplementary
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Fig. 8a). However, we cannot rule out that this may be also be due
to impairments of non-crossing over resolution activity.
Contrary to our speculation, a recent report suggested that
53BP1 is required for high ﬁdelity of HR repair on double-ended
DSBs, probably through the prevention of exacerbated DNA end
resection that channels excessive single-stranded annealing (SSA)
reaction34. However, we did not detect signiﬁcant changes in the
ssDNA formation (as measured by chromatin-bound RPA) in
unperturbed 53BP1hypo S-phase cells (Supplementary Fig. 8b). It
is possible that 53BP1 may inﬂuence HR ﬁdelity differently on
double-ended and single-ended DSBs, where the latter (associated
with replication forks) is not an ideal substrate for SSA even if
excessive DNA end resection occurs. On the other hand, loss of
53BP1, as shown previously to rescue HR in brca1−/− cells35,
may further relieve the constraints of HR at damaged forks.
Nevertheless, our data demonstrate that the HR pathway
participates to a certain extent on the formation/accumulation
of the FANCD2-negative sister-chromatid bridges in the
53BP1hypo cells.
DNA intertwinements lead to sister-chromatid rupture. We
next characterised this subclass of sister-chromatid bridges and
their effects on chromosome integrity. A very striking feature of
the FANCD2-negative UFBs is that they were frequently found to
emerge at the terminal regions of the separating or lagging sister
chromatids, which could represent telomeres32. Alternatively, this
may be explained as a result of two sister arms being tethered by
UFBs, leading to their termini pointing towards each other during
segregation (Fig. 5a). According to these hypotheses, telomeres
are expected to be always present on anaphase/DNA bridges as
shown as an example in Fig. 5b. Surprisingly, telomeres were
rarely found on the DNA bridges and, indeed, they were missing
at the UFB-tethered sister chromatids (Fig. 5c, d). In contrast,
inter-chromosomal fusion generated by overexpression of
TRF2ΔBΔM, as expected, led to the majority of anaphase bridges
linking via their telomeres (Fig. 5d, e; arrows), validating our
ability to detect such events when they arise. In parallel, we
observed the loss of telomeric regions on the lagging chromatid
pairs, speciﬁcally at the chromosomal termini where the UFBs
emerged (Fig. 5f; asterisks). A simple interpretation of these
results is that the UFB-tethered sister chromatids (whether they
exist as anaphase bridges or lagging chromatin) are broken
chromosomes. Most notably, the breakage of the sister-chromatid
axes occurred at the sites where the ultraﬁne DNA linkage
emerged and persisted.
53BP1 localises to kinetochores in early mitosis36. A previous
study has reported that 53BP1 knockdown can cause
kinetochore-microtubule attachment errors and the subsequent
formation of lagging chromosomes37. However, our extensive
chromosome analyses in anaphase cells have led us to reveal an
alternative explanation for the missegregation phenotype. The
facts that genuine intact lagging chromosomes were not detected
and the presence of UFB stretching between the lagging
chromatin pairs highly indicate that the missegregation is caused
by persistent DNA intertwinements rather than kinetochore-
microtubule mis-attachment38. Because of the unexpected ﬁnding
of chromatid breakage, we re-examined the failure of an EGFP-
53BP1 wild-type protein to suppress lagging chromatin in HeLa
53BP1hypo cells (as shown in Supplementary Fig. 5d). We found
that the ectopic overexpression of 53BP1 successfully reduced the
formation of the broken lagging chromatin pairs (Fig. 5g; single
telomere end). However, it also generated extra intact lagging
chromosomes (Fig. 5g, h). Thus, the overall anaphase population
with lagging chromatin remained unchanged. These data indicate
that overexpression, but not depletion, of 53BP1 probably
interferes with proper kinetochore-microtubule attachment.
More importantly, we found that the sister DNA bridges not
only caused distinct chromatid non-disjunction, but also led to
the identiﬁcation of a new mitotic damage phenomenon, we
termed sister-chromatid rupture and bridging. Contrary to
conventional anaphase bridge-breakage models, our data clearly
show that the occurrence of DNA damage on the intertwined
sister chromatids is not coupled to the breakage of the DNA
bridges and is independent of cytokinesis.
Sister-chromatid rupture occurs strictly upon anaphase onset.
One plausible explanation for the appearance of the ruptured (but
remaining intertwined) sister chromatids during anaphase is that
they have already broken during DNA replication. If this is
correct, we should expect to see chromosomes with broken arms
or sister-chromatid arm fusion7 in (pro)metaphase cells (Sup-
plementary Fig. 9a). Of the thousands of metaphase chromo-
somes analysed on both 53BP1Δ and 53BP1hypo HeLa cells, we
found that almost all (>99.9%) were in a normal intact conﬁg-
uration (both termini were present). Only <3% of metaphases
showed evidence of a chromosome with a sister-arm fusion
(Supplementary Fig. 9b), which cannot explain the high fraction
(>30%) of anaphase cells harbouring ruptured sister-chromatid
bridges or lagging chromatin. Thus, the chromatid breakage is
inferred to occur after anaphase onset. Next, we tested if the
microtubule pulling on the intertwined chromatids causes the
rupture. We triggered premature sister-chromatid separation by
knocking down Sgo1 in 53BP1hypo (pro)metaphase cells.
Fig. 4 The formation of sister DNA entanglements in 53BP1-depleted HeLa cells is dependent on RAD51. a Quantitation of 53BP1-depleted HeLa (left) and
U2OS (right) anaphase cells forming FANCD2-negative UFBs. Numbers of anaphase counted: HeLa= 135, B2= 112, D4= 105; U2OS= 91, B18= 90 from
three independent experiments. b Maximum z-projection high-resolution image showing multiple short FANCD2-negative PICH-coated UFBs (arrows),
linking the separating chromatin and lagging chromosomes in B2 (53BP1hypo) cells. Inset shows that PICH stained UFBs (green) are not associated with
FANCD2 foci (red). c Maximum z-projection high-resolution image showing the association of FANCD2 foci (red) on PICH-UFBs (green) in aphidicolin-
treated HeLa B2 (53BP1hypo) cells. Inset shows enlarged view of PICH-coated UFBs are positive of FANCD2 foci at their termini. d Representative images
showing γH2AX present on chromatin bridges and lagging chromatin pairs in HeLa 53BP1hypo cells. Left: maximum z-projection image showing γH2AX
(red) at the junction (arrows) of the differentially labelled sister-chromatid bridges (EdU; green). Right: a pair of lagging sister chromatin intertwined by a
PICH-UFB (red) and positive of γH2AX (blue) at their termini. Bottom Right: panels showing single-plane images of the intertwining lagging sister
chromatin. Blue arrows indicate γH2AX present at the tips of the chromatin. e HeLa B2 (53BP1hypo) cell showing the presence of γH2AX signals (red) at
the termini of chromatin that were tethered by PICH-coated UFBs (green). f HeLa B2 (53BP1hypo) cells were transfected with control or Rad51 siRNA oligos,
followed by IF analysis using anti-Rad51. Nuclei are outlined (grey). g RAD51 knockdown caused the formation of FANCD2-assoicated (red) PICH-UFBs
(green) in HeLa B2 (53BP1hypo) cells. h Quantitation of HeLa B2 (53BP1hypo) anaphase cells with FANCD2-positive UFBs following RAD51 knockdown. i
Quantitation of HeLa B2 (53BP1hypo) anaphase cells with FANCD2-negative UFBs following RAD51 knockdown. Numbers of anaphase cells scored: B2 +
control siRNA= 350, B2 + RAD51 siRNA= 220 from three independent experiments. j A model showing the potential roles of 53BP1 and RAD51 in the
formation of FANCD2-negative sister DNA bridges in the 53BP1-depleted cells. Error bars represent s.d of three independent experiments. Statistical
signiﬁcance was determined by T-test (* p< 0.05, ** p< 0.01, *** p< 0.001). Scale bars, 5 μm
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Although we detected increase in chromatin breakage on single
chromatids (Supplementary Fig. 9c; 10% in HeLa and 15% in B2
53BP1hypo cells), the frequency was still lower than the observed
one in anaphase (>30%). Collectively, these data strongly indicate
that the rupture of the sister-chromatid axes occurs strictly after
anaphase onset, which may infer their damage is mediated by
factors requiring APC/C activation rather than merely spindle
pulling.
Sister-chromatid rupture exacerbates chromosomal rearran-
gements. A prediction arising from the above ﬁndings is that it
will lead to chromosomal damage and CIN in the offspring cells.
In agreement with this, we observed increased numbers of G1
53BP1 nuclear bodies in HeLa 53BP1hypo daughter cells (Sup-
plementary Fig. 9d). Additionally, we observed an increase in
numerical chromosome alterations. Interestingly, chromosome
loss, over gain, seemed to be dominant in all 53BP1hypo clones
(Supplementary Fig. 10a). Next, we examined the structural
chromosome alterations. Although, the HeLa cancer genome is
considered unstable, we found that their karyotypes are relatively
stable, as reported previously39. Whole chromosome painting and
ﬂuorescence in situ hybridisation (FISH) analyses revealed that all
HeLa cells maintained four copies of chromosome7 plus one
derivative, whereas the majority of them (94%) maintaining three
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copies of chromosome16 and a 16p derivative, (6% with two
chr16 + one derivative) (Supplementary Fig. 10b, c). However, in
the 53BP1-depleted (53BP1hypo and 53BP1Δ) HeLa cells, we
found a variety of structural rearrangements on these chromo-
somes. They included deletions and translocations on the distal
arm of 16q, chr7 and 16 whole-arm deletion, chr7 and 16 whole-
arm (Robertsonian-like) translocations and 16p/16q isochromo-
some formation (Fig. 6a–e). Crucially, such rearrangements were
never observed in the parental HeLa cells (Fig. 6f). A common
breakpoint was assigned at a site just upstream of a common
fragile site (CFS), FRA16D, in the WWOX locus, while interest-
ingly another one was mapped to, or very close to, centromeres.
Together, these results suggest that the sister-chromatid rupture
in anaphase can lead to gross chromosome rearrangements.
Chromosome rearrangements link to sister-chromatid brid-
ging. To provide further evidence that the observed rearrange-
ments are directly related to the sister-chromatid rupture/
bridging, we carefully examined the existence of DNA entangle-
ments at these regions. By extending our FISH probes along the
FRA16D/WWOX locus (Fig. 7a), we revealed a hitherto uni-
dentiﬁed DNA thread structure linking the sister chromatids in
53BP1hypo HeLa metaphase spreads (but not in the parental HeLa
cells), which presumably is a precursor of the sister DNA bridging
structures in anaphase. It was mapped at the promoter (91O9), or
the gene body (264L1), of the WWOX locus (Fig. 7b–d; arrows
and Supplementary Fig. 10d). To our knowledge, this is the ﬁrst
time that a genuine DNA intertwining molecule on cohesed sister
chromatids has been visualised and mapped. Importantly, CFS
fragility was not observed in the intertwined FRA16D locus,
which supports our above data that the intertwining molecule is
unlikely originating from an incomplete replication intermediate.
By measuring inter-sister locus distances, we determined that the
promoter region (91O9) of one WWOX allele displayed the
highest frequency of DNA thread formation, something that was
absent in a region 2.7 Mb upstream (352J17) (Fig. 7d). Correla-
tively, this new form of DNA thread structure was found in
53BP1hypo clones (B2 and b9), each of which also harboured the
corresponding rearrangements at 16q distal regions in the new
derivative chromosome. By contrast, the 53BP1hypo clone (b15)
did not show either of these features. These observations
demonstrate a high correlation between region-speciﬁc rearran-
gements and sister DNA bridging.
We next investigated whether centromeres, another hotspot of
rearrangements, also have high incidence of rupture/bridging.
Because centromeres remain cohesed in early mitosis, we
examined the chromatin bridges and lagging chromatin
structures in anaphase cells. We did not observe centromeres
on the UFB-tethered chromatin bridges. Instead, centromeres
were detected at the point at which the vast majority of lagging
chromatin was intertwined (Fig. 7e, f). Importantly, the
centromeres were located at the chromatid ends where the
telomeric regions (or the distal arms) were missing, but remained
tethered (Fig. 7g). Live-cell imaging of 53BP1hypo (B2) cells stably
expressing mCherry-H2B revealed that the lagging chromatin
pairs failed to disjoin and co-segregated into the same daughter
cell (Supplementary Fig. 10e). This is presumably due to the
persistent DNA tethering at their sister centromeres counter-
acting the spindle-separation force. The co-segregation of
ruptured sister whole-arms, thus provides an ideal precursor for
isochromosome formation that was found in these cells. Taken
together, our study reveals that the illegitimate sister DNA
entanglements can drive gross chromosomal rearrangements via
a distinct sister-chromatid rupture-bridging action that has never
been reported before.
Sister-chromatid rupture occurs in cultured cancer cells. We
next addressed if this phenomenon is limited in the 53BP1-
depleted cancer cells, or occurs generally in other unmodiﬁed
human cancer cells. We carefully characterised the mis-
segregating chromatin in anaphases of a variety of human can-
cer cell lines, including HeLa, U2OS, Saos-2 and HCT116, in the
absence of exogenous perturbation. As expected, we observed
spontaneous chromosome missegregeation in these cells, but
most importantly, we detected a subset of non-disjunction fol-
lowing a similar pattern of sister-chromatid rupture and bridging
(Fig. 7h; HeLa (10%), U2OS (7%), Saos-2 (8%) and HCT116
(13%). Thus, our results highly suggest that in addition to the
conventional anaphase bridge-breakage mechanism, sister DNA
intertwining structures may contribute to inﬂuence the complex
karyotypes during cancer evolution. Indeed, we have determined
that the HeLa genome harbours several Robertsonian(-like)
translocations or deletions, they involved chromosomes 1, 3, 7, 9,
15 and 16 (Supplementary Fig. 11), and more reported pre-
viously39. Thus, our study of sister-chromatid rupture and brid-
ging may provide an alternative explanation for their formation.
In summary, we have revealed a distinct sister-chromatid
rupture and bridging phenomenon for how ultraﬁne sister DNA
entanglements may drive excessive gross chromosome rearrange-
ments that can be suppressed by 53BP1 in cultured cancer cells
(Fig. 8). Our study may provide an alternative explanation of how
complex karyotypes arise during cancer developments in the
context of illegitimate formation and resolution of sister DNA
intertwinements.
Fig. 5 Sister-chromatid rupture is associated with HR-mediated DNA intertwining. a Diagram depicting the formation of telomere-positive DNA bridges,
resulting from DNA entanglements between sister chromatids. b A single-plane high-resolution image showing the presence of telomeres (red) at the
termini of chromatin tethered by an UFB (PICH; green) in a HeLa B2 (53BP1hypo) anaphase cell. c Maximum z-projection image of an UFB-tethered
chromatin bridge missing telomeric regions (asterisks) at their terminal ends in HeLa B2 (53BP1hypo) (left) and in U20S B18 (53BP1Δ) cells (right). Insets
show enlarged images of the DNA/chromatin bridges. d Quantitation of DAPI bridges with and without telomeres in HeLa, HeLa 53BP1hypo, U2OS 53BP1Δ
and in HeLa 53BP1hypo cells overexpressing TRF2ΔBΔM. Note: Majority of DNA bridges are negative for telomere signals in 53BP1-depleted cells, except
after TRF2ΔBΔM overexpression. Total numbers of DAPI bridge analysed were B2= 85, B2 + TRF2ΔBΔM= 60, D4= 45 and B18= 55 from three
independent experiments. Statistical signiﬁcance was determined by T-test (***, p< 0.001). e A representative image showing telomeres were detected on
chromatin bridges induced by telomere end-joining. Inset indicates the presence of telomere signals (green) at chromatin bridges (arrows). f
Representative images of HeLa B2 (53BP1hypo) cells showing UFBs tethering a pair of lagging chromatin at their termini, at where telomere (red) signals are
absent (asterisks), but remained connected by PICH-UFBs. Insets showing consecutive single z-plane images of the lagging chromatin. g Quantitation of
telomeres present at one or both ends of lagging chromatin pairs. Note that all lagging chromatin pairs lack one telomere end in HeLa B2 (53BP1hypo) and
D4 (53BP1Δ) cells. In contrast, HeLa 53BP1hypo cells stably overexpressing GFP-tagged 53BP1 (B2G53BP1) cells contain lagging chromatin having telomere
signals at both, or single ends. Total numbers of lagging chromatin pair analysed were B2= 35, D4= 41 and B2G53BP1= 44, from three independent
experiments. h Representative images of B2G53BP1 cells showing intact lagging chromosome with telomere signals (red) at both termini. Insets showing
enlarged view of the lagging chromatin with telomere signals present at both their termini. Error bars represent s.d of three independent experiments. Scale
bars, 5 μm
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Fig. 6 Gross chromosomal hyper-rearrangements mediated by sister-chromatid bridging in 53BP1-depleted cancer cells. a Formation of new chromosome
16 and 7 derivatives in HeLa 53BP1hypo and 53BP1Δ clones. Left panels: whole chromosome 16 painting revealing 16p arm deletion and arm/centromeric
translocations in HeLa b9 (53BP1hypo) cells. Middle panels: 16q deletions and arm/centromeric translocations in HeLa B2 (53BP1hypo) cells;
Isochromosome 16q formation in HeLa b15 (53BP1hypo) cells. Right panels: whole chromosome 7 painting revealing centromeric translocation in HeLa D4
(53BP1Δ) cells and arm deletion and centromeric translocation in HeLa B2 (53BP1hypo) cells. b Ideogram of human chromosome 16, marking the positions
of FISH probes used in Fig. 6c–f. c 16q distal arm deletion, centromeric translocation and 16p isochromosome formation was identiﬁed in HeLa B2
(53BP1hypo) populations with the indicated percentages. d 16p whole-arm deletion, 16q whole-arm translocation and 16q distal-arm translocation were
detected in HeLa b9 (53BP1hypo) populations with the indicated percentages. e 16q isochromosome formation was detected in HeLa b15 (53BP1hypo)
populations with the indicated percentages. f Normal chromosome 16 showing both p-arm and q-arm is maintained in all HeLa cells
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Discussion
Extensive studies report that 53BP1 facilitates repair of double-
ended DSBs via the NHEJ pathway in G1, by protecting DNA
ends from resection24–26,35, a key initiation step for HR. During S
phase, this activity is neutralised by BRCA1-CtIP, which channels
it to an error-free HR repair pathway40. In the current study, we
have identiﬁed that a new role of 53BP1, shown in HeLa and
U2OS human cancer cells, is to limit the formation of illegitimate
sister DNA entanglements, which otherwise interferes with
proper chromosome segregation. The cultured cancer cells,
91O9 DAPI 352J17
264L1
DAPI
Allele
1
2
91O9 DAPI 352J17
264L1
DAPI91O9 
DAPI
DAPI
91O9 
352J17
264L1
352J17
264L1
DAPI
DAPI
352J17
91O9
352J17
91O9
352J17
91O9
DAPI
DAPI
DAPI
Allele
1
2
3
91O9 allele352J17 allele
HeLa
R
el
at
iv
e 
di
st
an
ce
be
tw
ee
n 
sis
te
r l
oc
i
1
2
1 2 31 2 3
91O9 allele352J17 allele
1 2 31 2 3
91O9 allele352J17 allele
1 21 2
264L191O9352J17
WWOX gene
FRA16D
FISH probe:
352J17
91O9
264L1(FRA16D)
Chr. 16
FISH probe
0.0
0.5
1.0
1.5
2.0
2.5
0.0
0.5
1.0
1.5
2.0
2.5
0.0
0.5
1.0
1.5
2.0
2.5
0.0
0.5
1.0
1.5
2.0
2.5
0.0
0.5
1.0
1.5
2.0
2.5
0.0
0.5
1.0
1.5
2.0
2.5
Allele
***
***
***ns
ns
ns
ns
ns
ns
ns
B2 (53BP1hypo) B2 (53BP1hypo)
B9 (53BP1hypo)
HeLa B9 (53BP1hypo)HeLa B2 (53BP1hypo)
DAPI
PICH
Telo
CENPB
CEN
Telomere
UFB
*
*
DAPI
PICH
CEN
UFB
UFB
DAPI
PICH
CEN
UFB
CEN
CEN
CEN
*
DAPI EdU PICHCENPB
Centromere-tethered lagging sister chromatin
gf
h
1
1
2 2
HeLa (10%)
DAPI
PICH
Telo
CEN
Telomere
CEN
UFB
*
*
*
*
Saos-2 (8%)
DAPI
PICH
Telo
CEN
*
*
UFB
*
Telomere
U2OS (7%)
* *
*UFB
Telomere
DAPI
PICH
Telo
CEN
Centromere
UFB
Sister chr. Sister chr.
Centromere
UFB
0%
20%
40%
60%
80%
100%
CE
N 
+v
e
CE
N 
–v
e
CE
N 
+v
e
CE
N 
–v
e%
 L
ag
gi
ng
 p
ai
rs
 lin
kin
g 
at
o
r 
o
u
ts
id
e 
ce
nt
ro
m
er
es *** ***
HeLa B2 (53BP1hypo)
HeLa
53BP1Δ(D4)
HeLa
53BP1hypo(B2)
HeLa B2(53BP1hypo)
HeLa D4 (53BP1Δ)
U2OS B18 (53BP1Δ)
a
b c
d
e
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03098-y
12 NATURE COMMUNICATIONS |  (2018) 9:677 |DOI: 10.1038/s41467-018-03098-y |www.nature.com/naturecommunications
however, not normal diploid cells, are more susceptible to the loss
of 53BP1 activities, even when NHEJ function is not fully com-
promised. This may reﬂect that 53BP1 has a cell-type speciﬁc
function. Alternatively, cancerous cell lines may bear high gen-
ome instability, DNA replication demands and/or recombination
activities, which predispose the formation or accumulation of
sister DNA intertwining molecules when 53BP1 activity is lim-
ited. Indeed, transformed cells—including HeLa—are reported to
display >3-fold increase in HR activity41. A striking consequence
of 53BP1 depletion in these cancer cells is the elevation of UFB
formation that is not associated with the FANCD2 protein (a
marker of replication stress or DNA crosslinking). Interestingly,
the DNA intertwinements are still found at a common fragile site,
but this is not coupled to chromosomal fragility (the latter being a
feature of replication stress induced by DNA polymerase inhibi-
tion or DNA repair deﬁciency42–46). The lack of fragility at these
sites suggest that the new form of UFB caused by 53BP1-
deﬁciency in the cancer cells, may be fundamentally different
from those originating from LRIs. The fact that depleting RAD51
can signiﬁcantly diminish the FANCD2-negative UFBs makes us
believe that they are likely a by-product of a HR reaction.
However, we cannot rule out that there is a distinct form of
replication intermediate structure that does not trigger the FA
pathway and chromosomal fragility, and then again retains the
intertwining of sister chromatids.
It remains unclear how 53BP1 prevents illegitimate formation
of sister-chromatid bridging in the examined cancer cells. It is
plausible that (partial) loss of 53BP1 function may lead to the
formation of a distinct type of replication intermediate that is
subsequently converted by RAD51 into FANCD2-negative DNA
intertwining molecules, to prevent fork stalling or incomplete
replication. Alternatively, 53BP1 may act to suppress HR initia-
tion and/or promote resolution of HR-mediated joint molecules
during DNA replication (Supplementary Fig. 12). Extensive stu-
dies have shown that 53BP1 exerts DNA end-blocking, but is
counteracted by BRAC1-CtIP during S phase24–26,40. It is con-
ceivable that the (partial) loss of 53BP1 activity may relieve the
constraints of HR initiation at damaged replication forks. On the
other hand, loss of 53BP1 may weaken the anti-recombinogenic
and/or dHJ dissolution activities exerted via interaction of the
BLM complex47–49. Therefore, defects in one or all of these
potential activities may result in excessive formation of sister-
chromatid bridges.
Another striking ﬁnding in the current study is that the new
type of sister DNA intertwinement can drive signature chromo-
some rearrangements, notably, via a distinct chromatid damage
process. We termed this as “sister-chromatid rupture-bridging”.
Models such as BFB cycle have been proposed to explain the
development of gross chromosomal rearrangements via single or
multiple rounds of DNA damage introduced, mostly on chro-
matid arms concomitant with the breakage of anaphase bridges
during or after cytokinesis. Subsequent fusion of the broken arms
leads to re-generation of anaphase bridges and further breakages
in the next cell cycle7,8. Contrary to this mechanism, we found
that the sister DNA intertwinements induce chromatid rupture
upon anaphase onset, and unexpectedly it happens prior to the
breakage of the DNA bridges. Consequently, the ruptured sister
arms remained tethered and gave rise to the characteristic non-
disjunction chromatid products. When occurring at centromeres,
it can drive co-segregation of the ruptured whole-arm chromatin
and the formation of signature chromosomal rearrangements,
including whole-arm (Robertsonian-like) deletions/translocations
and isochromosome formation that are as-yet-unexplained
alterations observed in tumour cells50. Our ﬁndings thus pro-
vide an alternative explanation for how distinct whole-arm
rearrangements may arise from illegitimate sister DNA bridging.
It is conceivable that if the rupture-bridging phenomenon occurs
on rDNA-bearing chromosomes in germ cells, this could lead to
Robertsonian translocations that are present in a subset of Patau
and Down syndrome patients51.
Lagging chromosomes are frequently observed in tumour cells.
Based on our in-depth cytogenetic analyses, we speculate that
some of the reported lagging chromosome formation may not be
due to kinetochore-microtubule attachment errors, but due to the
persistence of sister-chromatid bridges presented here. Further
examinations will need to revisit the origin(s) of chromosome
missegregation in cancers.
CIN is generally thought to be beneﬁcial for tumour progres-
sion1,2. A recent study has shown that whole-arm deletions are
positively correlated with loss of tumour suppressor islands that
may confer growth advantages52. Undoubtedly, 53BP1 serves as a
genome stability guardian and suppresses tumourigenesis as
shown in mouse studies53,54. However, our study also indicates
that in the examined cancer cells, 53BP1 is required to prevent
excessive chromosome missegregation and probably genome
hyper-instability, and also for optimal growth. Thus, we believe
that chromosomal (hyper-)instability may need to be restrained
in cancers, (e.g. by 53BP1-mediated pathway) otherwise the
adverse effects such as chromatid intertwining and unwanted
rearrangements may hinder tumour survival ﬁtness. Thus, tar-
geting the 53BP1 pathway may be, on the other hand, a promising
therapeutic remedy in cancer treatments.
In conclusion, we show a distinct mitotic chromatid rupture-
bridging process mediated by ultraﬁne sister DNA
Fig. 7 Sister-chromatid rupture-bridging is strongly linked to distinct chromosomal rearrangements. a Positions of FISH probes at WWOX gene locus on
chromosome 16. b Representative FISH images showing DNA thread structures linking the promoter region (left) and at CFS-FRA16D site (right) of
WWOX sister alleles on HeLa B2 (53BP1hypo) metaphase chromosomes. c DNA thread structures (91O9 probe; red) were also detected in HeLa b9
(53BP1hypo) cells. Arrows indicate DNA threads linking the well-separated chromatid arms. Probe 352J17 was used as a control. d Relative distance
between sister signals of FISH probes, 352J17 and 91O9, in HeLa and 53BP1hypo cells. FISH signals showing a line or connected dot is considered as zero
distance—DNA thread formation. Eighteen metaphase spreads were counted. Note: HeLa B2 (53BP1hypo) cells retain only two intact WWOX alleles. e
Examples of centromere-tethered lagging sister chromatin in 53BP1-depleted HeLa and U2OS cells. A pair of lagging sister chromatin as differentially
labelled by EdU (green), intertwined by a PICH-UFB (red) at their centromeres (CENB, blue) in HeLa B2 (53BP1hypo) anaphase cell (Top). Pairs of broken
lagging chromatin tethered at centromeres (red) by PICH-UFBs (green) in HeLa D4 (53BP1Δ) (Middle) and U2OS B18 (53BP1Δ) cells (Bottom). f
Frequencies of lagging-chromatin pairs with UFBs linking at centromeres in HeLa 53BP1hypo and 53BP1Δ cells. Numbers of lagging chromatin pairs
analysed, B2= 49 and D4= 44 from three independent experiments. g Immuno-FISH analysis revealed loss of whole chromatid arms on lagging chromatid
pairs tethered by UFBs at centromeres. A representative image of HeLa 53BP1hypo cell showing a PICH-UFB (green) intertwines the sister centromeres
(blue) of a pair of lagging chromatin, at where the telomeres (red) are missing (asterisks). h Frequencies of sister-chromatid rupture-bridging phenomenon
in unperturbed HeLa (4/40; 10%), U2OS (3/43; 7%) and Saos-2 (2/25; 8%) cells. Representative images showing ruptured chromatin tethered by PICH-
UFBs (green), sometimes at centromeres (blue). Asterisks mark the ruptured positions at where the rest of chromatids is lost, as determined by telomere
FISH (red). Scale bars, 5 μm. Error bars represent s.d. of three independent experiments. Statistical signiﬁcance was determined by T-test (***, p< 0.001;
ns, nonsigniﬁcant)
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intertwinements that promotes characteristic chromosomal
rearrangements in 53BP1-depleted human cancer cells.
Methods
Cell culture, treatment and transfection. All cell lines were obtained from Cell
Bank of Genome Damage and Stability Centre and were originally purchased from
ATCC. All cell lines were authenticated by STR genotyping from European
Collection of Cell Cultures and passed mycoplasma tests (Lonza Mycoplasma
testing kit). HeLa, U2OS and SAOS-2 cells were grown in DMEM containing 10%
foetal bovine serum (Gibco), L-glutamine and Pen/Strep antibiotics. RPE1-hTERT
cells were grown in DMEM/F-12 containing 10% foetal bovine serum (Gibco) and
Pen/Strep antibiotics. HCT116 cells were grown in McCoy’s 5 A containing 10%
foetal bovine serum (Gibco), L-glutamine and Pen/Strep antibiotics. HeLa
B2G53BP1 cells were maintained with 0.4 mg/ml G418. Cell cultures were main-
tained at 37 °C in a humidiﬁed atmosphere containing 5% CO2. As indicated, the
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Fig. 8Models of gross chromosomal rearrangements driven by conventional anaphase bridge-breakage and sister-chromatid rupture-bridging pathways. a
Conventional anaphase bridge-breakage (also known as breakage-fusion-bridge cycle) model driven gross chromosomal rearrangements (GCRs). Aberrant
chromatids or chromosomes, such as dicentric/radial chromosomes and sister-arm fusion lead to chromatin bridge formation in anaphase. The breakage of
anaphase bridges during or after cytokinesis results in chromosome damage, which subsequently can lead to deletions, translocations and/or the re-
formation of dicentric chromosomes and sister-arm fusion. Cells enter another anaphase bridge-breakage cycle in the next mitosis that accumulate further
chromosome alterations. b Sister-chromatid rupture-bridging model driven GCRs (in the current study). Illegitimate formation/accumulation of ultraﬁne
sister DNA intertwinements lead to a symmetrical rupture of sister-chromatid axes (asterisks). The resulting sister arms remain tethered by UFB structures
resulting in anaphase bridges or lagging chromatin pairs formation (when the rupture occurs at centromeres). Further breakage may occur on the UFB-
tethered anaphase bridges in late mitosis (e.g. during abscission in cytokinesis), which lead to arm deletions or translocations. On the other hand, the
centromere-tethered lagging chromatin pairs, which lose the entire opposite arms, may escape abscission and co-segregate into one of the daughter cells.
Hence, this provides an ideal precursor for isochromosome formation, or causes whole-arm translocations in the next cell cycle. Our current model,
therefore, provides an alternative explanation on the formation of whole-arm rearrangements that may arise in cancer karyotypes
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cells were treated with the DNA polymerase inhibitor aphidicolin (Sigma, A0781;
0.3 μM).
53BP1-knockout HeLa and RPE1 cells were generated using the CRISPR-Cas9
m, with the following guide-RNAs targeting exon 2
(CAGGTTCTAGAGGATGATTCTGG) for 53BP1hypo and exon 10 (TTTATC
GTTCCTAGCAGTCC) for 53BP1Δ knockout.
Brieﬂy, gene-speciﬁc gRNAs were cloned in pSpCas9(BB)-2A-Puro (Addgene)
containing a puromycin resistance cassette. HeLa cells were transfected (Fugene
HD, Promega) and RPE1 cells were electroporated (Neon Transfection System,
ThermoFisher) with pSpCas9(BB)-2A-Puro-53BP1gRNA. Transfected HeLa,
U2OS and RPE1 cells were selected by 0.25 μg/ml and 2 μg/ml of puromycin,
respectively, for 72 h. B2 (HeLa-53BP1hypo) cells were generated by cotransfecting
pMACSKKII and pSpCas9(BB)-2A-Puro-53BP1gRNA-b in HeLa cells. Forty-eight
hours later, the cells were labelled by MACSselectKKII microbeads and enriched by
MACSselect KKII column without any antibiotic selection.
Individually isolated clones were isolated and screened by immunoblotting and
immunoﬂuorescence. The presence of mutations in knockout cells were identiﬁed
by Sanger sequencing following TA-cloning (35 clones) using primers (Fwd:
CAGGATTGGACACAACATCCTAG; Rev: CTCTCAGCAAGATACTCCTTG
CC). Primers used for 53BP1 wild-type allele-speciﬁc PCR (Fwd; AAGCCAGGT
TCTAGAGGATG; Rev: CTCTCAGCAAGATACTCCTTGCC).
To generate B2G53BP1 cells, full-length pEGFP-C3-53BP1 (isoform1) construct
was transfected in B2 (53BP1hypo) cells and were selected by G418 (0.8 mg/ml) for
2 weeks. Individual clones were screened and cultured.
HeLa or B2 cells were transfected with siRNAs using Lipofectamine RNAiMAX
(Invitrogen) following the manufacturer's instruction. The sequences of stealth
siRNAs (ThermoFisher) are as follows:
RAD51 (CCACCAGACCCAGCUCCUUUAUCAA),
Non-targeting pool (UGGUUUACAUGUCGACUAA,UGGUUUACAUGU
UGUGUGA, UGGUUUACAUGUUUUCUGA and UGGUUUACAUGUUU
UCCUA).
Fluorescence immunostaining. For immunostaining analyses, the cells were
seeded onto No:1.5 H cover glass and ﬁxed with PFA buffer (250 mM HEPES, 1x
PBS, pH7.4, 0.1% Triton X-100, 4% methanol-free paraformaldehyde) for 20 min at
4 °C or with room temperature PFA buffer (1x PBS, 4% methanol-free paraf-
ormaldehyde) for 10 min. Pre-extraction was carried out in indicated experiments
before ﬁxation by incubation of the cover glass into pre-extraction buffer (20 mM
HEPES, pH 7.4, 0.5% Triton X-100, 50 mM NaCl, 3 mM MgCl2, 300 mM sucrose)
for 15 sec.
Primary antibodies used: anti-FANCD2 (Novusbio NB100-82; 1:600), anti-
53BP1 (Abcam ab36823; 1:800), anti-53BP1 (Bethyl Lab A300-272A; 1:1000), anti-
53BP1 (Millipore MAB3802; 1:800), anti-53BP1 (Santa Cruz H-300; 1:400), anti-
RIF1 (Bethyl Lab A300-568A-3; 1:200), anti-PICH (Abnova H00054821-B01P;
1:150), anti-PICH (Abnova; H00054821-D01P; 1:100), anti-γH2AX (Upstate JBW-
301; 1:400), anti-RAD51 (Abcam ab63801; 1:200), anti-RPA70 (Abcam ab79398;
1:200), anti-CENPB (Abcam ab25734; 1:600) and anti-centromere (ImmunoVision
HCT-0100; 1:800). All secondary antibodies were used in a dilution of 1:500 and
purchased from ThermoFisher Scientiﬁc, unless stated otherwise. Secondary
antibodies used: donkey anti-mouse Alexa Fluor 488 (A-21202), 555 (A-31570)
and 647 (A-31571); donkey anti-rabbit Alexa Fluor 488 (A-21206), 555 (A-31572)
and 647 (A-31573); donkey anti-goat Alexa Fluor 555 (A-21432); goat anti-rabbit
Abberior STAR 635 P (Abberior 2-0012-007-2) and goat anti-human DyLight 550
(Abcam ab96908) and 650 (Abcam ab96910). Immunoﬂuorescence staining was
performed according to previously described protocols13. In brief, the samples were
incubated with primary antibodies at 37 °C for 90 minutes and rinsed with 1 × PBS
followed by incubation of secondary antibodies in room temperature for 25
minutes. The cells were mounted using Vectasheild containing DAPI.
High-resolution deconvolution microscopy. Image acquisition was carried out
under a Zeiss AxioObserver Z1 epiﬂuorescence microscopy system with 40 × /1.3
oil Plan-Apochromat, 63 × /1.4 oil Plan-Aprochromat and 100 × /1.4 oil Plan-
Aprochromat objectives and a Hamamatsu ORCA-Flash4.0 LT camera. The system
is calibrated and aligned by using 200 nm-diameter TetraSpeck microspheres
(ThermoFisher). Z-stack images were acquired at 0.2 μm intervals covering a range
from 3–8 μm by using ZEN blue software.
Deconvolution was carried out using Huygens Professional deconvolution
software (SVI) with a measured point-spread-function generated by 200 nm-
diameter TetraSpeck microspheres. Classical maximum likelihood estimation
method with iterations of 40–60 and signal-to-noise of 20–40 was applied.
Anaphase bridges and lagging chromosomes counting. Cells were grown on
coverslips for 18 h and ﬁxed with 4% paraformaldehyde in 1X PBS at room tem-
perature for 10 min. The cells were then stained with Hoechst 33342 and slides
were mounted in Vectashield mounting medium. Anaphase cells with chromatin
bridges and lagging chromatin were scored under Zeiss Axio Observer Z1
microscope. The counting was completed by three different assessors between
experiments. The cells were counted from random microscopic ﬁelds.
Differential sister-chromatid labelling on mitotic cells. Differential labelling of
sister chromatids was performed by modifying the cell synchronisation method of
a double thymidine arrest. Brieﬂy, the cells were incubated with EdU during the
second thymidine arrest period. EdU was then maintained following the release
and washed away after 9 h of incubation. After 24–26 h, the samples were collected
for metaphase spread preparation or anaphase cell ﬁxation as mentioned before
and subjected to immunoﬂuorescence staining and microscopy analysis.
EdU was detected using Click-iT Plus EdU labelling kits (Alexa Fluor 488, 555
or 647). For EDU pulse labelling, the cells were treated with EdU (10 μM) 10–15
min prior to ﬁxation. EdU staining was performed according to the manufacturer’s
instruction.
Immunoblotting. Cells were trypsinized and lysed on ice for 20 min with lysis
buffer (50 mM Tris, pH 7.5, 300 mM Nacl, 5 mM EDTA, 1% Triton X-100, 1.25
mM DTT, 1 mM PMSF and cOmpleteTM protease inhibitor cocktail). Protein
concentration was quantiﬁed using Bradford assay (Bio-Rad). Immunoblotting (IB)
was performed following standard procedures. Primary antibodies used for IB in
this study: anti-53BP1 (Abcam, ab36823; 1:7000), anti-53BP1 (Santa Cruz, H-300;
1:800), anti-Ku80 (Abcam, ab80592; 1:10000) and anti-β-actin (Sigma, A5316;
1:5000).
Secondary antibodies used: goat anti-rabbit HRP (Amersham NA9340V;
1:25000) and goat anti-mouse HRP (Abcam ab6789; 1:10000).
MTT proliferation assay. Cell proliferation was assessed using MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). Brieﬂy, the cells were
seeded in triplicate on a 24-well plate and 50 μl of 0.5 g/L MTT was added at
indicated times. After incubation at 37 °C for 2 h, the MTT medium was aspirated
and 250 μl of DMSO was added to each well. The absorbance was measured using
CLARIOstar plate reader (BMG Labtech) at 595 nm.
Clonogenic cell survival and Micro-colony formation assay. For clonogenic cell
survival assay, HeLa, U2OS and its derived 53BP1 knockout cells or RPE1 and its
derived 53BP1 knockout cells were plated in 10‐cm tissue culture petri dishes. Five
hours later, the cells were treated with different doses of irradiation using an X-ray
machine. The treated cells were allowed to grow for 15 days to form colonies. The
colonies were ﬁxed with 70% ethanol and stained with 1 mg/ml bromophenol blue
for 2 h.
For micro-colony formation assay, ~50 single cells were seeded onto a coverslip
(24 × 24 mm) to form colonies. After 7 days, the cells were stained with CellMask™
Deep Red (ThermoFisher Scientiﬁc) and ﬁxed with PFA. The cells were mounted
in DAPI Vectasheild and captured under a 40 × objective using 3 × 3 tiling to image
the whole colony size in an area of 900 × 900 μm2.
Metaphase spread preparation. Cells were collected for metaphase spread pre-
paration after 1 h of colcemid (Gibco, 0.5 µg/ml) treatment and were swelled with
pre-warmed KCl (0.075M) hypotonic solution at 37 °C for 5 min. The cells were
washed twice and ﬁxed with 3:1 methanol:acetic acid. The cells were dropped onto
glass slides. For chromosome number frequency the metaphase spreads from
random microscopic ﬁelds were counted.
Telomere end-to-end fusion assay. For telomere fusion assay pLPC-NMYC
TRF2ΔBΔM construct (Addgene) was transiently transfected in HeLa or B2
(53BP1hypo) for 36 h using Fugene HD. Following transfection, the cells were
harvested for metaphase spread preparation and quantitation after FISH staining
(described below).
Fluorescence in situ hybridisation (FISH). Bacterial artiﬁcial chromosome (BAC)
clones were purchased from BACPAC resources centre, C.H.O.R.I. BAC DNA was
isolated using QIAGEN® Plasmid Puriﬁcation MaxiPrep kit. A volume of 1 μg of
BAC clone DNA was labelled by nick translation for 90 min at 15 °C with
digoxigenin-11-dUTP (Roche) using a nick translation kit (Roche) or ATTO
labelling kit (Jena Bioscience). Labelled probe together with cot-1 DNA (Roche)
was dehydrated. The denatured probe was re-suspended in hybridisation buffer
and placed on a metaphase slide (prepared as described earlier), which had been
dehydrated in a graded ethanol series (70%, 85% and 100%). The slide was sealed,
denatured (82.5 °C for 2 min) and incubated O/N at 37 °C. The slide was washed at
65 °C in 0.1 × SSC. DIG-labelled probe was detected with FITC-conjugated anti-
digoxigenin for 30 min at RT. Chromosomes were counterstained with DAPI
Vectasheild.
Peptide nucleic acid (PNA) ﬂuorescent in situ hybridisation. PNA probes were
hybridised according to the manufacturer’s instructions telomere-CY3 (DAKO,
Agilent technologies) or FAM488-CENPB (PNAbio). Brieﬂy, metaphase slides
were washed in TBS buffer, ﬁxed in 3.7% PFA and dehydrated in a graded ethanol
series (70%, 85% and 100%). The slides were air dried and hybridised with PNA
probe and co-denatured (80 °C for 2 min) and incubated for 2 h at room tem-
perature. Chromosomes were counterstained with DAPI Vectasheild.
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03098-y ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:677 |DOI: 10.1038/s41467-018-03098-y |www.nature.com/naturecommunications 15
Immuno-FISH. Immuno-FISH was performed after standard IF-staining proce-
dures. Brieﬂy, the cells were subjected to immunoﬂuorescence as described above
and re-ﬁxed with 8% paraformaldehyde at room temperature for 10 min. The
samples were co-denatured with 10 μl of Cy-3-labelled telomere speciﬁc PNA
probe (80 °C for 5 mins) and hybridised for 2 h at room temperature in the dark.
The cells were then washed and mounted with DAPI Vectasheild.
Flow cytometry. The cells were trypsinised, washed with PBS and ﬁxed with 70%
ice-cold ethanol. For cell cycle analysis, the cells were washed with PBS and re-
suspended in PI/RNase staining buffer. FACS proﬁle were then determined and
analysed using BD accuri C6 sampler.
Statistics. Statistical analysis was performed using GraphPad Prism software by
two-tailed unpaired Student’s t-test or two-way Anova as per the experimental
requirement. Data were presented as the mean + s.d. unless speciﬁed. Probability
value ‘p ≤ 0.05’ was considered to be signiﬁcant.
Data availability. All the data and materials supporting this work are available
upon reasonable request to the corresponding author.
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